data_1x5v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x5v _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.4 p . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 125.785 2.707 . . . . 1.54 108.893 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.617 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -52.18 128.32 34.25 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 113.221 -1.808 . . . . 0.77000000000000002 112.144 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.9 pt -110.21 176.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-O 126.288 2.947 . . . . 1.3799999999999999 110.66 -175.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -55.26 -11.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 111.821 -2.445 . . . . 1.78 113.731 -169.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -147.86 41.16 1.01 Allowed 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 125.991 2.805 . . . . 1.4399999999999999 110.314 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.468 ' HB2' HG12 ' A' ' 4' ' ' ILE . 14.3 t70 -107.21 121.49 44.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 125.681 2.658 . . . . 1.3 108.252 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 8.7 p30 -54.02 128.18 29.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 125.99 2.805 . . . . 2.8799999999999999 110.425 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -160.58 169.5 22.78 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.982 2.801 . . . . 1.3 110.218 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.24 153.96 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 125.698 2.666 . . . . 2.2200000000000002 108.863 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 83.5 t80 -73.32 76.91 1.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.303 2.954 . . . . 5.8799999999999999 110.668 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 m -127.09 79.93 72.3 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-O 126.22 2.914 . . . . 2.9500000000000002 109.86 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -65.69 -30.97 50.19 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 C-N-CA 122.901 2.4 . . . . 2.8599999999999999 112.411 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.4 40.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 126.096 2.855 . . . . 2.6000000000000001 110.984 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -134.96 55.08 1.91 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 126.2 2.905 . . . . 4.1200000000000001 108.368 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -55.46 115.87 10.39 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-O 125.796 2.712 . . . . 1.79 110.215 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 46.4 Cg_endo -86.77 -4.0 8.17 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 123.25 2.633 . . . . 1.3 112.69 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.617 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 91.5 m -86.62 167.0 14.94 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 126.51 3.052 . . . . 1.3 111.352 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.0 m -72.75 131.08 41.88 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.296 2.474 . . . . 1.3 107.822 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -54.04 108.42 0.36 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 126.532 3.063 . . . . 5.4900000000000002 110.599 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.81 -17.47 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 112.222 -2.263 . . . . 0.55000000000000004 110.815 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 19.1 mt -110.45 148.35 32.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.49 2.567 . . . . 1.8600000000000001 108.673 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -135.93 128.35 30.38 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 126.138 2.875 . . . . 3.4700000000000002 110.313 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 90.7 m -67.49 126.14 28.36 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 126.506 3.05 . . . . 1.3 111.563 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -108.51 149.03 29.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 124.649 2.166 . . . . 4.3300000000000001 106.952 168.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -55.6 90.24 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.418 3.008 . . . . 5.3200000000000003 110.465 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 139.1 -50.99 0.77 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 112.486 -2.143 . . . . 0.54000000000000004 111.141 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HE3' ' CD2' ' A' ' 30' ' ' LEU . 65.0 pttt -155.08 154.08 31.86 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.202 2.906 . . . . 2.6499999999999999 109.886 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.0 t -79.89 113.95 18.44 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 125.857 2.742 . . . . 1.3 108.923 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.424 ' CD2' ' HE3' ' A' ' 28' ' ' LYS . 81.7 mt -83.81 136.47 34.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 126.286 2.946 . . . . 1.8300000000000001 110.39 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.78 105.15 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 126.21 2.909 . . . . 2.1400000000000001 108.063 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 CA--C 1.509 -0.624 0 CA-C-O 126.357 2.98 . . . . 3.2599999999999998 110.313 -173.716 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 125.787 2.708 . . . . 1.54 109.638 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.21 152.58 52.56 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 113.709 -1.587 . . . . 0.77000000000000002 111.724 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.2 pt -109.04 168.25 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 126.582 3.087 . . . . 1.3799999999999999 111.182 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -69.13 14.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 125.214 2.435 . . . . 1.78 113.549 -169.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -160.37 39.9 0.17 Allowed 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 126.272 2.939 . . . . 1.4399999999999999 109.872 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -121.41 138.44 54.27 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.464 2.554 . . . . 1.3 108.555 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -56.05 136.11 52.41 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 126.148 2.88 . . . . 2.8799999999999999 110.043 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.445 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 17.4 t -159.26 143.86 15.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.015 2.817 . . . . 1.3 109.286 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.24 148.67 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 125.765 2.698 . . . . 2.2200000000000002 108.872 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 53.9 t80 -73.65 70.62 1.36 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 126.199 2.904 . . . . 5.8799999999999999 109.369 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -130.38 80.9 69.5 Favored Pre-proline 0 CA--C 1.516 -0.361 0 CA-C-O 126.345 2.974 . . . . 2.9500000000000002 109.475 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 -31.93 25.89 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 CA-C-O 125.559 2.233 . . . . 2.8599999999999999 112.627 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.23 68.7 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.121 2.867 . . . . 2.6000000000000001 110.525 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.33 50.33 1.4 Allowed 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 125.831 2.729 . . . . 4.1200000000000001 108.805 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 52.4 t-20 -50.88 111.81 2.52 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 125.557 2.598 . . . . 1.79 109.946 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -89.12 4.21 5.35 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.233 2.622 . . . . 1.3 112.786 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 21.3 t -90.82 161.93 15.05 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.517 2.579 . . . . 1.3 108.296 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 59.4 m -60.66 127.89 33.9 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 126.006 2.813 . . . . 1.3 109.496 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -55.42 116.08 2.66 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.325 2.964 . . . . 5.4900000000000002 110.072 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.62 7.99 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 112.651 -2.068 . . . . 0.55000000000000004 110.565 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 40.4 mt -107.87 148.69 29.24 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 125.56 2.6 . . . . 1.8600000000000001 108.505 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.423 ' OE1' ' HA ' ' A' ' 23' ' ' GLN . 5.9 tp60 -118.25 123.39 45.31 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 126.071 2.843 . . . . 3.4700000000000002 109.759 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.7 m -76.3 106.08 7.72 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 126.176 2.893 . . . . 1.3 110.665 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 27' ' ' GLY . 18.7 ttm180 -85.68 149.39 25.34 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.292 2.472 . . . . 4.3300000000000001 108.107 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 11' ' ' TYR . 53.5 t80 -56.76 89.03 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.234 2.921 . . . . 5.3200000000000003 109.602 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 141.63 -50.13 0.74 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 112.582 -2.099 . . . . 0.54000000000000004 111.071 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HA ' ' N ' ' A' ' 9' ' ' CYS . 23.5 pttm -161.88 161.21 28.79 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.926 2.774 . . . . 2.6499999999999999 109.538 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.1 t -82.78 139.69 33.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.707 2.67 . . . . 1.3 109.459 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.443 HD21 ' HE2' ' A' ' 28' ' ' LYS . 94.2 mt -128.81 167.11 17.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.039 2.828 . . . . 1.8300000000000001 109.465 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.82 134.58 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 125.92 2.771 . . . . 2.1400000000000001 110.235 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 CA--C 1.499 -1.015 0 CA-C-O 126.025 2.821 . . . . 3.2599999999999998 108.122 171.5 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.8 t . . . . . 0 CA--C 1.506 -0.742 0 CA-C-O 125.606 2.622 . . . . 1.54 108.837 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.31 119.18 11.09 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 113.68 -1.6 . . . . 0.77000000000000002 112.403 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.25 171.83 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 126.065 2.841 . . . . 1.3799999999999999 110.278 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.91 -15.9 46.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 125.209 2.433 . . . . 1.78 112.521 -164.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -131.87 52.94 2.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 126.499 3.047 . . . . 1.4399999999999999 109.84 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -129.31 133.81 47.62 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 125.92 2.771 . . . . 1.3 109.407 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.96 129.97 39.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.904 2.764 . . . . 2.8799999999999999 109.501 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -148.93 137.94 21.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 126.022 2.82 . . . . 1.3 110.427 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.07 135.64 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 125.741 2.686 . . . . 2.2200000000000002 108.94 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.21 86.37 0.06 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 126.304 2.954 . . . . 5.8799999999999999 111.334 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.79 104.11 27.27 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.97 2.795 . . . . 2.9500000000000002 108.827 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.36 -47.0 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.682 0 CA-C-O 125.666 2.278 . . . . 2.8599999999999999 113.266 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.21 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.982 2.801 . . . . 2.6000000000000001 110.425 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -108.85 42.24 1.45 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.84 2.734 . . . . 4.1200000000000001 109.425 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -60.24 111.88 4.65 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 125.949 2.785 . . . . 1.79 110.338 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -92.21 8.58 2.87 Favored 'Trans proline' 0 CA--C 1.506 -0.898 0 C-N-CA 123.466 2.778 . . . . 1.3 111.901 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 4.6 t -93.23 140.39 29.58 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.485 2.564 . . . . 1.3 109.367 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 m -60.86 125.08 22.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 125.507 2.575 . . . . 1.3 109.162 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 3.2 tpm_? -55.41 124.74 18.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 126.287 2.946 . . . . 5.4900000000000002 110.035 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.57 -34.74 4.64 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 112.775 -2.011 . . . . 0.55000000000000004 109.69 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.82 130.65 49.89 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 125.623 2.63 . . . . 1.8600000000000001 107.317 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -101.66 130.91 48.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.402 3.001 . . . . 3.4700000000000002 109.761 -176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 19.2 t -75.38 101.21 4.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 126.064 2.84 . . . . 1.3 109.081 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLY . 71.9 ttt180 -98.56 155.05 17.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.195 2.426 . . . . 4.3300000000000001 108.596 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -49.45 92.62 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.002 2.811 . . . . 5.3200000000000003 111.149 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 120.44 -35.01 3.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 113.483 -1.69 . . . . 0.54000000000000004 112.344 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -160.27 150.99 18.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.388 2.994 . . . . 2.6499999999999999 110.973 -173.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 m -80.25 130.01 34.9 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 125.849 2.738 . . . . 1.3 109.439 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -130.15 138.25 50.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 126.052 2.834 . . . . 1.8300000000000001 109.713 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.9 148.22 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 125.594 2.616 . . . . 2.1400000000000001 109.18 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 126.513 3.054 . . . . 3.2599999999999998 108.616 176.728 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 CA--C 1.505 -0.783 0 CA-C-O 125.909 2.766 . . . . 1.54 109.467 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.67 144.99 46.32 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 113.648 -1.615 . . . . 0.77000000000000002 111.032 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.428 ' HA ' HD23 ' A' ' 22' ' ' LEU . 32.4 pt -126.94 -178.57 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 126.337 2.97 . . . . 1.3799999999999999 110.564 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -55.94 -9.64 0.63 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.215 -2.266 . . . . 1.78 114.368 -166.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.797 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 30.1 p80 -147.16 34.47 0.89 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.943 2.783 . . . . 1.4399999999999999 110.462 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.8 114.55 26.96 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 125.493 2.568 . . . . 1.3 108.549 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -61.12 111.39 1.69 Allowed 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 126.109 2.861 . . . . 2.8799999999999999 108.686 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.7 t -145.12 142.58 29.78 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.012 2.815 . . . . 1.3 109.816 -163.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.67 147.21 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 125.955 2.788 . . . . 2.2200000000000002 109.033 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 67.1 t80 -72.1 79.23 0.94 Allowed 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 126.246 2.926 . . . . 5.8799999999999999 109.799 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.46 80.71 65.31 Favored Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 126.11 2.862 . . . . 2.9500000000000002 109.462 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.13 -37.2 6.29 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 CA-C-O 125.859 2.358 . . . . 2.8599999999999999 112.656 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.65 68.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 126.151 2.881 . . . . 2.6000000000000001 110.564 -175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -129.34 42.23 3.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 125.853 2.739 . . . . 4.1200000000000001 109.058 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -63.83 112.05 6.56 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-O 125.624 2.631 . . . . 1.79 110.171 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -90.97 16.32 1.62 Allowed 'Trans proline' 0 CA--C 1.508 -0.793 0 CA-C-O 126.687 2.703 . . . . 1.3 111.837 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -98.43 149.27 22.86 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.584 2.611 . . . . 1.3 108.607 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.31 153.9 25.31 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 126.411 3.005 . . . . 1.3 111.146 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -61.75 119.39 8.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 126.031 2.824 . . . . 5.4900000000000002 110.057 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.82 2.97 36.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.059 -1.882 . . . . 0.55000000000000004 111.241 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.532 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 4.9 mp -129.51 139.87 51.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 125.806 2.717 . . . . 1.8600000000000001 108.866 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 33.7 tt0 -123.22 123.76 41.49 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 125.739 2.685 . . . . 3.4700000000000002 110.422 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 23.2 m -70.82 97.49 1.4 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.891 2.758 . . . . 1.3 109.863 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 8.0 tmm_? -100.09 157.04 16.85 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.17 2.414 . . . . 4.3300000000000001 108.32 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -44.97 95.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.139 2.876 . . . . 5.3200000000000003 111.07 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 129.91 -57.08 0.73 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 112.993 -1.912 . . . . 0.54000000000000004 111.503 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.797 ' HD2' ' HA ' ' A' ' 6' ' ' HIS . 21.7 pttm -160.49 163.75 32.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 126.247 2.927 . . . . 2.6499999999999999 109.782 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 28.1 t -81.42 133.66 35.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 125.517 2.58 . . . . 1.3 108.79 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.85 150.09 43.33 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 125.991 2.805 . . . . 1.8300000000000001 110.018 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.29 92.44 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 126.087 2.851 . . . . 2.1400000000000001 110.23 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 CA--C 1.51 -0.574 0 CA-C-O 126.278 2.942 . . . . 3.2599999999999998 109.255 178.392 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.503 -0.836 0 CA-C-O 125.434 2.54 . . . . 1.54 108.072 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -56.28 123.21 30.61 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 113.674 -1.603 . . . . 0.77000000000000002 112.057 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.647 HG12 ' HB2' ' A' ' 7' ' ' ASP . 20.1 pt -90.57 173.36 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.257 2.932 . . . . 1.3799999999999999 110.011 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.86 6.24 0.72 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 125.279 2.466 . . . . 1.78 112.946 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -161.01 45.86 0.19 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 125.955 2.788 . . . . 1.4399999999999999 109.619 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.647 ' HB2' HG12 ' A' ' 4' ' ' ILE . 31.0 t70 -102.86 131.3 49.85 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.593 2.616 . . . . 1.3 109.184 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.05 133.09 51.66 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 126.104 2.859 . . . . 2.8799999999999999 110.976 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.7 p -170.58 145.05 2.48 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.944 2.783 . . . . 1.3 109.251 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.19 155.82 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 125.864 2.745 . . . . 2.2200000000000002 109.396 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.72 76.04 1.55 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 126.03 2.824 . . . . 5.8799999999999999 109.468 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.98 89.54 24.08 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 126.372 2.987 . . . . 2.9500000000000002 109.629 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.69 -39.05 77.29 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 CA-C-O 126.014 2.423 . . . . 2.8599999999999999 112.038 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -36.57 47.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 125.806 2.717 . . . . 2.6000000000000001 111.155 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -122.39 39.23 3.96 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 125.745 2.688 . . . . 4.1200000000000001 109.836 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.2 115.41 38.43 Favored Pre-proline 0 CA--C 1.508 -0.658 0 CA-C-O 125.813 2.72 . . . . 1.79 109.76 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -98.28 11.98 0.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.281 2.654 . . . . 1.3 112.655 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.5 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.6 t -91.92 149.41 21.57 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 125.771 2.701 . . . . 1.3 109.735 -174.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.465 ' HB2' HD23 ' A' ' 22' ' ' LEU . 72.5 m -59.51 143.15 50.87 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 125.943 2.782 . . . . 1.3 109.609 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.68 131.61 51.27 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.263 2.935 . . . . 5.4900000000000002 110.583 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.28 -22.5 36.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 112.94 -1.936 . . . . 0.55000000000000004 111.243 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.465 HD23 ' HB2' ' A' ' 19' ' ' CYS . 5.1 mp -97.7 135.2 39.83 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 125.645 2.64 . . . . 1.8600000000000001 108.404 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -114.91 132.8 56.42 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 125.867 2.746 . . . . 3.4700000000000002 110.116 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 m -85.04 114.78 22.45 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 126.109 2.861 . . . . 1.3 110.617 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 16.4 mmt180 -87.84 159.21 18.5 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 124.558 2.123 . . . . 4.3300000000000001 106.192 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.22 78.46 0.24 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 126.218 2.913 . . . . 5.3200000000000003 109.972 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 146.07 -33.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.974 -1.921 . . . . 0.54000000000000004 111.754 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.83 143.33 15.73 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 126.012 2.815 . . . . 2.6499999999999999 110.107 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 29.3 t -87.73 141.69 28.4 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.444 2.545 . . . . 1.3 108.28 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.59 138.73 38.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.583 2.611 . . . . 1.8300000000000001 108.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.56 113.05 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 126.215 2.912 . . . . 2.1400000000000001 109.918 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? . . . . . 0 CA--C 1.505 -0.786 0 CA-C-O 126.079 2.847 . . . . 3.2599999999999998 108.447 178.757 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 28.3 p . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 125.989 2.804 . . . . 1.54 109.463 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.94 150.93 51.97 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 113.203 -1.817 . . . . 0.77000000000000002 112.399 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.47 ' C ' ' H ' ' A' ' 6' ' ' HIS . 10.1 pt -92.86 167.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 126.137 2.875 . . . . 1.3799999999999999 110.455 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -68.47 18.92 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 125.45 2.548 . . . . 1.78 112.886 -172.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.47 ' H ' ' C ' ' A' ' 4' ' ' ILE . 14.8 p80 -161.58 41.91 0.15 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.168 2.89 . . . . 1.4399999999999999 109.714 173.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -116.29 152.96 32.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 125.552 2.596 . . . . 1.3 108.268 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 133.13 37.55 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.089 2.852 . . . . 2.8799999999999999 111.093 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 12.2 p 177.18 124.62 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 125.888 2.756 . . . . 1.3 108.559 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 12' ' ' VAL . 27.1 m -79.57 -159.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 125.558 2.599 . . . . 2.2200000000000002 110.695 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -70.27 75.05 0.52 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 126.707 3.146 . . . . 5.8799999999999999 110.582 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' VAL . 11.8 m -127.97 81.6 70.04 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.991 2.805 . . . . 2.9500000000000002 109.942 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 3.4 Cg_exo -75.94 -54.86 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.787 0 CA-C-O 125.881 2.367 . . . . 2.8599999999999999 111.913 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.72 77.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 126.212 2.91 . . . . 2.6000000000000001 110.077 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -108.68 39.1 2.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 125.65 2.643 . . . . 4.1200000000000001 109.723 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 54.9 t-20 -64.4 113.03 9.04 Favored Pre-proline 0 CA--C 1.512 -0.502 0 CA-C-O 125.803 2.716 . . . . 1.79 110.156 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 72.3 Cg_endo -91.1 -2.25 4.77 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 123.083 2.522 . . . . 1.3 112.37 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.1 t -87.18 161.37 18.1 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 125.796 2.712 . . . . 1.3 109.214 -175.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 84.4 m -63.77 135.24 56.5 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 126.181 2.896 . . . . 1.3 110.174 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.43 116.3 3.55 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.378 2.99 . . . . 5.4900000000000002 109.55 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 123.64 -14.9 8.07 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 112.818 -1.992 . . . . 0.55000000000000004 110.655 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.8 mt -119.16 158.79 25.25 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 125.563 2.602 . . . . 1.8600000000000001 108.86 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 28.2 mm-40 -131.89 134.57 45.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.817 2.722 . . . . 3.4700000000000002 110.051 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 87.3 m -83.03 120.11 25.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 126.147 2.88 . . . . 1.3 110.05 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 19.1 ttt180 -110.79 164.22 12.98 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.087 2.375 . . . . 4.3300000000000001 108.337 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -45.62 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.319 2.961 . . . . 5.3200000000000003 110.909 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.58 -54.66 0.73 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.441 -2.163 . . . . 0.54000000000000004 112.043 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -160.39 166.68 28.89 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 126.554 3.073 . . . . 2.6499999999999999 110.752 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 50.9 t -86.84 141.55 28.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 125.804 2.716 . . . . 1.3 109.778 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.67 174.25 10.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.661 2.648 . . . . 1.8300000000000001 108.792 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.42 136.74 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 125.554 2.597 . . . . 2.1400000000000001 109.266 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.559 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 6.7 pt20 . . . . . 0 CA--C 1.505 -0.771 0 CA-C-O 126.216 2.912 . . . . 3.2599999999999998 109.574 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 126.294 2.949 . . . . 1.54 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.415 ' HA2' ' OD2' ' A' ' 7' ' ' ASP . . . -72.71 123.81 9.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 113.213 -1.812 . . . . 0.77000000000000002 110.971 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.677 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 26.1 pt -90.01 177.23 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 125.848 2.737 . . . . 1.3799999999999999 110.307 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.8 12.0 0.58 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 125.731 2.682 . . . . 1.78 112.067 -168.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -160.26 43.32 0.2 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 126.47 3.033 . . . . 1.4399999999999999 108.59 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.634 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 47.0 t0 -114.4 138.12 50.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 125.686 2.66 . . . . 1.3 108.721 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.9 m-20 -67.96 130.65 43.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.856 2.741 . . . . 2.8799999999999999 110.389 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.2 p -153.1 145.48 24.03 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 126.206 2.907 . . . . 1.3 110.583 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.2 p -88.77 137.88 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 125.09 2.376 . . . . 2.2200000000000002 107.739 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 26' ' ' TYR . 8.0 p90 -70.45 79.69 0.56 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 126.81 3.195 . . . . 5.8799999999999999 110.878 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 10' ' ' VAL . 17.6 m -126.84 106.52 22.68 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 125.988 2.804 . . . . 2.9500000000000002 109.443 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.75 -38.25 4.43 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 CA-C-O 125.692 2.288 . . . . 2.8599999999999999 112.311 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.99 -52.02 21.48 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 125.88 2.752 . . . . 2.6000000000000001 110.727 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.17 61.52 0.9 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 126.031 2.824 . . . . 4.1200000000000001 107.807 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 17.4 t-20 -54.49 117.87 14.78 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 125.736 2.684 . . . . 1.79 110.662 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.68 -14.35 11.43 Favored 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 123.379 2.719 . . . . 1.3 112.777 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 55.7 m -79.42 146.18 32.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 126.013 2.816 . . . . 1.3 109.445 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.59 144.73 56.24 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.754 2.693 . . . . 1.3 108.586 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.446 ' C ' ' HD3' ' A' ' 20' ' ' ARG . 2.6 tmt_? -57.16 109.99 0.76 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 126.353 2.978 . . . . 5.4900000000000002 109.946 -172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.88 -11.86 7.35 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 112.654 -2.067 . . . . 0.55000000000000004 111.424 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.38 146.44 38.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.994 2.807 . . . . 1.8600000000000001 109.747 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 52.3 tt0 -106.19 137.11 44.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.421 2.534 . . . . 3.4700000000000002 109.173 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.659 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 52.2 t -92.47 109.94 21.35 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.448 3.023 . . . . 1.3 109.944 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' GLY . 35.1 mmt180 -96.83 137.07 36.48 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 124.727 2.204 . . . . 4.3300000000000001 106.917 170.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.536 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 35.0 p90 -50.32 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 126.659 3.123 . . . . 5.3200000000000003 110.541 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 134.65 -46.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 112.384 -2.189 . . . . 0.54000000000000004 111.836 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 22.0 pttm -160.08 154.16 23.24 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 126.539 3.066 . . . . 2.6499999999999999 111.036 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.677 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 84.6 m -79.75 138.87 37.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 125.798 2.713 . . . . 1.3 109.183 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.44 162.33 29.41 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.726 2.679 . . . . 1.8300000000000001 109.012 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.3 m -69.17 112.13 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 126.231 2.919 . . . . 2.1400000000000001 110.3 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 62.2 tt0 . . . . . 0 CA--C 1.507 -0.695 0 CA-C-O 126.367 2.984 . . . . 3.2599999999999998 109.374 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 CA--C 1.508 -0.636 0 CA-C-O 126.135 2.874 . . . . 1.54 109.655 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.92 126.41 36.76 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 113.116 -1.857 . . . . 0.77000000000000002 112.666 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.9 pt -108.29 176.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 126.257 2.932 . . . . 1.3799999999999999 110.069 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -64.89 3.62 0.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.844 2.259 . . . . 1.78 113.451 -169.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -152.56 36.1 0.51 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 126.16 2.886 . . . . 1.4399999999999999 109.711 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.451 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.7 t70 -111.31 137.69 48.73 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.657 2.646 . . . . 1.3 109.137 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.79 131.73 50.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.566 2.603 . . . . 2.8799999999999999 109.561 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -156.35 143.35 18.87 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 126.281 2.943 . . . . 1.3 110.717 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 12' ' ' VAL . 23.7 m -103.82 146.04 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-O 125.494 2.568 . . . . 2.2200000000000002 108.455 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.487 ' HD2' ' H ' ' A' ' 26' ' ' TYR . 3.2 t80 -70.24 86.32 0.58 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 126.176 2.893 . . . . 5.8799999999999999 110.175 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 10' ' ' VAL . 5.6 p -132.96 84.39 49.29 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-O 126.286 2.946 . . . . 2.9500000000000002 109.268 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.3 -43.66 17.56 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-O 125.808 2.337 . . . . 2.8599999999999999 112.833 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.34 -39.15 63.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 126.176 2.893 . . . . 2.6000000000000001 110.893 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -127.63 48.55 2.23 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.998 2.808 . . . . 4.1200000000000001 109.146 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -50.69 112.44 2.89 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-O 125.96 2.791 . . . . 1.79 110.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.85 -6.77 17.07 Favored 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 123.239 2.626 . . . . 1.3 112.398 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.9 m -78.75 154.31 30.11 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.292 2.949 . . . . 1.3 110.599 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.5 m -62.86 136.92 58.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 125.306 2.479 . . . . 1.3 107.964 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -55.97 107.7 0.38 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 126.302 2.953 . . . . 5.4900000000000002 110.426 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.34 -23.3 4.88 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 112.7 -2.046 . . . . 0.55000000000000004 111.3 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.557 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.8 mm? -94.62 134.21 37.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.948 2.785 . . . . 1.8600000000000001 109.255 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -105.63 118.07 35.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 126.265 2.936 . . . . 3.4700000000000002 109.203 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 36.6 t -79.59 132.42 36.26 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.963 2.792 . . . . 1.3 110.487 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.446 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 15.6 ttm180 -122.95 143.25 50.03 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 125.328 2.489 . . . . 4.3300000000000001 108.083 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.487 ' H ' ' HD2' ' A' ' 11' ' ' TYR . 9.6 p90 -50.1 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 126.501 3.048 . . . . 5.3200000000000003 110.726 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.5 -56.84 0.72 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 112.468 -2.151 . . . . 0.54000000000000004 110.916 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -156.81 161.42 39.74 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 126.619 3.104 . . . . 2.6499999999999999 109.733 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 11.9 t -88.42 138.02 31.8 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 125.53 2.586 . . . . 1.3 109.352 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.4 mt -124.66 167.54 14.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 126.015 2.817 . . . . 1.8300000000000001 109.633 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.97 136.3 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 CA-C-O 125.382 2.515 . . . . 2.1400000000000001 108.805 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.701 3.143 . . . . 3.2599999999999998 109.112 176.258 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.6 p . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 125.991 2.805 . . . . 1.54 109.849 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.457 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.65 136.89 44.39 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 113.302 -1.772 . . . . 0.77000000000000002 112.077 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.41 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 22.7 pt -100.67 169.03 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 126.684 3.135 . . . . 1.3799999999999999 111.233 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.09 -6.93 0.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 111.627 -2.533 . . . . 1.78 113.391 -171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -147.89 51.96 1.04 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.583 3.087 . . . . 1.4399999999999999 109.31 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.41 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 5.6 t0 -112.9 122.6 48.13 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 125.473 2.558 . . . . 1.3 108.559 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.94 123.04 15.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 125.582 2.61 . . . . 2.8799999999999999 109.661 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 t -161.92 152.79 17.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.068 2.842 . . . . 1.3 110.256 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 24' ' ' CYS . 30.8 m -97.8 171.89 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 125.963 2.792 . . . . 2.2200000000000002 109.582 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -81.8 73.98 8.81 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 126.178 2.894 . . . . 5.8799999999999999 110.168 -173.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.9 87.73 50.59 Favored Pre-proline 0 CA--C 1.514 -0.435 0 CA-C-O 126.264 2.935 . . . . 2.9500000000000002 110.588 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.22 -35.21 5.3 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.981 2.454 . . . . 2.8599999999999999 112.284 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.05 -28.69 25.95 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.056 2.836 . . . . 2.6000000000000001 111.152 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.403 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 46.8 tp60 -141.73 57.52 1.5 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 125.861 2.744 . . . . 4.1200000000000001 108.34 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.4 107.67 1.21 Allowed Pre-proline 0 CA--C 1.509 -0.622 0 CA-C-O 125.656 2.646 . . . . 1.79 109.161 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 79.3 Cg_endo -78.92 -8.76 15.62 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 C-N-CA 123.189 2.593 . . . . 1.3 112.469 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 87.0 m -77.49 150.36 34.9 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 126.232 2.92 . . . . 1.3 110.676 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.448 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 4.5 m -58.08 135.48 57.01 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.154 2.407 . . . . 1.3 107.947 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -57.78 113.28 1.78 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 126.509 3.052 . . . . 5.4900000000000002 110.343 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 126.68 -18.11 6.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 112.123 -2.308 . . . . 0.55000000000000004 110.331 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 33.9 mt -119.07 148.68 42.77 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 125.428 2.537 . . . . 1.8600000000000001 108.098 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -139.66 136.13 33.95 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 126.004 2.811 . . . . 3.4700000000000002 109.914 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 68.0 m -67.19 129.83 41.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.156 2.884 . . . . 1.3 110.492 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLY . 42.9 mtp180 -128.35 133.97 48.77 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 124.993 2.33 . . . . 4.3300000000000001 107.625 170.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -37.88 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 126.743 3.163 . . . . 5.3200000000000003 112.302 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 137.66 -58.5 0.63 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 112.226 -2.261 . . . . 0.54000000000000004 110.759 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 154.9 36.07 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.65 3.119 . . . . 2.6499999999999999 109.963 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.0 t -79.81 130.13 35.06 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 125.568 2.604 . . . . 1.3 108.545 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.34 160.94 29.86 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 125.912 2.768 . . . . 1.8300000000000001 109.556 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 t -71.78 109.99 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 125.52 2.581 . . . . 2.1400000000000001 107.199 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 18.0 pt20 . . . . . 0 CA--C 1.504 -0.795 0 CA-C-O 125.796 2.713 . . . . 3.2599999999999998 111.566 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 17.7 p . . . . . 0 CA--C 1.503 -0.837 0 CA-C-O 126.065 2.841 . . . . 1.54 109.915 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.524 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.69 128.54 15.17 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 113.271 -1.786 . . . . 0.77000000000000002 110.931 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.0 pt -98.34 177.95 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 126.079 2.847 . . . . 1.3799999999999999 110.183 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -57.12 -7.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.291 -2.231 . . . . 1.78 114.041 -167.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.45 48.5 0.36 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.184 2.897 . . . . 1.4399999999999999 109.788 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HB2' HG12 ' A' ' 4' ' ' ILE . 22.3 t70 -101.41 123.64 45.81 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.745 2.688 . . . . 1.3 109.655 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -64.63 123.17 18.61 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.132 2.872 . . . . 2.8799999999999999 110.502 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.4 p -157.97 174.25 15.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.73 2.681 . . . . 1.3 109.849 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.24 149.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 126.005 2.812 . . . . 2.2200000000000002 109.773 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.685 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 40.7 t80 -77.78 76.3 4.31 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 126.276 2.941 . . . . 5.8799999999999999 110.405 -170.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.49 85.92 48.44 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-O 125.607 2.623 . . . . 2.9500000000000002 109.271 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.72 -38.04 52.44 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.655 2.236 . . . . 2.8599999999999999 112.925 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.32 -23.15 63.99 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 126.184 2.897 . . . . 2.6000000000000001 110.518 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -135.29 47.69 2.3 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 125.917 2.77 . . . . 4.1200000000000001 109.079 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -58.02 113.58 6.78 Favored Pre-proline 0 CA--C 1.51 -0.595 0 CA-C-O 125.756 2.693 . . . . 1.79 109.406 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 64.2 Cg_endo -79.89 -6.84 14.32 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 123.241 2.627 . . . . 1.3 112.626 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 74.4 m -78.24 155.54 30.22 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 126.174 2.892 . . . . 1.3 110.852 -171.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.438 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -62.8 150.32 41.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 125.683 2.659 . . . . 1.3 109.092 174.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -59.87 103.24 0.2 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 126.238 2.923 . . . . 5.4900000000000002 110.371 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.04 -5.31 8.34 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 112.752 -2.022 . . . . 0.55000000000000004 111.973 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 75.8 mt -114.36 137.44 51.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 125.879 2.752 . . . . 1.8600000000000001 109.152 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -116.94 119.4 35.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 126.022 2.82 . . . . 3.4700000000000002 109.76 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.8 t -73.68 129.59 38.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 126.011 2.815 . . . . 1.3 109.912 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.685 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 36.6 ttm180 -111.97 154.08 25.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 125.154 2.407 . . . . 4.3300000000000001 108.321 174.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -52.51 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 126.452 3.025 . . . . 5.3200000000000003 109.697 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.4 -54.4 0.79 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 112.531 -2.122 . . . . 0.54000000000000004 110.912 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -161.43 159.43 28.14 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.461 3.029 . . . . 2.6499999999999999 110.344 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 22.8 t -81.47 145.7 30.61 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.4 2.524 . . . . 1.3 109.207 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 168.74 18.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 125.999 2.809 . . . . 1.8300000000000001 110.076 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.14 155.78 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-O 125.911 2.767 . . . . 2.1400000000000001 110.053 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 126.144 2.878 . . . . 3.2599999999999998 110.674 179.511 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.505 -0.762 0 CA-C-O 125.934 2.778 . . . . 1.54 108.395 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.826 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.5 119.81 19.91 Favored Glycine 0 C--O 1.236 0.257 0 CA-C-N 113.333 -1.758 . . . . 0.77000000000000002 112.333 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 6' ' ' HIS . 13.0 pt -102.16 164.73 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 126.179 2.895 . . . . 1.3799999999999999 110.236 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -66.77 12.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 125.293 2.473 . . . . 1.78 113.072 -171.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 4' ' ' ILE . 12.4 p80 -154.88 42.16 0.46 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.197 2.903 . . . . 1.4399999999999999 109.627 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.404 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 34.5 t70 -112.69 125.12 53.96 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 125.967 2.794 . . . . 1.3 109.12 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -76.1 122.48 24.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 126.163 2.887 . . . . 2.8799999999999999 109.764 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.6 p -149.04 171.61 16.11 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.774 2.702 . . . . 1.3 109.73 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.89 146.9 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 126.218 2.913 . . . . 2.2200000000000002 109.777 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.433 ' H ' ' HD1' ' A' ' 11' ' ' TYR . 2.5 p90 -71.63 71.58 0.72 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.503 3.049 . . . . 5.8799999999999999 110.741 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.31 94.07 31.19 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-O 125.834 2.73 . . . . 2.9500000000000002 109.261 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.93 -29.88 82.8 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.957 2.438 . . . . 2.8599999999999999 112.924 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.89 -38.93 17.45 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 125.996 2.807 . . . . 2.6000000000000001 110.533 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -132.4 65.7 1.57 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.941 2.781 . . . . 4.1200000000000001 108.498 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -61.47 109.76 2.48 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-O 125.625 2.631 . . . . 1.79 109.377 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 3' ' ' GLY . 70.6 Cg_endo -82.25 -10.04 11.35 Favored 'Trans proline' 0 CA--C 1.498 -1.283 0 CA-C-O 126.241 2.517 . . . . 1.3 112.204 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.826 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 94.4 m -79.69 154.07 28.87 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 126.0 2.809 . . . . 1.3 110.165 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.3 m -65.07 110.01 2.35 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 125.273 2.464 . . . . 1.3 106.308 167.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -51.12 118.6 3.33 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 127.054 3.312 . . . . 5.4900000000000002 109.935 -173.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -26.37 3.62 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 111.314 -2.676 . . . . 0.55000000000000004 109.356 -165.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 7.2 mp -105.02 152.53 22.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 125.613 2.625 . . . . 1.8600000000000001 108.714 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -121.49 135.26 55.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.195 2.902 . . . . 3.4700000000000002 110.566 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' A' ' 18' ' ' CYS . 3.0 m -77.3 97.44 4.87 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 125.962 2.791 . . . . 1.3 109.696 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HD2' HD11 ' A' ' 30' ' ' LEU . 87.8 mtt180 -86.23 157.39 19.96 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 124.922 2.296 . . . . 4.3300000000000001 107.241 172.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -49.6 94.3 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 126.378 2.99 . . . . 5.3200000000000003 110.522 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.19 -47.34 1.05 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 112.688 -2.051 . . . . 0.54000000000000004 112.492 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -130.95 138.68 49.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.582 3.087 . . . . 2.6499999999999999 111.564 -168.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.8 t -79.67 105.48 10.99 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 125.803 2.716 . . . . 1.3 107.852 170.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 25' ' ' ARG . 94.2 mt -120.6 142.43 49.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 126.016 2.817 . . . . 1.8300000000000001 109.488 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.595 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 34.5 t -59.15 128.84 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 CA-C-O 125.753 2.692 . . . . 2.1400000000000001 109.75 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 126.318 2.961 . . . . 3.2599999999999998 109.205 179.73 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t . . . . . 0 CA--C 1.505 -0.75 0 CA-C-O 125.861 2.743 . . . . 1.54 109.524 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -66.01 109.4 2.87 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 113.391 -1.731 . . . . 0.77000000000000002 111.666 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.8 pt -91.71 -178.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 125.452 2.549 . . . . 1.3799999999999999 110.536 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -37.05 -38.38 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 124.368 2.032 . . . . 1.78 114.617 -166.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -141.94 29.72 1.67 Allowed 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 125.477 2.561 . . . . 1.4399999999999999 111.284 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.79 132.67 44.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 125.675 2.655 . . . . 1.3 109.049 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -75.31 123.71 25.82 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.022 2.82 . . . . 2.8799999999999999 110.254 -173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 p -161.47 178.16 9.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 126.002 2.81 . . . . 1.3 110.44 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.66 143.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 125.954 2.788 . . . . 2.2200000000000002 109.666 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -69.61 82.46 0.42 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.968 2.794 . . . . 5.8799999999999999 110.134 -177.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.97 91.85 46.05 Favored Pre-proline 0 CA--C 1.513 -0.475 0 CA-C-O 126.133 2.873 . . . . 2.9500000000000002 108.84 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.527 ' HD3' ' HD1' ' A' ' 11' ' ' TYR . 37.0 Cg_endo -65.98 -47.65 3.45 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 122.791 2.327 . . . . 2.8599999999999999 113.4 -173.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.17 62.49 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 125.831 2.729 . . . . 2.6000000000000001 111.241 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -128.65 42.78 3.26 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.008 2.813 . . . . 4.1200000000000001 109.352 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -59.33 113.34 6.75 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.635 2.636 . . . . 1.79 110.471 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.13 -3.95 11.07 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.047 2.498 . . . . 1.3 112.214 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 4.8 t -79.63 144.99 33.28 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.531 2.586 . . . . 1.3 108.647 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -59.42 143.52 49.53 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.12 2.867 . . . . 1.3 110.177 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -62.73 118.46 7.71 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 126.159 2.885 . . . . 5.4900000000000002 109.526 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 111.25 -3.23 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.039 -1.891 . . . . 0.55000000000000004 111.129 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.9 mt -127.95 133.81 49.26 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.756 2.693 . . . . 1.8600000000000001 108.328 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.492 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 16.3 mm100 -110.98 120.86 43.79 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 126.148 2.88 . . . . 3.4700000000000002 109.56 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 38.1 t -79.93 120.46 24.17 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 125.859 2.742 . . . . 1.3 109.65 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.675 HH11 ' HB2' ' A' ' 30' ' ' LEU . 6.1 mpt_? -101.95 164.27 11.8 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 125.176 2.417 . . . . 4.3300000000000001 108.595 175.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -58.95 85.83 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.428 3.013 . . . . 5.3200000000000003 110.867 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 144.66 -51.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.731 -2.031 . . . . 0.54000000000000004 110.894 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -163.19 174.24 12.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.351 2.977 . . . . 2.6499999999999999 110.272 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.5 m -77.98 145.21 36.14 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.117 2.865 . . . . 1.3 110.049 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.675 ' HB2' HH11 ' A' ' 25' ' ' ARG . 87.4 mt -126.45 145.12 50.61 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.917 2.77 . . . . 1.8300000000000001 108.426 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.3 m -80.38 119.73 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 126.399 2.999 . . . . 2.1400000000000001 111.195 -172.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 16.2 mm100 . . . . . 0 CA--C 1.497 -1.096 0 CA-C-O 126.461 3.029 . . . . 3.2599999999999998 109.099 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.3 p . . . . . 0 CA--C 1.504 -0.819 0 CA-C-O 125.768 2.699 . . . . 1.54 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.485 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.31 139.11 39.38 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 113.564 -1.653 . . . . 0.77000000000000002 110.697 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 8.5 pt -111.06 -175.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 125.671 2.653 . . . . 1.3799999999999999 111.357 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -41.58 -35.24 0.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 124.443 2.068 . . . . 1.78 114.375 -165.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -145.07 38.6 1.18 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 125.722 2.677 . . . . 1.4399999999999999 110.847 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 20.0 t70 -88.03 142.16 28.0 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 125.747 2.689 . . . . 1.3 108.697 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 4.6 p-10 -71.33 138.45 49.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 125.718 2.675 . . . . 2.8799999999999999 110.21 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 p -168.61 175.26 6.25 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 126.211 2.91 . . . . 1.3 109.849 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' O ' HG21 ' A' ' 12' ' ' VAL . 47.8 t -111.19 144.42 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 125.276 2.465 . . . . 2.2200000000000002 108.334 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -66.34 80.84 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 126.596 3.093 . . . . 5.8799999999999999 110.189 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 10' ' ' VAL . 18.2 m -128.13 79.58 73.66 Favored Pre-proline 0 CA--C 1.511 -0.552 0 CA-C-O 125.8 2.714 . . . . 2.9500000000000002 109.266 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 18.8 Cg_endo -58.59 -44.85 33.67 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 CA-C-O 125.996 2.415 . . . . 2.8599999999999999 112.286 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.61 -24.48 67.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 126.114 2.864 . . . . 2.6000000000000001 110.495 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.421 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 17.3 mm-40 -118.28 31.55 6.62 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 125.652 2.644 . . . . 4.1200000000000001 109.537 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 46.1 t-20 -52.67 110.14 1.8 Allowed Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-O 125.694 2.664 . . . . 1.79 110.913 -175.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -95.08 7.47 2.07 Favored 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 123.599 2.866 . . . . 1.3 111.575 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.485 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 5.1 t -102.8 157.6 16.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 125.269 2.462 . . . . 1.3 108.191 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.71 138.84 58.63 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.557 3.075 . . . . 1.3 109.842 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -65.38 105.81 1.24 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 126.331 2.967 . . . . 5.4900000000000002 109.837 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.492 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 133.85 -9.74 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 112.613 -2.085 . . . . 0.55000000000000004 110.936 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -115.98 130.75 56.95 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.263 2.935 . . . . 1.8600000000000001 109.46 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -81.99 95.65 7.47 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.83 2.729 . . . . 3.4700000000000002 109.818 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 40.3 t -68.1 99.63 0.91 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 126.405 3.002 . . . . 1.3 108.746 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -113.37 167.59 10.44 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.292 2.473 . . . . 4.3300000000000001 108.928 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -51.1 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.088 2.851 . . . . 5.3200000000000003 111.134 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 113.1 -40.24 2.59 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 113.225 -1.807 . . . . 0.54000000000000004 112.498 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -161.21 161.26 30.82 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.585 3.088 . . . . 2.6499999999999999 110.932 -172.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 65.0 m -78.78 139.21 38.44 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 125.693 2.663 . . . . 1.3 108.694 170.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.78 114.11 19.46 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 126.145 2.879 . . . . 1.8300000000000001 109.382 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.31 131.55 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 125.626 2.631 . . . . 2.1400000000000001 108.761 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 12.7 pt20 . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 126.589 3.09 . . . . 3.2599999999999998 109.954 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.702 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 30.7 p . . . . . 0 CA--C 1.506 -0.723 0 CA-C-O 125.845 2.736 . . . . 1.54 109.405 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -53.87 143.94 27.93 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 113.017 -1.901 . . . . 0.77000000000000002 113.107 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 7' ' ' ASP . 40.3 pt -79.32 169.07 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 126.648 3.118 . . . . 1.3799999999999999 111.169 -176.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.79 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 2.1 pt? -57.44 -6.62 0.47 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 111.796 -2.456 . . . . 1.78 113.54 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 29.5 p80 -154.88 43.36 0.48 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 125.667 2.651 . . . . 1.4399999999999999 110.722 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.1 t70 -87.56 148.24 24.96 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.79 2.71 . . . . 1.3 109.109 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.0 117.74 18.88 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 125.789 2.709 . . . . 2.8799999999999999 109.488 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 6.7 p -156.01 152.21 27.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 126.216 2.912 . . . . 1.3 109.864 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -81.0 152.53 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-O 125.992 2.806 . . . . 2.2200000000000002 109.211 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -73.25 66.8 0.92 Allowed 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 126.247 2.927 . . . . 5.8799999999999999 111.197 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.24 88.23 45.32 Favored Pre-proline 0 CA--C 1.512 -0.503 0 CA-C-O 126.262 2.934 . . . . 2.9500000000000002 109.064 174.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.7 -39.06 12.49 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 CA-C-O 125.682 2.284 . . . . 2.8599999999999999 112.628 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.36 62.28 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 126.013 2.816 . . . . 2.6000000000000001 111.226 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 15' ' ' GLN . 51.6 tp60 -139.54 47.4 1.87 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 126.326 2.965 . . . . 4.1200000000000001 108.432 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -64.26 116.32 26.93 Favored Pre-proline 0 CA--C 1.512 -0.509 0 CA-C-O 125.986 2.803 . . . . 1.79 110.192 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.08 -10.53 17.92 Favored 'Trans proline' 0 CA--C 1.503 -1.049 0 CA-C-O 126.16 2.483 . . . . 1.3 111.994 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 7.5 t -79.01 158.85 27.85 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 125.707 2.67 . . . . 1.3 108.6 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.702 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -68.67 148.44 50.42 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 126.308 2.956 . . . . 1.3 109.877 -176.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.53 126.41 27.76 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 126.049 2.833 . . . . 5.4900000000000002 109.899 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.22 -10.14 46.84 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 112.934 -1.939 . . . . 0.55000000000000004 110.766 -171.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 13.0 mt -119.15 135.95 54.42 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.49 2.566 . . . . 1.8600000000000001 107.573 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.43 122.83 39.91 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.249 2.928 . . . . 3.4700000000000002 110.429 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 56.2 m -69.31 111.59 5.32 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 126.072 2.844 . . . . 1.3 110.69 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 59.5 ttt180 -92.74 155.3 17.77 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 124.721 2.2 . . . . 4.3300000000000001 106.641 171.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -47.62 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 126.534 3.064 . . . . 5.3200000000000003 111.622 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 119.1 -48.21 0.96 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 112.573 -2.103 . . . . 0.54000000000000004 112.172 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -138.29 141.51 39.83 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 126.201 2.905 . . . . 2.6499999999999999 110.027 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.7 t -79.02 138.76 38.17 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 125.834 2.731 . . . . 1.3 108.449 174.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.12 137.52 51.93 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 126.308 2.956 . . . . 1.8300000000000001 109.971 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.79 ' HB ' ' HB2' ' A' ' 5' ' ' LEU . 6.2 p -73.07 99.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 126.332 2.968 . . . . 2.1400000000000001 109.223 175.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 5.8 tp60 . . . . . 0 CA--C 1.501 -0.926 0 CA-C-O 126.384 2.993 . . . . 3.2599999999999998 109.026 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 CA--C 1.503 -0.828 0 CA-C-O 125.364 2.506 . . . . 1.54 107.721 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.626 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -83.34 111.16 3.37 Favored Glycine 0 N--CA 1.444 -0.804 0 O-C-N 120.19 -1.569 . . . . 0.77000000000000002 110.767 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.501 ' HA ' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -117.87 -179.82 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.939 2.78 . . . . 1.3799999999999999 110.029 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -56.42 -4.6 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.168 -2.287 . . . . 1.78 114.238 -166.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.15 37.75 0.63 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 125.861 2.744 . . . . 1.4399999999999999 110.507 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.99 107.63 19.93 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 125.515 2.579 . . . . 1.3 108.877 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -58.46 117.24 4.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 126.441 3.02 . . . . 2.8799999999999999 109.666 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.4 t -161.31 141.43 10.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 125.828 2.728 . . . . 1.3 108.815 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.512 HG22 HG13 ' A' ' 12' ' ' VAL . 17.1 m -93.6 -178.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 126.111 2.863 . . . . 2.2200000000000002 110.274 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.417 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 6.9 p90 -68.39 76.68 0.26 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 126.341 2.972 . . . . 5.8799999999999999 110.837 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 HG22 ' A' ' 10' ' ' VAL . 18.7 m -123.03 74.15 48.06 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-O 125.975 2.798 . . . . 2.9500000000000002 110.374 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 4.1 Cg_exo -74.68 -40.24 1.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 CA-C-O 125.944 2.393 . . . . 2.8599999999999999 111.856 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -16.75 60.17 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 126.033 2.825 . . . . 2.6000000000000001 110.837 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.07 36.18 3.67 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.117 2.389 . . . . 4.1200000000000001 109.449 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -49.95 104.66 0.44 Allowed Pre-proline 0 N--CA 1.473 0.717 0 CA-C-O 125.887 2.756 . . . . 1.79 111.078 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -85.35 -4.73 9.39 Favored 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 123.438 2.759 . . . . 1.3 111.883 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.626 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 79.4 m -78.57 146.58 34.15 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 125.882 2.753 . . . . 1.3 110.418 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m -62.32 134.17 56.12 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 125.922 2.772 . . . . 1.3 107.515 172.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -54.69 115.33 2.1 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 126.707 3.146 . . . . 5.4900000000000002 111.901 -163.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.35 -23.53 4.84 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 111.999 -2.364 . . . . 0.55000000000000004 111.267 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 6.3 mp -102.8 150.35 23.58 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 125.869 2.747 . . . . 1.8600000000000001 109.523 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -138.29 139.35 39.1 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 126.132 2.873 . . . . 3.4700000000000002 109.682 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.8 m -67.92 112.43 4.94 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 126.055 2.836 . . . . 1.3 110.338 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 27' ' ' GLY . 56.7 ttt180 -91.67 159.55 15.81 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 124.58 2.133 . . . . 4.3300000000000001 107.409 170.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -52.03 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 126.254 2.93 . . . . 5.3200000000000003 111.312 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 140.94 -50.24 0.75 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 113.092 -1.867 . . . . 0.54000000000000004 111.494 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 164.21 32.68 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 126.441 3.02 . . . . 2.6499999999999999 110.105 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 45.5 t -78.89 132.51 36.81 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 125.694 2.664 . . . . 1.3 108.878 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.07 155.85 44.78 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 126.051 2.834 . . . . 1.8300000000000001 109.634 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 38.7 t -73.34 106.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.78 2.705 . . . . 2.1400000000000001 108.445 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 125.708 2.67 . . . . 3.2599999999999998 109.855 -176.136 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.503 -0.829 0 CA-C-O 125.996 2.808 . . . . 1.54 109.51 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.57 124.02 26.09 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 113.491 -1.686 . . . . 0.77000000000000002 110.574 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 24.9 pt -117.6 168.23 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 126.039 2.828 . . . . 1.3799999999999999 110.128 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.93 2.85 1.78 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 125.453 2.549 . . . . 1.78 112.676 -166.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -150.25 45.57 0.89 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 126.554 3.074 . . . . 1.4399999999999999 109.858 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 8.3 t70 -123.05 127.93 49.45 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.356 2.503 . . . . 1.3 108.538 174.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.69 135.03 43.66 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 125.532 2.586 . . . . 2.8799999999999999 109.914 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.5 p -165.97 172.27 11.68 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 125.872 2.748 . . . . 1.3 109.663 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.24 153.62 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.434 3.016 . . . . 2.2200000000000002 110.471 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -75.85 87.44 2.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 126.209 2.909 . . . . 5.8799999999999999 110.264 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.17 68.55 11.38 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 126.457 3.027 . . . . 2.9500000000000002 109.777 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.45 -19.83 54.87 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 C-N-CA 122.944 2.429 . . . . 2.8599999999999999 112.781 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.44 -27.92 62.85 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 126.13 2.871 . . . . 2.6000000000000001 110.497 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -130.98 49.35 2.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.492 3.044 . . . . 4.1200000000000001 107.647 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -56.68 116.08 12.03 Favored Pre-proline 0 CA--C 1.511 -0.541 0 CA-C-O 126.103 2.859 . . . . 1.79 111.249 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.52 -11.05 15.83 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 123.33 2.686 . . . . 1.3 112.172 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.51 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 74.1 m -79.13 158.65 27.71 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 125.889 2.757 . . . . 1.3 110.18 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.8 m -66.36 142.8 57.5 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.723 2.677 . . . . 1.3 108.761 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -59.01 110.98 1.14 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 126.641 3.115 . . . . 5.4900000000000002 110.39 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.24 -26.27 3.75 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 112.238 -2.255 . . . . 0.55000000000000004 110.739 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 4.6 mp -105.24 152.4 22.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.565 2.603 . . . . 1.8600000000000001 109.068 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -133.69 129.82 37.32 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.674 2.654 . . . . 3.4700000000000002 110.267 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.7 m -69.64 105.56 2.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.198 2.904 . . . . 1.3 110.193 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -101.27 163.56 12.22 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 125.051 2.357 . . . . 4.3300000000000001 107.941 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -50.58 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 126.275 2.94 . . . . 5.3200000000000003 111.221 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.9 -49.39 0.89 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 112.857 -1.974 . . . . 0.54000000000000004 111.899 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.4 pttt -159.96 162.57 34.42 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 126.808 3.194 . . . . 2.6499999999999999 110.638 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 47.8 t -79.68 124.75 28.85 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 125.894 2.759 . . . . 1.3 109.173 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.446 HD21 ' HE3' ' A' ' 28' ' ' LYS . 97.8 mt -122.62 131.53 53.86 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 126.126 2.869 . . . . 1.8300000000000001 109.491 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 7.7 p -75.1 145.17 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 125.315 2.483 . . . . 2.1400000000000001 108.096 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.278 2.942 . . . . 3.2599999999999998 109.871 -176.826 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p . . . . . 0 CA--C 1.506 -0.722 0 CA-C-O 125.962 2.792 . . . . 1.54 109.554 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.8 118.24 6.93 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 113.537 -1.665 . . . . 0.77000000000000002 110.224 170.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.483 ' C ' ' H ' ' A' ' 6' ' ' HIS . 8.0 pt -115.02 167.55 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 125.858 2.742 . . . . 1.3799999999999999 110.119 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.19 12.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 125.42 2.534 . . . . 1.78 112.952 -169.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.483 ' H ' ' C ' ' A' ' 4' ' ' ILE . 18.7 p80 -157.44 41.16 0.31 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 126.068 2.842 . . . . 1.4399999999999999 110.294 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -115.51 119.23 35.51 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.674 2.654 . . . . 1.3 108.816 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.12 123.83 23.7 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.894 2.759 . . . . 2.8799999999999999 109.523 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.2 160.38 43.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 126.034 2.826 . . . . 1.3 110.22 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.87 130.56 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.062 2.839 . . . . 2.2200000000000002 109.255 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 21.3 p90 -70.14 74.52 0.49 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 126.52 3.057 . . . . 5.8799999999999999 111.626 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.12 89.07 38.55 Favored Pre-proline 0 CA--C 1.513 -0.48 0 CA-C-O 126.098 2.856 . . . . 2.9500000000000002 109.664 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.69 -34.07 89.42 Favored 'Trans proline' 0 CA--C 1.507 -0.873 0 C-N-CA 122.995 2.463 . . . . 2.8599999999999999 112.686 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 -25.06 59.31 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 125.784 2.707 . . . . 2.6000000000000001 110.881 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -132.83 39.09 3.35 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 126.021 2.819 . . . . 4.1200000000000001 108.941 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -56.2 111.82 3.66 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 125.884 2.754 . . . . 1.79 109.594 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.25 -12.84 19.07 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 CA-C-O 126.267 2.528 . . . . 1.3 112.299 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.53 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 63.1 m -77.73 150.67 34.4 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 126.054 2.835 . . . . 1.3 110.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.43 145.96 41.82 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 125.75 2.69 . . . . 1.3 108.586 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -62.23 102.11 0.28 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 126.399 2.999 . . . . 5.4900000000000002 110.147 -170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.46 -26.04 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 112.483 -2.144 . . . . 0.55000000000000004 110.931 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 6.0 mp -101.2 148.78 24.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 125.821 2.724 . . . . 1.8600000000000001 109.238 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 32' ' ' GLN . 48.5 tp60 -121.23 129.4 53.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.132 2.872 . . . . 3.4700000000000002 109.543 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 53.5 t -69.58 104.49 2.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.182 2.896 . . . . 1.3 108.563 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' GLY . 15.1 mmt180 -86.21 174.6 9.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.562 2.601 . . . . 4.3300000000000001 109.332 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.405 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 m-85 -61.25 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.243 2.925 . . . . 5.3200000000000003 110.608 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 116.19 -26.54 8.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.767 -2.015 . . . . 0.54000000000000004 112.636 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -160.17 149.4 17.53 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 126.418 3.009 . . . . 2.6499999999999999 110.626 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.5 t -79.71 129.66 34.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.872 2.749 . . . . 1.3 109.817 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 156.77 47.97 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 125.86 2.743 . . . . 1.8300000000000001 109.034 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.19 115.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-O 126.068 2.842 . . . . 2.1400000000000001 109.152 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 58.2 tp60 . . . . . 0 CA--C 1.506 -0.733 0 CA-C-O 125.909 2.766 . . . . 3.2599999999999998 109.796 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.503 -0.833 0 CA-C-O 125.766 2.698 . . . . 1.54 108.879 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.558 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -58.75 127.67 45.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 113.627 -1.624 . . . . 0.77000000000000002 111.329 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 5.9 pt -94.71 -176.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 125.469 2.557 . . . . 1.3799999999999999 110.912 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' A' ' 6' ' ' HIS . 2.0 pt? -34.8 -45.43 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 124.841 2.258 . . . . 1.78 114.186 -166.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.617 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 33.4 p80 -142.66 37.75 1.48 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.774 2.702 . . . . 1.4399999999999999 110.628 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 21.2 t70 -73.97 130.59 40.17 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 125.832 2.729 . . . . 1.3 109.253 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.0 m-20 -64.95 134.79 54.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.974 2.797 . . . . 2.8799999999999999 110.39 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.81 161.79 42.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.193 2.901 . . . . 1.3 110.209 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 12' ' ' VAL . 23.9 m -89.6 143.54 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 CA-C-O 125.384 2.516 . . . . 2.2200000000000002 108.362 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -69.11 75.64 0.33 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.449 3.024 . . . . 5.8799999999999999 110.116 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' VAL . 95.2 t -128.38 98.83 25.1 Favored Pre-proline 0 CA--C 1.506 -0.712 0 CA-C-O 125.572 2.606 . . . . 2.9500000000000002 108.606 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.74 -54.46 0.22 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 122.945 2.43 . . . . 2.8599999999999999 113.201 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.76 75.34 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 125.684 2.659 . . . . 2.6000000000000001 111.612 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -116.35 35.82 4.37 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 125.952 2.787 . . . . 4.1200000000000001 109.216 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.97 108.86 3.79 Favored Pre-proline 0 CA--C 1.509 -0.623 0 CA-C-O 125.686 2.66 . . . . 1.79 110.126 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 83.4 Cg_endo -83.36 48.71 2.75 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 CA-C-O 126.737 2.724 . . . . 1.3 110.983 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.558 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 10.6 t -136.86 143.75 43.23 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.105 2.383 . . . . 1.3 107.585 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -59.91 145.87 44.3 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.356 2.979 . . . . 1.3 110.67 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.602 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.59 122.1 21.72 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.322 2.963 . . . . 5.4900000000000002 108.899 -174.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 117.95 -7.4 15.03 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 112.625 -2.08 . . . . 0.55000000000000004 110.171 -171.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.78 139.42 49.74 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.895 2.76 . . . . 1.8600000000000001 108.708 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 26.3 pt20 -104.47 121.69 43.98 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.624 2.63 . . . . 3.4700000000000002 109.685 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.3 t -80.58 102.05 9.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 126.074 2.845 . . . . 1.3 108.632 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 25.4 mmt180 -97.93 163.05 12.94 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 125.197 2.427 . . . . 4.3300000000000001 108.645 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -53.1 93.45 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.018 2.818 . . . . 5.3200000000000003 109.941 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 128.55 -50.82 0.87 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.854 -1.975 . . . . 0.54000000000000004 112.404 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 20.8 pttp -162.47 173.88 13.44 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.395 2.998 . . . . 2.6499999999999999 111.312 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 87.4 m -78.65 143.05 36.71 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 126.043 2.83 . . . . 1.3 109.806 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 91.0 mt -126.69 126.82 44.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 125.886 2.755 . . . . 1.8300000000000001 108.469 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 5' ' ' LEU . 2.2 m -66.64 102.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 126.35 2.976 . . . . 2.1400000000000001 110.741 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 23' ' ' GLN . 90.2 mt-30 . . . . . 0 CA--C 1.499 -1.007 0 CA-C-O 126.69 3.138 . . . . 3.2599999999999998 108.795 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 125.684 2.659 . . . . 1.54 108.874 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.8 127.66 39.23 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 113.543 -1.662 . . . . 0.77000000000000002 112.532 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 pt -117.88 178.69 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 126.338 2.97 . . . . 1.3799999999999999 110.827 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -56.57 -11.71 1.44 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 111.952 -2.386 . . . . 1.78 113.786 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -151.1 47.09 0.84 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.499 3.047 . . . . 1.4399999999999999 110.067 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.29 119.19 38.41 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 125.434 2.54 . . . . 1.3 109.158 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -60.06 112.11 1.76 Allowed 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 126.058 2.837 . . . . 2.8799999999999999 108.802 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.8 t -133.39 149.04 51.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 126.086 2.85 . . . . 1.3 110.778 -165.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.87 133.1 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 125.723 2.678 . . . . 2.2200000000000002 108.515 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -67.81 86.94 0.23 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 125.981 2.801 . . . . 5.8799999999999999 110.485 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.73 90.14 33.37 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-O 125.947 2.784 . . . . 2.9500000000000002 109.488 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.2 -47.98 15.49 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 123.23 2.62 . . . . 2.8599999999999999 113.579 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.67 83.53 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.093 2.854 . . . . 2.6000000000000001 110.598 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -111.41 42.31 1.7 Allowed 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 125.579 2.609 . . . . 4.1200000000000001 109.399 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -54.85 113.43 5.34 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 125.877 2.751 . . . . 1.79 110.293 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.75 -13.8 14.34 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.012 2.474 . . . . 1.3 112.388 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 98.5 m -78.19 148.21 34.14 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 126.174 2.892 . . . . 1.3 110.568 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.8 m -66.26 162.11 20.76 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 125.852 2.739 . . . . 1.3 109.578 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -61.0 119.76 8.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.302 2.953 . . . . 5.4900000000000002 110.142 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.81 -4.56 56.28 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 113.127 -1.851 . . . . 0.55000000000000004 111.819 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.15 134.97 43.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.008 2.813 . . . . 1.8600000000000001 109.252 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -111.73 110.18 20.43 Favored 'General case' 0 CA--C 1.5 -0.942 0 CA-C-O 125.886 2.755 . . . . 3.4700000000000002 109.325 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.7 t -75.3 129.51 37.53 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.896 2.76 . . . . 1.3 109.039 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -117.62 144.57 45.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 124.672 2.177 . . . . 4.3300000000000001 106.875 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -55.79 97.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.569 3.08 . . . . 5.3200000000000003 109.887 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.68 -53.39 0.79 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 112.489 -2.141 . . . . 0.54000000000000004 111.179 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -150.68 153.84 36.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 126.293 2.949 . . . . 2.6499999999999999 109.938 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 35.2 t -95.93 130.78 42.81 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 125.383 2.516 . . . . 1.3 108.301 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.18 173.14 8.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.28 2.943 . . . . 1.8300000000000001 110.161 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.39 112.93 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-O 125.735 2.683 . . . . 2.1400000000000001 108.756 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.189 2.899 . . . . 3.2599999999999998 109.742 -178.519 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 CA--C 1.505 -0.763 0 CA-C-O 125.96 2.791 . . . . 1.54 109.501 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.494 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -63.47 138.54 43.07 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 113.392 -1.731 . . . . 0.77000000000000002 111.097 172.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 19.7 pt -115.51 175.56 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 126.486 3.041 . . . . 1.3799999999999999 111.047 -174.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.07 -6.9 0.94 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 111.922 -2.399 . . . . 1.78 113.223 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -150.1 49.06 0.91 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.253 2.93 . . . . 1.4399999999999999 109.862 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 39.1 t70 -115.08 133.72 55.8 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.471 2.558 . . . . 1.3 109.01 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -75.88 133.03 40.67 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 125.671 2.653 . . . . 2.8799999999999999 109.831 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.5 p -162.24 162.06 28.04 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 125.905 2.764 . . . . 1.3 110.214 -176.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.1 m -92.41 151.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 125.77 2.7 . . . . 2.2200000000000002 109.389 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -71.43 76.4 0.77 Allowed 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 126.462 3.029 . . . . 5.8799999999999999 110.521 -172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.28 70.65 79.26 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-O 125.984 2.802 . . . . 2.9500000000000002 110.247 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.09 -32.65 95.02 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-O 125.87 2.362 . . . . 2.8599999999999999 111.945 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.16 -40.28 58.24 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 126.22 2.914 . . . . 2.6000000000000001 110.419 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.56 46.91 2.11 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.914 2.769 . . . . 4.1200000000000001 108.461 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -49.97 113.12 3.14 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-O 125.876 2.751 . . . . 1.79 110.31 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.14 -18.8 14.09 Favored 'Trans proline' 0 CA--C 1.506 -0.895 0 CA-C-O 125.997 2.415 . . . . 1.3 112.257 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.6 m -79.7 161.16 25.96 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 125.923 2.773 . . . . 1.3 109.87 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -67.73 142.83 56.17 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.11 2.862 . . . . 1.3 109.227 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -59.94 115.82 3.69 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 126.302 2.954 . . . . 5.4900000000000002 109.929 -175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.16 -10.0 8.33 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.609 -2.087 . . . . 0.55000000000000004 110.902 -175.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.06 140.87 40.59 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.189 2.899 . . . . 1.8600000000000001 109.637 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -104.76 101.95 11.54 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.056 2.836 . . . . 3.4700000000000002 109.592 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.8 t -77.33 106.46 9.08 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.184 2.897 . . . . 1.3 109.181 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -101.67 150.39 23.16 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 125.193 2.425 . . . . 4.3300000000000001 108.077 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -50.25 100.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.313 2.959 . . . . 5.3200000000000003 110.306 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.66 -50.9 0.78 Allowed Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 112.555 -2.111 . . . . 0.54000000000000004 111.714 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -143.3 134.3 25.57 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 126.406 3.003 . . . . 2.6499999999999999 110.275 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 34.6 t -87.58 123.26 32.27 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 125.676 2.655 . . . . 1.3 108.315 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.2 mt -116.65 173.7 6.48 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.993 2.806 . . . . 1.8300000000000001 109.879 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.04 118.52 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 125.778 2.704 . . . . 2.1400000000000001 108.724 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 125.833 2.73 . . . . 3.2599999999999998 107.707 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.501 -0.908 0 CA-C-O 125.746 2.689 . . . . 1.54 108.706 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -61.4 120.01 20.81 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 113.565 -1.652 . . . . 0.77000000000000002 111.16 173.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.448 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 23.6 pt -117.08 178.18 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 125.723 2.678 . . . . 1.3799999999999999 109.674 -178.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.95 14.38 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 125.256 2.455 . . . . 1.78 113.324 -164.611 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -160.48 31.61 0.16 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 125.914 2.769 . . . . 1.4399999999999999 110.129 172.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -100.93 130.05 46.87 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 125.386 2.517 . . . . 1.3 109.36 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -60.9 116.88 4.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.345 2.974 . . . . 2.8799999999999999 109.009 178.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.5 t -139.03 136.37 35.22 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 126.119 2.866 . . . . 1.3 109.64 -173.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 12' ' ' VAL . 27.9 m -93.5 145.22 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 125.455 2.55 . . . . 2.2200000000000002 108.215 175.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -62.02 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 126.38 2.991 . . . . 5.8799999999999999 111.579 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 15' ' ' GLN . 12.2 m -127.86 93.18 40.37 Favored Pre-proline 0 CA--C 1.506 -0.718 0 CA-C-O 126.115 2.864 . . . . 2.9500000000000002 109.295 174.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.84 -49.94 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.69 0 CA-C-O 126.145 2.477 . . . . 2.8599999999999999 111.749 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.22 -6.7 25.01 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 125.942 2.782 . . . . 2.6000000000000001 110.91 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.589 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 28.9 tt0 -138.56 36.64 2.24 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.038 2.828 . . . . 4.1200000000000001 108.839 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 24.9 t-20 -57.74 113.8 7.12 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 125.799 2.714 . . . . 1.79 110.574 -177.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -84.35 -8.31 9.7 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.239 2.626 . . . . 1.3 112.139 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.512 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 71.3 m -78.99 159.08 27.81 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 125.742 2.686 . . . . 1.3 110.017 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.36 132.21 44.52 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 125.933 2.778 . . . . 1.3 108.139 172.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -56.86 108.61 0.52 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.346 2.974 . . . . 5.4900000000000002 110.327 -172.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.16 -19.49 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 112.68 -2.055 . . . . 0.55000000000000004 110.995 -175.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.36 138.38 41.65 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 125.985 2.802 . . . . 1.8600000000000001 109.562 177.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -94.04 131.64 39.33 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 125.767 2.699 . . . . 3.4700000000000002 109.351 -178.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.0 t -90.91 111.19 22.52 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.04 2.829 . . . . 1.3 108.654 174.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -108.31 152.81 24.13 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.324 2.487 . . . . 4.3300000000000001 108.793 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -46.8 96.35 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.082 2.849 . . . . 5.3200000000000003 110.918 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.34 -49.38 0.89 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.045 -1.889 . . . . 0.54000000000000004 112.374 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.96 156.17 42.37 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 126.531 3.062 . . . . 2.6499999999999999 110.42 -174.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 14.6 t -90.87 147.3 23.25 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.29 2.471 . . . . 1.3 107.731 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 pp -150.36 161.57 42.22 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 126.03 2.824 . . . . 1.8300000000000001 110.004 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' ' 5' ' ' LEU . 11.7 m -74.39 115.39 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.12 2.867 . . . . 2.1400000000000001 109.748 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 126.486 3.041 . . . . 3.2599999999999998 109.695 -175.665 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.506 -0.734 0 CA-C-O 125.92 2.771 . . . . 1.54 108.777 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.73 129.3 33.01 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 113.27 -1.787 . . . . 0.77000000000000002 111.883 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.2 pt -112.72 168.5 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 126.328 2.966 . . . . 1.3799999999999999 110.35 -176.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -59.54 -4.42 0.62 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 125.255 2.455 . . . . 1.78 113.119 -171.206 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.91 50.0 1.27 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 126.358 2.98 . . . . 1.4399999999999999 109.57 176.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.01 165.68 14.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.191 2.424 . . . . 1.3 107.869 172.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 93.6 m-20 -108.42 124.75 50.88 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 125.584 2.611 . . . . 2.8799999999999999 110.08 -172.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 10.4 p -163.12 156.52 19.54 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 125.903 2.763 . . . . 1.3 110.102 -173.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.68 152.71 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 126.2 2.905 . . . . 2.2200000000000002 110.195 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 64.1 t80 -75.69 77.61 2.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 126.243 2.925 . . . . 5.8799999999999999 110.455 -176.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 102.54 35.84 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-O 126.006 2.812 . . . . 2.9500000000000002 108.09 173.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.1 -52.01 9.76 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.649 2.899 . . . . 2.8599999999999999 113.644 -172.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -19.37 64.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 125.687 2.661 . . . . 2.6000000000000001 111.439 -176.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 52.5 tt0 -126.24 36.01 4.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.961 2.791 . . . . 4.1200000000000001 109.886 -177.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -71.59 106.27 1.85 Allowed Pre-proline 0 CA--C 1.511 -0.529 0 CA-C-O 125.796 2.712 . . . . 1.79 108.219 173.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 64.1 Cg_endo -80.95 -8.29 13.2 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 123.242 2.628 . . . . 1.3 113.136 -170.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 71.9 m -78.87 145.13 34.35 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 126.395 2.997 . . . . 1.3 111.074 -171.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -54.78 139.1 40.67 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.294 2.473 . . . . 1.3 109.121 177.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -48.13 108.26 0.16 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 126.488 3.042 . . . . 5.4900000000000002 110.979 -175.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.31 -20.41 5.88 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 112.656 -2.065 . . . . 0.55000000000000004 111.318 -176.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.714 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.5 mt -103.19 145.87 29.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 125.667 2.651 . . . . 1.8600000000000001 109.185 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.27 135.78 37.46 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 125.615 2.626 . . . . 3.4700000000000002 109.285 -177.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 88.6 m -78.95 129.43 34.48 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.447 3.022 . . . . 1.3 111.637 -177.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLY . 7.0 tpp180 -84.1 145.92 28.18 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.314 -2.106 . . . . 4.3300000000000001 105.314 159.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -58.44 81.05 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 126.28 2.943 . . . . 5.3200000000000003 110.26 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 145.29 -45.68 0.82 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.135 -1.848 . . . . 0.54000000000000004 111.345 -177.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 20.8 ptmt -149.62 148.35 29.22 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.246 2.927 . . . . 2.6499999999999999 110.758 -176.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 24.0 t -79.83 144.61 33.35 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 125.784 2.707 . . . . 1.3 109.682 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -132.28 160.76 35.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.128 2.87 . . . . 1.8300000000000001 110.071 -176.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.85 105.65 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 125.764 2.697 . . . . 2.1400000000000001 109.189 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? . . . . . 0 CA--C 1.504 -0.826 0 CA-C-O 126.135 2.874 . . . . 3.2599999999999998 108.547 178.777 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.505 -0.78 0 CA-C-O 125.899 2.761 . . . . 1.54 109.583 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -57.09 124.68 36.61 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 113.234 -1.803 . . . . 0.77000000000000002 112.302 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.7 pt -93.13 177.65 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 126.327 2.965 . . . . 1.3799999999999999 110.778 -176.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.15 -18.58 0.6 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 111.993 -2.367 . . . . 1.78 114.013 -167.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.408 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 19.2 p80 -150.54 48.66 0.88 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 125.927 2.775 . . . . 1.4399999999999999 110.11 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -91.79 140.92 29.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 125.675 2.655 . . . . 1.3 109.253 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.98 125.25 29.0 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.833 2.73 . . . . 2.8799999999999999 109.907 -176.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.7 p -175.35 146.1 0.79 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.045 2.831 . . . . 1.3 109.871 -177.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -79.09 168.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 125.983 2.802 . . . . 2.2200000000000002 109.749 178.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -77.56 76.52 4.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.452 3.025 . . . . 5.8799999999999999 109.576 -174.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 m -120.78 87.68 42.81 Favored Pre-proline 0 CA--C 1.512 -0.512 0 CA-C-O 126.2 2.905 . . . . 2.9500000000000002 109.622 176.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.56 -30.89 3.67 Favored 'Trans proline' 0 CA--C 1.509 -0.732 0 C-N-CA 122.595 2.196 . . . . 2.8599999999999999 113.195 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.41 66.4 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.281 2.943 . . . . 2.6000000000000001 110.015 -176.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -124.41 58.58 1.2 Allowed 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.001 2.81 . . . . 4.1200000000000001 108.25 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' OD1' ' HA ' ' A' ' 23' ' ' GLN . 11.5 t30 -61.09 109.1 1.82 Allowed Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-O 126.076 2.846 . . . . 1.79 109.92 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.38 -7.86 14.99 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.582 2.855 . . . . 1.3 113.565 -171.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 90.3 m -78.54 155.09 29.9 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 126.076 2.846 . . . . 1.3 110.319 -175.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.3 m -59.65 150.29 27.95 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 125.361 2.505 . . . . 1.3 109.067 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -61.21 99.98 0.11 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 126.214 2.911 . . . . 5.4900000000000002 110.254 -173.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 130.1 -2.61 5.9 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 112.958 -1.928 . . . . 0.55000000000000004 111.464 -176.053 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.6 mt -123.76 151.06 43.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 125.274 2.464 . . . . 1.8600000000000001 108.668 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.44 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 65.6 tt0 -140.66 134.2 30.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.847 2.737 . . . . 3.4700000000000002 110.214 -176.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 64.6 m -71.43 118.46 14.27 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.182 2.896 . . . . 1.3 110.812 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 27.8 tpt180 -93.89 156.55 16.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.014 2.34 . . . . 4.3300000000000001 107.093 170.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.22 92.92 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 126.187 2.898 . . . . 5.3200000000000003 110.215 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.93 -46.25 1.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 112.952 -1.931 . . . . 0.54000000000000004 111.975 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -159.3 158.04 31.67 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.576 3.084 . . . . 2.6499999999999999 110.393 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 13.4 t -78.89 142.58 36.67 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.79 2.709 . . . . 1.3 109.516 -175.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.1 mt -128.44 159.46 35.33 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.26 2.933 . . . . 1.8300000000000001 109.863 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.43 118.43 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 126.294 2.95 . . . . 2.1400000000000001 110.419 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 80.1 mt-30 . . . . . 0 CA--C 1.5 -0.954 0 CA-C-O 125.921 2.772 . . . . 3.2599999999999998 110.234 177.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 17.3 p . . . . . 0 CA--C 1.508 -0.67 0 CA-C-O 125.831 2.729 . . . . 1.54 109.983 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.603 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -73.01 153.56 48.63 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 113.407 -1.724 . . . . 0.77000000000000002 111.351 173.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.9 pt -101.91 172.21 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 126.877 3.227 . . . . 1.3799999999999999 111.961 -174.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.1 pt? -58.31 -1.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.093 -2.776 . . . . 1.78 113.961 -169.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 27.4 p80 -156.3 50.27 0.51 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.107 2.86 . . . . 1.4399999999999999 110.335 176.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -99.54 -172.25 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 125.351 2.5 . . . . 1.3 109.044 175.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -113.32 131.61 55.88 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.477 2.56 . . . . 2.8799999999999999 109.502 -175.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 11.5 p -176.77 151.19 0.87 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.299 2.952 . . . . 1.3 110.521 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.12 154.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 125.737 2.684 . . . . 2.2200000000000002 108.749 175.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.9 77.68 0.89 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 126.209 2.909 . . . . 5.8799999999999999 109.795 -178.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.85 99.05 29.78 Favored Pre-proline 0 CA--C 1.513 -0.459 0 CA-C-O 126.1 2.857 . . . . 2.9500000000000002 109.023 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.83 -40.86 26.42 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 CA-C-O 125.695 2.29 . . . . 2.8599999999999999 112.371 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.63 -32.31 63.03 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 125.91 2.767 . . . . 2.6000000000000001 111.0 -177.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 13.8 mm100 -127.51 48.19 2.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.708 2.671 . . . . 4.1200000000000001 110.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -67.6 109.58 4.0 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.517 2.579 . . . . 1.79 108.574 172.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 96.9 Cg_endo -79.39 -17.16 11.65 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 CA-C-O 125.847 2.353 . . . . 1.3 112.775 -175.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.603 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 93.6 m -79.97 161.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 126.179 2.895 . . . . 1.3 110.728 -174.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 m -61.44 146.8 47.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 126.149 2.881 . . . . 1.3 109.432 175.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -67.81 112.67 5.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 126.688 3.137 . . . . 5.4900000000000002 109.777 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.57 -7.34 7.91 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 112.14 -2.3 . . . . 0.55000000000000004 110.74 -172.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.8 mt -108.48 144.35 36.22 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.854 2.74 . . . . 1.8600000000000001 108.947 177.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -112.14 125.7 54.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.045 2.831 . . . . 3.4700000000000002 110.275 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.414 ' SG ' ' HD2' ' A' ' 17' ' ' PRO . 5.2 m -89.29 102.08 14.74 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 125.844 2.735 . . . . 1.3 109.623 173.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 52.7 mtp180 -92.22 168.4 11.37 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 125.297 2.475 . . . . 4.3300000000000001 108.494 174.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -55.0 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.238 2.923 . . . . 5.3200000000000003 110.821 -174.376 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.6 -38.69 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 113.131 -1.85 . . . . 0.54000000000000004 112.744 176.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -140.15 147.41 40.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 126.742 3.163 . . . . 2.6499999999999999 111.582 -169.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 37.0 t -94.81 136.65 34.87 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 125.388 2.518 . . . . 1.3 108.036 175.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 2.9 pp -141.64 157.3 45.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.998 2.808 . . . . 1.8300000000000001 110.015 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.15 121.4 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 126.203 2.906 . . . . 2.1400000000000001 109.068 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 CA--C 1.502 -0.89 0 CA-C-O 126.066 2.841 . . . . 3.2599999999999998 109.033 -179.396 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 CA--C 1.508 -0.673 0 CA-C-O 126.119 2.866 . . . . 1.54 110.062 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -66.35 147.1 49.66 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 112.985 -1.916 . . . . 0.77000000000000002 112.727 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.57 172.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 126.039 2.828 . . . . 1.3799999999999999 110.396 -175.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.52 -0.4 0.92 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 125.401 2.524 . . . . 1.78 112.63 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -140.85 46.42 1.77 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 126.597 3.094 . . . . 1.4399999999999999 109.694 175.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -135.35 129.22 33.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.473 2.559 . . . . 1.3 108.109 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 41.7 m-80 -70.26 148.24 48.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 125.346 2.498 . . . . 2.8799999999999999 109.677 -177.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 43.0 t -159.68 160.67 34.42 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.277 2.941 . . . . 1.3 110.574 -170.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.83 152.46 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-O 126.226 2.917 . . . . 2.2200000000000002 109.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -71.76 69.02 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 126.271 2.939 . . . . 5.8799999999999999 110.932 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.09 82.56 24.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 126.398 2.999 . . . . 2.9500000000000002 109.927 177.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.51 -31.84 32.96 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 122.881 2.388 . . . . 2.8599999999999999 112.317 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.08 -37.1 14.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 126.022 2.82 . . . . 2.6000000000000001 111.167 -176.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.45 59.32 1.51 Allowed 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 126.283 2.944 . . . . 4.1200000000000001 108.564 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.03 123.06 78.76 Favored Pre-proline 0 CA--C 1.508 -0.656 0 CA-C-O 126.1 2.857 . . . . 1.79 109.711 175.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 -5.36 16.98 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 123.296 2.664 . . . . 1.3 112.549 -176.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 84.5 m -79.09 151.74 31.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 126.353 2.978 . . . . 1.3 110.774 -173.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.1 m -61.01 144.24 53.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.392 2.52 . . . . 1.3 108.868 177.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -55.49 110.79 0.75 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.194 2.902 . . . . 5.4900000000000002 109.506 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.7 -19.89 5.82 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 112.956 -1.929 . . . . 0.55000000000000004 111.469 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.4 mm? -99.97 166.27 11.13 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 125.751 2.691 . . . . 1.8600000000000001 109.547 178.003 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.75 138.5 19.83 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 125.847 2.737 . . . . 3.4700000000000002 109.332 177.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 85.0 m -80.12 121.0 25.01 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.23 2.919 . . . . 1.3 110.467 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -97.34 158.34 15.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 125.088 2.375 . . . . 4.3300000000000001 107.086 172.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -57.24 91.01 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.451 3.024 . . . . 5.3200000000000003 110.069 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 130.5 -46.0 1.1 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 112.389 -2.187 . . . . 0.54000000000000004 111.948 -179.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HA ' ' N ' ' A' ' 9' ' ' CYS . 24.5 pttm -160.57 165.78 30.17 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 126.551 3.072 . . . . 2.6499999999999999 111.182 -174.199 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 17.0 t -86.7 134.28 33.61 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 125.908 2.766 . . . . 1.3 109.961 -176.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.78 174.27 10.12 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 125.855 2.74 . . . . 1.8300000000000001 109.299 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 m -85.35 145.32 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-O 126.211 2.91 . . . . 2.1400000000000001 110.381 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 . . . . . 0 CA--C 1.501 -0.905 0 CA-C-O 125.833 2.73 . . . . 3.2599999999999998 108.62 175.848 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 126.107 2.86 . . . . 2.4900000000000002 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.4 p -80.11 137.61 36.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 125.785 2.707 . . . . 1.54 108.893 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.617 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -52.18 128.32 34.25 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 113.221 -1.808 . . . . 0.77000000000000002 112.144 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.9 pt -110.21 176.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-O 126.288 2.947 . . . . 1.3799999999999999 110.66 -175.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -55.26 -11.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 111.821 -2.445 . . . . 1.78 113.731 -169.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -147.86 41.16 1.01 Allowed 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 125.991 2.805 . . . . 1.4399999999999999 110.314 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' HB2' HG12 ' A' ' 4' ' ' ILE . 14.3 t70 -107.21 121.49 44.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 125.681 2.658 . . . . 1.3 108.252 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 8.7 p30 -54.02 128.18 29.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 125.99 2.805 . . . . 2.8799999999999999 110.425 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -160.58 169.5 22.78 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.982 2.801 . . . . 1.3 110.218 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.24 153.96 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 125.698 2.666 . . . . 2.2200000000000002 108.863 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 83.5 t80 -73.32 76.91 1.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.303 2.954 . . . . 5.8799999999999999 110.668 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.2 m -127.09 79.93 72.3 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-O 126.22 2.914 . . . . 2.9500000000000002 109.86 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -65.69 -30.97 50.19 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 C-N-CA 122.901 2.4 . . . . 2.8599999999999999 112.411 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.4 40.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 126.096 2.855 . . . . 2.6000000000000001 110.984 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -134.96 55.08 1.91 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 126.2 2.905 . . . . 4.1200000000000001 108.368 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -55.46 115.87 10.39 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-O 125.796 2.712 . . . . 1.79 110.215 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 46.4 Cg_endo -86.77 -4.0 8.17 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 123.25 2.633 . . . . 1.3 112.69 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.617 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 91.5 m -86.62 167.0 14.94 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 126.51 3.052 . . . . 1.3 111.352 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.0 m -72.75 131.08 41.88 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.296 2.474 . . . . 1.3 107.822 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -54.04 108.42 0.36 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 126.532 3.063 . . . . 5.4900000000000002 110.599 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.81 -17.47 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 112.222 -2.263 . . . . 0.55000000000000004 110.815 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 19.1 mt -110.45 148.35 32.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.49 2.567 . . . . 1.8600000000000001 108.673 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -135.93 128.35 30.38 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 126.138 2.875 . . . . 3.4700000000000002 110.313 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 90.7 m -67.49 126.14 28.36 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 126.506 3.05 . . . . 1.3 111.563 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -108.51 149.03 29.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 124.649 2.166 . . . . 4.3300000000000001 106.952 168.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -55.6 90.24 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.418 3.008 . . . . 5.3200000000000003 110.465 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 139.1 -50.99 0.77 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 112.486 -2.143 . . . . 0.54000000000000004 111.141 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HE3' ' CD2' ' A' ' 30' ' ' LEU . 65.0 pttt -155.08 154.08 31.86 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.202 2.906 . . . . 2.6499999999999999 109.886 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.0 t -79.89 113.95 18.44 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 125.857 2.742 . . . . 1.3 108.923 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.424 ' CD2' ' HE3' ' A' ' 28' ' ' LYS . 81.7 mt -83.81 136.47 34.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 126.286 2.946 . . . . 1.8300000000000001 110.39 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -75.78 105.15 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 126.21 2.909 . . . . 2.1400000000000001 108.063 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -74.32 66.55 1.32 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.357 2.98 . . . . 3.2599999999999998 110.313 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 149.86 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 125.984 2.802 . . . . 3.9399999999999999 108.753 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 126.151 2.881 . . . . 2.4900000000000002 110.528 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p -90.66 156.36 18.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.787 2.708 . . . . 1.54 109.638 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.21 152.58 52.56 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 113.709 -1.587 . . . . 0.77000000000000002 111.724 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.2 pt -109.04 168.25 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 126.582 3.087 . . . . 1.3799999999999999 111.182 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -69.13 14.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 125.214 2.435 . . . . 1.78 113.549 -169.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -160.37 39.9 0.17 Allowed 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 126.272 2.939 . . . . 1.4399999999999999 109.872 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -121.41 138.44 54.27 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.464 2.554 . . . . 1.3 108.555 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -56.05 136.11 52.41 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 126.148 2.88 . . . . 2.8799999999999999 110.043 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.445 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 17.4 t -159.26 143.86 15.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.015 2.817 . . . . 1.3 109.286 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.24 148.67 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 125.765 2.698 . . . . 2.2200000000000002 108.872 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 53.9 t80 -73.65 70.62 1.36 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 126.199 2.904 . . . . 5.8799999999999999 109.369 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -130.38 80.9 69.5 Favored Pre-proline 0 CA--C 1.516 -0.361 0 CA-C-O 126.345 2.974 . . . . 2.9500000000000002 109.475 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 -31.93 25.89 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 CA-C-O 125.559 2.233 . . . . 2.8599999999999999 112.627 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.23 68.7 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.121 2.867 . . . . 2.6000000000000001 110.525 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.33 50.33 1.4 Allowed 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 125.831 2.729 . . . . 4.1200000000000001 108.805 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 52.4 t-20 -50.88 111.81 2.52 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 125.557 2.598 . . . . 1.79 109.946 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -89.12 4.21 5.35 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.233 2.622 . . . . 1.3 112.786 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 21.3 t -90.82 161.93 15.05 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.517 2.579 . . . . 1.3 108.296 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 59.4 m -60.66 127.89 33.9 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 126.006 2.813 . . . . 1.3 109.496 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -55.42 116.08 2.66 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.325 2.964 . . . . 5.4900000000000002 110.072 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.62 7.99 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 112.651 -2.068 . . . . 0.55000000000000004 110.565 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.498 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 40.4 mt -107.87 148.69 29.24 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 125.56 2.6 . . . . 1.8600000000000001 108.505 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.423 ' OE1' ' HA ' ' A' ' 23' ' ' GLN . 5.9 tp60 -118.25 123.39 45.31 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 126.071 2.843 . . . . 3.4700000000000002 109.759 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.7 m -76.3 106.08 7.72 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 126.176 2.893 . . . . 1.3 110.665 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 27' ' ' GLY . 18.7 ttm180 -85.68 149.39 25.34 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.292 2.472 . . . . 4.3300000000000001 108.107 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 11' ' ' TYR . 53.5 t80 -56.76 89.03 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.234 2.921 . . . . 5.3200000000000003 109.602 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 141.63 -50.13 0.74 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 112.582 -2.099 . . . . 0.54000000000000004 111.071 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HA ' ' N ' ' A' ' 9' ' ' CYS . 23.5 pttm -161.88 161.21 28.79 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.926 2.774 . . . . 2.6499999999999999 109.538 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.1 t -82.78 139.69 33.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.707 2.67 . . . . 1.3 109.459 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.443 HD21 ' HE2' ' A' ' 28' ' ' LYS . 94.2 mt -128.81 167.11 17.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.039 2.828 . . . . 1.8300000000000001 109.465 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.82 134.58 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 125.92 2.771 . . . . 2.1400000000000001 110.235 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -77.29 110.42 12.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 126.025 2.821 . . . . 3.2599999999999998 108.122 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.6 80.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 126.582 3.087 . . . . 3.9399999999999999 109.184 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 125.987 2.803 . . . . 2.4900000000000002 110.746 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.8 t -90.7 138.36 31.63 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.606 2.622 . . . . 1.54 108.837 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.31 119.18 11.09 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 113.68 -1.6 . . . . 0.77000000000000002 112.403 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.25 171.83 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 126.065 2.841 . . . . 1.3799999999999999 110.278 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.91 -15.9 46.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 125.209 2.433 . . . . 1.78 112.521 -164.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -131.87 52.94 2.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 126.499 3.047 . . . . 1.4399999999999999 109.84 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -129.31 133.81 47.62 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 125.92 2.771 . . . . 1.3 109.407 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.96 129.97 39.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.904 2.764 . . . . 2.8799999999999999 109.501 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -148.93 137.94 21.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 126.022 2.82 . . . . 1.3 110.427 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.07 135.64 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 125.741 2.686 . . . . 2.2200000000000002 108.94 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.21 86.37 0.06 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 126.304 2.954 . . . . 5.8799999999999999 111.334 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.79 104.11 27.27 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.97 2.795 . . . . 2.9500000000000002 108.827 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.36 -47.0 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.682 0 CA-C-O 125.666 2.278 . . . . 2.8599999999999999 113.266 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.21 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.982 2.801 . . . . 2.6000000000000001 110.425 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -108.85 42.24 1.45 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.84 2.734 . . . . 4.1200000000000001 109.425 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -60.24 111.88 4.65 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 125.949 2.785 . . . . 1.79 110.338 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -92.21 8.58 2.87 Favored 'Trans proline' 0 CA--C 1.506 -0.898 0 C-N-CA 123.466 2.778 . . . . 1.3 111.901 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 4.6 t -93.23 140.39 29.58 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.485 2.564 . . . . 1.3 109.367 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 m -60.86 125.08 22.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 125.507 2.575 . . . . 1.3 109.162 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 3.2 tpm_? -55.41 124.74 18.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 126.287 2.946 . . . . 5.4900000000000002 110.035 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.57 -34.74 4.64 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 112.775 -2.011 . . . . 0.55000000000000004 109.69 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mp -102.82 130.65 49.89 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 125.623 2.63 . . . . 1.8600000000000001 107.317 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -101.66 130.91 48.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.402 3.001 . . . . 3.4700000000000002 109.761 -176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 19.2 t -75.38 101.21 4.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 126.064 2.84 . . . . 1.3 109.081 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 27' ' ' GLY . 71.9 ttt180 -98.56 155.05 17.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.195 2.426 . . . . 4.3300000000000001 108.596 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -49.45 92.62 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.002 2.811 . . . . 5.3200000000000003 111.149 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 120.44 -35.01 3.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 113.483 -1.69 . . . . 0.54000000000000004 112.344 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -160.27 150.99 18.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.388 2.994 . . . . 2.6499999999999999 110.973 -173.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 m -80.25 130.01 34.9 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 125.849 2.738 . . . . 1.3 109.439 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -130.15 138.25 50.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 126.052 2.834 . . . . 1.8300000000000001 109.713 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.9 148.22 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 125.594 2.616 . . . . 2.1400000000000001 109.18 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -75.65 94.75 3.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.513 3.054 . . . . 3.2599999999999998 108.616 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -80.85 95.06 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 125.992 2.806 . . . . 3.9399999999999999 109.719 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 126.204 2.906 . . . . 2.4900000000000002 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p -74.96 163.09 28.0 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 125.909 2.766 . . . . 1.54 109.467 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.67 144.99 46.32 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 113.648 -1.615 . . . . 0.77000000000000002 111.032 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.428 ' HA ' HD23 ' A' ' 22' ' ' LEU . 32.4 pt -126.94 -178.57 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 126.337 2.97 . . . . 1.3799999999999999 110.564 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -55.94 -9.64 0.63 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.215 -2.266 . . . . 1.78 114.368 -166.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.797 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 30.1 p80 -147.16 34.47 0.89 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.943 2.783 . . . . 1.4399999999999999 110.462 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.8 114.55 26.96 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 125.493 2.568 . . . . 1.3 108.549 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -61.12 111.39 1.69 Allowed 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 126.109 2.861 . . . . 2.8799999999999999 108.686 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 34.7 t -145.12 142.58 29.78 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.012 2.815 . . . . 1.3 109.816 -163.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.67 147.21 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 125.955 2.788 . . . . 2.2200000000000002 109.033 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 67.1 t80 -72.1 79.23 0.94 Allowed 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 126.246 2.926 . . . . 5.8799999999999999 109.799 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.46 80.71 65.31 Favored Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 126.11 2.862 . . . . 2.9500000000000002 109.462 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.13 -37.2 6.29 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 CA-C-O 125.859 2.358 . . . . 2.8599999999999999 112.656 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.65 68.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 126.151 2.881 . . . . 2.6000000000000001 110.564 -175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -129.34 42.23 3.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 125.853 2.739 . . . . 4.1200000000000001 109.058 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -63.83 112.05 6.56 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-O 125.624 2.631 . . . . 1.79 110.171 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -90.97 16.32 1.62 Allowed 'Trans proline' 0 CA--C 1.508 -0.793 0 CA-C-O 126.687 2.703 . . . . 1.3 111.837 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -98.43 149.27 22.86 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.584 2.611 . . . . 1.3 108.607 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.31 153.9 25.31 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 126.411 3.005 . . . . 1.3 111.146 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -61.75 119.39 8.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 126.031 2.824 . . . . 5.4900000000000002 110.057 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.82 2.97 36.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.059 -1.882 . . . . 0.55000000000000004 111.241 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.532 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 4.9 mp -129.51 139.87 51.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 125.806 2.717 . . . . 1.8600000000000001 108.866 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 33.7 tt0 -123.22 123.76 41.49 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 125.739 2.685 . . . . 3.4700000000000002 110.422 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 23.2 m -70.82 97.49 1.4 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.891 2.758 . . . . 1.3 109.863 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 8.0 tmm_? -100.09 157.04 16.85 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.17 2.414 . . . . 4.3300000000000001 108.32 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -44.97 95.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.139 2.876 . . . . 5.3200000000000003 111.07 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 129.91 -57.08 0.73 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 112.993 -1.912 . . . . 0.54000000000000004 111.503 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.797 ' HD2' ' HA ' ' A' ' 6' ' ' HIS . 21.7 pttm -160.49 163.75 32.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 126.247 2.927 . . . . 2.6499999999999999 109.782 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 28.1 t -81.42 133.66 35.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 125.517 2.58 . . . . 1.3 108.79 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp -122.85 150.09 43.33 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 125.991 2.805 . . . . 1.8300000000000001 110.018 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 m -73.29 92.44 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 126.087 2.851 . . . . 2.1400000000000001 110.23 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -67.8 116.96 9.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 126.278 2.942 . . . . 3.2599999999999998 109.255 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.78 -7.95 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 126.328 2.966 . . . . 3.9399999999999999 109.902 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 125.884 2.754 . . . . 2.4900000000000002 110.822 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.1 t -91.5 122.83 34.43 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.434 2.54 . . . . 1.54 108.072 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -56.28 123.21 30.61 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 113.674 -1.603 . . . . 0.77000000000000002 112.057 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.647 HG12 ' HB2' ' A' ' 7' ' ' ASP . 20.1 pt -90.57 173.36 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.257 2.932 . . . . 1.3799999999999999 110.011 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.86 6.24 0.72 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 125.279 2.466 . . . . 1.78 112.946 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -161.01 45.86 0.19 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 125.955 2.788 . . . . 1.4399999999999999 109.619 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.647 ' HB2' HG12 ' A' ' 4' ' ' ILE . 31.0 t70 -102.86 131.3 49.85 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.593 2.616 . . . . 1.3 109.184 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.05 133.09 51.66 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 126.104 2.859 . . . . 2.8799999999999999 110.976 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.7 p -170.58 145.05 2.48 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.944 2.783 . . . . 1.3 109.251 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.19 155.82 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 125.864 2.745 . . . . 2.2200000000000002 109.396 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.72 76.04 1.55 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 126.03 2.824 . . . . 5.8799999999999999 109.468 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.98 89.54 24.08 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 126.372 2.987 . . . . 2.9500000000000002 109.629 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.69 -39.05 77.29 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 CA-C-O 126.014 2.423 . . . . 2.8599999999999999 112.038 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -36.57 47.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 125.806 2.717 . . . . 2.6000000000000001 111.155 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -122.39 39.23 3.96 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 125.745 2.688 . . . . 4.1200000000000001 109.836 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.2 115.41 38.43 Favored Pre-proline 0 CA--C 1.508 -0.658 0 CA-C-O 125.813 2.72 . . . . 1.79 109.76 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -98.28 11.98 0.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.281 2.654 . . . . 1.3 112.655 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.5 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.6 t -91.92 149.41 21.57 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 125.771 2.701 . . . . 1.3 109.735 -174.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.465 ' HB2' HD23 ' A' ' 22' ' ' LEU . 72.5 m -59.51 143.15 50.87 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 125.943 2.782 . . . . 1.3 109.609 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.68 131.61 51.27 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.263 2.935 . . . . 5.4900000000000002 110.583 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.28 -22.5 36.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 112.94 -1.936 . . . . 0.55000000000000004 111.243 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.465 HD23 ' HB2' ' A' ' 19' ' ' CYS . 5.1 mp -97.7 135.2 39.83 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 125.645 2.64 . . . . 1.8600000000000001 108.404 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -114.91 132.8 56.42 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 125.867 2.746 . . . . 3.4700000000000002 110.116 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 m -85.04 114.78 22.45 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 126.109 2.861 . . . . 1.3 110.617 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 16.4 mmt180 -87.84 159.21 18.5 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 124.558 2.123 . . . . 4.3300000000000001 106.192 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.22 78.46 0.24 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 126.218 2.913 . . . . 5.3200000000000003 109.972 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 146.07 -33.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.974 -1.921 . . . . 0.54000000000000004 111.754 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.83 143.33 15.73 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 126.012 2.815 . . . . 2.6499999999999999 110.107 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 29.3 t -87.73 141.69 28.4 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.444 2.545 . . . . 1.3 108.28 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.59 138.73 38.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.583 2.611 . . . . 1.8300000000000001 108.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.56 113.05 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 126.215 2.912 . . . . 2.1400000000000001 109.918 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -87.28 103.06 15.09 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 126.079 2.847 . . . . 3.2599999999999998 108.447 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.77 128.92 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 125.89 2.757 . . . . 3.9399999999999999 109.404 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.962 0 CA-C-O 125.573 2.606 . . . . 2.4900000000000002 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 28.3 p -90.53 139.01 31.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 125.989 2.804 . . . . 1.54 109.463 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.94 150.93 51.97 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 113.203 -1.817 . . . . 0.77000000000000002 112.399 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.47 ' C ' ' H ' ' A' ' 6' ' ' HIS . 10.1 pt -92.86 167.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 126.137 2.875 . . . . 1.3799999999999999 110.455 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -68.47 18.92 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 125.45 2.548 . . . . 1.78 112.886 -172.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.47 ' H ' ' C ' ' A' ' 4' ' ' ILE . 14.8 p80 -161.58 41.91 0.15 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.168 2.89 . . . . 1.4399999999999999 109.714 173.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -116.29 152.96 32.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 125.552 2.596 . . . . 1.3 108.268 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 133.13 37.55 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.089 2.852 . . . . 2.8799999999999999 111.093 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 12.2 p 177.18 124.62 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 125.888 2.756 . . . . 1.3 108.559 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 12' ' ' VAL . 27.1 m -79.57 -159.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 125.558 2.599 . . . . 2.2200000000000002 110.695 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -70.27 75.05 0.52 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 126.707 3.146 . . . . 5.8799999999999999 110.582 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' VAL . 11.8 m -127.97 81.6 70.04 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.991 2.805 . . . . 2.9500000000000002 109.942 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 3.4 Cg_exo -75.94 -54.86 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.787 0 CA-C-O 125.881 2.367 . . . . 2.8599999999999999 111.913 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.72 77.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 126.212 2.91 . . . . 2.6000000000000001 110.077 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -108.68 39.1 2.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 125.65 2.643 . . . . 4.1200000000000001 109.723 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 54.9 t-20 -64.4 113.03 9.04 Favored Pre-proline 0 CA--C 1.512 -0.502 0 CA-C-O 125.803 2.716 . . . . 1.79 110.156 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 72.3 Cg_endo -91.1 -2.25 4.77 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 123.083 2.522 . . . . 1.3 112.37 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.1 t -87.18 161.37 18.1 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 125.796 2.712 . . . . 1.3 109.214 -175.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 84.4 m -63.77 135.24 56.5 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 126.181 2.896 . . . . 1.3 110.174 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.43 116.3 3.55 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.378 2.99 . . . . 5.4900000000000002 109.55 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 123.64 -14.9 8.07 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 112.818 -1.992 . . . . 0.55000000000000004 110.655 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.455 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.8 mt -119.16 158.79 25.25 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 125.563 2.602 . . . . 1.8600000000000001 108.86 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 28.2 mm-40 -131.89 134.57 45.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.817 2.722 . . . . 3.4700000000000002 110.051 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 87.3 m -83.03 120.11 25.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 126.147 2.88 . . . . 1.3 110.05 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 19.1 ttt180 -110.79 164.22 12.98 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.087 2.375 . . . . 4.3300000000000001 108.337 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -45.62 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.319 2.961 . . . . 5.3200000000000003 110.909 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.58 -54.66 0.73 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.441 -2.163 . . . . 0.54000000000000004 112.043 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -160.39 166.68 28.89 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 126.554 3.073 . . . . 2.6499999999999999 110.752 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 50.9 t -86.84 141.55 28.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 125.804 2.716 . . . . 1.3 109.778 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.67 174.25 10.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.661 2.648 . . . . 1.8300000000000001 108.792 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.42 136.74 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 125.554 2.597 . . . . 2.1400000000000001 109.266 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.559 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 6.7 pt20 -88.84 115.25 26.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.216 2.912 . . . . 3.2599999999999998 109.574 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.93 56.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 127.09 3.328 . . . . 3.9399999999999999 108.419 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 126.067 2.842 . . . . 2.4900000000000002 110.515 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.47 111.55 22.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 126.294 2.949 . . . . 1.54 110.602 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.415 ' HA2' ' OD2' ' A' ' 7' ' ' ASP . . . -72.71 123.81 9.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 113.213 -1.812 . . . . 0.77000000000000002 110.971 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.677 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 26.1 pt -90.01 177.23 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 125.848 2.737 . . . . 1.3799999999999999 110.307 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.8 12.0 0.58 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 125.731 2.682 . . . . 1.78 112.067 -168.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -160.26 43.32 0.2 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 126.47 3.033 . . . . 1.4399999999999999 108.59 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.634 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 47.0 t0 -114.4 138.12 50.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 125.686 2.66 . . . . 1.3 108.721 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.9 m-20 -67.96 130.65 43.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.856 2.741 . . . . 2.8799999999999999 110.389 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.2 p -153.1 145.48 24.03 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 126.206 2.907 . . . . 1.3 110.583 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.2 p -88.77 137.88 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 125.09 2.376 . . . . 2.2200000000000002 107.739 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 26' ' ' TYR . 8.0 p90 -70.45 79.69 0.56 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 126.81 3.195 . . . . 5.8799999999999999 110.878 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 10' ' ' VAL . 17.6 m -126.84 106.52 22.68 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 125.988 2.804 . . . . 2.9500000000000002 109.443 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.75 -38.25 4.43 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 CA-C-O 125.692 2.288 . . . . 2.8599999999999999 112.311 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.99 -52.02 21.48 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 125.88 2.752 . . . . 2.6000000000000001 110.727 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.17 61.52 0.9 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 126.031 2.824 . . . . 4.1200000000000001 107.807 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 17.4 t-20 -54.49 117.87 14.78 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 125.736 2.684 . . . . 1.79 110.662 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.68 -14.35 11.43 Favored 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 123.379 2.719 . . . . 1.3 112.777 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 55.7 m -79.42 146.18 32.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 126.013 2.816 . . . . 1.3 109.445 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.59 144.73 56.24 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.754 2.693 . . . . 1.3 108.586 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' C ' ' HD3' ' A' ' 20' ' ' ARG . 2.6 tmt_? -57.16 109.99 0.76 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 126.353 2.978 . . . . 5.4900000000000002 109.946 -172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.88 -11.86 7.35 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 112.654 -2.067 . . . . 0.55000000000000004 111.424 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.38 146.44 38.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.994 2.807 . . . . 1.8600000000000001 109.747 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 52.3 tt0 -106.19 137.11 44.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.421 2.534 . . . . 3.4700000000000002 109.173 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.659 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 52.2 t -92.47 109.94 21.35 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.448 3.023 . . . . 1.3 109.944 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' GLY . 35.1 mmt180 -96.83 137.07 36.48 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 124.727 2.204 . . . . 4.3300000000000001 106.917 170.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.536 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 35.0 p90 -50.32 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 126.659 3.123 . . . . 5.3200000000000003 110.541 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 134.65 -46.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 112.384 -2.189 . . . . 0.54000000000000004 111.836 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 22.0 pttm -160.08 154.16 23.24 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 126.539 3.066 . . . . 2.6499999999999999 111.036 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.677 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 84.6 m -79.75 138.87 37.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 125.798 2.713 . . . . 1.3 109.183 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.44 162.33 29.41 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.726 2.679 . . . . 1.8300000000000001 109.012 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.3 m -69.17 112.13 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 126.231 2.919 . . . . 2.1400000000000001 110.3 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 62.2 tt0 -84.83 64.92 8.88 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 126.367 2.984 . . . . 3.2599999999999998 109.374 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.08 154.85 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 125.773 2.702 . . . . 3.9399999999999999 109.044 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 125.837 2.732 . . . . 2.4900000000000002 110.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -81.09 156.79 25.63 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 126.135 2.874 . . . . 1.54 109.655 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.92 126.41 36.76 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 113.116 -1.857 . . . . 0.77000000000000002 112.666 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.9 pt -108.29 176.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 126.257 2.932 . . . . 1.3799999999999999 110.069 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -64.89 3.62 0.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.844 2.259 . . . . 1.78 113.451 -169.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -152.56 36.1 0.51 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 126.16 2.886 . . . . 1.4399999999999999 109.711 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.451 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.7 t70 -111.31 137.69 48.73 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.657 2.646 . . . . 1.3 109.137 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.79 131.73 50.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.566 2.603 . . . . 2.8799999999999999 109.561 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -156.35 143.35 18.87 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 126.281 2.943 . . . . 1.3 110.717 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 12' ' ' VAL . 23.7 m -103.82 146.04 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-O 125.494 2.568 . . . . 2.2200000000000002 108.455 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.487 ' HD2' ' H ' ' A' ' 26' ' ' TYR . 3.2 t80 -70.24 86.32 0.58 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 126.176 2.893 . . . . 5.8799999999999999 110.175 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 10' ' ' VAL . 5.6 p -132.96 84.39 49.29 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-O 126.286 2.946 . . . . 2.9500000000000002 109.268 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.3 -43.66 17.56 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-O 125.808 2.337 . . . . 2.8599999999999999 112.833 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.34 -39.15 63.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 126.176 2.893 . . . . 2.6000000000000001 110.893 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -127.63 48.55 2.23 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.998 2.808 . . . . 4.1200000000000001 109.146 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -50.69 112.44 2.89 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-O 125.96 2.791 . . . . 1.79 110.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.85 -6.77 17.07 Favored 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 123.239 2.626 . . . . 1.3 112.398 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.9 m -78.75 154.31 30.11 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.292 2.949 . . . . 1.3 110.599 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.5 m -62.86 136.92 58.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 125.306 2.479 . . . . 1.3 107.964 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -55.97 107.7 0.38 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 126.302 2.953 . . . . 5.4900000000000002 110.426 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.34 -23.3 4.88 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 112.7 -2.046 . . . . 0.55000000000000004 111.3 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.557 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.8 mm? -94.62 134.21 37.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.948 2.785 . . . . 1.8600000000000001 109.255 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -105.63 118.07 35.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 126.265 2.936 . . . . 3.4700000000000002 109.203 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 36.6 t -79.59 132.42 36.26 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.963 2.792 . . . . 1.3 110.487 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.446 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 15.6 ttm180 -122.95 143.25 50.03 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 125.328 2.489 . . . . 4.3300000000000001 108.083 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.487 ' H ' ' HD2' ' A' ' 11' ' ' TYR . 9.6 p90 -50.1 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 126.501 3.048 . . . . 5.3200000000000003 110.726 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.5 -56.84 0.72 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 112.468 -2.151 . . . . 0.54000000000000004 110.916 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -156.81 161.42 39.74 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 126.619 3.104 . . . . 2.6499999999999999 109.733 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 11.9 t -88.42 138.02 31.8 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 125.53 2.586 . . . . 1.3 109.352 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.4 mt -124.66 167.54 14.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 126.015 2.817 . . . . 1.8300000000000001 109.633 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.97 136.3 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 CA-C-O 125.382 2.515 . . . . 2.1400000000000001 108.805 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -75.13 67.61 1.81 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.701 3.143 . . . . 3.2599999999999998 109.112 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.35 116.12 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 126.183 2.897 . . . . 3.9399999999999999 108.779 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 126.124 2.869 . . . . 2.4900000000000002 110.494 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.6 p -90.09 143.24 26.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 125.991 2.805 . . . . 1.54 109.849 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.457 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.65 136.89 44.39 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 113.302 -1.772 . . . . 0.77000000000000002 112.077 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 22.7 pt -100.67 169.03 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 126.684 3.135 . . . . 1.3799999999999999 111.233 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.09 -6.93 0.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 111.627 -2.533 . . . . 1.78 113.391 -171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -147.89 51.96 1.04 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.583 3.087 . . . . 1.4399999999999999 109.31 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 5.6 t0 -112.9 122.6 48.13 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 125.473 2.558 . . . . 1.3 108.559 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.94 123.04 15.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 125.582 2.61 . . . . 2.8799999999999999 109.661 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 t -161.92 152.79 17.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.068 2.842 . . . . 1.3 110.256 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 24' ' ' CYS . 30.8 m -97.8 171.89 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 125.963 2.792 . . . . 2.2200000000000002 109.582 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -81.8 73.98 8.81 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 126.178 2.894 . . . . 5.8799999999999999 110.168 -173.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.9 87.73 50.59 Favored Pre-proline 0 CA--C 1.514 -0.435 0 CA-C-O 126.264 2.935 . . . . 2.9500000000000002 110.588 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.22 -35.21 5.3 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.981 2.454 . . . . 2.8599999999999999 112.284 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.05 -28.69 25.95 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.056 2.836 . . . . 2.6000000000000001 111.152 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.403 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 46.8 tp60 -141.73 57.52 1.5 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 125.861 2.744 . . . . 4.1200000000000001 108.34 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.4 107.67 1.21 Allowed Pre-proline 0 CA--C 1.509 -0.622 0 CA-C-O 125.656 2.646 . . . . 1.79 109.161 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 79.3 Cg_endo -78.92 -8.76 15.62 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 C-N-CA 123.189 2.593 . . . . 1.3 112.469 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 87.0 m -77.49 150.36 34.9 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 126.232 2.92 . . . . 1.3 110.676 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.448 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 4.5 m -58.08 135.48 57.01 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.154 2.407 . . . . 1.3 107.947 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -57.78 113.28 1.78 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 126.509 3.052 . . . . 5.4900000000000002 110.343 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 126.68 -18.11 6.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 112.123 -2.308 . . . . 0.55000000000000004 110.331 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 33.9 mt -119.07 148.68 42.77 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 125.428 2.537 . . . . 1.8600000000000001 108.098 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -139.66 136.13 33.95 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 126.004 2.811 . . . . 3.4700000000000002 109.914 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 68.0 m -67.19 129.83 41.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.156 2.884 . . . . 1.3 110.492 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 27' ' ' GLY . 42.9 mtp180 -128.35 133.97 48.77 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 124.993 2.33 . . . . 4.3300000000000001 107.625 170.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -37.88 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 126.743 3.163 . . . . 5.3200000000000003 112.302 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 137.66 -58.5 0.63 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 112.226 -2.261 . . . . 0.54000000000000004 110.759 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 154.9 36.07 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.65 3.119 . . . . 2.6499999999999999 109.963 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.0 t -79.81 130.13 35.06 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 125.568 2.604 . . . . 1.3 108.545 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.34 160.94 29.86 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 125.912 2.768 . . . . 1.8300000000000001 109.556 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 t -71.78 109.99 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 125.52 2.581 . . . . 2.1400000000000001 107.199 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 18.0 pt20 -51.98 -32.06 31.97 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 125.796 2.713 . . . . 3.2599999999999998 111.566 -171.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.86 140.35 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 125.9 2.762 . . . . 3.9399999999999999 109.16 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 126.45 3.024 . . . . 2.4900000000000002 110.065 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 17.7 p -90.62 153.66 20.16 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 126.065 2.841 . . . . 1.54 109.915 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.524 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.69 128.54 15.17 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 113.271 -1.786 . . . . 0.77000000000000002 110.931 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.0 pt -98.34 177.95 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 126.079 2.847 . . . . 1.3799999999999999 110.183 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -57.12 -7.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.291 -2.231 . . . . 1.78 114.041 -167.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.45 48.5 0.36 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.184 2.897 . . . . 1.4399999999999999 109.788 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HB2' HG12 ' A' ' 4' ' ' ILE . 22.3 t70 -101.41 123.64 45.81 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.745 2.688 . . . . 1.3 109.655 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -64.63 123.17 18.61 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.132 2.872 . . . . 2.8799999999999999 110.502 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.4 p -157.97 174.25 15.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.73 2.681 . . . . 1.3 109.849 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.24 149.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 126.005 2.812 . . . . 2.2200000000000002 109.773 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.685 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 40.7 t80 -77.78 76.3 4.31 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 126.276 2.941 . . . . 5.8799999999999999 110.405 -170.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.49 85.92 48.44 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-O 125.607 2.623 . . . . 2.9500000000000002 109.271 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.72 -38.04 52.44 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.655 2.236 . . . . 2.8599999999999999 112.925 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.32 -23.15 63.99 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 126.184 2.897 . . . . 2.6000000000000001 110.518 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -135.29 47.69 2.3 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 125.917 2.77 . . . . 4.1200000000000001 109.079 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -58.02 113.58 6.78 Favored Pre-proline 0 CA--C 1.51 -0.595 0 CA-C-O 125.756 2.693 . . . . 1.79 109.406 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 64.2 Cg_endo -79.89 -6.84 14.32 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 123.241 2.627 . . . . 1.3 112.626 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 74.4 m -78.24 155.54 30.22 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 126.174 2.892 . . . . 1.3 110.852 -171.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.438 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -62.8 150.32 41.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 125.683 2.659 . . . . 1.3 109.092 174.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -59.87 103.24 0.2 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 126.238 2.923 . . . . 5.4900000000000002 110.371 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.04 -5.31 8.34 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 112.752 -2.022 . . . . 0.55000000000000004 111.973 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 75.8 mt -114.36 137.44 51.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 125.879 2.752 . . . . 1.8600000000000001 109.152 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -116.94 119.4 35.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 126.022 2.82 . . . . 3.4700000000000002 109.76 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.8 t -73.68 129.59 38.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 126.011 2.815 . . . . 1.3 109.912 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.685 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 36.6 ttm180 -111.97 154.08 25.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 125.154 2.407 . . . . 4.3300000000000001 108.321 174.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -52.51 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 126.452 3.025 . . . . 5.3200000000000003 109.697 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.4 -54.4 0.79 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 112.531 -2.122 . . . . 0.54000000000000004 110.912 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -161.43 159.43 28.14 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.461 3.029 . . . . 2.6499999999999999 110.344 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.838 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 22.8 t -81.47 145.7 30.61 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.4 2.524 . . . . 1.3 109.207 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 168.74 18.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 125.999 2.809 . . . . 1.8300000000000001 110.076 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.14 155.78 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-O 125.911 2.767 . . . . 2.1400000000000001 110.053 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.38 59.69 0.6 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 126.144 2.878 . . . . 3.2599999999999998 110.674 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.06 57.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 127.077 3.322 . . . . 3.9399999999999999 109.152 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 126.045 2.831 . . . . 2.4900000000000002 110.467 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.99 110.54 21.79 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.934 2.778 . . . . 1.54 108.395 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.826 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.5 119.81 19.91 Favored Glycine 0 C--O 1.236 0.257 0 CA-C-N 113.333 -1.758 . . . . 0.77000000000000002 112.333 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 6' ' ' HIS . 13.0 pt -102.16 164.73 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 126.179 2.895 . . . . 1.3799999999999999 110.236 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -66.77 12.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 125.293 2.473 . . . . 1.78 113.072 -171.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 4' ' ' ILE . 12.4 p80 -154.88 42.16 0.46 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.197 2.903 . . . . 1.4399999999999999 109.627 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.404 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 34.5 t70 -112.69 125.12 53.96 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 125.967 2.794 . . . . 1.3 109.12 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -76.1 122.48 24.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 126.163 2.887 . . . . 2.8799999999999999 109.764 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.6 p -149.04 171.61 16.11 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.774 2.702 . . . . 1.3 109.73 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.89 146.9 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 126.218 2.913 . . . . 2.2200000000000002 109.777 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.433 ' H ' ' HD1' ' A' ' 11' ' ' TYR . 2.5 p90 -71.63 71.58 0.72 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.503 3.049 . . . . 5.8799999999999999 110.741 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.31 94.07 31.19 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-O 125.834 2.73 . . . . 2.9500000000000002 109.261 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.93 -29.88 82.8 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.957 2.438 . . . . 2.8599999999999999 112.924 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.89 -38.93 17.45 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 125.996 2.807 . . . . 2.6000000000000001 110.533 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -132.4 65.7 1.57 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.941 2.781 . . . . 4.1200000000000001 108.498 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -61.47 109.76 2.48 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-O 125.625 2.631 . . . . 1.79 109.377 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 3' ' ' GLY . 70.6 Cg_endo -82.25 -10.04 11.35 Favored 'Trans proline' 0 CA--C 1.498 -1.283 0 CA-C-O 126.241 2.517 . . . . 1.3 112.204 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.826 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 94.4 m -79.69 154.07 28.87 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 126.0 2.809 . . . . 1.3 110.165 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.3 m -65.07 110.01 2.35 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 125.273 2.464 . . . . 1.3 106.308 167.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -51.12 118.6 3.33 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 127.054 3.312 . . . . 5.4900000000000002 109.935 -173.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -26.37 3.62 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 111.314 -2.676 . . . . 0.55000000000000004 109.356 -165.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 7.2 mp -105.02 152.53 22.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 125.613 2.625 . . . . 1.8600000000000001 108.714 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -121.49 135.26 55.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.195 2.902 . . . . 3.4700000000000002 110.566 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' A' ' 18' ' ' CYS . 3.0 m -77.3 97.44 4.87 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 125.962 2.791 . . . . 1.3 109.696 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HD2' HD11 ' A' ' 30' ' ' LEU . 87.8 mtt180 -86.23 157.39 19.96 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 124.922 2.296 . . . . 4.3300000000000001 107.241 172.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -49.6 94.3 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 126.378 2.99 . . . . 5.3200000000000003 110.522 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.19 -47.34 1.05 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 112.688 -2.051 . . . . 0.54000000000000004 112.492 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -130.95 138.68 49.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.582 3.087 . . . . 2.6499999999999999 111.564 -168.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.8 t -79.67 105.48 10.99 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 125.803 2.716 . . . . 1.3 107.852 170.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 25' ' ' ARG . 94.2 mt -120.6 142.43 49.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 126.016 2.817 . . . . 1.8300000000000001 109.488 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.595 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 34.5 t -59.15 128.84 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 CA-C-O 125.753 2.692 . . . . 2.1400000000000001 109.75 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.2 76.98 2.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.318 2.961 . . . . 3.2599999999999998 109.205 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.04 139.87 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-O 125.921 2.772 . . . . 3.9399999999999999 109.247 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.89 0 CA-C-O 126.014 2.816 . . . . 2.4900000000000002 109.866 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t -80.9 138.29 36.15 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.861 2.743 . . . . 1.54 109.524 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -66.01 109.4 2.87 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 113.391 -1.731 . . . . 0.77000000000000002 111.666 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.8 pt -91.71 -178.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 125.452 2.549 . . . . 1.3799999999999999 110.536 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -37.05 -38.38 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 124.368 2.032 . . . . 1.78 114.617 -166.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -141.94 29.72 1.67 Allowed 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 125.477 2.561 . . . . 1.4399999999999999 111.284 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.79 132.67 44.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 125.675 2.655 . . . . 1.3 109.049 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -75.31 123.71 25.82 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.022 2.82 . . . . 2.8799999999999999 110.254 -173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 p -161.47 178.16 9.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 126.002 2.81 . . . . 1.3 110.44 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.66 143.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 125.954 2.788 . . . . 2.2200000000000002 109.666 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -69.61 82.46 0.42 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.968 2.794 . . . . 5.8799999999999999 110.134 -177.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.97 91.85 46.05 Favored Pre-proline 0 CA--C 1.513 -0.475 0 CA-C-O 126.133 2.873 . . . . 2.9500000000000002 108.84 172.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.527 ' HD3' ' HD1' ' A' ' 11' ' ' TYR . 37.0 Cg_endo -65.98 -47.65 3.45 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 122.791 2.327 . . . . 2.8599999999999999 113.4 -173.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.17 62.49 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 125.831 2.729 . . . . 2.6000000000000001 111.241 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -128.65 42.78 3.26 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.008 2.813 . . . . 4.1200000000000001 109.352 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -59.33 113.34 6.75 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.635 2.636 . . . . 1.79 110.471 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.13 -3.95 11.07 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.047 2.498 . . . . 1.3 112.214 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 4.8 t -79.63 144.99 33.28 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.531 2.586 . . . . 1.3 108.647 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.3 m -59.42 143.52 49.53 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.12 2.867 . . . . 1.3 110.177 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -62.73 118.46 7.71 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 126.159 2.885 . . . . 5.4900000000000002 109.526 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 111.25 -3.23 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.039 -1.891 . . . . 0.55000000000000004 111.129 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.9 mt -127.95 133.81 49.26 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.756 2.693 . . . . 1.8600000000000001 108.328 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.492 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 16.3 mm100 -110.98 120.86 43.79 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 126.148 2.88 . . . . 3.4700000000000002 109.56 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 38.1 t -79.93 120.46 24.17 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 125.859 2.742 . . . . 1.3 109.65 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.675 HH11 ' HB2' ' A' ' 30' ' ' LEU . 6.1 mpt_? -101.95 164.27 11.8 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 125.176 2.417 . . . . 4.3300000000000001 108.595 175.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -58.95 85.83 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.428 3.013 . . . . 5.3200000000000003 110.867 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 144.66 -51.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.731 -2.031 . . . . 0.54000000000000004 110.894 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -163.19 174.24 12.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.351 2.977 . . . . 2.6499999999999999 110.272 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.5 m -77.98 145.21 36.14 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.117 2.865 . . . . 1.3 110.049 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.675 ' HB2' HH11 ' A' ' 25' ' ' ARG . 87.4 mt -126.45 145.12 50.61 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.917 2.77 . . . . 1.8300000000000001 108.426 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.3 m -80.38 119.73 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 126.399 2.999 . . . . 2.1400000000000001 111.195 -172.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 16.2 mm100 -90.93 -55.12 3.67 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 126.461 3.029 . . . . 3.2599999999999998 109.099 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.01 84.51 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 126.239 2.924 . . . . 3.9399999999999999 109.226 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 125.773 2.701 . . . . 2.4900000000000002 110.385 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.3 p -90.63 158.66 16.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.768 2.699 . . . . 1.54 109.511 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.485 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.31 139.11 39.38 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 113.564 -1.653 . . . . 0.77000000000000002 110.697 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 8.5 pt -111.06 -175.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 125.671 2.653 . . . . 1.3799999999999999 111.357 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -41.58 -35.24 0.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 124.443 2.068 . . . . 1.78 114.375 -165.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -145.07 38.6 1.18 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 125.722 2.677 . . . . 1.4399999999999999 110.847 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 20.0 t70 -88.03 142.16 28.0 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 125.747 2.689 . . . . 1.3 108.697 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 4.6 p-10 -71.33 138.45 49.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 125.718 2.675 . . . . 2.8799999999999999 110.21 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 p -168.61 175.26 6.25 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 126.211 2.91 . . . . 1.3 109.849 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' O ' HG21 ' A' ' 12' ' ' VAL . 47.8 t -111.19 144.42 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 125.276 2.465 . . . . 2.2200000000000002 108.334 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -66.34 80.84 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 126.596 3.093 . . . . 5.8799999999999999 110.189 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 10' ' ' VAL . 18.2 m -128.13 79.58 73.66 Favored Pre-proline 0 CA--C 1.511 -0.552 0 CA-C-O 125.8 2.714 . . . . 2.9500000000000002 109.266 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 18.8 Cg_endo -58.59 -44.85 33.67 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 CA-C-O 125.996 2.415 . . . . 2.8599999999999999 112.286 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.61 -24.48 67.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 126.114 2.864 . . . . 2.6000000000000001 110.495 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.421 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 17.3 mm-40 -118.28 31.55 6.62 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 125.652 2.644 . . . . 4.1200000000000001 109.537 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 46.1 t-20 -52.67 110.14 1.8 Allowed Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-O 125.694 2.664 . . . . 1.79 110.913 -175.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -95.08 7.47 2.07 Favored 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 123.599 2.866 . . . . 1.3 111.575 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.485 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 5.1 t -102.8 157.6 16.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 125.269 2.462 . . . . 1.3 108.191 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.71 138.84 58.63 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.557 3.075 . . . . 1.3 109.842 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -65.38 105.81 1.24 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 126.331 2.967 . . . . 5.4900000000000002 109.837 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.492 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 133.85 -9.74 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 112.613 -2.085 . . . . 0.55000000000000004 110.936 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -115.98 130.75 56.95 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.263 2.935 . . . . 1.8600000000000001 109.46 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -81.99 95.65 7.47 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.83 2.729 . . . . 3.4700000000000002 109.818 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 40.3 t -68.1 99.63 0.91 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 126.405 3.002 . . . . 1.3 108.746 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -113.37 167.59 10.44 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.292 2.473 . . . . 4.3300000000000001 108.928 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -51.1 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.088 2.851 . . . . 5.3200000000000003 111.134 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 113.1 -40.24 2.59 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 113.225 -1.807 . . . . 0.54000000000000004 112.498 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -161.21 161.26 30.82 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.585 3.088 . . . . 2.6499999999999999 110.932 -172.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 65.0 m -78.78 139.21 38.44 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 125.693 2.663 . . . . 1.3 108.694 170.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.78 114.11 19.46 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 126.145 2.879 . . . . 1.8300000000000001 109.382 175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.31 131.55 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 125.626 2.631 . . . . 2.1400000000000001 108.761 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 12.7 pt20 -74.37 63.47 1.05 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 126.589 3.09 . . . . 3.2599999999999998 109.954 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.21 59.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 127.012 3.291 . . . . 3.9399999999999999 109.55 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 125.655 2.645 . . . . 2.4900000000000002 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.702 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 30.7 p -67.43 128.3 35.91 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 125.845 2.736 . . . . 1.54 109.405 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -53.87 143.94 27.93 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 113.017 -1.901 . . . . 0.77000000000000002 113.107 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 7' ' ' ASP . 40.3 pt -79.32 169.07 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 126.648 3.118 . . . . 1.3799999999999999 111.169 -176.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.79 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 2.1 pt? -57.44 -6.62 0.47 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 111.796 -2.456 . . . . 1.78 113.54 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 29.5 p80 -154.88 43.36 0.48 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 125.667 2.651 . . . . 1.4399999999999999 110.722 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.1 t70 -87.56 148.24 24.96 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.79 2.71 . . . . 1.3 109.109 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.0 117.74 18.88 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 125.789 2.709 . . . . 2.8799999999999999 109.488 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 6.7 p -156.01 152.21 27.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 126.216 2.912 . . . . 1.3 109.864 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.6 p -81.0 152.53 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-O 125.992 2.806 . . . . 2.2200000000000002 109.211 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -73.25 66.8 0.92 Allowed 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 126.247 2.927 . . . . 5.8799999999999999 111.197 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.24 88.23 45.32 Favored Pre-proline 0 CA--C 1.512 -0.503 0 CA-C-O 126.262 2.934 . . . . 2.9500000000000002 109.064 174.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.7 -39.06 12.49 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 CA-C-O 125.682 2.284 . . . . 2.8599999999999999 112.628 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.36 62.28 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 126.013 2.816 . . . . 2.6000000000000001 111.226 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 15' ' ' GLN . 51.6 tp60 -139.54 47.4 1.87 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 126.326 2.965 . . . . 4.1200000000000001 108.432 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -64.26 116.32 26.93 Favored Pre-proline 0 CA--C 1.512 -0.509 0 CA-C-O 125.986 2.803 . . . . 1.79 110.192 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.08 -10.53 17.92 Favored 'Trans proline' 0 CA--C 1.503 -1.049 0 CA-C-O 126.16 2.483 . . . . 1.3 111.994 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 7.5 t -79.01 158.85 27.85 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 125.707 2.67 . . . . 1.3 108.6 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.702 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -68.67 148.44 50.42 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 126.308 2.956 . . . . 1.3 109.877 -176.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.53 126.41 27.76 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 126.049 2.833 . . . . 5.4900000000000002 109.899 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.22 -10.14 46.84 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 112.934 -1.939 . . . . 0.55000000000000004 110.766 -171.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.44 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 13.0 mt -119.15 135.95 54.42 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.49 2.566 . . . . 1.8600000000000001 107.573 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.43 122.83 39.91 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.249 2.928 . . . . 3.4700000000000002 110.429 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 56.2 m -69.31 111.59 5.32 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 126.072 2.844 . . . . 1.3 110.69 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 59.5 ttt180 -92.74 155.3 17.77 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 124.721 2.2 . . . . 4.3300000000000001 106.641 171.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -47.62 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 126.534 3.064 . . . . 5.3200000000000003 111.622 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 119.1 -48.21 0.96 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 112.573 -2.103 . . . . 0.54000000000000004 112.172 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -138.29 141.51 39.83 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 126.201 2.905 . . . . 2.6499999999999999 110.027 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.7 t -79.02 138.76 38.17 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 125.834 2.731 . . . . 1.3 108.449 174.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.12 137.52 51.93 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 126.308 2.956 . . . . 1.8300000000000001 109.971 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.79 ' HB ' ' HB2' ' A' ' 5' ' ' LEU . 6.2 p -73.07 99.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 126.332 2.968 . . . . 2.1400000000000001 109.223 175.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 5.8 tp60 -73.64 -50.2 22.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 126.384 2.993 . . . . 3.2599999999999998 109.026 -177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -81.9 60.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 126.738 3.161 . . . . 3.9399999999999999 109.644 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 125.744 2.688 . . . . 2.4900000000000002 110.762 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.3 p -89.15 -174.44 4.43 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.364 2.506 . . . . 1.54 107.721 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.626 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -83.34 111.16 3.37 Favored Glycine 0 N--CA 1.444 -0.804 0 O-C-N 120.19 -1.569 . . . . 0.77000000000000002 110.767 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.501 ' HA ' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -117.87 -179.82 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.939 2.78 . . . . 1.3799999999999999 110.029 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -56.42 -4.6 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.168 -2.287 . . . . 1.78 114.238 -166.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.15 37.75 0.63 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 125.861 2.744 . . . . 1.4399999999999999 110.507 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.99 107.63 19.93 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 125.515 2.579 . . . . 1.3 108.877 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -58.46 117.24 4.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 126.441 3.02 . . . . 2.8799999999999999 109.666 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.4 t -161.31 141.43 10.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 125.828 2.728 . . . . 1.3 108.815 -166.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.512 HG22 HG13 ' A' ' 12' ' ' VAL . 17.1 m -93.6 -178.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 126.111 2.863 . . . . 2.2200000000000002 110.274 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 6.9 p90 -68.39 76.68 0.26 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 126.341 2.972 . . . . 5.8799999999999999 110.837 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 HG22 ' A' ' 10' ' ' VAL . 18.7 m -123.03 74.15 48.06 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-O 125.975 2.798 . . . . 2.9500000000000002 110.374 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 4.1 Cg_exo -74.68 -40.24 1.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 CA-C-O 125.944 2.393 . . . . 2.8599999999999999 111.856 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -16.75 60.17 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 126.033 2.825 . . . . 2.6000000000000001 110.837 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.07 36.18 3.67 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.117 2.389 . . . . 4.1200000000000001 109.449 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -49.95 104.66 0.44 Allowed Pre-proline 0 N--CA 1.473 0.717 0 CA-C-O 125.887 2.756 . . . . 1.79 111.078 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -85.35 -4.73 9.39 Favored 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 123.438 2.759 . . . . 1.3 111.883 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.626 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 79.4 m -78.57 146.58 34.15 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 125.882 2.753 . . . . 1.3 110.418 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m -62.32 134.17 56.12 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 125.922 2.772 . . . . 1.3 107.515 172.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -54.69 115.33 2.1 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 126.707 3.146 . . . . 5.4900000000000002 111.901 -163.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.35 -23.53 4.84 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 111.999 -2.364 . . . . 0.55000000000000004 111.267 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 6.3 mp -102.8 150.35 23.58 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 125.869 2.747 . . . . 1.8600000000000001 109.523 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -138.29 139.35 39.1 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 126.132 2.873 . . . . 3.4700000000000002 109.682 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.8 m -67.92 112.43 4.94 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 126.055 2.836 . . . . 1.3 110.338 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 27' ' ' GLY . 56.7 ttt180 -91.67 159.55 15.81 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 124.58 2.133 . . . . 4.3300000000000001 107.409 170.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -52.03 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 126.254 2.93 . . . . 5.3200000000000003 111.312 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 140.94 -50.24 0.75 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 113.092 -1.867 . . . . 0.54000000000000004 111.494 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.34 164.21 32.68 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 126.441 3.02 . . . . 2.6499999999999999 110.105 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 45.5 t -78.89 132.51 36.81 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 125.694 2.664 . . . . 1.3 108.878 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.07 155.85 44.78 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 126.051 2.834 . . . . 1.8300000000000001 109.634 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 38.7 t -73.34 106.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.78 2.705 . . . . 2.1400000000000001 108.445 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -68.86 124.69 24.38 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 125.708 2.67 . . . . 3.2599999999999998 109.855 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.5 71.14 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 126.978 3.275 . . . . 3.9399999999999999 109.13 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 126.399 3.0 . . . . 2.4900000000000002 110.033 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.5 p -85.39 179.06 7.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.996 2.808 . . . . 1.54 109.51 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.57 124.02 26.09 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 113.491 -1.686 . . . . 0.77000000000000002 110.574 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 24.9 pt -117.6 168.23 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 126.039 2.828 . . . . 1.3799999999999999 110.128 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.93 2.85 1.78 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 125.453 2.549 . . . . 1.78 112.676 -166.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -150.25 45.57 0.89 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 126.554 3.074 . . . . 1.4399999999999999 109.858 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 8.3 t70 -123.05 127.93 49.45 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.356 2.503 . . . . 1.3 108.538 174.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.69 135.03 43.66 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 125.532 2.586 . . . . 2.8799999999999999 109.914 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.5 p -165.97 172.27 11.68 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 125.872 2.748 . . . . 1.3 109.663 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.24 153.62 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.434 3.016 . . . . 2.2200000000000002 110.471 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -75.85 87.44 2.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 126.209 2.909 . . . . 5.8799999999999999 110.264 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.17 68.55 11.38 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 126.457 3.027 . . . . 2.9500000000000002 109.777 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.45 -19.83 54.87 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 C-N-CA 122.944 2.429 . . . . 2.8599999999999999 112.781 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.44 -27.92 62.85 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 126.13 2.871 . . . . 2.6000000000000001 110.497 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -130.98 49.35 2.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.492 3.044 . . . . 4.1200000000000001 107.647 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -56.68 116.08 12.03 Favored Pre-proline 0 CA--C 1.511 -0.541 0 CA-C-O 126.103 2.859 . . . . 1.79 111.249 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.52 -11.05 15.83 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 123.33 2.686 . . . . 1.3 112.172 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.51 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 74.1 m -79.13 158.65 27.71 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 125.889 2.757 . . . . 1.3 110.18 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.8 m -66.36 142.8 57.5 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.723 2.677 . . . . 1.3 108.761 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -59.01 110.98 1.14 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 126.641 3.115 . . . . 5.4900000000000002 110.39 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.24 -26.27 3.75 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 112.238 -2.255 . . . . 0.55000000000000004 110.739 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 4.6 mp -105.24 152.4 22.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.565 2.603 . . . . 1.8600000000000001 109.068 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -133.69 129.82 37.32 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.674 2.654 . . . . 3.4700000000000002 110.267 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.7 m -69.64 105.56 2.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.198 2.904 . . . . 1.3 110.193 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -101.27 163.56 12.22 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 125.051 2.357 . . . . 4.3300000000000001 107.941 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -50.58 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 126.275 2.94 . . . . 5.3200000000000003 111.221 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.9 -49.39 0.89 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 112.857 -1.974 . . . . 0.54000000000000004 111.899 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.4 pttt -159.96 162.57 34.42 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 126.808 3.194 . . . . 2.6499999999999999 110.638 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 47.8 t -79.68 124.75 28.85 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 125.894 2.759 . . . . 1.3 109.173 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.446 HD21 ' HE3' ' A' ' 28' ' ' LYS . 97.8 mt -122.62 131.53 53.86 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 126.126 2.869 . . . . 1.8300000000000001 109.491 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 7.7 p -75.1 145.17 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 125.315 2.483 . . . . 2.1400000000000001 108.096 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.71 80.82 0.28 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.278 2.942 . . . . 3.2599999999999998 109.871 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 31' ' ' VAL . 29.8 m -84.0 158.98 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 CA-C-O 126.279 2.942 . . . . 3.9399999999999999 110.096 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 126.441 3.019 . . . . 2.4900000000000002 110.194 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p -90.33 -172.62 3.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 125.962 2.792 . . . . 1.54 109.554 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.8 118.24 6.93 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 113.537 -1.665 . . . . 0.77000000000000002 110.224 170.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.483 ' C ' ' H ' ' A' ' 6' ' ' HIS . 8.0 pt -115.02 167.55 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 125.858 2.742 . . . . 1.3799999999999999 110.119 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.19 12.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 125.42 2.534 . . . . 1.78 112.952 -169.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.483 ' H ' ' C ' ' A' ' 4' ' ' ILE . 18.7 p80 -157.44 41.16 0.31 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 126.068 2.842 . . . . 1.4399999999999999 110.294 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -115.51 119.23 35.51 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.674 2.654 . . . . 1.3 108.816 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.12 123.83 23.7 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.894 2.759 . . . . 2.8799999999999999 109.523 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.2 160.38 43.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 126.034 2.826 . . . . 1.3 110.22 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.87 130.56 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.062 2.839 . . . . 2.2200000000000002 109.255 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 21.3 p90 -70.14 74.52 0.49 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 126.52 3.057 . . . . 5.8799999999999999 111.626 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.12 89.07 38.55 Favored Pre-proline 0 CA--C 1.513 -0.48 0 CA-C-O 126.098 2.856 . . . . 2.9500000000000002 109.664 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.69 -34.07 89.42 Favored 'Trans proline' 0 CA--C 1.507 -0.873 0 C-N-CA 122.995 2.463 . . . . 2.8599999999999999 112.686 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 -25.06 59.31 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 125.784 2.707 . . . . 2.6000000000000001 110.881 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -132.83 39.09 3.35 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 126.021 2.819 . . . . 4.1200000000000001 108.941 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -56.2 111.82 3.66 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 125.884 2.754 . . . . 1.79 109.594 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.25 -12.84 19.07 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 CA-C-O 126.267 2.528 . . . . 1.3 112.299 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.53 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 63.1 m -77.73 150.67 34.4 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 126.054 2.835 . . . . 1.3 110.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.43 145.96 41.82 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 125.75 2.69 . . . . 1.3 108.586 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -62.23 102.11 0.28 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 126.399 2.999 . . . . 5.4900000000000002 110.147 -170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.46 -26.04 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 112.483 -2.144 . . . . 0.55000000000000004 110.931 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 6.0 mp -101.2 148.78 24.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 125.821 2.724 . . . . 1.8600000000000001 109.238 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 32' ' ' GLN . 48.5 tp60 -121.23 129.4 53.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.132 2.872 . . . . 3.4700000000000002 109.543 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 53.5 t -69.58 104.49 2.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.182 2.896 . . . . 1.3 108.563 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' GLY . 15.1 mmt180 -86.21 174.6 9.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.562 2.601 . . . . 4.3300000000000001 109.332 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 m-85 -61.25 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.243 2.925 . . . . 5.3200000000000003 110.608 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 116.19 -26.54 8.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.767 -2.015 . . . . 0.54000000000000004 112.636 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -160.17 149.4 17.53 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 126.418 3.009 . . . . 2.6499999999999999 110.626 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.5 t -79.71 129.66 34.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.872 2.749 . . . . 1.3 109.817 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 156.77 47.97 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 125.86 2.743 . . . . 1.8300000000000001 109.034 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.19 115.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-O 126.068 2.842 . . . . 2.1400000000000001 109.152 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 58.2 tp60 -90.17 140.12 29.98 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.909 2.766 . . . . 3.2599999999999998 109.796 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.4 63.52 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 126.883 3.23 . . . . 3.9399999999999999 108.004 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.983 0 CA-C-O 125.833 2.73 . . . . 2.4900000000000002 110.452 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.0 p -84.5 157.55 21.27 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.766 2.698 . . . . 1.54 108.879 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.558 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -58.75 127.67 45.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 113.627 -1.624 . . . . 0.77000000000000002 111.329 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 5.9 pt -94.71 -176.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 125.469 2.557 . . . . 1.3799999999999999 110.912 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' A' ' 6' ' ' HIS . 2.0 pt? -34.8 -45.43 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 124.841 2.258 . . . . 1.78 114.186 -166.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.617 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 33.4 p80 -142.66 37.75 1.48 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.774 2.702 . . . . 1.4399999999999999 110.628 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 21.2 t70 -73.97 130.59 40.17 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 125.832 2.729 . . . . 1.3 109.253 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.0 m-20 -64.95 134.79 54.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.974 2.797 . . . . 2.8799999999999999 110.39 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.81 161.79 42.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.193 2.901 . . . . 1.3 110.209 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 12' ' ' VAL . 23.9 m -89.6 143.54 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 CA-C-O 125.384 2.516 . . . . 2.2200000000000002 108.362 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -69.11 75.64 0.33 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.449 3.024 . . . . 5.8799999999999999 110.116 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' VAL . 95.2 t -128.38 98.83 25.1 Favored Pre-proline 0 CA--C 1.506 -0.712 0 CA-C-O 125.572 2.606 . . . . 2.9500000000000002 108.606 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.74 -54.46 0.22 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 122.945 2.43 . . . . 2.8599999999999999 113.201 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.76 75.34 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 125.684 2.659 . . . . 2.6000000000000001 111.612 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -116.35 35.82 4.37 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 125.952 2.787 . . . . 4.1200000000000001 109.216 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.97 108.86 3.79 Favored Pre-proline 0 CA--C 1.509 -0.623 0 CA-C-O 125.686 2.66 . . . . 1.79 110.126 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 83.4 Cg_endo -83.36 48.71 2.75 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 CA-C-O 126.737 2.724 . . . . 1.3 110.983 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.558 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 10.6 t -136.86 143.75 43.23 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.105 2.383 . . . . 1.3 107.585 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -59.91 145.87 44.3 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.356 2.979 . . . . 1.3 110.67 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.602 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.59 122.1 21.72 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.322 2.963 . . . . 5.4900000000000002 108.899 -174.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 117.95 -7.4 15.03 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 112.625 -2.08 . . . . 0.55000000000000004 110.171 -171.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.78 139.42 49.74 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.895 2.76 . . . . 1.8600000000000001 108.708 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 30' ' ' LEU . 26.3 pt20 -104.47 121.69 43.98 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.624 2.63 . . . . 3.4700000000000002 109.685 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.3 t -80.58 102.05 9.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 126.074 2.845 . . . . 1.3 108.632 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 25.4 mmt180 -97.93 163.05 12.94 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 125.197 2.427 . . . . 4.3300000000000001 108.645 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -53.1 93.45 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.018 2.818 . . . . 5.3200000000000003 109.941 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 128.55 -50.82 0.87 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.854 -1.975 . . . . 0.54000000000000004 112.404 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 20.8 pttp -162.47 173.88 13.44 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.395 2.998 . . . . 2.6499999999999999 111.312 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 87.4 m -78.65 143.05 36.71 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 126.043 2.83 . . . . 1.3 109.806 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 91.0 mt -126.69 126.82 44.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 125.886 2.755 . . . . 1.8300000000000001 108.469 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 5' ' ' LEU . 2.2 m -66.64 102.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 126.35 2.976 . . . . 2.1400000000000001 110.741 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 23' ' ' GLN . 90.2 mt-30 -59.16 -50.98 71.97 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 126.69 3.138 . . . . 3.2599999999999998 108.795 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.1 m -82.47 62.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-O 126.503 3.049 . . . . 3.9399999999999999 110.276 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 125.857 2.741 . . . . 2.4900000000000002 110.896 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t -90.5 134.58 34.27 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 125.684 2.659 . . . . 1.54 108.874 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.8 127.66 39.23 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 113.543 -1.662 . . . . 0.77000000000000002 112.532 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.9 pt -117.88 178.69 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 126.338 2.97 . . . . 1.3799999999999999 110.827 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -56.57 -11.71 1.44 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 111.952 -2.386 . . . . 1.78 113.786 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -151.1 47.09 0.84 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.499 3.047 . . . . 1.4399999999999999 110.067 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.29 119.19 38.41 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 125.434 2.54 . . . . 1.3 109.158 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -60.06 112.11 1.76 Allowed 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 126.058 2.837 . . . . 2.8799999999999999 108.802 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.8 t -133.39 149.04 51.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 126.086 2.85 . . . . 1.3 110.778 -165.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.87 133.1 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 125.723 2.678 . . . . 2.2200000000000002 108.515 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -67.81 86.94 0.23 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 125.981 2.801 . . . . 5.8799999999999999 110.485 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.73 90.14 33.37 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-O 125.947 2.784 . . . . 2.9500000000000002 109.488 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.2 -47.98 15.49 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 123.23 2.62 . . . . 2.8599999999999999 113.579 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.67 83.53 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.093 2.854 . . . . 2.6000000000000001 110.598 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -111.41 42.31 1.7 Allowed 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 125.579 2.609 . . . . 4.1200000000000001 109.399 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -54.85 113.43 5.34 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 125.877 2.751 . . . . 1.79 110.293 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.75 -13.8 14.34 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.012 2.474 . . . . 1.3 112.388 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 98.5 m -78.19 148.21 34.14 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 126.174 2.892 . . . . 1.3 110.568 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.8 m -66.26 162.11 20.76 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 125.852 2.739 . . . . 1.3 109.578 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -61.0 119.76 8.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.302 2.953 . . . . 5.4900000000000002 110.142 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.81 -4.56 56.28 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 113.127 -1.851 . . . . 0.55000000000000004 111.819 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -101.15 134.97 43.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.008 2.813 . . . . 1.8600000000000001 109.252 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -111.73 110.18 20.43 Favored 'General case' 0 CA--C 1.5 -0.942 0 CA-C-O 125.886 2.755 . . . . 3.4700000000000002 109.325 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.7 t -75.3 129.51 37.53 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.896 2.76 . . . . 1.3 109.039 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -117.62 144.57 45.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 124.672 2.177 . . . . 4.3300000000000001 106.875 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -55.79 97.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.569 3.08 . . . . 5.3200000000000003 109.887 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.68 -53.39 0.79 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 112.489 -2.141 . . . . 0.54000000000000004 111.179 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -150.68 153.84 36.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 126.293 2.949 . . . . 2.6499999999999999 109.938 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 35.2 t -95.93 130.78 42.81 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 125.383 2.516 . . . . 1.3 108.301 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.18 173.14 8.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.28 2.943 . . . . 1.8300000000000001 110.161 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.39 112.93 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-O 125.735 2.683 . . . . 2.1400000000000001 108.756 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 34' ' ' HSL . 42.7 tt0 -60.67 121.36 12.04 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.189 2.899 . . . . 3.2599999999999998 109.742 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.62 -34.64 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 126.208 2.908 . . . . 3.9399999999999999 109.458 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . 0.689 ' O ' ' NE2' ' A' ' 32' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 125.886 2.755 . . . . 2.4900000000000002 110.355 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.1 p -90.12 157.53 17.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.96 2.791 . . . . 1.54 109.501 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.494 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -63.47 138.54 43.07 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 113.392 -1.731 . . . . 0.77000000000000002 111.097 172.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 19.7 pt -115.51 175.56 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 126.486 3.041 . . . . 1.3799999999999999 111.047 -174.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.07 -6.9 0.94 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 111.922 -2.399 . . . . 1.78 113.223 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -150.1 49.06 0.91 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.253 2.93 . . . . 1.4399999999999999 109.862 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 39.1 t70 -115.08 133.72 55.8 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.471 2.558 . . . . 1.3 109.01 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -75.88 133.03 40.67 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 125.671 2.653 . . . . 2.8799999999999999 109.831 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.5 p -162.24 162.06 28.04 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 125.905 2.764 . . . . 1.3 110.214 -176.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.1 m -92.41 151.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 125.77 2.7 . . . . 2.2200000000000002 109.389 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -71.43 76.4 0.77 Allowed 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 126.462 3.029 . . . . 5.8799999999999999 110.521 -172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.28 70.65 79.26 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-O 125.984 2.802 . . . . 2.9500000000000002 110.247 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.09 -32.65 95.02 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-O 125.87 2.362 . . . . 2.8599999999999999 111.945 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.16 -40.28 58.24 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 126.22 2.914 . . . . 2.6000000000000001 110.419 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.56 46.91 2.11 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.914 2.769 . . . . 4.1200000000000001 108.461 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -49.97 113.12 3.14 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-O 125.876 2.751 . . . . 1.79 110.31 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.14 -18.8 14.09 Favored 'Trans proline' 0 CA--C 1.506 -0.895 0 CA-C-O 125.997 2.415 . . . . 1.3 112.257 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.6 m -79.7 161.16 25.96 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 125.923 2.773 . . . . 1.3 109.87 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -67.73 142.83 56.17 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.11 2.862 . . . . 1.3 109.227 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -59.94 115.82 3.69 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 126.302 2.954 . . . . 5.4900000000000002 109.929 -175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.16 -10.0 8.33 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.609 -2.087 . . . . 0.55000000000000004 110.902 -175.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.06 140.87 40.59 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.189 2.899 . . . . 1.8600000000000001 109.637 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -104.76 101.95 11.54 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.056 2.836 . . . . 3.4700000000000002 109.592 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.8 t -77.33 106.46 9.08 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.184 2.897 . . . . 1.3 109.181 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -101.67 150.39 23.16 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 125.193 2.425 . . . . 4.3300000000000001 108.077 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -50.25 100.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.313 2.959 . . . . 5.3200000000000003 110.306 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.66 -50.9 0.78 Allowed Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 112.555 -2.111 . . . . 0.54000000000000004 111.714 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -143.3 134.3 25.57 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 126.406 3.003 . . . . 2.6499999999999999 110.275 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 34.6 t -87.58 123.26 32.27 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 125.676 2.655 . . . . 1.3 108.315 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.2 mt -116.65 173.7 6.48 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.993 2.806 . . . . 1.8300000000000001 109.879 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.04 118.52 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 125.778 2.704 . . . . 2.1400000000000001 108.724 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.83 93.71 0.77 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 125.833 2.73 . . . . 3.2599999999999998 107.707 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.39 104.2 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-O 126.097 2.856 . . . . 3.9399999999999999 109.548 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.931 2.777 . . . . 2.4900000000000002 110.407 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.6 p -83.1 166.8 18.41 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 125.746 2.689 . . . . 1.54 108.706 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -61.4 120.01 20.81 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 113.565 -1.652 . . . . 0.77000000000000002 111.16 173.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.448 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 23.6 pt -117.08 178.18 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 125.723 2.678 . . . . 1.3799999999999999 109.674 -178.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.95 14.38 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 125.256 2.455 . . . . 1.78 113.324 -164.611 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -160.48 31.61 0.16 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 125.914 2.769 . . . . 1.4399999999999999 110.129 172.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -100.93 130.05 46.87 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 125.386 2.517 . . . . 1.3 109.36 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -60.9 116.88 4.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.345 2.974 . . . . 2.8799999999999999 109.009 178.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.5 t -139.03 136.37 35.22 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 126.119 2.866 . . . . 1.3 109.64 -173.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 12' ' ' VAL . 27.9 m -93.5 145.22 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 125.455 2.55 . . . . 2.2200000000000002 108.215 175.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -62.02 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 126.38 2.991 . . . . 5.8799999999999999 111.579 -174.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 15' ' ' GLN . 12.2 m -127.86 93.18 40.37 Favored Pre-proline 0 CA--C 1.506 -0.718 0 CA-C-O 126.115 2.864 . . . . 2.9500000000000002 109.295 174.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.84 -49.94 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.69 0 CA-C-O 126.145 2.477 . . . . 2.8599999999999999 111.749 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.22 -6.7 25.01 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 125.942 2.782 . . . . 2.6000000000000001 110.91 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.589 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 28.9 tt0 -138.56 36.64 2.24 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.038 2.828 . . . . 4.1200000000000001 108.839 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 24.9 t-20 -57.74 113.8 7.12 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 125.799 2.714 . . . . 1.79 110.574 -177.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -84.35 -8.31 9.7 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.239 2.626 . . . . 1.3 112.139 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.512 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 71.3 m -78.99 159.08 27.81 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 125.742 2.686 . . . . 1.3 110.017 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.36 132.21 44.52 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 125.933 2.778 . . . . 1.3 108.139 172.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -56.86 108.61 0.52 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.346 2.974 . . . . 5.4900000000000002 110.327 -172.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.16 -19.49 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 112.68 -2.055 . . . . 0.55000000000000004 110.995 -175.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.36 138.38 41.65 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 125.985 2.802 . . . . 1.8600000000000001 109.562 177.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -94.04 131.64 39.33 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 125.767 2.699 . . . . 3.4700000000000002 109.351 -178.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.0 t -90.91 111.19 22.52 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.04 2.829 . . . . 1.3 108.654 174.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -108.31 152.81 24.13 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.324 2.487 . . . . 4.3300000000000001 108.793 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -46.8 96.35 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.082 2.849 . . . . 5.3200000000000003 110.918 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.34 -49.38 0.89 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.045 -1.889 . . . . 0.54000000000000004 112.374 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.96 156.17 42.37 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 126.531 3.062 . . . . 2.6499999999999999 110.42 -174.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 14.6 t -90.87 147.3 23.25 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.29 2.471 . . . . 1.3 107.731 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 pp -150.36 161.57 42.22 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 126.03 2.824 . . . . 1.8300000000000001 110.004 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' ' 5' ' ' LEU . 11.7 m -74.39 115.39 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.12 2.867 . . . . 2.1400000000000001 109.748 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -78.68 54.2 1.46 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 126.486 3.041 . . . . 3.2599999999999998 109.695 -175.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.0 m -95.94 151.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 125.87 2.747 . . . . 3.9399999999999999 109.86 -177.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 125.916 2.769 . . . . 2.4900000000000002 110.443 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t -87.92 125.17 34.35 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 125.92 2.771 . . . . 1.54 108.777 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.73 129.3 33.01 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 113.27 -1.787 . . . . 0.77000000000000002 111.883 179.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.2 pt -112.72 168.5 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 126.328 2.966 . . . . 1.3799999999999999 110.35 -176.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -59.54 -4.42 0.62 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 125.255 2.455 . . . . 1.78 113.119 -171.206 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.91 50.0 1.27 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 126.358 2.98 . . . . 1.4399999999999999 109.57 176.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.01 165.68 14.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.191 2.424 . . . . 1.3 107.869 172.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 93.6 m-20 -108.42 124.75 50.88 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 125.584 2.611 . . . . 2.8799999999999999 110.08 -172.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 10.4 p -163.12 156.52 19.54 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 125.903 2.763 . . . . 1.3 110.102 -173.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.68 152.71 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 126.2 2.905 . . . . 2.2200000000000002 110.195 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 64.1 t80 -75.69 77.61 2.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 126.243 2.925 . . . . 5.8799999999999999 110.455 -176.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 102.54 35.84 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-O 126.006 2.812 . . . . 2.9500000000000002 108.09 173.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.1 -52.01 9.76 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.649 2.899 . . . . 2.8599999999999999 113.644 -172.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -19.37 64.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 125.687 2.661 . . . . 2.6000000000000001 111.439 -176.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 52.5 tt0 -126.24 36.01 4.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.961 2.791 . . . . 4.1200000000000001 109.886 -177.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -71.59 106.27 1.85 Allowed Pre-proline 0 CA--C 1.511 -0.529 0 CA-C-O 125.796 2.712 . . . . 1.79 108.219 173.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 64.1 Cg_endo -80.95 -8.29 13.2 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 123.242 2.628 . . . . 1.3 113.136 -170.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 71.9 m -78.87 145.13 34.35 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 126.395 2.997 . . . . 1.3 111.074 -171.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -54.78 139.1 40.67 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.294 2.473 . . . . 1.3 109.121 177.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -48.13 108.26 0.16 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 126.488 3.042 . . . . 5.4900000000000002 110.979 -175.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.31 -20.41 5.88 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 112.656 -2.065 . . . . 0.55000000000000004 111.318 -176.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.714 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.5 mt -103.19 145.87 29.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 125.667 2.651 . . . . 1.8600000000000001 109.185 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.27 135.78 37.46 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 125.615 2.626 . . . . 3.4700000000000002 109.285 -177.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 88.6 m -78.95 129.43 34.48 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.447 3.022 . . . . 1.3 111.637 -177.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLY . 7.0 tpp180 -84.1 145.92 28.18 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.314 -2.106 . . . . 4.3300000000000001 105.314 159.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -58.44 81.05 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 126.28 2.943 . . . . 5.3200000000000003 110.26 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 145.29 -45.68 0.82 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.135 -1.848 . . . . 0.54000000000000004 111.345 -177.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 20.8 ptmt -149.62 148.35 29.22 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.246 2.927 . . . . 2.6499999999999999 110.758 -176.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 24.0 t -79.83 144.61 33.35 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 125.784 2.707 . . . . 1.3 109.682 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -132.28 160.76 35.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.128 2.87 . . . . 1.8300000000000001 110.071 -176.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.85 105.65 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 125.764 2.697 . . . . 2.1400000000000001 109.189 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -80.66 102.24 9.74 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 126.135 2.874 . . . . 3.2599999999999998 108.547 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.89 67.22 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 126.866 3.222 . . . . 3.9399999999999999 109.241 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 125.789 2.709 . . . . 2.4900000000000002 110.565 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 p -68.66 151.45 46.69 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 125.899 2.761 . . . . 1.54 109.583 176.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -57.09 124.68 36.61 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 113.234 -1.803 . . . . 0.77000000000000002 112.302 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.7 pt -93.13 177.65 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 126.327 2.965 . . . . 1.3799999999999999 110.778 -176.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.15 -18.58 0.6 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 111.993 -2.367 . . . . 1.78 114.013 -167.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.408 ' O ' ' ND1' ' A' ' 6' ' ' HIS . 19.2 p80 -150.54 48.66 0.88 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 125.927 2.775 . . . . 1.4399999999999999 110.11 178.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -91.79 140.92 29.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 125.675 2.655 . . . . 1.3 109.253 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.98 125.25 29.0 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.833 2.73 . . . . 2.8799999999999999 109.907 -176.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.7 p -175.35 146.1 0.79 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.045 2.831 . . . . 1.3 109.871 -177.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -79.09 168.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 125.983 2.802 . . . . 2.2200000000000002 109.749 178.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -77.56 76.52 4.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.452 3.025 . . . . 5.8799999999999999 109.576 -174.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 m -120.78 87.68 42.81 Favored Pre-proline 0 CA--C 1.512 -0.512 0 CA-C-O 126.2 2.905 . . . . 2.9500000000000002 109.622 176.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.56 -30.89 3.67 Favored 'Trans proline' 0 CA--C 1.509 -0.732 0 C-N-CA 122.595 2.196 . . . . 2.8599999999999999 113.195 -177.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.41 66.4 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.281 2.943 . . . . 2.6000000000000001 110.015 -176.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -124.41 58.58 1.2 Allowed 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.001 2.81 . . . . 4.1200000000000001 108.25 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' OD1' ' HA ' ' A' ' 23' ' ' GLN . 11.5 t30 -61.09 109.1 1.82 Allowed Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-O 126.076 2.846 . . . . 1.79 109.92 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.38 -7.86 14.99 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.582 2.855 . . . . 1.3 113.565 -171.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 90.3 m -78.54 155.09 29.9 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 126.076 2.846 . . . . 1.3 110.319 -175.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.3 m -59.65 150.29 27.95 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 125.361 2.505 . . . . 1.3 109.067 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -61.21 99.98 0.11 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 126.214 2.911 . . . . 5.4900000000000002 110.254 -173.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 130.1 -2.61 5.9 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 112.958 -1.928 . . . . 0.55000000000000004 111.464 -176.053 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.6 mt -123.76 151.06 43.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 125.274 2.464 . . . . 1.8600000000000001 108.668 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 65.6 tt0 -140.66 134.2 30.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.847 2.737 . . . . 3.4700000000000002 110.214 -176.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 64.6 m -71.43 118.46 14.27 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.182 2.896 . . . . 1.3 110.812 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 27.8 tpt180 -93.89 156.55 16.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.014 2.34 . . . . 4.3300000000000001 107.093 170.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.22 92.92 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 126.187 2.898 . . . . 5.3200000000000003 110.215 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.93 -46.25 1.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 112.952 -1.931 . . . . 0.54000000000000004 111.975 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -159.3 158.04 31.67 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.576 3.084 . . . . 2.6499999999999999 110.393 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 13.4 t -78.89 142.58 36.67 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.79 2.709 . . . . 1.3 109.516 -175.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.1 mt -128.44 159.46 35.33 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.26 2.933 . . . . 1.8300000000000001 109.863 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.43 118.43 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 126.294 2.95 . . . . 2.1400000000000001 110.419 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 80.1 mt-30 -73.4 82.51 1.43 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 125.921 2.772 . . . . 3.2599999999999998 110.234 177.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.76 61.45 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 126.864 3.221 . . . . 3.9399999999999999 108.669 172.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 125.641 2.639 . . . . 2.4900000000000002 110.225 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.573 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 17.3 p -81.13 147.96 29.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 125.831 2.729 . . . . 1.54 109.983 -177.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.603 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -73.01 153.56 48.63 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 113.407 -1.724 . . . . 0.77000000000000002 111.351 173.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.9 pt -101.91 172.21 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 126.877 3.227 . . . . 1.3799999999999999 111.961 -174.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.1 pt? -58.31 -1.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.093 -2.776 . . . . 1.78 113.961 -169.496 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 27.4 p80 -156.3 50.27 0.51 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.107 2.86 . . . . 1.4399999999999999 110.335 176.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -99.54 -172.25 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 125.351 2.5 . . . . 1.3 109.044 175.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -113.32 131.61 55.88 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.477 2.56 . . . . 2.8799999999999999 109.502 -175.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 11.5 p -176.77 151.19 0.87 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.299 2.952 . . . . 1.3 110.521 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.12 154.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 125.737 2.684 . . . . 2.2200000000000002 108.749 175.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.9 77.68 0.89 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 126.209 2.909 . . . . 5.8799999999999999 109.795 -178.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.85 99.05 29.78 Favored Pre-proline 0 CA--C 1.513 -0.459 0 CA-C-O 126.1 2.857 . . . . 2.9500000000000002 109.023 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.83 -40.86 26.42 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 CA-C-O 125.695 2.29 . . . . 2.8599999999999999 112.371 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.63 -32.31 63.03 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 125.91 2.767 . . . . 2.6000000000000001 111.0 -177.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 13.8 mm100 -127.51 48.19 2.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.708 2.671 . . . . 4.1200000000000001 110.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -67.6 109.58 4.0 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.517 2.579 . . . . 1.79 108.574 172.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 96.9 Cg_endo -79.39 -17.16 11.65 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 CA-C-O 125.847 2.353 . . . . 1.3 112.775 -175.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.603 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 93.6 m -79.97 161.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 126.179 2.895 . . . . 1.3 110.728 -174.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 m -61.44 146.8 47.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 126.149 2.881 . . . . 1.3 109.432 175.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -67.81 112.67 5.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 126.688 3.137 . . . . 5.4900000000000002 109.777 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.57 -7.34 7.91 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 112.14 -2.3 . . . . 0.55000000000000004 110.74 -172.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.8 mt -108.48 144.35 36.22 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.854 2.74 . . . . 1.8600000000000001 108.947 177.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -112.14 125.7 54.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.045 2.831 . . . . 3.4700000000000002 110.275 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.414 ' SG ' ' HD2' ' A' ' 17' ' ' PRO . 5.2 m -89.29 102.08 14.74 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 125.844 2.735 . . . . 1.3 109.623 173.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 52.7 mtp180 -92.22 168.4 11.37 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 125.297 2.475 . . . . 4.3300000000000001 108.494 174.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -55.0 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.238 2.923 . . . . 5.3200000000000003 110.821 -174.376 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.6 -38.69 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 113.131 -1.85 . . . . 0.54000000000000004 112.744 176.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -140.15 147.41 40.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 126.742 3.163 . . . . 2.6499999999999999 111.582 -169.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 37.0 t -94.81 136.65 34.87 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 125.388 2.518 . . . . 1.3 108.036 175.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 5' ' ' LEU . 2.9 pp -141.64 157.3 45.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.998 2.808 . . . . 1.8300000000000001 110.015 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.15 121.4 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 126.203 2.906 . . . . 2.1400000000000001 109.068 178.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -90.11 129.18 36.43 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.066 2.841 . . . . 3.2599999999999998 109.033 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.89 134.02 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 125.941 2.782 . . . . 3.9399999999999999 109.954 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 125.796 2.713 . . . . 2.4900000000000002 110.017 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -90.44 152.73 20.84 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 126.119 2.866 . . . . 1.54 110.062 -178.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -66.35 147.1 49.66 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 112.985 -1.916 . . . . 0.77000000000000002 112.727 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.57 172.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 126.039 2.828 . . . . 1.3799999999999999 110.396 -175.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.52 -0.4 0.92 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 125.401 2.524 . . . . 1.78 112.63 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -140.85 46.42 1.77 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 126.597 3.094 . . . . 1.4399999999999999 109.694 175.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -135.35 129.22 33.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.473 2.559 . . . . 1.3 108.109 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 41.7 m-80 -70.26 148.24 48.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 125.346 2.498 . . . . 2.8799999999999999 109.677 -177.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 43.0 t -159.68 160.67 34.42 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.277 2.941 . . . . 1.3 110.574 -170.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.83 152.46 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-O 126.226 2.917 . . . . 2.2200000000000002 109.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -71.76 69.02 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 126.271 2.939 . . . . 5.8799999999999999 110.932 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.09 82.56 24.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 126.398 2.999 . . . . 2.9500000000000002 109.927 177.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.51 -31.84 32.96 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 122.881 2.388 . . . . 2.8599999999999999 112.317 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.08 -37.1 14.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 126.022 2.82 . . . . 2.6000000000000001 111.167 -176.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.45 59.32 1.51 Allowed 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 126.283 2.944 . . . . 4.1200000000000001 108.564 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.03 123.06 78.76 Favored Pre-proline 0 CA--C 1.508 -0.656 0 CA-C-O 126.1 2.857 . . . . 1.79 109.711 175.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 -5.36 16.98 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 123.296 2.664 . . . . 1.3 112.549 -176.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 84.5 m -79.09 151.74 31.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 126.353 2.978 . . . . 1.3 110.774 -173.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.1 m -61.01 144.24 53.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.392 2.52 . . . . 1.3 108.868 177.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -55.49 110.79 0.75 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.194 2.902 . . . . 5.4900000000000002 109.506 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.7 -19.89 5.82 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 112.956 -1.929 . . . . 0.55000000000000004 111.469 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.4 mm? -99.97 166.27 11.13 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 125.751 2.691 . . . . 1.8600000000000001 109.547 178.003 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.75 138.5 19.83 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 125.847 2.737 . . . . 3.4700000000000002 109.332 177.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 85.0 m -80.12 121.0 25.01 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.23 2.919 . . . . 1.3 110.467 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -97.34 158.34 15.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 125.088 2.375 . . . . 4.3300000000000001 107.086 172.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -57.24 91.01 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.451 3.024 . . . . 5.3200000000000003 110.069 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 130.5 -46.0 1.1 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 112.389 -2.187 . . . . 0.54000000000000004 111.948 -179.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HA ' ' N ' ' A' ' 9' ' ' CYS . 24.5 pttm -160.57 165.78 30.17 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 126.551 3.072 . . . . 2.6499999999999999 111.182 -174.199 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 17.0 t -86.7 134.28 33.61 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 125.908 2.766 . . . . 1.3 109.961 -176.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.78 174.27 10.12 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 125.855 2.74 . . . . 1.8300000000000001 109.299 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 m -85.35 145.32 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-O 126.211 2.91 . . . . 2.1400000000000001 110.381 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -80.73 94.14 6.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.833 2.73 . . . . 3.2599999999999998 108.62 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.98 75.33 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 126.416 3.008 . . . . 3.9399999999999999 109.058 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.4 p . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 125.785 2.707 . . . . 1.05 108.893 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.669 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -52.18 128.32 34.25 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 113.221 -1.808 . . . . 0.59999999999999998 112.144 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.9 pt -110.21 176.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-O 126.288 2.947 . . . . 0.75 110.66 -175.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.2 pt? -55.26 -11.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 111.821 -2.445 . . . . 1.25 113.731 -169.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -147.86 41.16 1.01 Allowed 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 125.991 2.805 . . . . 1.23 110.314 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.601 ' HB2' HG12 ' A' ' 4' ' ' ILE . 14.3 t70 -107.21 121.49 44.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 125.681 2.658 . . . . 0.96999999999999997 108.252 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 8.7 p30 -54.02 128.18 29.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 125.99 2.805 . . . . 2.1899999999999999 110.425 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -160.58 169.5 22.78 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.982 2.801 . . . . 1.1100000000000001 110.218 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 12' ' ' VAL . 18.6 m -121.24 153.96 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 125.698 2.666 . . . . 1.7 108.863 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 83.5 t80 -73.32 76.91 1.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.303 2.954 . . . . 5.54 110.668 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 10' ' ' VAL . 14.2 m -127.09 79.93 72.3 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-O 126.22 2.914 . . . . 2.4500000000000002 109.86 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -65.69 -30.97 50.19 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 C-N-CA 122.901 2.4 . . . . 2.3500000000000001 112.411 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.4 40.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 126.096 2.855 . . . . 2.1699999999999999 110.984 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -134.96 55.08 1.91 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 126.2 2.905 . . . . 3.5699999999999998 108.368 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 23.5 t-20 -55.46 115.87 10.39 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-O 125.796 2.712 . . . . 1.6299999999999999 110.215 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 46.4 Cg_endo -86.77 -4.0 8.17 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 123.25 2.633 . . . . 0.93999999999999995 112.69 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.669 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 91.5 m -86.62 167.0 14.94 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 126.51 3.052 . . . . 1.03 111.352 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 3.0 m -72.75 131.08 41.88 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.296 2.474 . . . . 1.1200000000000001 107.822 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -54.04 108.42 0.36 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 126.532 3.063 . . . . 4.7199999999999998 110.599 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.81 -17.47 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 112.222 -2.263 . . . . 0.55000000000000004 110.815 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.587 HD22 ' HA ' ' A' ' 31' ' ' VAL . 19.1 mt -110.45 148.35 32.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.49 2.567 . . . . 1.25 108.673 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -135.93 128.35 30.38 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 126.138 2.875 . . . . 2.8399999999999999 110.313 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 90.7 m -67.49 126.14 28.36 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 126.506 3.05 . . . . 1.1399999999999999 111.563 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -108.51 149.03 29.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 124.649 2.166 . . . . 3.7599999999999998 106.952 168.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -55.6 90.24 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.418 3.008 . . . . 5.0199999999999996 110.465 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 139.1 -50.99 0.77 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 112.486 -2.143 . . . . 0.42999999999999999 111.141 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HE3' ' CD2' ' A' ' 30' ' ' LEU . 65.0 pttt -155.08 154.08 31.86 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.202 2.906 . . . . 2.2000000000000002 109.886 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.0 t -79.89 113.95 18.44 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 125.857 2.742 . . . . 0.94999999999999996 108.923 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD2' ' HE3' ' A' ' 28' ' ' LYS . 81.7 mt -83.81 136.47 34.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 126.286 2.946 . . . . 1.3500000000000001 110.39 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.587 ' HA ' HD22 ' A' ' 22' ' ' LEU . 7.0 p -75.78 105.15 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 126.21 2.909 . . . . 1.54 108.063 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 CA--C 1.509 -0.624 0 CA-C-O 126.357 2.98 . . . . 2.71 110.313 -173.716 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.473 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 125.787 2.708 . . . . 1.05 109.638 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.21 152.58 52.56 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 113.709 -1.587 . . . . 0.59999999999999998 111.724 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 28.2 pt -109.04 168.25 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 126.582 3.087 . . . . 0.75 111.182 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -69.13 14.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 125.214 2.435 . . . . 1.25 113.549 -169.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 4' ' ' ILE . 27.9 p-80 -160.37 39.9 0.17 Allowed 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 126.272 2.939 . . . . 1.23 109.872 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 37.8 t70 -121.41 138.44 54.27 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.464 2.554 . . . . 0.96999999999999997 108.555 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -56.05 136.11 52.41 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 126.148 2.88 . . . . 2.1899999999999999 110.043 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 17.4 t -159.26 143.86 15.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.015 2.817 . . . . 1.1100000000000001 109.286 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.24 148.67 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 125.765 2.698 . . . . 1.7 108.872 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 53.9 t80 -73.65 70.62 1.36 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 126.199 2.904 . . . . 5.54 109.369 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -130.38 80.9 69.5 Favored Pre-proline 0 CA--C 1.516 -0.361 0 CA-C-O 126.345 2.974 . . . . 2.4500000000000002 109.475 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 -31.93 25.89 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 CA-C-O 125.559 2.233 . . . . 2.3500000000000001 112.627 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.23 68.7 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.121 2.867 . . . . 2.1699999999999999 110.525 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.33 50.33 1.4 Allowed 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 125.831 2.729 . . . . 3.5699999999999998 108.805 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 52.4 t-20 -50.88 111.81 2.52 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 125.557 2.598 . . . . 1.6299999999999999 109.946 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -89.12 4.21 5.35 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.233 2.622 . . . . 0.93999999999999995 112.786 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 21.3 t -90.82 161.93 15.05 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.517 2.579 . . . . 1.03 108.296 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.473 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 59.4 m -60.66 127.89 33.9 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 126.006 2.813 . . . . 1.1200000000000001 109.496 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -55.42 116.08 2.66 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.325 2.964 . . . . 4.7199999999999998 110.072 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.62 7.99 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 112.651 -2.068 . . . . 0.55000000000000004 110.565 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 40.4 mt -107.87 148.69 29.24 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 125.56 2.6 . . . . 1.25 108.505 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 23' ' ' GLN . 5.9 tp60 -118.25 123.39 45.31 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 126.071 2.843 . . . . 2.8399999999999999 109.759 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.7 m -76.3 106.08 7.72 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 126.176 2.893 . . . . 1.1399999999999999 110.665 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 27' ' ' GLY . 18.7 ttm180 -85.68 149.39 25.34 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.292 2.472 . . . . 3.7599999999999998 108.107 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 11' ' ' TYR . 53.5 t80 -56.76 89.03 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.234 2.921 . . . . 5.0199999999999996 109.602 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 141.63 -50.13 0.74 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 112.582 -2.099 . . . . 0.42999999999999999 111.071 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.717 ' HE2' HD21 ' A' ' 30' ' ' LEU . 23.5 pttm -161.88 161.21 28.79 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.926 2.774 . . . . 2.2000000000000002 109.538 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.1 t -82.78 139.69 33.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.707 2.67 . . . . 0.94999999999999996 109.459 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.717 HD21 ' HE2' ' A' ' 28' ' ' LYS . 94.2 mt -128.81 167.11 17.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.039 2.828 . . . . 1.3500000000000001 109.465 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 5' ' ' LEU . 23.2 m -80.82 134.58 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 125.92 2.771 . . . . 1.54 110.235 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 . . . . . 0 CA--C 1.499 -1.015 0 CA-C-O 126.025 2.821 . . . . 2.71 108.122 171.5 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.8 t . . . . . 0 CA--C 1.506 -0.742 0 CA-C-O 125.606 2.622 . . . . 1.05 108.837 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -67.31 119.18 11.09 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 113.68 -1.6 . . . . 0.59999999999999998 112.403 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.25 171.83 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 126.065 2.841 . . . . 0.75 110.278 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.91 -15.9 46.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 125.209 2.433 . . . . 1.25 112.521 -164.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -131.87 52.94 2.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 126.499 3.047 . . . . 1.23 109.84 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -129.31 133.81 47.62 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 125.92 2.771 . . . . 0.96999999999999997 109.407 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.96 129.97 39.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.904 2.764 . . . . 2.1899999999999999 109.501 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -148.93 137.94 21.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 126.022 2.82 . . . . 1.1100000000000001 110.427 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.07 135.64 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 125.741 2.686 . . . . 1.7 108.94 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.21 86.37 0.06 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 126.304 2.954 . . . . 5.54 111.334 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.79 104.11 27.27 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.97 2.795 . . . . 2.4500000000000002 108.827 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.36 -47.0 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.682 0 CA-C-O 125.666 2.278 . . . . 2.3500000000000001 113.266 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.21 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.982 2.801 . . . . 2.1699999999999999 110.425 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 15' ' ' GLN . 53.1 tt0 -108.85 42.24 1.45 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.84 2.734 . . . . 3.5699999999999998 109.425 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -60.24 111.88 4.65 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 125.949 2.785 . . . . 1.6299999999999999 110.338 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -92.21 8.58 2.87 Favored 'Trans proline' 0 CA--C 1.506 -0.898 0 C-N-CA 123.466 2.778 . . . . 0.93999999999999995 111.901 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 4.6 t -93.23 140.39 29.58 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.485 2.564 . . . . 1.03 109.367 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 m -60.86 125.08 22.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 125.507 2.575 . . . . 1.1200000000000001 109.162 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 3.2 tpm_? -55.41 124.74 18.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 126.287 2.946 . . . . 4.7199999999999998 110.035 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.57 -34.74 4.64 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 112.775 -2.011 . . . . 0.55000000000000004 109.69 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.661 ' HG ' HG12 ' A' ' 31' ' ' VAL . 4.5 mp -102.82 130.65 49.89 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 125.623 2.63 . . . . 1.25 107.317 171.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -101.66 130.91 48.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.402 3.001 . . . . 2.8399999999999999 109.761 -176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 19.2 t -75.38 101.21 4.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 126.064 2.84 . . . . 1.1399999999999999 109.081 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HD3' HD12 ' A' ' 30' ' ' LEU . 71.9 ttt180 -98.56 155.05 17.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.195 2.426 . . . . 3.7599999999999998 108.596 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -49.45 92.62 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.002 2.811 . . . . 5.0199999999999996 111.149 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 120.44 -35.01 3.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 113.483 -1.69 . . . . 0.42999999999999999 112.344 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HE2' HD11 ' A' ' 30' ' ' LEU . 23.9 pttm -160.27 150.99 18.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.388 2.994 . . . . 2.2000000000000002 110.973 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 m -80.25 130.01 34.9 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 125.849 2.738 . . . . 0.94999999999999996 109.439 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.6 HD12 ' HD3' ' A' ' 25' ' ' ARG . 95.4 mt -130.15 138.25 50.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 126.052 2.834 . . . . 1.3500000000000001 109.713 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.661 HG12 ' HG ' ' A' ' 22' ' ' LEU . 27.5 m -66.9 148.22 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 125.594 2.616 . . . . 1.54 109.18 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 126.513 3.054 . . . . 2.71 108.616 176.728 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 CA--C 1.505 -0.783 0 CA-C-O 125.909 2.766 . . . . 1.05 109.467 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.67 144.99 46.32 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 113.648 -1.615 . . . . 0.59999999999999998 111.032 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.463 ' HB ' HD23 ' A' ' 5' ' ' LEU . 32.4 pt -126.94 -178.57 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 126.337 2.97 . . . . 0.75 110.564 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.3 pt? -55.94 -9.64 0.63 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.215 -2.266 . . . . 1.25 114.368 -166.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.88 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 20.1 p-80 -147.16 34.47 0.89 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.943 2.783 . . . . 1.23 110.462 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 16.7 t70 -90.8 114.55 26.96 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 125.493 2.568 . . . . 0.96999999999999997 108.549 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -61.12 111.39 1.69 Allowed 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 126.109 2.861 . . . . 2.1899999999999999 108.686 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.485 ' H ' ' HA ' ' A' ' 28' ' ' LYS . 34.7 t -145.12 142.58 29.78 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.012 2.815 . . . . 1.1100000000000001 109.816 -163.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG13 HG22 ' A' ' 12' ' ' VAL . 7.6 p -81.67 147.21 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 125.955 2.788 . . . . 1.7 109.033 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 67.1 t80 -72.1 79.23 0.94 Allowed 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 126.246 2.926 . . . . 5.54 109.799 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 10' ' ' VAL . 15.3 m -125.46 80.71 65.31 Favored Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 126.11 2.862 . . . . 2.4500000000000002 109.462 175.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 9.6 Cg_exo -71.13 -37.2 6.29 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 CA-C-O 125.859 2.358 . . . . 2.3500000000000001 112.656 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.65 68.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 126.151 2.881 . . . . 2.1699999999999999 110.564 -175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -129.34 42.23 3.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 125.853 2.739 . . . . 3.5699999999999998 109.058 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 65.0 t30 -63.83 112.05 6.56 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-O 125.624 2.631 . . . . 1.6299999999999999 110.171 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -90.97 16.32 1.62 Allowed 'Trans proline' 0 CA--C 1.508 -0.793 0 CA-C-O 126.687 2.703 . . . . 0.93999999999999995 111.837 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -98.43 149.27 22.86 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.584 2.611 . . . . 1.03 108.607 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.31 153.9 25.31 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 126.411 3.005 . . . . 1.1200000000000001 111.146 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -61.75 119.39 8.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 126.031 2.824 . . . . 4.7199999999999998 110.057 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 22' ' ' LEU . . . 106.82 2.97 36.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.059 -1.882 . . . . 0.55000000000000004 111.241 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.585 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 4.9 mp -129.51 139.87 51.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 125.806 2.717 . . . . 1.25 108.866 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 33.7 tt0 -123.22 123.76 41.49 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 125.739 2.685 . . . . 2.8399999999999999 110.422 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 23.2 m -70.82 97.49 1.4 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.891 2.758 . . . . 1.1399999999999999 109.863 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 8.0 tmm_? -100.09 157.04 16.85 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.17 2.414 . . . . 3.7599999999999998 108.32 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -44.97 95.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.139 2.876 . . . . 5.0199999999999996 111.07 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 129.91 -57.08 0.73 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 112.993 -1.912 . . . . 0.42999999999999999 111.503 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.88 ' HD2' ' HA ' ' A' ' 6' ' ' HIS . 21.7 pttm -160.49 163.75 32.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 126.247 2.927 . . . . 2.2000000000000002 109.782 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 28.1 t -81.42 133.66 35.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 125.517 2.58 . . . . 0.94999999999999996 108.79 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.8 pp -122.85 150.09 43.33 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 125.991 2.805 . . . . 1.3500000000000001 110.018 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.401 HG12 ' HG ' ' A' ' 22' ' ' LEU . 7.9 m -73.29 92.44 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 126.087 2.851 . . . . 1.54 110.23 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' HB2' ' A' ' 23' ' ' GLN . 20.8 pt20 . . . . . 0 CA--C 1.51 -0.574 0 CA-C-O 126.278 2.942 . . . . 2.71 109.255 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.503 -0.836 0 CA-C-O 125.434 2.54 . . . . 1.05 108.072 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -56.28 123.21 30.61 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 113.674 -1.603 . . . . 0.59999999999999998 112.057 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.805 HG12 ' HB2' ' A' ' 7' ' ' ASP . 20.1 pt -90.57 173.36 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.257 2.932 . . . . 0.75 110.011 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.86 6.24 0.72 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 125.279 2.466 . . . . 1.25 112.946 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 4' ' ' ILE . 10.0 p80 -161.01 45.86 0.19 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 125.955 2.788 . . . . 1.23 109.619 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 4' ' ' ILE . 31.0 t70 -102.86 131.3 49.85 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.593 2.616 . . . . 0.96999999999999997 109.184 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -56.05 133.09 51.66 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 126.104 2.859 . . . . 2.1899999999999999 110.976 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.7 p -170.58 145.05 2.48 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.944 2.783 . . . . 1.1100000000000001 109.251 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.574 HG23 HG12 ' A' ' 12' ' ' VAL . 23.3 m -82.19 155.82 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 125.864 2.745 . . . . 1.7 109.396 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.72 76.04 1.55 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 126.03 2.824 . . . . 5.54 109.468 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.574 HG12 HG23 ' A' ' 10' ' ' VAL . 8.1 p -134.98 89.54 24.08 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 126.372 2.987 . . . . 2.4500000000000002 109.629 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 35.3 Cg_exo -59.69 -39.05 77.29 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 CA-C-O 126.014 2.423 . . . . 2.3500000000000001 112.038 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -36.57 47.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 125.806 2.717 . . . . 2.1699999999999999 111.155 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.406 ' H ' HG22 ' A' ' 12' ' ' VAL . 51.0 mt-30 -122.39 39.23 3.96 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 125.745 2.688 . . . . 3.5699999999999998 109.836 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 25.1 t-20 -72.2 115.41 38.43 Favored Pre-proline 0 CA--C 1.508 -0.658 0 CA-C-O 125.813 2.72 . . . . 1.6299999999999999 109.76 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 16' ' ' ASN . 87.8 Cg_endo -98.28 11.98 0.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.281 2.654 . . . . 0.93999999999999995 112.655 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.556 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.6 t -91.92 149.41 21.57 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 125.771 2.701 . . . . 1.03 109.735 -174.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' HB2' HD22 ' A' ' 22' ' ' LEU . 72.5 m -59.51 143.15 50.87 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 125.943 2.782 . . . . 1.1200000000000001 109.609 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.68 131.61 51.27 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.263 2.935 . . . . 4.7199999999999998 110.583 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.28 -22.5 36.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 112.94 -1.936 . . . . 0.55000000000000004 111.243 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.502 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 5.1 mp -97.7 135.2 39.83 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 125.645 2.64 . . . . 1.25 108.404 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -114.91 132.8 56.42 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 125.867 2.746 . . . . 2.8399999999999999 110.116 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 m -85.04 114.78 22.45 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 126.109 2.861 . . . . 1.1399999999999999 110.617 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 16.4 mmt180 -87.84 159.21 18.5 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 124.558 2.123 . . . . 3.7599999999999998 106.192 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.22 78.46 0.24 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 126.218 2.913 . . . . 5.0199999999999996 109.972 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 146.07 -33.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.974 -1.921 . . . . 0.42999999999999999 111.754 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.83 143.33 15.73 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 126.012 2.815 . . . . 2.2000000000000002 110.107 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 29.3 t -87.73 141.69 28.4 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.444 2.545 . . . . 0.94999999999999996 108.28 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.59 138.73 38.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.583 2.611 . . . . 1.3500000000000001 108.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.56 113.05 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 126.215 2.912 . . . . 1.54 109.918 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? . . . . . 0 CA--C 1.505 -0.786 0 CA-C-O 126.079 2.847 . . . . 2.71 108.447 178.757 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.52 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 28.3 p . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 125.989 2.804 . . . . 1.05 109.463 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.94 150.93 51.97 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 113.203 -1.817 . . . . 0.59999999999999998 112.399 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 6' ' ' HIS . 10.1 pt -92.86 167.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 126.137 2.875 . . . . 0.75 110.455 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.531 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -68.47 18.92 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 125.45 2.548 . . . . 1.25 112.886 -172.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.535 ' H ' ' C ' ' A' ' 4' ' ' ILE . 24.5 p-80 -161.58 41.91 0.15 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.168 2.89 . . . . 1.23 109.714 173.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.2 t0 -116.29 152.96 32.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 125.552 2.596 . . . . 0.96999999999999997 108.268 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 133.13 37.55 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.089 2.852 . . . . 2.1899999999999999 111.093 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 12.2 p 177.18 124.62 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 125.888 2.756 . . . . 1.1100000000000001 108.559 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 12' ' ' VAL . 27.1 m -79.57 -159.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 125.558 2.599 . . . . 1.7 110.695 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.417 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 10.8 p90 -70.27 75.05 0.52 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 126.707 3.146 . . . . 5.54 110.582 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' VAL . 11.8 m -127.97 81.6 70.04 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.991 2.805 . . . . 2.4500000000000002 109.942 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 3.4 Cg_exo -75.94 -54.86 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.787 0 CA-C-O 125.881 2.367 . . . . 2.3500000000000001 111.913 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.72 77.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 126.212 2.91 . . . . 2.1699999999999999 110.077 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -108.68 39.1 2.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 125.65 2.643 . . . . 3.5699999999999998 109.723 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 54.9 t-20 -64.4 113.03 9.04 Favored Pre-proline 0 CA--C 1.512 -0.502 0 CA-C-O 125.803 2.716 . . . . 1.6299999999999999 110.156 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 72.3 Cg_endo -91.1 -2.25 4.77 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 123.083 2.522 . . . . 0.93999999999999995 112.37 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.1 t -87.18 161.37 18.1 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 125.796 2.712 . . . . 1.03 109.214 -175.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.52 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 84.4 m -63.77 135.24 56.5 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 126.181 2.896 . . . . 1.1200000000000001 110.174 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -58.43 116.3 3.55 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.378 2.99 . . . . 4.7199999999999998 109.55 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 123.64 -14.9 8.07 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 112.818 -1.992 . . . . 0.55000000000000004 110.655 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.8 mt -119.16 158.79 25.25 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 125.563 2.602 . . . . 1.25 108.86 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.675 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 28.2 mm-40 -131.89 134.57 45.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.817 2.722 . . . . 2.8399999999999999 110.051 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 87.3 m -83.03 120.11 25.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 126.147 2.88 . . . . 1.1399999999999999 110.05 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 19.1 ttt180 -110.79 164.22 12.98 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.087 2.375 . . . . 3.7599999999999998 108.337 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' N ' ' HG2' ' A' ' 25' ' ' ARG . 70.5 m-85 -45.62 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.319 2.961 . . . . 5.0199999999999996 110.909 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.58 -54.66 0.73 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.441 -2.163 . . . . 0.42999999999999999 112.043 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -160.39 166.68 28.89 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 126.554 3.073 . . . . 2.2000000000000002 110.752 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.725 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 50.9 t -86.84 141.55 28.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 125.804 2.716 . . . . 0.94999999999999996 109.778 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.67 174.25 10.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.661 2.648 . . . . 1.3500000000000001 108.792 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.42 136.74 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 125.554 2.597 . . . . 1.54 109.266 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.675 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 6.7 pt20 . . . . . 0 CA--C 1.505 -0.771 0 CA-C-O 126.216 2.912 . . . . 2.71 109.574 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 126.294 2.949 . . . . 1.05 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.427 ' HA2' ' OD2' ' A' ' 7' ' ' ASP . . . -72.71 123.81 9.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 113.213 -1.812 . . . . 0.59999999999999998 110.971 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.778 HG12 ' HB2' ' A' ' 7' ' ' ASP . 26.1 pt -90.01 177.23 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 125.848 2.737 . . . . 0.75 110.307 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.8 12.0 0.58 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 125.731 2.682 . . . . 1.25 112.067 -168.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 4' ' ' ILE . 14.1 p80 -160.26 43.32 0.2 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 126.47 3.033 . . . . 1.23 108.59 172.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.778 ' HB2' HG12 ' A' ' 4' ' ' ILE . 47.0 t0 -114.4 138.12 50.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 125.686 2.66 . . . . 0.96999999999999997 108.721 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.9 m-20 -67.96 130.65 43.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.856 2.741 . . . . 2.1899999999999999 110.389 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 17' ' ' PRO . 14.2 p -153.1 145.48 24.03 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 126.206 2.907 . . . . 1.1100000000000001 110.583 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.2 p -88.77 137.88 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 125.09 2.376 . . . . 1.7 107.739 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 26' ' ' TYR . 8.0 p90 -70.45 79.69 0.56 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 126.81 3.195 . . . . 5.54 110.878 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 10' ' ' VAL . 17.6 m -126.84 106.52 22.68 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 125.988 2.804 . . . . 2.4500000000000002 109.443 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.75 -38.25 4.43 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 CA-C-O 125.692 2.288 . . . . 2.3500000000000001 112.311 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.99 -52.02 21.48 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 125.88 2.752 . . . . 2.1699999999999999 110.727 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.17 61.52 0.9 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 126.031 2.824 . . . . 3.5699999999999998 107.807 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 17.4 t-20 -54.49 117.87 14.78 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 125.736 2.684 . . . . 1.6299999999999999 110.662 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.413 ' CG ' ' HB2' ' A' ' 9' ' ' CYS . 92.8 Cg_endo -80.68 -14.35 11.43 Favored 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 123.379 2.719 . . . . 0.93999999999999995 112.777 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 55.7 m -79.42 146.18 32.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 126.013 2.816 . . . . 1.03 109.445 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.59 144.73 56.24 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.754 2.693 . . . . 1.1200000000000001 108.586 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' C ' ' HD3' ' A' ' 20' ' ' ARG . 2.6 tmt_? -57.16 109.99 0.76 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 126.353 2.978 . . . . 4.7199999999999998 109.946 -172.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.88 -11.86 7.35 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 112.654 -2.067 . . . . 0.55000000000000004 111.424 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 31' ' ' VAL . 78.7 mt -112.38 146.44 38.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.994 2.807 . . . . 1.25 109.747 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.646 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 52.3 tt0 -106.19 137.11 44.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.421 2.534 . . . . 2.8399999999999999 109.173 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 52.2 t -92.47 109.94 21.35 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.448 3.023 . . . . 1.1399999999999999 109.944 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.575 ' HG3' HD12 ' A' ' 30' ' ' LEU . 35.1 mmt180 -96.83 137.07 36.48 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 124.727 2.204 . . . . 3.7599999999999998 106.917 170.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.587 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 35.0 p90 -50.32 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 126.659 3.123 . . . . 5.0199999999999996 110.541 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 134.65 -46.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 112.384 -2.189 . . . . 0.42999999999999999 111.836 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 22.0 pttm -160.08 154.16 23.24 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 126.539 3.066 . . . . 2.2000000000000002 111.036 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 84.6 m -79.75 138.87 37.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 125.798 2.713 . . . . 0.94999999999999996 109.183 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.575 HD12 ' HG3' ' A' ' 25' ' ' ARG . 96.0 mt -130.44 162.33 29.41 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.726 2.679 . . . . 1.3500000000000001 109.012 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 13.3 m -69.17 112.13 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 126.231 2.919 . . . . 1.54 110.3 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 62.2 tt0 . . . . . 0 CA--C 1.507 -0.695 0 CA-C-O 126.367 2.984 . . . . 2.71 109.374 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 CA--C 1.508 -0.636 0 CA-C-O 126.135 2.874 . . . . 1.05 109.655 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.92 126.41 36.76 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 113.116 -1.857 . . . . 0.59999999999999998 112.666 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.644 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.9 pt -108.29 176.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 126.257 2.932 . . . . 0.75 110.069 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -64.89 3.62 0.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.844 2.259 . . . . 1.25 113.451 -169.161 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -152.56 36.1 0.51 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 126.16 2.886 . . . . 1.23 109.711 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.603 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.7 t70 -111.31 137.69 48.73 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.657 2.646 . . . . 0.96999999999999997 109.137 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.79 131.73 50.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.566 2.603 . . . . 2.1899999999999999 109.561 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -156.35 143.35 18.87 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 126.281 2.943 . . . . 1.1100000000000001 110.717 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 12' ' ' VAL . 23.7 m -103.82 146.04 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-O 125.494 2.568 . . . . 1.7 108.455 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' HD2' ' H ' ' A' ' 26' ' ' TYR . 3.2 t80 -70.24 86.32 0.58 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 126.176 2.893 . . . . 5.54 110.175 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' VAL . 5.6 p -132.96 84.39 49.29 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-O 126.286 2.946 . . . . 2.4500000000000002 109.268 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.3 -43.66 17.56 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-O 125.808 2.337 . . . . 2.3500000000000001 112.833 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.34 -39.15 63.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 126.176 2.893 . . . . 2.1699999999999999 110.893 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -127.63 48.55 2.23 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.998 2.808 . . . . 3.5699999999999998 109.146 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -50.69 112.44 2.89 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-O 125.96 2.791 . . . . 1.6299999999999999 110.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.85 -6.77 17.07 Favored 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 123.239 2.626 . . . . 0.93999999999999995 112.398 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.9 m -78.75 154.31 30.11 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.292 2.949 . . . . 1.03 110.599 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' HD23 ' A' ' 22' ' ' LEU . 23.5 m -62.86 136.92 58.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 125.306 2.479 . . . . 1.1200000000000001 107.964 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -55.97 107.7 0.38 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 126.302 2.953 . . . . 4.7199999999999998 110.426 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.34 -23.3 4.88 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 112.7 -2.046 . . . . 0.55000000000000004 111.3 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.8 mm? -94.62 134.21 37.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.948 2.785 . . . . 1.25 109.255 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -105.63 118.07 35.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 126.265 2.936 . . . . 2.8399999999999999 109.203 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 36.6 t -79.59 132.42 36.26 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.963 2.792 . . . . 1.1399999999999999 110.487 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 15.6 ttm180 -122.95 143.25 50.03 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 125.328 2.489 . . . . 3.7599999999999998 108.083 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.52 ' H ' ' HD2' ' A' ' 11' ' ' TYR . 9.6 p90 -50.1 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 126.501 3.048 . . . . 5.0199999999999996 110.726 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.5 -56.84 0.72 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 112.468 -2.151 . . . . 0.42999999999999999 110.916 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HE3' HD21 ' A' ' 30' ' ' LEU . 64.3 pttt -156.81 161.42 39.74 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 126.619 3.104 . . . . 2.2000000000000002 109.733 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 11.9 t -88.42 138.02 31.8 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 125.53 2.586 . . . . 0.94999999999999996 109.352 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.459 HD21 ' HE3' ' A' ' 28' ' ' LYS . 75.4 mt -124.66 167.54 14.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 126.015 2.817 . . . . 1.3500000000000001 109.633 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.97 136.3 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 CA-C-O 125.382 2.515 . . . . 1.54 108.805 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.701 3.143 . . . . 2.71 109.112 176.258 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.6 p . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 125.991 2.805 . . . . 1.05 109.849 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.499 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.65 136.89 44.39 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 113.302 -1.772 . . . . 0.59999999999999998 112.077 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.448 ' H ' ' HB2' ' A' ' 7' ' ' ASP . 22.7 pt -100.67 169.03 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 126.684 3.135 . . . . 0.75 111.233 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.653 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.1 pt? -57.09 -6.93 0.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 111.627 -2.533 . . . . 1.25 113.391 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -147.89 51.96 1.04 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.583 3.087 . . . . 1.23 109.31 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 5.6 t0 -112.9 122.6 48.13 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 125.473 2.558 . . . . 0.96999999999999997 108.559 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.94 123.04 15.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 125.582 2.61 . . . . 2.1899999999999999 109.661 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 t -161.92 152.79 17.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.068 2.842 . . . . 1.1100000000000001 110.256 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 24' ' ' CYS . 30.8 m -97.8 171.89 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 125.963 2.792 . . . . 1.7 109.582 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -81.8 73.98 8.81 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 126.178 2.894 . . . . 5.54 110.168 -173.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.9 87.73 50.59 Favored Pre-proline 0 CA--C 1.514 -0.435 0 CA-C-O 126.264 2.935 . . . . 2.4500000000000002 110.588 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.22 -35.21 5.3 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.981 2.454 . . . . 2.3500000000000001 112.284 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.05 -28.69 25.95 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.056 2.836 . . . . 2.1699999999999999 111.152 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 46.8 tp60 -141.73 57.52 1.5 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 125.861 2.744 . . . . 3.5699999999999998 108.34 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.4 107.67 1.21 Allowed Pre-proline 0 CA--C 1.509 -0.622 0 CA-C-O 125.656 2.646 . . . . 1.6299999999999999 109.161 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 79.3 Cg_endo -78.92 -8.76 15.62 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 C-N-CA 123.189 2.593 . . . . 0.93999999999999995 112.469 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 87.0 m -77.49 150.36 34.9 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 126.232 2.92 . . . . 1.03 110.676 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.499 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 4.5 m -58.08 135.48 57.01 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.154 2.407 . . . . 1.1200000000000001 107.947 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -57.78 113.28 1.78 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 126.509 3.052 . . . . 4.7199999999999998 110.343 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 126.68 -18.11 6.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 112.123 -2.308 . . . . 0.55000000000000004 110.331 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 33.9 mt -119.07 148.68 42.77 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 125.428 2.537 . . . . 1.25 108.098 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -139.66 136.13 33.95 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 126.004 2.811 . . . . 2.8399999999999999 109.914 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 68.0 m -67.19 129.83 41.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.156 2.884 . . . . 1.1399999999999999 110.492 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.667 ' HD3' HD12 ' A' ' 30' ' ' LEU . 42.9 mtp180 -128.35 133.97 48.77 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 124.993 2.33 . . . . 3.7599999999999998 107.625 170.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -37.88 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 126.743 3.163 . . . . 5.0199999999999996 112.302 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 137.66 -58.5 0.63 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 112.226 -2.261 . . . . 0.42999999999999999 110.759 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 154.9 36.07 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.65 3.119 . . . . 2.2000000000000002 109.963 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.0 t -79.81 130.13 35.06 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 125.568 2.604 . . . . 0.94999999999999996 108.545 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.667 HD12 ' HD3' ' A' ' 25' ' ' ARG . 95.9 mt -127.34 160.94 29.86 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 125.912 2.768 . . . . 1.3500000000000001 109.556 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 t -71.78 109.99 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 125.52 2.581 . . . . 1.54 107.199 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 18.0 pt20 . . . . . 0 CA--C 1.504 -0.795 0 CA-C-O 125.796 2.713 . . . . 2.71 111.566 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 17.7 p . . . . . 0 CA--C 1.503 -0.837 0 CA-C-O 126.065 2.841 . . . . 1.05 109.915 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.577 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.69 128.54 15.17 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 113.271 -1.786 . . . . 0.59999999999999998 110.931 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.698 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.0 pt -98.34 177.95 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 126.079 2.847 . . . . 0.75 110.183 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.5 pt? -57.12 -7.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.291 -2.231 . . . . 1.25 114.041 -167.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.45 48.5 0.36 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.184 2.897 . . . . 1.23 109.788 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.698 ' HB2' HG12 ' A' ' 4' ' ' ILE . 22.3 t70 -101.41 123.64 45.81 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.745 2.688 . . . . 0.96999999999999997 109.655 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -64.63 123.17 18.61 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.132 2.872 . . . . 2.1899999999999999 110.502 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.4 p -157.97 174.25 15.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.73 2.681 . . . . 1.1100000000000001 109.849 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.24 149.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 126.005 2.812 . . . . 1.7 109.773 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.747 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 40.7 t80 -77.78 76.3 4.31 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 126.276 2.941 . . . . 5.54 110.405 -170.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.49 85.92 48.44 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-O 125.607 2.623 . . . . 2.4500000000000002 109.271 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.72 -38.04 52.44 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.655 2.236 . . . . 2.3500000000000001 112.925 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.32 -23.15 63.99 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 126.184 2.897 . . . . 2.1699999999999999 110.518 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -135.29 47.69 2.3 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 125.917 2.77 . . . . 3.5699999999999998 109.079 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -58.02 113.58 6.78 Favored Pre-proline 0 CA--C 1.51 -0.595 0 CA-C-O 125.756 2.693 . . . . 1.6299999999999999 109.406 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 64.2 Cg_endo -79.89 -6.84 14.32 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 123.241 2.627 . . . . 0.93999999999999995 112.626 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 74.4 m -78.24 155.54 30.22 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 126.174 2.892 . . . . 1.03 110.852 -171.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -62.8 150.32 41.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 125.683 2.659 . . . . 1.1200000000000001 109.092 174.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -59.87 103.24 0.2 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 126.238 2.923 . . . . 4.7199999999999998 110.371 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.04 -5.31 8.34 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 112.752 -2.022 . . . . 0.55000000000000004 111.973 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 75.8 mt -114.36 137.44 51.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 125.879 2.752 . . . . 1.25 109.152 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -116.94 119.4 35.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 126.022 2.82 . . . . 2.8399999999999999 109.76 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.8 t -73.68 129.59 38.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 126.011 2.815 . . . . 1.1399999999999999 109.912 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.747 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 36.6 ttm180 -111.97 154.08 25.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 125.154 2.407 . . . . 3.7599999999999998 108.321 174.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -52.51 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 126.452 3.025 . . . . 5.0199999999999996 109.697 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.4 -54.4 0.79 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 112.531 -2.122 . . . . 0.42999999999999999 110.912 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -161.43 159.43 28.14 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.461 3.029 . . . . 2.2000000000000002 110.344 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 22.8 t -81.47 145.7 30.61 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.4 2.524 . . . . 0.94999999999999996 109.207 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 168.74 18.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 125.999 2.809 . . . . 1.3500000000000001 110.076 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.14 155.78 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-O 125.911 2.767 . . . . 1.54 110.053 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 126.144 2.878 . . . . 2.71 110.674 179.511 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.505 -0.762 0 CA-C-O 125.934 2.778 . . . . 1.05 108.395 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.919 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.5 119.81 19.91 Favored Glycine 0 C--O 1.236 0.257 0 CA-C-N 113.333 -1.758 . . . . 0.59999999999999998 112.333 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 6' ' ' HIS . 13.0 pt -102.16 164.73 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 126.179 2.895 . . . . 0.75 110.236 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -66.77 12.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 125.293 2.473 . . . . 1.25 113.072 -171.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 4' ' ' ILE . 20.5 p-80 -154.88 42.16 0.46 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.197 2.903 . . . . 1.23 109.627 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 34.5 t70 -112.69 125.12 53.96 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 125.967 2.794 . . . . 0.96999999999999997 109.12 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.0 p-10 -76.1 122.48 24.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 126.163 2.887 . . . . 2.1899999999999999 109.764 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.6 p -149.04 171.61 16.11 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.774 2.702 . . . . 1.1100000000000001 109.73 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.89 146.9 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 126.218 2.913 . . . . 1.7 109.777 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.572 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.5 p90 -71.63 71.58 0.72 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.503 3.049 . . . . 5.54 110.741 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.31 94.07 31.19 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-O 125.834 2.73 . . . . 2.4500000000000002 109.261 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.93 -29.88 82.8 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.957 2.438 . . . . 2.3500000000000001 112.924 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.89 -38.93 17.45 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 125.996 2.807 . . . . 2.1699999999999999 110.533 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 18.3 tt0 -132.4 65.7 1.57 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.941 2.781 . . . . 3.5699999999999998 108.498 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -61.47 109.76 2.48 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-O 125.625 2.631 . . . . 1.6299999999999999 109.377 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 3' ' ' GLY . 70.6 Cg_endo -82.25 -10.04 11.35 Favored 'Trans proline' 0 CA--C 1.498 -1.283 0 CA-C-O 126.241 2.517 . . . . 0.93999999999999995 112.204 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.919 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 94.4 m -79.69 154.07 28.87 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 126.0 2.809 . . . . 1.03 110.165 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.3 m -65.07 110.01 2.35 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 125.273 2.464 . . . . 1.1200000000000001 106.308 167.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -51.12 118.6 3.33 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 127.054 3.312 . . . . 4.7199999999999998 109.935 -173.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -26.37 3.62 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 111.314 -2.676 . . . . 0.55000000000000004 109.356 -165.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 7.2 mp -105.02 152.53 22.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 125.613 2.625 . . . . 1.25 108.714 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -121.49 135.26 55.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.195 2.902 . . . . 2.8399999999999999 110.566 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' A' ' 18' ' ' CYS . 3.0 m -77.3 97.44 4.87 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 125.962 2.791 . . . . 1.1399999999999999 109.696 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.734 ' HD2' HD12 ' A' ' 30' ' ' LEU . 87.8 mtt180 -86.23 157.39 19.96 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 124.922 2.296 . . . . 3.7599999999999998 107.241 172.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -49.6 94.3 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 126.378 2.99 . . . . 5.0199999999999996 110.522 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.19 -47.34 1.05 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 112.688 -2.051 . . . . 0.42999999999999999 112.492 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -130.95 138.68 49.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.582 3.087 . . . . 2.2000000000000002 111.564 -168.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.8 t -79.67 105.48 10.99 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 125.803 2.716 . . . . 0.94999999999999996 107.852 170.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 25' ' ' ARG . 94.2 mt -120.6 142.43 49.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 126.016 2.817 . . . . 1.3500000000000001 109.488 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.701 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 34.5 t -59.15 128.84 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 CA-C-O 125.753 2.692 . . . . 1.54 109.75 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 126.318 2.961 . . . . 2.71 109.205 179.73 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t . . . . . 0 CA--C 1.505 -0.75 0 CA-C-O 125.861 2.743 . . . . 1.05 109.524 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -66.01 109.4 2.87 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 113.391 -1.731 . . . . 0.59999999999999998 111.666 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.8 pt -91.71 -178.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 125.452 2.549 . . . . 0.75 110.536 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.42 ' N ' HD23 ' A' ' 5' ' ' LEU . 2.5 pt? -37.05 -38.38 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 124.368 2.032 . . . . 1.25 114.617 -166.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -141.94 29.72 1.67 Allowed 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 125.477 2.561 . . . . 1.23 111.284 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.79 132.67 44.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 125.675 2.655 . . . . 0.96999999999999997 109.049 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 79.7 m-20 -75.31 123.71 25.82 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.022 2.82 . . . . 2.1899999999999999 110.254 -173.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 p -161.47 178.16 9.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 126.002 2.81 . . . . 1.1100000000000001 110.44 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.66 143.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 125.954 2.788 . . . . 1.7 109.666 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -69.61 82.46 0.42 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.968 2.794 . . . . 5.54 110.134 -177.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 7.7 p -119.97 91.85 46.05 Favored Pre-proline 0 CA--C 1.513 -0.475 0 CA-C-O 126.133 2.873 . . . . 2.4500000000000002 108.84 172.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HD3' ' HD1' ' A' ' 11' ' ' TYR . 37.0 Cg_endo -65.98 -47.65 3.45 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 122.791 2.327 . . . . 2.3500000000000001 113.4 -173.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.17 62.49 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 125.831 2.729 . . . . 2.1699999999999999 111.241 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -128.65 42.78 3.26 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.008 2.813 . . . . 3.5699999999999998 109.352 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -59.33 113.34 6.75 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.635 2.636 . . . . 1.6299999999999999 110.471 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.13 -3.95 11.07 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.047 2.498 . . . . 0.93999999999999995 112.214 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.549 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 4.8 t -79.63 144.99 33.28 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.531 2.586 . . . . 1.03 108.647 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 22' ' ' LEU . 71.3 m -59.42 143.52 49.53 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.12 2.867 . . . . 1.1200000000000001 110.177 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -62.73 118.46 7.71 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 126.159 2.885 . . . . 4.7199999999999998 109.526 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 111.25 -3.23 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.039 -1.891 . . . . 0.55000000000000004 111.129 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 19' ' ' CYS . 54.9 mt -127.95 133.81 49.26 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.756 2.693 . . . . 1.25 108.328 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.65 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 16.3 mm100 -110.98 120.86 43.79 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 126.148 2.88 . . . . 2.8399999999999999 109.56 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 38.1 t -79.93 120.46 24.17 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 125.859 2.742 . . . . 1.1399999999999999 109.65 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.76 HH11 ' HB2' ' A' ' 30' ' ' LEU . 6.1 mpt_? -101.95 164.27 11.8 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 125.176 2.417 . . . . 3.7599999999999998 108.595 175.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -58.95 85.83 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.428 3.013 . . . . 5.0199999999999996 110.867 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 144.66 -51.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.731 -2.031 . . . . 0.42999999999999999 110.894 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 63.5 pttt -163.19 174.24 12.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.351 2.977 . . . . 2.2000000000000002 110.272 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.5 m -77.98 145.21 36.14 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.117 2.865 . . . . 0.94999999999999996 110.049 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.76 ' HB2' HH11 ' A' ' 25' ' ' ARG . 87.4 mt -126.45 145.12 50.61 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.917 2.77 . . . . 1.3500000000000001 108.426 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HA ' HD22 ' A' ' 22' ' ' LEU . 24.3 m -80.38 119.73 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 126.399 2.999 . . . . 1.54 111.195 -172.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HG3' ' HG2' ' A' ' 23' ' ' GLN . 16.2 mm100 . . . . . 0 CA--C 1.497 -1.096 0 CA-C-O 126.461 3.029 . . . . 2.71 109.099 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.3 p . . . . . 0 CA--C 1.504 -0.819 0 CA-C-O 125.768 2.699 . . . . 1.05 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.627 ' H ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.31 139.11 39.38 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 113.564 -1.653 . . . . 0.59999999999999998 110.697 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.582 ' HB ' HD23 ' A' ' 5' ' ' LEU . 8.5 pt -111.06 -175.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 125.671 2.653 . . . . 0.75 111.357 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 5' ' ' LEU . 1.1 pt? -41.58 -35.24 0.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 124.443 2.068 . . . . 1.25 114.375 -165.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -145.07 38.6 1.18 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 125.722 2.677 . . . . 1.23 110.847 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' HB2' HG13 ' A' ' 4' ' ' ILE . 20.0 t70 -88.03 142.16 28.0 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 125.747 2.689 . . . . 0.96999999999999997 108.697 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 4.6 p-10 -71.33 138.45 49.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 125.718 2.675 . . . . 2.1899999999999999 110.21 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 p -168.61 175.26 6.25 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 126.211 2.91 . . . . 1.1100000000000001 109.849 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 12' ' ' VAL . 47.8 t -111.19 144.42 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 125.276 2.465 . . . . 1.7 108.334 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 81.5 t80 -66.34 80.84 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 126.596 3.093 . . . . 5.54 110.189 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 10' ' ' VAL . 18.2 m -128.13 79.58 73.66 Favored Pre-proline 0 CA--C 1.511 -0.552 0 CA-C-O 125.8 2.714 . . . . 2.4500000000000002 109.266 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 18.8 Cg_endo -58.59 -44.85 33.67 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 CA-C-O 125.996 2.415 . . . . 2.3500000000000001 112.286 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.61 -24.48 67.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 126.114 2.864 . . . . 2.1699999999999999 110.495 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 17.3 mm-40 -118.28 31.55 6.62 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 125.652 2.644 . . . . 3.5699999999999998 109.537 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 46.1 t-20 -52.67 110.14 1.8 Allowed Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-O 125.694 2.664 . . . . 1.6299999999999999 110.913 -175.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -95.08 7.47 2.07 Favored 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 123.599 2.866 . . . . 0.93999999999999995 111.575 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 5.1 t -102.8 157.6 16.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 125.269 2.462 . . . . 1.03 108.191 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.2 m -64.71 138.84 58.63 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.557 3.075 . . . . 1.1200000000000001 109.842 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -65.38 105.81 1.24 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 126.331 2.967 . . . . 4.7199999999999998 109.837 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 133.85 -9.74 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 112.613 -2.085 . . . . 0.55000000000000004 110.936 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 22' ' ' LEU . 5.1 mp -115.98 130.75 56.95 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.263 2.935 . . . . 1.25 109.46 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.99 95.65 7.47 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.83 2.729 . . . . 2.8399999999999999 109.818 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 40.3 t -68.1 99.63 0.91 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 126.405 3.002 . . . . 1.1399999999999999 108.746 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 25' ' ' ARG . 16.1 ttt180 -113.37 167.59 10.44 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.292 2.473 . . . . 3.7599999999999998 108.928 -173.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -51.1 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.088 2.851 . . . . 5.0199999999999996 111.134 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 113.1 -40.24 2.59 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 113.225 -1.807 . . . . 0.42999999999999999 112.498 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.851 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.1 pttt -161.21 161.26 30.82 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.585 3.088 . . . . 2.2000000000000002 110.932 -172.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 65.0 m -78.78 139.21 38.44 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 125.693 2.663 . . . . 0.94999999999999996 108.694 170.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.851 HD21 ' HE3' ' A' ' 28' ' ' LYS . 94.8 mt -123.78 114.11 19.46 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 126.145 2.879 . . . . 1.3500000000000001 109.382 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.31 131.55 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 125.626 2.631 . . . . 1.54 108.761 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 12.7 pt20 . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 126.589 3.09 . . . . 2.71 109.954 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.77 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 30.7 p . . . . . 0 CA--C 1.506 -0.723 0 CA-C-O 125.845 2.736 . . . . 1.05 109.405 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -53.87 143.94 27.93 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 113.017 -1.901 . . . . 0.59999999999999998 113.107 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.62 HG12 ' HB2' ' A' ' 7' ' ' ASP . 40.3 pt -79.32 169.07 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 126.648 3.118 . . . . 0.75 111.169 -176.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.874 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 2.1 pt? -57.44 -6.62 0.47 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 111.796 -2.456 . . . . 1.25 113.54 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 29.5 p80 -154.88 43.36 0.48 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 125.667 2.651 . . . . 1.23 110.722 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.1 t70 -87.56 148.24 24.96 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.79 2.71 . . . . 0.96999999999999997 109.109 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.0 117.74 18.88 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 125.789 2.709 . . . . 2.1899999999999999 109.488 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 6.7 p -156.01 152.21 27.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 126.216 2.912 . . . . 1.1100000000000001 109.864 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 12' ' ' VAL . 14.6 p -81.0 152.53 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-O 125.992 2.806 . . . . 1.7 109.211 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -73.25 66.8 0.92 Allowed 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 126.247 2.927 . . . . 5.54 111.197 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 10' ' ' VAL . 7.2 p -121.24 88.23 45.32 Favored Pre-proline 0 CA--C 1.512 -0.503 0 CA-C-O 126.262 2.934 . . . . 2.4500000000000002 109.064 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 38.6 Cg_endo -67.7 -39.06 12.49 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 CA-C-O 125.682 2.284 . . . . 2.3500000000000001 112.628 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.36 62.28 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 126.013 2.816 . . . . 2.1699999999999999 111.226 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 51.6 tp60 -139.54 47.4 1.87 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 126.326 2.965 . . . . 3.5699999999999998 108.432 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 21.6 p-10 -64.26 116.32 26.93 Favored Pre-proline 0 CA--C 1.512 -0.509 0 CA-C-O 125.986 2.803 . . . . 1.6299999999999999 110.192 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.08 -10.53 17.92 Favored 'Trans proline' 0 CA--C 1.503 -1.049 0 CA-C-O 126.16 2.483 . . . . 0.93999999999999995 111.994 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 7.5 t -79.01 158.85 27.85 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 125.707 2.67 . . . . 1.03 108.6 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.77 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -68.67 148.44 50.42 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 126.308 2.956 . . . . 1.1200000000000001 109.877 -176.298 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.53 126.41 27.76 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 126.049 2.833 . . . . 4.7199999999999998 109.899 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.22 -10.14 46.84 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 112.934 -1.939 . . . . 0.55000000000000004 110.766 -171.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 5' ' ' LEU . 13.0 mt -119.15 135.95 54.42 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.49 2.566 . . . . 1.25 107.573 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.43 122.83 39.91 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.249 2.928 . . . . 2.8399999999999999 110.429 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.816 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 56.2 m -69.31 111.59 5.32 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 126.072 2.844 . . . . 1.1399999999999999 110.69 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 59.5 ttt180 -92.74 155.3 17.77 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 124.721 2.2 . . . . 3.7599999999999998 106.641 171.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -47.62 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 126.534 3.064 . . . . 5.0199999999999996 111.622 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 119.1 -48.21 0.96 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 112.573 -2.103 . . . . 0.42999999999999999 112.172 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -138.29 141.51 39.83 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 126.201 2.905 . . . . 2.2000000000000002 110.027 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.816 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.7 t -79.02 138.76 38.17 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 125.834 2.731 . . . . 0.94999999999999996 108.449 174.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.12 137.52 51.93 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 126.308 2.956 . . . . 1.3500000000000001 109.971 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.874 ' HB ' ' HB2' ' A' ' 5' ' ' LEU . 6.2 p -73.07 99.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 126.332 2.968 . . . . 1.54 109.223 175.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 5.8 tp60 . . . . . 0 CA--C 1.501 -0.926 0 CA-C-O 126.384 2.993 . . . . 2.71 109.026 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 CA--C 1.503 -0.828 0 CA-C-O 125.364 2.506 . . . . 1.05 107.721 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.693 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -83.34 111.16 3.37 Favored Glycine 0 N--CA 1.444 -0.804 0 O-C-N 120.19 -1.569 . . . . 0.59999999999999998 110.767 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.579 ' HA ' HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -117.87 -179.82 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.939 2.78 . . . . 0.75 110.029 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 5' ' ' LEU . 1.5 pt? -56.42 -4.6 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.168 -2.287 . . . . 1.25 114.238 -166.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.15 37.75 0.63 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 125.861 2.744 . . . . 1.23 110.507 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.99 107.63 19.93 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 125.515 2.579 . . . . 0.96999999999999997 108.877 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -58.46 117.24 4.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 126.441 3.02 . . . . 2.1899999999999999 109.666 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.469 ' H ' ' HA ' ' A' ' 28' ' ' LYS . 40.4 t -161.31 141.43 10.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 125.828 2.728 . . . . 1.1100000000000001 108.815 -166.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.618 HG23 HG13 ' A' ' 12' ' ' VAL . 17.1 m -93.6 -178.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 126.111 2.863 . . . . 1.7 110.274 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.494 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 6.9 p90 -68.39 76.68 0.26 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 126.341 2.972 . . . . 5.54 110.837 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 HG23 ' A' ' 10' ' ' VAL . 18.7 m -123.03 74.15 48.06 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-O 125.975 2.798 . . . . 2.4500000000000002 110.374 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 4.1 Cg_exo -74.68 -40.24 1.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 CA-C-O 125.944 2.393 . . . . 2.3500000000000001 111.856 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -16.75 60.17 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 126.033 2.825 . . . . 2.1699999999999999 110.837 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.07 36.18 3.67 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.117 2.389 . . . . 3.5699999999999998 109.449 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -49.95 104.66 0.44 Allowed Pre-proline 0 N--CA 1.473 0.717 0 CA-C-O 125.887 2.756 . . . . 1.6299999999999999 111.078 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -85.35 -4.73 9.39 Favored 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 123.438 2.759 . . . . 0.93999999999999995 111.883 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 79.4 m -78.57 146.58 34.15 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 125.882 2.753 . . . . 1.03 110.418 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m -62.32 134.17 56.12 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 125.922 2.772 . . . . 1.1200000000000001 107.515 172.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -54.69 115.33 2.1 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 126.707 3.146 . . . . 4.7199999999999998 111.901 -163.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.35 -23.53 4.84 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 111.999 -2.364 . . . . 0.55000000000000004 111.267 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.624 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 6.3 mp -102.8 150.35 23.58 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 125.869 2.747 . . . . 1.25 109.523 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -138.29 139.35 39.1 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 126.132 2.873 . . . . 2.8399999999999999 109.682 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.8 m -67.92 112.43 4.94 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 126.055 2.836 . . . . 1.1399999999999999 110.338 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 27' ' ' GLY . 56.7 ttt180 -91.67 159.55 15.81 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 124.58 2.133 . . . . 3.7599999999999998 107.409 170.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -52.03 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 126.254 2.93 . . . . 5.0199999999999996 111.312 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 140.94 -50.24 0.75 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 113.092 -1.867 . . . . 0.42999999999999999 111.494 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -160.34 164.21 32.68 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 126.441 3.02 . . . . 2.2000000000000002 110.105 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 45.5 t -78.89 132.51 36.81 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 125.694 2.664 . . . . 0.94999999999999996 108.878 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.07 155.85 44.78 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 126.051 2.834 . . . . 1.3500000000000001 109.634 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.624 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 38.7 t -73.34 106.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.78 2.705 . . . . 1.54 108.445 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 125.708 2.67 . . . . 2.71 109.855 -176.136 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.503 -0.829 0 CA-C-O 125.996 2.808 . . . . 1.05 109.51 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.57 124.02 26.09 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 113.491 -1.686 . . . . 0.59999999999999998 110.574 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.607 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 24.9 pt -117.6 168.23 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 126.039 2.828 . . . . 0.75 110.128 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.93 2.85 1.78 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 125.453 2.549 . . . . 1.25 112.676 -166.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -150.25 45.57 0.89 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 126.554 3.074 . . . . 1.23 109.858 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.607 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 8.3 t70 -123.05 127.93 49.45 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.356 2.503 . . . . 0.96999999999999997 108.538 174.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.69 135.03 43.66 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 125.532 2.586 . . . . 2.1899999999999999 109.914 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.5 p -165.97 172.27 11.68 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 125.872 2.748 . . . . 1.1100000000000001 109.663 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 12' ' ' VAL . 35.8 m -99.24 153.62 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.434 3.016 . . . . 1.7 110.471 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -75.85 87.44 2.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 126.209 2.909 . . . . 5.54 110.264 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 10' ' ' VAL . 8.6 p -147.17 68.55 11.38 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 126.457 3.027 . . . . 2.4500000000000002 109.777 174.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 19.2 Cg_exo -66.45 -19.83 54.87 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 C-N-CA 122.944 2.429 . . . . 2.3500000000000001 112.781 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.44 -27.92 62.85 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 126.13 2.871 . . . . 2.1699999999999999 110.497 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -130.98 49.35 2.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.492 3.044 . . . . 3.5699999999999998 107.647 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 60.8 t30 -56.68 116.08 12.03 Favored Pre-proline 0 CA--C 1.511 -0.541 0 CA-C-O 126.103 2.859 . . . . 1.6299999999999999 111.249 -173.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.52 -11.05 15.83 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 123.33 2.686 . . . . 0.93999999999999995 112.172 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.569 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 74.1 m -79.13 158.65 27.71 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 125.889 2.757 . . . . 1.03 110.18 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.8 m -66.36 142.8 57.5 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.723 2.677 . . . . 1.1200000000000001 108.761 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -59.01 110.98 1.14 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 126.641 3.115 . . . . 4.7199999999999998 110.39 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.24 -26.27 3.75 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 112.238 -2.255 . . . . 0.55000000000000004 110.739 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 4.6 mp -105.24 152.4 22.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.565 2.603 . . . . 1.25 109.068 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -133.69 129.82 37.32 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.674 2.654 . . . . 2.8399999999999999 110.267 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.7 m -69.64 105.56 2.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.198 2.904 . . . . 1.1399999999999999 110.193 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -101.27 163.56 12.22 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 125.051 2.357 . . . . 3.7599999999999998 107.941 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -50.58 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 126.275 2.94 . . . . 5.0199999999999996 111.221 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.9 -49.39 0.89 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 112.857 -1.974 . . . . 0.42999999999999999 111.899 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.872 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.4 pttt -159.96 162.57 34.42 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 126.808 3.194 . . . . 2.2000000000000002 110.638 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 47.8 t -79.68 124.75 28.85 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 125.894 2.759 . . . . 0.94999999999999996 109.173 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.872 HD21 ' HE3' ' A' ' 28' ' ' LYS . 97.8 mt -122.62 131.53 53.86 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 126.126 2.869 . . . . 1.3500000000000001 109.491 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 7.7 p -75.1 145.17 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 125.315 2.483 . . . . 1.54 108.096 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.278 2.942 . . . . 2.71 109.871 -176.826 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p . . . . . 0 CA--C 1.506 -0.722 0 CA-C-O 125.962 2.792 . . . . 1.05 109.554 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.587 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.8 118.24 6.93 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 113.537 -1.665 . . . . 0.59999999999999998 110.224 170.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.516 ' C ' ' H ' ' A' ' 6' ' ' HIS . 8.0 pt -115.02 167.55 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 125.858 2.742 . . . . 0.75 110.119 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.19 12.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 125.42 2.534 . . . . 1.25 112.952 -169.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 4' ' ' ILE . 8.4 p-80 -157.44 41.16 0.31 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 126.068 2.842 . . . . 1.23 110.294 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -115.51 119.23 35.51 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.674 2.654 . . . . 0.96999999999999997 108.816 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.12 123.83 23.7 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.894 2.759 . . . . 2.1899999999999999 109.523 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.2 160.38 43.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 126.034 2.826 . . . . 1.1100000000000001 110.22 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 12' ' ' VAL . 9.3 p -85.87 130.56 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.062 2.839 . . . . 1.7 109.255 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 21.3 p90 -70.14 74.52 0.49 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 126.52 3.057 . . . . 5.54 111.626 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 10' ' ' VAL . 15.7 m -119.12 89.07 38.55 Favored Pre-proline 0 CA--C 1.513 -0.48 0 CA-C-O 126.098 2.856 . . . . 2.4500000000000002 109.664 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.69 -34.07 89.42 Favored 'Trans proline' 0 CA--C 1.507 -0.873 0 C-N-CA 122.995 2.463 . . . . 2.3500000000000001 112.686 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 -25.06 59.31 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 125.784 2.707 . . . . 2.1699999999999999 110.881 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -132.83 39.09 3.35 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 126.021 2.819 . . . . 3.5699999999999998 108.941 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -56.2 111.82 3.66 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 125.884 2.754 . . . . 1.6299999999999999 109.594 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.25 -12.84 19.07 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 CA-C-O 126.267 2.528 . . . . 0.93999999999999995 112.299 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 63.1 m -77.73 150.67 34.4 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 126.054 2.835 . . . . 1.03 110.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.43 145.96 41.82 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 125.75 2.69 . . . . 1.1200000000000001 108.586 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -62.23 102.11 0.28 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 126.399 2.999 . . . . 4.7199999999999998 110.147 -170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.46 -26.04 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 112.483 -2.144 . . . . 0.55000000000000004 110.931 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 6.0 mp -101.2 148.78 24.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 125.821 2.724 . . . . 1.25 109.238 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 32' ' ' GLN . 48.5 tp60 -121.23 129.4 53.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.132 2.872 . . . . 2.8399999999999999 109.543 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 53.5 t -69.58 104.49 2.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.182 2.896 . . . . 1.1399999999999999 108.563 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' GLY . 15.1 mmt180 -86.21 174.6 9.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.562 2.601 . . . . 3.7599999999999998 109.332 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 m-85 -61.25 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.243 2.925 . . . . 5.0199999999999996 110.608 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 116.19 -26.54 8.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.767 -2.015 . . . . 0.42999999999999999 112.636 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 19.1 ptpt -160.17 149.4 17.53 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 126.418 3.009 . . . . 2.2000000000000002 110.626 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.5 t -79.71 129.66 34.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.872 2.749 . . . . 0.94999999999999996 109.817 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 156.77 47.97 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 125.86 2.743 . . . . 1.3500000000000001 109.034 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 61.3 t -69.19 115.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-O 126.068 2.842 . . . . 1.54 109.152 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 58.2 tp60 . . . . . 0 CA--C 1.506 -0.733 0 CA-C-O 125.909 2.766 . . . . 2.71 109.796 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.503 -0.833 0 CA-C-O 125.766 2.698 . . . . 1.05 108.879 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.591 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -58.75 127.67 45.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 113.627 -1.624 . . . . 0.59999999999999998 111.329 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.559 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 5.9 pt -94.71 -176.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 125.469 2.557 . . . . 0.75 110.912 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 5' ' ' LEU . 2.0 pt? -34.8 -45.43 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 124.841 2.258 . . . . 1.25 114.186 -166.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.649 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 33.4 p80 -142.66 37.75 1.48 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.774 2.702 . . . . 1.23 110.628 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 21.2 t70 -73.97 130.59 40.17 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 125.832 2.729 . . . . 0.96999999999999997 109.253 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.0 m-20 -64.95 134.79 54.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.974 2.797 . . . . 2.1899999999999999 110.39 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.81 161.79 42.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.193 2.901 . . . . 1.1100000000000001 110.209 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 12' ' ' VAL . 23.9 m -89.6 143.54 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 CA-C-O 125.384 2.516 . . . . 1.7 108.362 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -69.11 75.64 0.33 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.449 3.024 . . . . 5.54 110.116 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' VAL . 95.2 t -128.38 98.83 25.1 Favored Pre-proline 0 CA--C 1.506 -0.712 0 CA-C-O 125.572 2.606 . . . . 2.4500000000000002 108.606 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.74 -54.46 0.22 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 122.945 2.43 . . . . 2.3500000000000001 113.201 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.76 75.34 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 125.684 2.659 . . . . 2.1699999999999999 111.612 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.514 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -116.35 35.82 4.37 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 125.952 2.787 . . . . 3.5699999999999998 109.216 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.97 108.86 3.79 Favored Pre-proline 0 CA--C 1.509 -0.623 0 CA-C-O 125.686 2.66 . . . . 1.6299999999999999 110.126 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 83.4 Cg_endo -83.36 48.71 2.75 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 CA-C-O 126.737 2.724 . . . . 0.93999999999999995 110.983 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.591 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 10.6 t -136.86 143.75 43.23 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.105 2.383 . . . . 1.03 107.585 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -59.91 145.87 44.3 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.356 2.979 . . . . 1.1200000000000001 110.67 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.674 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.59 122.1 21.72 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.322 2.963 . . . . 4.7199999999999998 108.899 -174.279 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 117.95 -7.4 15.03 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 112.625 -2.08 . . . . 0.55000000000000004 110.171 -171.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 22' ' ' LEU . 6.3 mp -114.78 139.42 49.74 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.895 2.76 . . . . 1.25 108.708 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.519 ' HB3' HE21 ' A' ' 32' ' ' GLN . 26.3 pt20 -104.47 121.69 43.98 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.624 2.63 . . . . 2.8399999999999999 109.685 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.3 t -80.58 102.05 9.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 126.074 2.845 . . . . 1.1399999999999999 108.632 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.562 ' HG3' HD12 ' A' ' 30' ' ' LEU . 25.4 mmt180 -97.93 163.05 12.94 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 125.197 2.427 . . . . 3.7599999999999998 108.645 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -53.1 93.45 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.018 2.818 . . . . 5.0199999999999996 109.941 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 128.55 -50.82 0.87 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.854 -1.975 . . . . 0.42999999999999999 112.404 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 20.8 pttp -162.47 173.88 13.44 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.395 2.998 . . . . 2.2000000000000002 111.312 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 87.4 m -78.65 143.05 36.71 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 126.043 2.83 . . . . 0.94999999999999996 109.806 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.562 HD12 ' HG3' ' A' ' 25' ' ' ARG . 91.0 mt -126.69 126.82 44.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 125.886 2.755 . . . . 1.3500000000000001 108.469 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 5' ' ' LEU . 2.2 m -66.64 102.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 126.35 2.976 . . . . 1.54 110.741 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.519 HE21 ' HB3' ' A' ' 23' ' ' GLN . 90.2 mt-30 . . . . . 0 CA--C 1.499 -1.007 0 CA-C-O 126.69 3.138 . . . . 2.71 108.795 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 125.684 2.659 . . . . 1.05 108.874 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.8 127.66 39.23 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 113.543 -1.662 . . . . 0.59999999999999998 112.532 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.512 ' HB ' HD23 ' A' ' 5' ' ' LEU . 22.9 pt -117.88 178.69 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 126.338 2.97 . . . . 0.75 110.827 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.4 pt? -56.57 -11.71 1.44 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 111.952 -2.386 . . . . 1.25 113.786 -169.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -151.1 47.09 0.84 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.499 3.047 . . . . 1.23 110.067 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.29 119.19 38.41 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 125.434 2.54 . . . . 0.96999999999999997 109.158 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -60.06 112.11 1.76 Allowed 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 126.058 2.837 . . . . 2.1899999999999999 108.802 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.8 t -133.39 149.04 51.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 126.086 2.85 . . . . 1.1100000000000001 110.778 -165.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 12' ' ' VAL . 70.6 t -97.87 133.1 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 125.723 2.678 . . . . 1.7 108.515 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -67.81 86.94 0.23 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 125.981 2.801 . . . . 5.54 110.485 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 10' ' ' VAL . 13.2 m -132.73 90.14 33.37 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-O 125.947 2.784 . . . . 2.4500000000000002 109.488 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.2 -47.98 15.49 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 123.23 2.62 . . . . 2.3500000000000001 113.579 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.67 83.53 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.093 2.854 . . . . 2.1699999999999999 110.598 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -111.41 42.31 1.7 Allowed 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 125.579 2.609 . . . . 3.5699999999999998 109.399 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -54.85 113.43 5.34 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 125.877 2.751 . . . . 1.6299999999999999 110.293 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.75 -13.8 14.34 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.012 2.474 . . . . 0.93999999999999995 112.388 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 98.5 m -78.19 148.21 34.14 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 126.174 2.892 . . . . 1.03 110.568 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' HB2' HD23 ' A' ' 22' ' ' LEU . 54.8 m -66.26 162.11 20.76 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 125.852 2.739 . . . . 1.1200000000000001 109.578 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 20' ' ' ARG . 15.3 ptt180 -61.0 119.76 8.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.302 2.953 . . . . 4.7199999999999998 110.142 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.81 -4.56 56.28 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 113.127 -1.851 . . . . 0.55000000000000004 111.819 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 19' ' ' CYS . 3.7 mm? -101.15 134.97 43.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.008 2.813 . . . . 1.25 109.252 175.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HB2' ' HG3' ' A' ' 32' ' ' GLN . 29.4 tp60 -111.73 110.18 20.43 Favored 'General case' 0 CA--C 1.5 -0.942 0 CA-C-O 125.886 2.755 . . . . 2.8399999999999999 109.325 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.7 t -75.3 129.51 37.53 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.896 2.76 . . . . 1.1399999999999999 109.039 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -117.62 144.57 45.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 124.672 2.177 . . . . 3.7599999999999998 106.875 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -55.79 97.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.569 3.08 . . . . 5.0199999999999996 109.887 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.68 -53.39 0.79 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 112.489 -2.141 . . . . 0.42999999999999999 111.179 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -150.68 153.84 36.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 126.293 2.949 . . . . 2.2000000000000002 109.938 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 35.2 t -95.93 130.78 42.81 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 125.383 2.516 . . . . 0.94999999999999996 108.301 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.18 173.14 8.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.28 2.943 . . . . 1.3500000000000001 110.161 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.39 112.93 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-O 125.735 2.683 . . . . 1.54 108.756 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 42.7 tt0 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.189 2.899 . . . . 2.71 109.742 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 CA--C 1.505 -0.763 0 CA-C-O 125.96 2.791 . . . . 1.05 109.501 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.547 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -63.47 138.54 43.07 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 113.392 -1.731 . . . . 0.59999999999999998 111.097 172.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.518 ' HB ' HD23 ' A' ' 5' ' ' LEU . 19.7 pt -115.51 175.56 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 126.486 3.041 . . . . 0.75 111.047 -174.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.4 pt? -59.07 -6.9 0.94 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 111.922 -2.399 . . . . 1.25 113.223 -171.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -150.1 49.06 0.91 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.253 2.93 . . . . 1.23 109.862 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.506 ' HB2' HG12 ' A' ' 4' ' ' ILE . 39.1 t70 -115.08 133.72 55.8 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.471 2.558 . . . . 0.96999999999999997 109.01 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.6 m-20 -75.88 133.03 40.67 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 125.671 2.653 . . . . 2.1899999999999999 109.831 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.5 p -162.24 162.06 28.04 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 125.905 2.764 . . . . 1.1100000000000001 110.214 -176.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.1 m -92.41 151.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 125.77 2.7 . . . . 1.7 109.389 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.476 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 2.7 p90 -71.43 76.4 0.77 Allowed 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 126.462 3.029 . . . . 5.54 110.521 -172.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.28 70.65 79.26 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-O 125.984 2.802 . . . . 2.4500000000000002 110.247 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 31.7 Cg_exo -60.09 -32.65 95.02 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-O 125.87 2.362 . . . . 2.3500000000000001 111.945 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.16 -40.28 58.24 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 126.22 2.914 . . . . 2.1699999999999999 110.419 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -123.56 46.91 2.11 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.914 2.769 . . . . 3.5699999999999998 108.461 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 46.8 t-20 -49.97 113.12 3.14 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-O 125.876 2.751 . . . . 1.6299999999999999 110.31 -176.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.14 -18.8 14.09 Favored 'Trans proline' 0 CA--C 1.506 -0.895 0 CA-C-O 125.997 2.415 . . . . 0.93999999999999995 112.257 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.6 m -79.7 161.16 25.96 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 125.923 2.773 . . . . 1.03 109.87 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -67.73 142.83 56.17 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.11 2.862 . . . . 1.1200000000000001 109.227 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 32.7 mmt180 -59.94 115.82 3.69 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 126.302 2.954 . . . . 4.7199999999999998 109.929 -175.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.16 -10.0 8.33 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.609 -2.087 . . . . 0.55000000000000004 110.902 -175.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.06 140.87 40.59 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.189 2.899 . . . . 1.25 109.637 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -104.76 101.95 11.54 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.056 2.836 . . . . 2.8399999999999999 109.592 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.8 t -77.33 106.46 9.08 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.184 2.897 . . . . 1.1399999999999999 109.181 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HD3' HD12 ' A' ' 30' ' ' LEU . 79.2 mtp180 -101.67 150.39 23.16 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 125.193 2.425 . . . . 3.7599999999999998 108.077 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -50.25 100.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.313 2.959 . . . . 5.0199999999999996 110.306 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 118.66 -50.9 0.78 Allowed Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 112.555 -2.111 . . . . 0.42999999999999999 111.714 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -143.3 134.3 25.57 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 126.406 3.003 . . . . 2.2000000000000002 110.275 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 34.6 t -87.58 123.26 32.27 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 125.676 2.655 . . . . 0.94999999999999996 108.315 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.406 HD12 ' HD3' ' A' ' 25' ' ' ARG . 82.2 mt -116.65 173.7 6.48 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.993 2.806 . . . . 1.3500000000000001 109.879 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.04 118.52 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 125.778 2.704 . . . . 1.54 108.724 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 125.833 2.73 . . . . 2.71 107.707 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.501 -0.908 0 CA-C-O 125.746 2.689 . . . . 1.05 108.706 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -61.4 120.01 20.81 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 113.565 -1.652 . . . . 0.59999999999999998 111.16 173.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 23.6 pt -117.08 178.18 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 125.723 2.678 . . . . 0.75 109.674 -178.277 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.95 14.38 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 125.256 2.455 . . . . 1.25 113.324 -164.611 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -160.48 31.61 0.16 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 125.914 2.769 . . . . 1.23 110.129 172.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.454 ' HB2' HG12 ' A' ' 4' ' ' ILE . 29.7 t70 -100.93 130.05 46.87 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 125.386 2.517 . . . . 0.96999999999999997 109.36 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -60.9 116.88 4.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.345 2.974 . . . . 2.1899999999999999 109.009 178.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.5 t -139.03 136.37 35.22 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 126.119 2.866 . . . . 1.1100000000000001 109.64 -173.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.546 ' O ' HG22 ' A' ' 12' ' ' VAL . 27.9 m -93.5 145.22 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 125.455 2.55 . . . . 1.7 108.215 175.238 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' H ' ' HD1' ' A' ' 11' ' ' TYR . 8.7 p90 -62.02 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 126.38 2.991 . . . . 5.54 111.579 -174.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 15' ' ' GLN . 12.2 m -127.86 93.18 40.37 Favored Pre-proline 0 CA--C 1.506 -0.718 0 CA-C-O 126.115 2.864 . . . . 2.4500000000000002 109.295 174.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.84 -49.94 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.69 0 CA-C-O 126.145 2.477 . . . . 2.3500000000000001 111.749 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.22 -6.7 25.01 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 125.942 2.782 . . . . 2.1699999999999999 110.91 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 28.9 tt0 -138.56 36.64 2.24 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.038 2.828 . . . . 3.5699999999999998 108.839 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 24.9 t-20 -57.74 113.8 7.12 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 125.799 2.714 . . . . 1.6299999999999999 110.574 -177.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -84.35 -8.31 9.7 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.239 2.626 . . . . 0.93999999999999995 112.139 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.568 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 71.3 m -78.99 159.08 27.81 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 125.742 2.686 . . . . 1.03 110.017 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.36 132.21 44.52 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 125.933 2.778 . . . . 1.1200000000000001 108.139 172.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 20' ' ' ARG . 23.4 mmt180 -56.86 108.61 0.52 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.346 2.974 . . . . 4.7199999999999998 110.327 -172.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.16 -19.49 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 112.68 -2.055 . . . . 0.55000000000000004 110.995 -175.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 22' ' ' LEU . 6.9 mp -105.36 138.38 41.65 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 125.985 2.802 . . . . 1.25 109.562 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 41.1 tt0 -94.04 131.64 39.33 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 125.767 2.699 . . . . 2.8399999999999999 109.351 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 39.0 t -90.91 111.19 22.52 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.04 2.829 . . . . 1.1399999999999999 108.654 174.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -108.31 152.81 24.13 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.324 2.487 . . . . 3.7599999999999998 108.793 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -46.8 96.35 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.082 2.849 . . . . 5.0199999999999996 110.918 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.34 -49.38 0.89 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.045 -1.889 . . . . 0.42999999999999999 112.374 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.96 156.17 42.37 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 126.531 3.062 . . . . 2.2000000000000002 110.42 -174.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 14.6 t -90.87 147.3 23.25 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.29 2.471 . . . . 0.94999999999999996 107.731 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 pp -150.36 161.57 42.22 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 126.03 2.824 . . . . 1.3500000000000001 110.004 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 5' ' ' LEU . 11.7 m -74.39 115.39 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.12 2.867 . . . . 1.54 109.748 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 44.4 tt0 . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 126.486 3.041 . . . . 2.71 109.695 -175.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.506 -0.734 0 CA-C-O 125.92 2.771 . . . . 1.05 108.777 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.73 129.3 33.01 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 113.27 -1.787 . . . . 0.59999999999999998 111.883 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.2 pt -112.72 168.5 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 126.328 2.966 . . . . 0.75 110.35 -176.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -59.54 -4.42 0.62 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 125.255 2.455 . . . . 1.25 113.119 -171.206 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -144.91 50.0 1.27 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 126.358 2.98 . . . . 1.23 109.57 176.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.01 165.68 14.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.191 2.424 . . . . 0.96999999999999997 107.869 172.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 93.6 m-20 -108.42 124.75 50.88 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 125.584 2.611 . . . . 2.1899999999999999 110.08 -172.398 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 10.4 p -163.12 156.52 19.54 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 125.903 2.763 . . . . 1.1100000000000001 110.102 -173.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.68 152.71 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 126.2 2.905 . . . . 1.7 110.195 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.426 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 64.1 t80 -75.69 77.61 2.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 126.243 2.925 . . . . 5.54 110.455 -176.183 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 102.54 35.84 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-O 126.006 2.812 . . . . 2.4500000000000002 108.09 173.258 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.1 -52.01 9.76 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.649 2.899 . . . . 2.3500000000000001 113.644 -172.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -19.37 64.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 125.687 2.661 . . . . 2.1699999999999999 111.439 -176.507 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.503 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 52.5 tt0 -126.24 36.01 4.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.961 2.791 . . . . 3.5699999999999998 109.886 -177.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -71.59 106.27 1.85 Allowed Pre-proline 0 CA--C 1.511 -0.529 0 CA-C-O 125.796 2.712 . . . . 1.6299999999999999 108.219 173.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 64.1 Cg_endo -80.95 -8.29 13.2 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 123.242 2.628 . . . . 0.93999999999999995 113.136 -170.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.854 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 71.9 m -78.87 145.13 34.35 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 126.395 2.997 . . . . 1.03 111.074 -171.174 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -54.78 139.1 40.67 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.294 2.473 . . . . 1.1200000000000001 109.121 177.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -48.13 108.26 0.16 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 126.488 3.042 . . . . 4.7199999999999998 110.979 -175.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.31 -20.41 5.88 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 112.656 -2.065 . . . . 0.55000000000000004 111.318 -176.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.854 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.5 mt -103.19 145.87 29.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 125.667 2.651 . . . . 1.25 109.185 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.27 135.78 37.46 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 125.615 2.626 . . . . 2.8399999999999999 109.285 -177.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 88.6 m -78.95 129.43 34.48 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.447 3.022 . . . . 1.1399999999999999 111.637 -177.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLY . 7.0 tpp180 -84.1 145.92 28.18 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.314 -2.106 . . . . 3.7599999999999998 105.314 159.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -58.44 81.05 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 126.28 2.943 . . . . 5.0199999999999996 110.26 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 145.29 -45.68 0.82 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.135 -1.848 . . . . 0.42999999999999999 111.345 -177.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 20.8 ptmt -149.62 148.35 29.22 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.246 2.927 . . . . 2.2000000000000002 110.758 -176.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 24.0 t -79.83 144.61 33.35 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 125.784 2.707 . . . . 0.94999999999999996 109.682 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -132.28 160.76 35.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.128 2.87 . . . . 1.3500000000000001 110.071 -176.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.85 105.65 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 125.764 2.697 . . . . 1.54 109.189 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? . . . . . 0 CA--C 1.504 -0.826 0 CA-C-O 126.135 2.874 . . . . 2.71 108.547 178.777 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.505 -0.78 0 CA-C-O 125.899 2.761 . . . . 1.05 109.583 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -57.09 124.68 36.61 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 113.234 -1.803 . . . . 0.59999999999999998 112.302 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' ' 7' ' ' ASP . 33.7 pt -93.13 177.65 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 126.327 2.965 . . . . 0.75 110.778 -176.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.15 -18.58 0.6 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 111.993 -2.367 . . . . 1.25 114.013 -167.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.54 48.66 0.88 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 125.927 2.775 . . . . 1.23 110.11 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 34.9 t70 -91.79 140.92 29.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 125.675 2.655 . . . . 0.96999999999999997 109.253 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.98 125.25 29.0 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.833 2.73 . . . . 2.1899999999999999 109.907 -176.114 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.7 p -175.35 146.1 0.79 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.045 2.831 . . . . 1.1100000000000001 109.871 -177.077 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 12' ' ' VAL . 30.4 m -79.09 168.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 125.983 2.802 . . . . 1.7 109.749 178.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -77.56 76.52 4.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.452 3.025 . . . . 5.54 109.576 -174.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 HG23 ' A' ' 10' ' ' VAL . 9.6 m -120.78 87.68 42.81 Favored Pre-proline 0 CA--C 1.512 -0.512 0 CA-C-O 126.2 2.905 . . . . 2.4500000000000002 109.622 176.6 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 74.0 Cg_endo -77.56 -30.89 3.67 Favored 'Trans proline' 0 CA--C 1.509 -0.732 0 C-N-CA 122.595 2.196 . . . . 2.3500000000000001 113.195 -177.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.41 66.4 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.281 2.943 . . . . 2.1699999999999999 110.015 -176.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -124.41 58.58 1.2 Allowed 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.001 2.81 . . . . 3.5699999999999998 108.25 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 11.5 t30 -61.09 109.1 1.82 Allowed Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-O 126.076 2.846 . . . . 1.6299999999999999 109.92 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.38 -7.86 14.99 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.582 2.855 . . . . 0.93999999999999995 113.565 -171.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 90.3 m -78.54 155.09 29.9 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 126.076 2.846 . . . . 1.03 110.319 -175.469 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.3 m -59.65 150.29 27.95 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 125.361 2.505 . . . . 1.1200000000000001 109.067 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -61.21 99.98 0.11 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 126.214 2.911 . . . . 4.7199999999999998 110.254 -173.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 130.1 -2.61 5.9 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 112.958 -1.928 . . . . 0.55000000000000004 111.464 -176.053 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.6 mt -123.76 151.06 43.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 125.274 2.464 . . . . 1.25 108.668 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 65.6 tt0 -140.66 134.2 30.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.847 2.737 . . . . 2.8399999999999999 110.214 -176.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 64.6 m -71.43 118.46 14.27 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.182 2.896 . . . . 1.1399999999999999 110.812 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 27.8 tpt180 -93.89 156.55 16.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.014 2.34 . . . . 3.7599999999999998 107.093 170.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.22 92.92 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 126.187 2.898 . . . . 5.0199999999999996 110.215 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.93 -46.25 1.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 112.952 -1.931 . . . . 0.42999999999999999 111.975 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -159.3 158.04 31.67 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.576 3.084 . . . . 2.2000000000000002 110.393 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 13.4 t -78.89 142.58 36.67 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.79 2.709 . . . . 0.94999999999999996 109.516 -175.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.1 mt -128.44 159.46 35.33 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.26 2.933 . . . . 1.3500000000000001 109.863 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.43 118.43 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 126.294 2.95 . . . . 1.54 110.419 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 80.1 mt-30 . . . . . 0 CA--C 1.5 -0.954 0 CA-C-O 125.921 2.772 . . . . 2.71 110.234 177.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.63 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 17.3 p . . . . . 0 CA--C 1.508 -0.67 0 CA-C-O 125.831 2.729 . . . . 1.05 109.983 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.654 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -73.01 153.56 48.63 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 113.407 -1.724 . . . . 0.59999999999999998 111.351 173.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.532 ' HB ' HD23 ' A' ' 5' ' ' LEU . 19.9 pt -101.91 172.21 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 126.877 3.227 . . . . 0.75 111.961 -174.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.1 pt? -58.31 -1.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.093 -2.776 . . . . 1.25 113.961 -169.496 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 27.4 p80 -156.3 50.27 0.51 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.107 2.86 . . . . 1.23 110.335 176.401 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 8' ' ' ASN . 5.7 t70 -99.54 -172.25 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 125.351 2.5 . . . . 0.96999999999999997 109.044 175.009 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 7.8 t30 -113.32 131.61 55.88 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.477 2.56 . . . . 2.1899999999999999 109.502 -175.265 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.783 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 11.5 p -176.77 151.19 0.87 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.299 2.952 . . . . 1.1100000000000001 110.521 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.12 154.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 125.737 2.684 . . . . 1.7 108.749 175.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.9 77.68 0.89 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 126.209 2.909 . . . . 5.54 109.795 -178.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -126.85 99.05 29.78 Favored Pre-proline 0 CA--C 1.513 -0.459 0 CA-C-O 126.1 2.857 . . . . 2.4500000000000002 109.023 173.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.83 -40.86 26.42 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 CA-C-O 125.695 2.29 . . . . 2.3500000000000001 112.371 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.63 -32.31 63.03 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 125.91 2.767 . . . . 2.1699999999999999 111.0 -177.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 13.8 mm100 -127.51 48.19 2.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.708 2.671 . . . . 3.5699999999999998 110.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -67.6 109.58 4.0 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.517 2.579 . . . . 1.6299999999999999 108.574 172.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 96.9 Cg_endo -79.39 -17.16 11.65 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 CA-C-O 125.847 2.353 . . . . 0.93999999999999995 112.775 -175.244 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.654 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 93.6 m -79.97 161.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 126.179 2.895 . . . . 1.03 110.728 -174.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.63 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 m -61.44 146.8 47.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 126.149 2.881 . . . . 1.1200000000000001 109.432 175.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 20' ' ' ARG . 60.7 mtt180 -67.81 112.67 5.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 126.688 3.137 . . . . 4.7199999999999998 109.777 -174.039 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.57 -7.34 7.91 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 112.14 -2.3 . . . . 0.55000000000000004 110.74 -172.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.8 mt -108.48 144.35 36.22 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.854 2.74 . . . . 1.25 108.947 177.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -112.14 125.7 54.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.045 2.831 . . . . 2.8399999999999999 110.275 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 17' ' ' PRO . 5.2 m -89.29 102.08 14.74 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 125.844 2.735 . . . . 1.1399999999999999 109.623 173.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.957 ' HD3' HD21 ' A' ' 30' ' ' LEU . 52.7 mtp180 -92.22 168.4 11.37 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 125.297 2.475 . . . . 3.7599999999999998 108.494 174.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -55.0 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.238 2.923 . . . . 5.0199999999999996 110.821 -174.376 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.6 -38.69 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 113.131 -1.85 . . . . 0.42999999999999999 112.744 176.589 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -140.15 147.41 40.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 126.742 3.163 . . . . 2.2000000000000002 111.582 -169.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.783 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 37.0 t -94.81 136.65 34.87 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 125.388 2.518 . . . . 0.94999999999999996 108.036 175.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.957 HD21 ' HD3' ' A' ' 25' ' ' ARG . 2.9 pp -141.64 157.3 45.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.998 2.808 . . . . 1.3500000000000001 110.015 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 7.4 p -71.15 121.4 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 126.203 2.906 . . . . 1.54 109.068 178.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 CA--C 1.502 -0.89 0 CA-C-O 126.066 2.841 . . . . 2.71 109.033 -179.396 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p . . . . . 0 CA--C 1.508 -0.673 0 CA-C-O 126.119 2.866 . . . . 1.05 110.062 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -66.35 147.1 49.66 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 112.985 -1.916 . . . . 0.59999999999999998 112.727 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.57 172.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 126.039 2.828 . . . . 0.75 110.396 -175.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.52 -0.4 0.92 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 125.401 2.524 . . . . 1.25 112.63 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -140.85 46.42 1.77 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 126.597 3.094 . . . . 1.23 109.694 175.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -135.35 129.22 33.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.473 2.559 . . . . 0.96999999999999997 108.109 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 41.7 m-80 -70.26 148.24 48.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 125.346 2.498 . . . . 2.1899999999999999 109.677 -177.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 43.0 t -159.68 160.67 34.42 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.277 2.941 . . . . 1.1100000000000001 110.574 -170.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.83 152.46 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-O 126.226 2.917 . . . . 1.7 109.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -71.76 69.02 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 126.271 2.939 . . . . 5.54 110.932 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.09 82.56 24.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 126.398 2.999 . . . . 2.4500000000000002 109.927 177.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.51 -31.84 32.96 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 122.881 2.388 . . . . 2.3500000000000001 112.317 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.08 -37.1 14.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 126.022 2.82 . . . . 2.1699999999999999 111.167 -176.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.45 59.32 1.51 Allowed 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 126.283 2.944 . . . . 3.5699999999999998 108.564 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.03 123.06 78.76 Favored Pre-proline 0 CA--C 1.508 -0.656 0 CA-C-O 126.1 2.857 . . . . 1.6299999999999999 109.711 175.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 -5.36 16.98 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 123.296 2.664 . . . . 0.93999999999999995 112.549 -176.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 84.5 m -79.09 151.74 31.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 126.353 2.978 . . . . 1.03 110.774 -173.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB2' HD23 ' A' ' 22' ' ' LEU . 8.1 m -61.01 144.24 53.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.392 2.52 . . . . 1.1200000000000001 108.868 177.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -55.49 110.79 0.75 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.194 2.902 . . . . 4.7199999999999998 109.506 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.7 -19.89 5.82 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 112.956 -1.929 . . . . 0.55000000000000004 111.469 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.4 mm? -99.97 166.27 11.13 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 125.751 2.691 . . . . 1.25 109.547 178.003 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.75 138.5 19.83 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 125.847 2.737 . . . . 2.8399999999999999 109.332 177.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 85.0 m -80.12 121.0 25.01 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.23 2.919 . . . . 1.1399999999999999 110.467 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -97.34 158.34 15.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 125.088 2.375 . . . . 3.7599999999999998 107.086 172.117 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -57.24 91.01 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.451 3.024 . . . . 5.0199999999999996 110.069 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 130.5 -46.0 1.1 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 112.389 -2.187 . . . . 0.42999999999999999 111.948 -179.343 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' N ' ' A' ' 9' ' ' CYS . 24.5 pttm -160.57 165.78 30.17 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 126.551 3.072 . . . . 2.2000000000000002 111.182 -174.199 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 17.0 t -86.7 134.28 33.61 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 125.908 2.766 . . . . 0.94999999999999996 109.961 -176.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.78 174.27 10.12 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 125.855 2.74 . . . . 1.3500000000000001 109.299 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 m -85.35 145.32 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-O 126.211 2.91 . . . . 1.54 110.381 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 . . . . . 0 CA--C 1.501 -0.905 0 CA-C-O 125.833 2.73 . . . . 2.71 108.62 175.848 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 126.107 2.86 . . . . 2.1499999999999999 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.4 p -80.11 137.61 36.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 125.785 2.707 . . . . 1.05 108.893 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.669 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -52.18 128.32 34.25 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 113.221 -1.808 . . . . 0.59999999999999998 112.144 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.9 pt -110.21 176.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-O 126.288 2.947 . . . . 0.75 110.66 -175.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.2 pt? -55.26 -11.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 111.821 -2.445 . . . . 1.25 113.731 -169.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -147.86 41.16 1.01 Allowed 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 125.991 2.805 . . . . 1.23 110.314 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.601 ' HB2' HG12 ' A' ' 4' ' ' ILE . 14.3 t70 -107.21 121.49 44.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 125.681 2.658 . . . . 0.96999999999999997 108.252 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 8.7 p30 -54.02 128.18 29.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 125.99 2.805 . . . . 2.1899999999999999 110.425 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -160.58 169.5 22.78 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.982 2.801 . . . . 1.1100000000000001 110.218 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 12' ' ' VAL . 18.6 m -121.24 153.96 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 125.698 2.666 . . . . 1.7 108.863 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 83.5 t80 -73.32 76.91 1.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.303 2.954 . . . . 5.54 110.668 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 10' ' ' VAL . 14.2 m -127.09 79.93 72.3 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-O 126.22 2.914 . . . . 2.4500000000000002 109.86 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -65.69 -30.97 50.19 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 C-N-CA 122.901 2.4 . . . . 2.3500000000000001 112.411 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.4 40.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 126.096 2.855 . . . . 2.1699999999999999 110.984 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -134.96 55.08 1.91 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 126.2 2.905 . . . . 3.5699999999999998 108.368 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 23.5 t-20 -55.46 115.87 10.39 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-O 125.796 2.712 . . . . 1.6299999999999999 110.215 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 46.4 Cg_endo -86.77 -4.0 8.17 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 123.25 2.633 . . . . 0.93999999999999995 112.69 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.669 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 91.5 m -86.62 167.0 14.94 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 126.51 3.052 . . . . 1.03 111.352 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 3.0 m -72.75 131.08 41.88 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.296 2.474 . . . . 1.1200000000000001 107.822 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -54.04 108.42 0.36 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 126.532 3.063 . . . . 4.7199999999999998 110.599 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.81 -17.47 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 112.222 -2.263 . . . . 0.55000000000000004 110.815 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.587 HD22 ' HA ' ' A' ' 31' ' ' VAL . 19.1 mt -110.45 148.35 32.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.49 2.567 . . . . 1.25 108.673 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -135.93 128.35 30.38 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 126.138 2.875 . . . . 2.8399999999999999 110.313 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 90.7 m -67.49 126.14 28.36 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 126.506 3.05 . . . . 1.1399999999999999 111.563 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -108.51 149.03 29.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 124.649 2.166 . . . . 3.7599999999999998 106.952 168.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -55.6 90.24 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.418 3.008 . . . . 5.0199999999999996 110.465 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 139.1 -50.99 0.77 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 112.486 -2.143 . . . . 0.42999999999999999 111.141 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HE3' ' CD2' ' A' ' 30' ' ' LEU . 65.0 pttt -155.08 154.08 31.86 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.202 2.906 . . . . 2.2000000000000002 109.886 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.0 t -79.89 113.95 18.44 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 125.857 2.742 . . . . 0.94999999999999996 108.923 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD2' ' HE3' ' A' ' 28' ' ' LYS . 81.7 mt -83.81 136.47 34.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 126.286 2.946 . . . . 1.3500000000000001 110.39 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.587 ' HA ' HD22 ' A' ' 22' ' ' LEU . 7.0 p -75.78 105.15 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 126.21 2.909 . . . . 1.54 108.063 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -74.32 66.55 1.32 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.357 2.98 . . . . 2.71 110.313 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 149.86 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 125.984 2.802 . . . . 3.48 108.753 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 126.151 2.881 . . . . 2.1499999999999999 110.528 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.473 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p -90.66 156.36 18.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.787 2.708 . . . . 1.05 109.638 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.21 152.58 52.56 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 113.709 -1.587 . . . . 0.59999999999999998 111.724 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 28.2 pt -109.04 168.25 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 126.582 3.087 . . . . 0.75 111.182 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -69.13 14.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 125.214 2.435 . . . . 1.25 113.549 -169.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 4' ' ' ILE . 27.9 p-80 -160.37 39.9 0.17 Allowed 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 126.272 2.939 . . . . 1.23 109.872 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 37.8 t70 -121.41 138.44 54.27 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.464 2.554 . . . . 0.96999999999999997 108.555 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -56.05 136.11 52.41 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 126.148 2.88 . . . . 2.1899999999999999 110.043 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 17.4 t -159.26 143.86 15.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.015 2.817 . . . . 1.1100000000000001 109.286 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.24 148.67 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 125.765 2.698 . . . . 1.7 108.872 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 53.9 t80 -73.65 70.62 1.36 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 126.199 2.904 . . . . 5.54 109.369 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -130.38 80.9 69.5 Favored Pre-proline 0 CA--C 1.516 -0.361 0 CA-C-O 126.345 2.974 . . . . 2.4500000000000002 109.475 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 -31.93 25.89 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 CA-C-O 125.559 2.233 . . . . 2.3500000000000001 112.627 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.23 68.7 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.121 2.867 . . . . 2.1699999999999999 110.525 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.33 50.33 1.4 Allowed 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 125.831 2.729 . . . . 3.5699999999999998 108.805 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 52.4 t-20 -50.88 111.81 2.52 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 125.557 2.598 . . . . 1.6299999999999999 109.946 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -89.12 4.21 5.35 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.233 2.622 . . . . 0.93999999999999995 112.786 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 21.3 t -90.82 161.93 15.05 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.517 2.579 . . . . 1.03 108.296 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.473 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 59.4 m -60.66 127.89 33.9 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 126.006 2.813 . . . . 1.1200000000000001 109.496 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -55.42 116.08 2.66 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.325 2.964 . . . . 4.7199999999999998 110.072 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.62 7.99 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 112.651 -2.068 . . . . 0.55000000000000004 110.565 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 40.4 mt -107.87 148.69 29.24 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 125.56 2.6 . . . . 1.25 108.505 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 23' ' ' GLN . 5.9 tp60 -118.25 123.39 45.31 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 126.071 2.843 . . . . 2.8399999999999999 109.759 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.7 m -76.3 106.08 7.72 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 126.176 2.893 . . . . 1.1399999999999999 110.665 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 27' ' ' GLY . 18.7 ttm180 -85.68 149.39 25.34 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.292 2.472 . . . . 3.7599999999999998 108.107 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 11' ' ' TYR . 53.5 t80 -56.76 89.03 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.234 2.921 . . . . 5.0199999999999996 109.602 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 141.63 -50.13 0.74 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 112.582 -2.099 . . . . 0.42999999999999999 111.071 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.717 ' HE2' HD21 ' A' ' 30' ' ' LEU . 23.5 pttm -161.88 161.21 28.79 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.926 2.774 . . . . 2.2000000000000002 109.538 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.1 t -82.78 139.69 33.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.707 2.67 . . . . 0.94999999999999996 109.459 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.717 HD21 ' HE2' ' A' ' 28' ' ' LYS . 94.2 mt -128.81 167.11 17.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.039 2.828 . . . . 1.3500000000000001 109.465 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 5' ' ' LEU . 23.2 m -80.82 134.58 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 125.92 2.771 . . . . 1.54 110.235 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -77.29 110.42 12.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 126.025 2.821 . . . . 2.71 108.122 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.6 80.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 126.582 3.087 . . . . 3.48 109.184 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 125.987 2.803 . . . . 2.1499999999999999 110.746 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.8 t -90.7 138.36 31.63 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.606 2.622 . . . . 1.05 108.837 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -67.31 119.18 11.09 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 113.68 -1.6 . . . . 0.59999999999999998 112.403 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.25 171.83 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 126.065 2.841 . . . . 0.75 110.278 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.91 -15.9 46.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 125.209 2.433 . . . . 1.25 112.521 -164.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -131.87 52.94 2.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 126.499 3.047 . . . . 1.23 109.84 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -129.31 133.81 47.62 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 125.92 2.771 . . . . 0.96999999999999997 109.407 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.96 129.97 39.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.904 2.764 . . . . 2.1899999999999999 109.501 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -148.93 137.94 21.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 126.022 2.82 . . . . 1.1100000000000001 110.427 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.07 135.64 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 125.741 2.686 . . . . 1.7 108.94 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.21 86.37 0.06 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 126.304 2.954 . . . . 5.54 111.334 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.79 104.11 27.27 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.97 2.795 . . . . 2.4500000000000002 108.827 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.36 -47.0 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.682 0 CA-C-O 125.666 2.278 . . . . 2.3500000000000001 113.266 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.21 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.982 2.801 . . . . 2.1699999999999999 110.425 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 15' ' ' GLN . 53.1 tt0 -108.85 42.24 1.45 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.84 2.734 . . . . 3.5699999999999998 109.425 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -60.24 111.88 4.65 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 125.949 2.785 . . . . 1.6299999999999999 110.338 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -92.21 8.58 2.87 Favored 'Trans proline' 0 CA--C 1.506 -0.898 0 C-N-CA 123.466 2.778 . . . . 0.93999999999999995 111.901 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 4.6 t -93.23 140.39 29.58 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.485 2.564 . . . . 1.03 109.367 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 m -60.86 125.08 22.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 125.507 2.575 . . . . 1.1200000000000001 109.162 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 3.2 tpm_? -55.41 124.74 18.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 126.287 2.946 . . . . 4.7199999999999998 110.035 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.57 -34.74 4.64 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 112.775 -2.011 . . . . 0.55000000000000004 109.69 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.661 ' HG ' HG12 ' A' ' 31' ' ' VAL . 4.5 mp -102.82 130.65 49.89 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 125.623 2.63 . . . . 1.25 107.317 171.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -101.66 130.91 48.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.402 3.001 . . . . 2.8399999999999999 109.761 -176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 19.2 t -75.38 101.21 4.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 126.064 2.84 . . . . 1.1399999999999999 109.081 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HD3' HD12 ' A' ' 30' ' ' LEU . 71.9 ttt180 -98.56 155.05 17.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.195 2.426 . . . . 3.7599999999999998 108.596 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -49.45 92.62 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.002 2.811 . . . . 5.0199999999999996 111.149 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 120.44 -35.01 3.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 113.483 -1.69 . . . . 0.42999999999999999 112.344 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HE2' HD11 ' A' ' 30' ' ' LEU . 23.9 pttm -160.27 150.99 18.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.388 2.994 . . . . 2.2000000000000002 110.973 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 m -80.25 130.01 34.9 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 125.849 2.738 . . . . 0.94999999999999996 109.439 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.6 HD12 ' HD3' ' A' ' 25' ' ' ARG . 95.4 mt -130.15 138.25 50.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 126.052 2.834 . . . . 1.3500000000000001 109.713 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.661 HG12 ' HG ' ' A' ' 22' ' ' LEU . 27.5 m -66.9 148.22 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 125.594 2.616 . . . . 1.54 109.18 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -75.65 94.75 3.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.513 3.054 . . . . 2.71 108.616 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -80.85 95.06 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 125.992 2.806 . . . . 3.48 109.719 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 126.204 2.906 . . . . 2.1499999999999999 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p -74.96 163.09 28.0 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 125.909 2.766 . . . . 1.05 109.467 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.67 144.99 46.32 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 113.648 -1.615 . . . . 0.59999999999999998 111.032 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.463 ' HB ' HD23 ' A' ' 5' ' ' LEU . 32.4 pt -126.94 -178.57 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 126.337 2.97 . . . . 0.75 110.564 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.3 pt? -55.94 -9.64 0.63 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.215 -2.266 . . . . 1.25 114.368 -166.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.88 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 20.1 p-80 -147.16 34.47 0.89 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.943 2.783 . . . . 1.23 110.462 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 16.7 t70 -90.8 114.55 26.96 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 125.493 2.568 . . . . 0.96999999999999997 108.549 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -61.12 111.39 1.69 Allowed 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 126.109 2.861 . . . . 2.1899999999999999 108.686 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.485 ' H ' ' HA ' ' A' ' 28' ' ' LYS . 34.7 t -145.12 142.58 29.78 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.012 2.815 . . . . 1.1100000000000001 109.816 -163.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG13 HG22 ' A' ' 12' ' ' VAL . 7.6 p -81.67 147.21 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 125.955 2.788 . . . . 1.7 109.033 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 67.1 t80 -72.1 79.23 0.94 Allowed 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 126.246 2.926 . . . . 5.54 109.799 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 10' ' ' VAL . 15.3 m -125.46 80.71 65.31 Favored Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 126.11 2.862 . . . . 2.4500000000000002 109.462 175.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 9.6 Cg_exo -71.13 -37.2 6.29 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 CA-C-O 125.859 2.358 . . . . 2.3500000000000001 112.656 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.65 68.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 126.151 2.881 . . . . 2.1699999999999999 110.564 -175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -129.34 42.23 3.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 125.853 2.739 . . . . 3.5699999999999998 109.058 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 65.0 t30 -63.83 112.05 6.56 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-O 125.624 2.631 . . . . 1.6299999999999999 110.171 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -90.97 16.32 1.62 Allowed 'Trans proline' 0 CA--C 1.508 -0.793 0 CA-C-O 126.687 2.703 . . . . 0.93999999999999995 111.837 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -98.43 149.27 22.86 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.584 2.611 . . . . 1.03 108.607 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.31 153.9 25.31 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 126.411 3.005 . . . . 1.1200000000000001 111.146 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -61.75 119.39 8.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 126.031 2.824 . . . . 4.7199999999999998 110.057 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 22' ' ' LEU . . . 106.82 2.97 36.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.059 -1.882 . . . . 0.55000000000000004 111.241 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.585 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 4.9 mp -129.51 139.87 51.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 125.806 2.717 . . . . 1.25 108.866 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 33.7 tt0 -123.22 123.76 41.49 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 125.739 2.685 . . . . 2.8399999999999999 110.422 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 23.2 m -70.82 97.49 1.4 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.891 2.758 . . . . 1.1399999999999999 109.863 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 8.0 tmm_? -100.09 157.04 16.85 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.17 2.414 . . . . 3.7599999999999998 108.32 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -44.97 95.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.139 2.876 . . . . 5.0199999999999996 111.07 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 129.91 -57.08 0.73 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 112.993 -1.912 . . . . 0.42999999999999999 111.503 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.88 ' HD2' ' HA ' ' A' ' 6' ' ' HIS . 21.7 pttm -160.49 163.75 32.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 126.247 2.927 . . . . 2.2000000000000002 109.782 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 28.1 t -81.42 133.66 35.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 125.517 2.58 . . . . 0.94999999999999996 108.79 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.8 pp -122.85 150.09 43.33 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 125.991 2.805 . . . . 1.3500000000000001 110.018 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.401 HG12 ' HG ' ' A' ' 22' ' ' LEU . 7.9 m -73.29 92.44 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 126.087 2.851 . . . . 1.54 110.23 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' HB2' ' A' ' 23' ' ' GLN . 20.8 pt20 -67.8 116.96 9.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 126.278 2.942 . . . . 2.71 109.255 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.78 -7.95 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 126.328 2.966 . . . . 3.48 109.902 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 125.884 2.754 . . . . 2.1499999999999999 110.822 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.1 t -91.5 122.83 34.43 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.434 2.54 . . . . 1.05 108.072 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -56.28 123.21 30.61 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 113.674 -1.603 . . . . 0.59999999999999998 112.057 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.805 HG12 ' HB2' ' A' ' 7' ' ' ASP . 20.1 pt -90.57 173.36 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.257 2.932 . . . . 0.75 110.011 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.86 6.24 0.72 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 125.279 2.466 . . . . 1.25 112.946 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 4' ' ' ILE . 10.0 p80 -161.01 45.86 0.19 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 125.955 2.788 . . . . 1.23 109.619 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 4' ' ' ILE . 31.0 t70 -102.86 131.3 49.85 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.593 2.616 . . . . 0.96999999999999997 109.184 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -56.05 133.09 51.66 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 126.104 2.859 . . . . 2.1899999999999999 110.976 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.7 p -170.58 145.05 2.48 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.944 2.783 . . . . 1.1100000000000001 109.251 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.574 HG23 HG12 ' A' ' 12' ' ' VAL . 23.3 m -82.19 155.82 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 125.864 2.745 . . . . 1.7 109.396 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.72 76.04 1.55 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 126.03 2.824 . . . . 5.54 109.468 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.574 HG12 HG23 ' A' ' 10' ' ' VAL . 8.1 p -134.98 89.54 24.08 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 126.372 2.987 . . . . 2.4500000000000002 109.629 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 35.3 Cg_exo -59.69 -39.05 77.29 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 CA-C-O 126.014 2.423 . . . . 2.3500000000000001 112.038 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -36.57 47.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 125.806 2.717 . . . . 2.1699999999999999 111.155 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' H ' HG22 ' A' ' 12' ' ' VAL . 51.0 mt-30 -122.39 39.23 3.96 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 125.745 2.688 . . . . 3.5699999999999998 109.836 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 25.1 t-20 -72.2 115.41 38.43 Favored Pre-proline 0 CA--C 1.508 -0.658 0 CA-C-O 125.813 2.72 . . . . 1.6299999999999999 109.76 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 16' ' ' ASN . 87.8 Cg_endo -98.28 11.98 0.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.281 2.654 . . . . 0.93999999999999995 112.655 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.556 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.6 t -91.92 149.41 21.57 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 125.771 2.701 . . . . 1.03 109.735 -174.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' HB2' HD22 ' A' ' 22' ' ' LEU . 72.5 m -59.51 143.15 50.87 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 125.943 2.782 . . . . 1.1200000000000001 109.609 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.68 131.61 51.27 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.263 2.935 . . . . 4.7199999999999998 110.583 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.28 -22.5 36.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 112.94 -1.936 . . . . 0.55000000000000004 111.243 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.502 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 5.1 mp -97.7 135.2 39.83 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 125.645 2.64 . . . . 1.25 108.404 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -114.91 132.8 56.42 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 125.867 2.746 . . . . 2.8399999999999999 110.116 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 m -85.04 114.78 22.45 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 126.109 2.861 . . . . 1.1399999999999999 110.617 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 16.4 mmt180 -87.84 159.21 18.5 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 124.558 2.123 . . . . 3.7599999999999998 106.192 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.22 78.46 0.24 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 126.218 2.913 . . . . 5.0199999999999996 109.972 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 146.07 -33.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.974 -1.921 . . . . 0.42999999999999999 111.754 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.83 143.33 15.73 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 126.012 2.815 . . . . 2.2000000000000002 110.107 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 29.3 t -87.73 141.69 28.4 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.444 2.545 . . . . 0.94999999999999996 108.28 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.59 138.73 38.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.583 2.611 . . . . 1.3500000000000001 108.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.56 113.05 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 126.215 2.912 . . . . 1.54 109.918 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -87.28 103.06 15.09 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 126.079 2.847 . . . . 2.71 108.447 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.77 128.92 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 125.89 2.757 . . . . 3.48 109.404 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.962 0 CA-C-O 125.573 2.606 . . . . 2.1499999999999999 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.52 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 28.3 p -90.53 139.01 31.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 125.989 2.804 . . . . 1.05 109.463 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.94 150.93 51.97 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 113.203 -1.817 . . . . 0.59999999999999998 112.399 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 6' ' ' HIS . 10.1 pt -92.86 167.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 126.137 2.875 . . . . 0.75 110.455 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.531 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -68.47 18.92 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 125.45 2.548 . . . . 1.25 112.886 -172.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.535 ' H ' ' C ' ' A' ' 4' ' ' ILE . 24.5 p-80 -161.58 41.91 0.15 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.168 2.89 . . . . 1.23 109.714 173.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.2 t0 -116.29 152.96 32.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 125.552 2.596 . . . . 0.96999999999999997 108.268 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 133.13 37.55 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.089 2.852 . . . . 2.1899999999999999 111.093 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 12.2 p 177.18 124.62 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 125.888 2.756 . . . . 1.1100000000000001 108.559 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 12' ' ' VAL . 27.1 m -79.57 -159.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 125.558 2.599 . . . . 1.7 110.695 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 10.8 p90 -70.27 75.05 0.52 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 126.707 3.146 . . . . 5.54 110.582 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' VAL . 11.8 m -127.97 81.6 70.04 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.991 2.805 . . . . 2.4500000000000002 109.942 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 3.4 Cg_exo -75.94 -54.86 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.787 0 CA-C-O 125.881 2.367 . . . . 2.3500000000000001 111.913 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.72 77.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 126.212 2.91 . . . . 2.1699999999999999 110.077 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -108.68 39.1 2.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 125.65 2.643 . . . . 3.5699999999999998 109.723 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 54.9 t-20 -64.4 113.03 9.04 Favored Pre-proline 0 CA--C 1.512 -0.502 0 CA-C-O 125.803 2.716 . . . . 1.6299999999999999 110.156 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 72.3 Cg_endo -91.1 -2.25 4.77 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 123.083 2.522 . . . . 0.93999999999999995 112.37 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.1 t -87.18 161.37 18.1 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 125.796 2.712 . . . . 1.03 109.214 -175.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.52 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 84.4 m -63.77 135.24 56.5 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 126.181 2.896 . . . . 1.1200000000000001 110.174 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -58.43 116.3 3.55 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.378 2.99 . . . . 4.7199999999999998 109.55 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 123.64 -14.9 8.07 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 112.818 -1.992 . . . . 0.55000000000000004 110.655 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.8 mt -119.16 158.79 25.25 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 125.563 2.602 . . . . 1.25 108.86 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.675 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 28.2 mm-40 -131.89 134.57 45.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.817 2.722 . . . . 2.8399999999999999 110.051 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 87.3 m -83.03 120.11 25.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 126.147 2.88 . . . . 1.1399999999999999 110.05 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 19.1 ttt180 -110.79 164.22 12.98 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.087 2.375 . . . . 3.7599999999999998 108.337 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' N ' ' HG2' ' A' ' 25' ' ' ARG . 70.5 m-85 -45.62 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.319 2.961 . . . . 5.0199999999999996 110.909 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.58 -54.66 0.73 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.441 -2.163 . . . . 0.42999999999999999 112.043 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -160.39 166.68 28.89 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 126.554 3.073 . . . . 2.2000000000000002 110.752 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.725 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 50.9 t -86.84 141.55 28.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 125.804 2.716 . . . . 0.94999999999999996 109.778 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.67 174.25 10.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.661 2.648 . . . . 1.3500000000000001 108.792 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.42 136.74 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 125.554 2.597 . . . . 1.54 109.266 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.675 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 6.7 pt20 -88.84 115.25 26.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.216 2.912 . . . . 2.71 109.574 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.93 56.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 127.09 3.328 . . . . 3.48 108.419 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 126.067 2.842 . . . . 2.1499999999999999 110.515 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.47 111.55 22.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 126.294 2.949 . . . . 1.05 110.602 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.427 ' HA2' ' OD2' ' A' ' 7' ' ' ASP . . . -72.71 123.81 9.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 113.213 -1.812 . . . . 0.59999999999999998 110.971 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.778 HG12 ' HB2' ' A' ' 7' ' ' ASP . 26.1 pt -90.01 177.23 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 125.848 2.737 . . . . 0.75 110.307 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.8 12.0 0.58 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 125.731 2.682 . . . . 1.25 112.067 -168.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 4' ' ' ILE . 14.1 p80 -160.26 43.32 0.2 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 126.47 3.033 . . . . 1.23 108.59 172.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.778 ' HB2' HG12 ' A' ' 4' ' ' ILE . 47.0 t0 -114.4 138.12 50.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 125.686 2.66 . . . . 0.96999999999999997 108.721 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.9 m-20 -67.96 130.65 43.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.856 2.741 . . . . 2.1899999999999999 110.389 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 17' ' ' PRO . 14.2 p -153.1 145.48 24.03 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 126.206 2.907 . . . . 1.1100000000000001 110.583 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.2 p -88.77 137.88 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 125.09 2.376 . . . . 1.7 107.739 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 26' ' ' TYR . 8.0 p90 -70.45 79.69 0.56 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 126.81 3.195 . . . . 5.54 110.878 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 10' ' ' VAL . 17.6 m -126.84 106.52 22.68 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 125.988 2.804 . . . . 2.4500000000000002 109.443 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.75 -38.25 4.43 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 CA-C-O 125.692 2.288 . . . . 2.3500000000000001 112.311 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.99 -52.02 21.48 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 125.88 2.752 . . . . 2.1699999999999999 110.727 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.17 61.52 0.9 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 126.031 2.824 . . . . 3.5699999999999998 107.807 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 17.4 t-20 -54.49 117.87 14.78 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 125.736 2.684 . . . . 1.6299999999999999 110.662 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.413 ' CG ' ' HB2' ' A' ' 9' ' ' CYS . 92.8 Cg_endo -80.68 -14.35 11.43 Favored 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 123.379 2.719 . . . . 0.93999999999999995 112.777 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 55.7 m -79.42 146.18 32.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 126.013 2.816 . . . . 1.03 109.445 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.59 144.73 56.24 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.754 2.693 . . . . 1.1200000000000001 108.586 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' C ' ' HD3' ' A' ' 20' ' ' ARG . 2.6 tmt_? -57.16 109.99 0.76 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 126.353 2.978 . . . . 4.7199999999999998 109.946 -172.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.88 -11.86 7.35 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 112.654 -2.067 . . . . 0.55000000000000004 111.424 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 31' ' ' VAL . 78.7 mt -112.38 146.44 38.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.994 2.807 . . . . 1.25 109.747 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.646 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 52.3 tt0 -106.19 137.11 44.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.421 2.534 . . . . 2.8399999999999999 109.173 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 52.2 t -92.47 109.94 21.35 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.448 3.023 . . . . 1.1399999999999999 109.944 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.575 ' HG3' HD12 ' A' ' 30' ' ' LEU . 35.1 mmt180 -96.83 137.07 36.48 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 124.727 2.204 . . . . 3.7599999999999998 106.917 170.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.587 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 35.0 p90 -50.32 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 126.659 3.123 . . . . 5.0199999999999996 110.541 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 134.65 -46.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 112.384 -2.189 . . . . 0.42999999999999999 111.836 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 22.0 pttm -160.08 154.16 23.24 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 126.539 3.066 . . . . 2.2000000000000002 111.036 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 84.6 m -79.75 138.87 37.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 125.798 2.713 . . . . 0.94999999999999996 109.183 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.575 HD12 ' HG3' ' A' ' 25' ' ' ARG . 96.0 mt -130.44 162.33 29.41 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.726 2.679 . . . . 1.3500000000000001 109.012 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 13.3 m -69.17 112.13 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 126.231 2.919 . . . . 1.54 110.3 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 62.2 tt0 -84.83 64.92 8.88 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 126.367 2.984 . . . . 2.71 109.374 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.08 154.85 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 125.773 2.702 . . . . 3.48 109.044 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 125.837 2.732 . . . . 2.1499999999999999 110.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -81.09 156.79 25.63 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 126.135 2.874 . . . . 1.05 109.655 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.92 126.41 36.76 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 113.116 -1.857 . . . . 0.59999999999999998 112.666 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.644 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.9 pt -108.29 176.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 126.257 2.932 . . . . 0.75 110.069 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -64.89 3.62 0.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.844 2.259 . . . . 1.25 113.451 -169.161 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -152.56 36.1 0.51 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 126.16 2.886 . . . . 1.23 109.711 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.603 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.7 t70 -111.31 137.69 48.73 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.657 2.646 . . . . 0.96999999999999997 109.137 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.79 131.73 50.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.566 2.603 . . . . 2.1899999999999999 109.561 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -156.35 143.35 18.87 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 126.281 2.943 . . . . 1.1100000000000001 110.717 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 12' ' ' VAL . 23.7 m -103.82 146.04 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-O 125.494 2.568 . . . . 1.7 108.455 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' HD2' ' H ' ' A' ' 26' ' ' TYR . 3.2 t80 -70.24 86.32 0.58 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 126.176 2.893 . . . . 5.54 110.175 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' VAL . 5.6 p -132.96 84.39 49.29 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-O 126.286 2.946 . . . . 2.4500000000000002 109.268 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.3 -43.66 17.56 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-O 125.808 2.337 . . . . 2.3500000000000001 112.833 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.34 -39.15 63.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 126.176 2.893 . . . . 2.1699999999999999 110.893 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -127.63 48.55 2.23 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.998 2.808 . . . . 3.5699999999999998 109.146 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -50.69 112.44 2.89 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-O 125.96 2.791 . . . . 1.6299999999999999 110.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.85 -6.77 17.07 Favored 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 123.239 2.626 . . . . 0.93999999999999995 112.398 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.9 m -78.75 154.31 30.11 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.292 2.949 . . . . 1.03 110.599 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' HD23 ' A' ' 22' ' ' LEU . 23.5 m -62.86 136.92 58.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 125.306 2.479 . . . . 1.1200000000000001 107.964 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -55.97 107.7 0.38 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 126.302 2.953 . . . . 4.7199999999999998 110.426 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.34 -23.3 4.88 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 112.7 -2.046 . . . . 0.55000000000000004 111.3 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.8 mm? -94.62 134.21 37.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.948 2.785 . . . . 1.25 109.255 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -105.63 118.07 35.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 126.265 2.936 . . . . 2.8399999999999999 109.203 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 36.6 t -79.59 132.42 36.26 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.963 2.792 . . . . 1.1399999999999999 110.487 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 15.6 ttm180 -122.95 143.25 50.03 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 125.328 2.489 . . . . 3.7599999999999998 108.083 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.52 ' H ' ' HD2' ' A' ' 11' ' ' TYR . 9.6 p90 -50.1 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 126.501 3.048 . . . . 5.0199999999999996 110.726 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.5 -56.84 0.72 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 112.468 -2.151 . . . . 0.42999999999999999 110.916 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HE3' HD21 ' A' ' 30' ' ' LEU . 64.3 pttt -156.81 161.42 39.74 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 126.619 3.104 . . . . 2.2000000000000002 109.733 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 11.9 t -88.42 138.02 31.8 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 125.53 2.586 . . . . 0.94999999999999996 109.352 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.459 HD21 ' HE3' ' A' ' 28' ' ' LYS . 75.4 mt -124.66 167.54 14.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 126.015 2.817 . . . . 1.3500000000000001 109.633 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.97 136.3 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 CA-C-O 125.382 2.515 . . . . 1.54 108.805 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -75.13 67.61 1.81 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.701 3.143 . . . . 2.71 109.112 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.35 116.12 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 126.183 2.897 . . . . 3.48 108.779 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 126.124 2.869 . . . . 2.1499999999999999 110.494 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.6 p -90.09 143.24 26.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 125.991 2.805 . . . . 1.05 109.849 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.65 136.89 44.39 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 113.302 -1.772 . . . . 0.59999999999999998 112.077 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.448 ' H ' ' HB2' ' A' ' 7' ' ' ASP . 22.7 pt -100.67 169.03 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 126.684 3.135 . . . . 0.75 111.233 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.653 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.1 pt? -57.09 -6.93 0.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 111.627 -2.533 . . . . 1.25 113.391 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -147.89 51.96 1.04 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.583 3.087 . . . . 1.23 109.31 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 5.6 t0 -112.9 122.6 48.13 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 125.473 2.558 . . . . 0.96999999999999997 108.559 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.94 123.04 15.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 125.582 2.61 . . . . 2.1899999999999999 109.661 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 t -161.92 152.79 17.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.068 2.842 . . . . 1.1100000000000001 110.256 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 24' ' ' CYS . 30.8 m -97.8 171.89 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 125.963 2.792 . . . . 1.7 109.582 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -81.8 73.98 8.81 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 126.178 2.894 . . . . 5.54 110.168 -173.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.9 87.73 50.59 Favored Pre-proline 0 CA--C 1.514 -0.435 0 CA-C-O 126.264 2.935 . . . . 2.4500000000000002 110.588 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.22 -35.21 5.3 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.981 2.454 . . . . 2.3500000000000001 112.284 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.05 -28.69 25.95 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.056 2.836 . . . . 2.1699999999999999 111.152 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 46.8 tp60 -141.73 57.52 1.5 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 125.861 2.744 . . . . 3.5699999999999998 108.34 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.4 107.67 1.21 Allowed Pre-proline 0 CA--C 1.509 -0.622 0 CA-C-O 125.656 2.646 . . . . 1.6299999999999999 109.161 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 79.3 Cg_endo -78.92 -8.76 15.62 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 C-N-CA 123.189 2.593 . . . . 0.93999999999999995 112.469 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 87.0 m -77.49 150.36 34.9 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 126.232 2.92 . . . . 1.03 110.676 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.499 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 4.5 m -58.08 135.48 57.01 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.154 2.407 . . . . 1.1200000000000001 107.947 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -57.78 113.28 1.78 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 126.509 3.052 . . . . 4.7199999999999998 110.343 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 126.68 -18.11 6.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 112.123 -2.308 . . . . 0.55000000000000004 110.331 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 33.9 mt -119.07 148.68 42.77 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 125.428 2.537 . . . . 1.25 108.098 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -139.66 136.13 33.95 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 126.004 2.811 . . . . 2.8399999999999999 109.914 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 68.0 m -67.19 129.83 41.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.156 2.884 . . . . 1.1399999999999999 110.492 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.667 ' HD3' HD12 ' A' ' 30' ' ' LEU . 42.9 mtp180 -128.35 133.97 48.77 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 124.993 2.33 . . . . 3.7599999999999998 107.625 170.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -37.88 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 126.743 3.163 . . . . 5.0199999999999996 112.302 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 137.66 -58.5 0.63 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 112.226 -2.261 . . . . 0.42999999999999999 110.759 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 154.9 36.07 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.65 3.119 . . . . 2.2000000000000002 109.963 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.0 t -79.81 130.13 35.06 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 125.568 2.604 . . . . 0.94999999999999996 108.545 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.667 HD12 ' HD3' ' A' ' 25' ' ' ARG . 95.9 mt -127.34 160.94 29.86 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 125.912 2.768 . . . . 1.3500000000000001 109.556 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 t -71.78 109.99 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 125.52 2.581 . . . . 1.54 107.199 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 18.0 pt20 -51.98 -32.06 31.97 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 125.796 2.713 . . . . 2.71 111.566 -171.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.86 140.35 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 125.9 2.762 . . . . 3.48 109.16 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 126.45 3.024 . . . . 2.1499999999999999 110.065 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 17.7 p -90.62 153.66 20.16 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 126.065 2.841 . . . . 1.05 109.915 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.577 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.69 128.54 15.17 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 113.271 -1.786 . . . . 0.59999999999999998 110.931 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.698 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.0 pt -98.34 177.95 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 126.079 2.847 . . . . 0.75 110.183 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.5 pt? -57.12 -7.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.291 -2.231 . . . . 1.25 114.041 -167.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.45 48.5 0.36 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.184 2.897 . . . . 1.23 109.788 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.698 ' HB2' HG12 ' A' ' 4' ' ' ILE . 22.3 t70 -101.41 123.64 45.81 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.745 2.688 . . . . 0.96999999999999997 109.655 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -64.63 123.17 18.61 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.132 2.872 . . . . 2.1899999999999999 110.502 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.4 p -157.97 174.25 15.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.73 2.681 . . . . 1.1100000000000001 109.849 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.24 149.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 126.005 2.812 . . . . 1.7 109.773 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.747 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 40.7 t80 -77.78 76.3 4.31 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 126.276 2.941 . . . . 5.54 110.405 -170.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.49 85.92 48.44 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-O 125.607 2.623 . . . . 2.4500000000000002 109.271 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.72 -38.04 52.44 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.655 2.236 . . . . 2.3500000000000001 112.925 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.32 -23.15 63.99 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 126.184 2.897 . . . . 2.1699999999999999 110.518 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -135.29 47.69 2.3 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 125.917 2.77 . . . . 3.5699999999999998 109.079 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -58.02 113.58 6.78 Favored Pre-proline 0 CA--C 1.51 -0.595 0 CA-C-O 125.756 2.693 . . . . 1.6299999999999999 109.406 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 64.2 Cg_endo -79.89 -6.84 14.32 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 123.241 2.627 . . . . 0.93999999999999995 112.626 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 74.4 m -78.24 155.54 30.22 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 126.174 2.892 . . . . 1.03 110.852 -171.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -62.8 150.32 41.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 125.683 2.659 . . . . 1.1200000000000001 109.092 174.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -59.87 103.24 0.2 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 126.238 2.923 . . . . 4.7199999999999998 110.371 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.04 -5.31 8.34 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 112.752 -2.022 . . . . 0.55000000000000004 111.973 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 75.8 mt -114.36 137.44 51.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 125.879 2.752 . . . . 1.25 109.152 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -116.94 119.4 35.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 126.022 2.82 . . . . 2.8399999999999999 109.76 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.8 t -73.68 129.59 38.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 126.011 2.815 . . . . 1.1399999999999999 109.912 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.747 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 36.6 ttm180 -111.97 154.08 25.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 125.154 2.407 . . . . 3.7599999999999998 108.321 174.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -52.51 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 126.452 3.025 . . . . 5.0199999999999996 109.697 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.4 -54.4 0.79 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 112.531 -2.122 . . . . 0.42999999999999999 110.912 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -161.43 159.43 28.14 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.461 3.029 . . . . 2.2000000000000002 110.344 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 22.8 t -81.47 145.7 30.61 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.4 2.524 . . . . 0.94999999999999996 109.207 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 168.74 18.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 125.999 2.809 . . . . 1.3500000000000001 110.076 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.14 155.78 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-O 125.911 2.767 . . . . 1.54 110.053 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.38 59.69 0.6 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 126.144 2.878 . . . . 2.71 110.674 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.06 57.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 127.077 3.322 . . . . 3.48 109.152 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 126.045 2.831 . . . . 2.1499999999999999 110.467 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.99 110.54 21.79 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.934 2.778 . . . . 1.05 108.395 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.919 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.5 119.81 19.91 Favored Glycine 0 C--O 1.236 0.257 0 CA-C-N 113.333 -1.758 . . . . 0.59999999999999998 112.333 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 6' ' ' HIS . 13.0 pt -102.16 164.73 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 126.179 2.895 . . . . 0.75 110.236 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -66.77 12.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 125.293 2.473 . . . . 1.25 113.072 -171.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 4' ' ' ILE . 20.5 p-80 -154.88 42.16 0.46 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.197 2.903 . . . . 1.23 109.627 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 34.5 t70 -112.69 125.12 53.96 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 125.967 2.794 . . . . 0.96999999999999997 109.12 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.0 p-10 -76.1 122.48 24.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 126.163 2.887 . . . . 2.1899999999999999 109.764 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.6 p -149.04 171.61 16.11 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.774 2.702 . . . . 1.1100000000000001 109.73 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.89 146.9 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 126.218 2.913 . . . . 1.7 109.777 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.572 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.5 p90 -71.63 71.58 0.72 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.503 3.049 . . . . 5.54 110.741 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.31 94.07 31.19 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-O 125.834 2.73 . . . . 2.4500000000000002 109.261 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.93 -29.88 82.8 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.957 2.438 . . . . 2.3500000000000001 112.924 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.89 -38.93 17.45 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 125.996 2.807 . . . . 2.1699999999999999 110.533 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 18.3 tt0 -132.4 65.7 1.57 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.941 2.781 . . . . 3.5699999999999998 108.498 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -61.47 109.76 2.48 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-O 125.625 2.631 . . . . 1.6299999999999999 109.377 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 3' ' ' GLY . 70.6 Cg_endo -82.25 -10.04 11.35 Favored 'Trans proline' 0 CA--C 1.498 -1.283 0 CA-C-O 126.241 2.517 . . . . 0.93999999999999995 112.204 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.919 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 94.4 m -79.69 154.07 28.87 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 126.0 2.809 . . . . 1.03 110.165 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.3 m -65.07 110.01 2.35 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 125.273 2.464 . . . . 1.1200000000000001 106.308 167.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -51.12 118.6 3.33 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 127.054 3.312 . . . . 4.7199999999999998 109.935 -173.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -26.37 3.62 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 111.314 -2.676 . . . . 0.55000000000000004 109.356 -165.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 7.2 mp -105.02 152.53 22.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 125.613 2.625 . . . . 1.25 108.714 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -121.49 135.26 55.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.195 2.902 . . . . 2.8399999999999999 110.566 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' A' ' 18' ' ' CYS . 3.0 m -77.3 97.44 4.87 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 125.962 2.791 . . . . 1.1399999999999999 109.696 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.734 ' HD2' HD12 ' A' ' 30' ' ' LEU . 87.8 mtt180 -86.23 157.39 19.96 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 124.922 2.296 . . . . 3.7599999999999998 107.241 172.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -49.6 94.3 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 126.378 2.99 . . . . 5.0199999999999996 110.522 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.19 -47.34 1.05 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 112.688 -2.051 . . . . 0.42999999999999999 112.492 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -130.95 138.68 49.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.582 3.087 . . . . 2.2000000000000002 111.564 -168.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.8 t -79.67 105.48 10.99 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 125.803 2.716 . . . . 0.94999999999999996 107.852 170.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 25' ' ' ARG . 94.2 mt -120.6 142.43 49.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 126.016 2.817 . . . . 1.3500000000000001 109.488 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.701 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 34.5 t -59.15 128.84 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 CA-C-O 125.753 2.692 . . . . 1.54 109.75 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.2 76.98 2.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.318 2.961 . . . . 2.71 109.205 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.04 139.87 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-O 125.921 2.772 . . . . 3.48 109.247 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.89 0 CA-C-O 126.014 2.816 . . . . 2.1499999999999999 109.866 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t -80.9 138.29 36.15 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.861 2.743 . . . . 1.05 109.524 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -66.01 109.4 2.87 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 113.391 -1.731 . . . . 0.59999999999999998 111.666 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.8 pt -91.71 -178.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 125.452 2.549 . . . . 0.75 110.536 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.42 ' N ' HD23 ' A' ' 5' ' ' LEU . 2.5 pt? -37.05 -38.38 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 124.368 2.032 . . . . 1.25 114.617 -166.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -141.94 29.72 1.67 Allowed 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 125.477 2.561 . . . . 1.23 111.284 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.79 132.67 44.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 125.675 2.655 . . . . 0.96999999999999997 109.049 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 79.7 m-20 -75.31 123.71 25.82 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.022 2.82 . . . . 2.1899999999999999 110.254 -173.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 p -161.47 178.16 9.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 126.002 2.81 . . . . 1.1100000000000001 110.44 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.66 143.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 125.954 2.788 . . . . 1.7 109.666 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -69.61 82.46 0.42 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.968 2.794 . . . . 5.54 110.134 -177.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 7.7 p -119.97 91.85 46.05 Favored Pre-proline 0 CA--C 1.513 -0.475 0 CA-C-O 126.133 2.873 . . . . 2.4500000000000002 108.84 172.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HD3' ' HD1' ' A' ' 11' ' ' TYR . 37.0 Cg_endo -65.98 -47.65 3.45 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 122.791 2.327 . . . . 2.3500000000000001 113.4 -173.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.17 62.49 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 125.831 2.729 . . . . 2.1699999999999999 111.241 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -128.65 42.78 3.26 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.008 2.813 . . . . 3.5699999999999998 109.352 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -59.33 113.34 6.75 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.635 2.636 . . . . 1.6299999999999999 110.471 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.13 -3.95 11.07 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.047 2.498 . . . . 0.93999999999999995 112.214 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.549 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 4.8 t -79.63 144.99 33.28 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.531 2.586 . . . . 1.03 108.647 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 22' ' ' LEU . 71.3 m -59.42 143.52 49.53 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.12 2.867 . . . . 1.1200000000000001 110.177 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -62.73 118.46 7.71 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 126.159 2.885 . . . . 4.7199999999999998 109.526 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 111.25 -3.23 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.039 -1.891 . . . . 0.55000000000000004 111.129 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 19' ' ' CYS . 54.9 mt -127.95 133.81 49.26 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.756 2.693 . . . . 1.25 108.328 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.65 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 16.3 mm100 -110.98 120.86 43.79 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 126.148 2.88 . . . . 2.8399999999999999 109.56 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 38.1 t -79.93 120.46 24.17 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 125.859 2.742 . . . . 1.1399999999999999 109.65 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.76 HH11 ' HB2' ' A' ' 30' ' ' LEU . 6.1 mpt_? -101.95 164.27 11.8 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 125.176 2.417 . . . . 3.7599999999999998 108.595 175.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -58.95 85.83 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.428 3.013 . . . . 5.0199999999999996 110.867 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 144.66 -51.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.731 -2.031 . . . . 0.42999999999999999 110.894 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 63.5 pttt -163.19 174.24 12.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.351 2.977 . . . . 2.2000000000000002 110.272 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.5 m -77.98 145.21 36.14 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.117 2.865 . . . . 0.94999999999999996 110.049 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.76 ' HB2' HH11 ' A' ' 25' ' ' ARG . 87.4 mt -126.45 145.12 50.61 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.917 2.77 . . . . 1.3500000000000001 108.426 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HA ' HD22 ' A' ' 22' ' ' LEU . 24.3 m -80.38 119.73 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 126.399 2.999 . . . . 1.54 111.195 -172.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HG3' ' HG2' ' A' ' 23' ' ' GLN . 16.2 mm100 -90.93 -55.12 3.67 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 126.461 3.029 . . . . 2.71 109.099 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.01 84.51 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 126.239 2.924 . . . . 3.48 109.226 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 125.773 2.701 . . . . 2.1499999999999999 110.385 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.3 p -90.63 158.66 16.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.768 2.699 . . . . 1.05 109.511 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.627 ' H ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.31 139.11 39.38 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 113.564 -1.653 . . . . 0.59999999999999998 110.697 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.582 ' HB ' HD23 ' A' ' 5' ' ' LEU . 8.5 pt -111.06 -175.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 125.671 2.653 . . . . 0.75 111.357 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 5' ' ' LEU . 1.1 pt? -41.58 -35.24 0.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 124.443 2.068 . . . . 1.25 114.375 -165.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -145.07 38.6 1.18 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 125.722 2.677 . . . . 1.23 110.847 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' HB2' HG13 ' A' ' 4' ' ' ILE . 20.0 t70 -88.03 142.16 28.0 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 125.747 2.689 . . . . 0.96999999999999997 108.697 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 4.6 p-10 -71.33 138.45 49.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 125.718 2.675 . . . . 2.1899999999999999 110.21 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 p -168.61 175.26 6.25 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 126.211 2.91 . . . . 1.1100000000000001 109.849 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 12' ' ' VAL . 47.8 t -111.19 144.42 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 125.276 2.465 . . . . 1.7 108.334 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 81.5 t80 -66.34 80.84 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 126.596 3.093 . . . . 5.54 110.189 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 10' ' ' VAL . 18.2 m -128.13 79.58 73.66 Favored Pre-proline 0 CA--C 1.511 -0.552 0 CA-C-O 125.8 2.714 . . . . 2.4500000000000002 109.266 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 18.8 Cg_endo -58.59 -44.85 33.67 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 CA-C-O 125.996 2.415 . . . . 2.3500000000000001 112.286 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.61 -24.48 67.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 126.114 2.864 . . . . 2.1699999999999999 110.495 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 17.3 mm-40 -118.28 31.55 6.62 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 125.652 2.644 . . . . 3.5699999999999998 109.537 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 46.1 t-20 -52.67 110.14 1.8 Allowed Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-O 125.694 2.664 . . . . 1.6299999999999999 110.913 -175.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -95.08 7.47 2.07 Favored 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 123.599 2.866 . . . . 0.93999999999999995 111.575 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 5.1 t -102.8 157.6 16.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 125.269 2.462 . . . . 1.03 108.191 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.2 m -64.71 138.84 58.63 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.557 3.075 . . . . 1.1200000000000001 109.842 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -65.38 105.81 1.24 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 126.331 2.967 . . . . 4.7199999999999998 109.837 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 133.85 -9.74 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 112.613 -2.085 . . . . 0.55000000000000004 110.936 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 22' ' ' LEU . 5.1 mp -115.98 130.75 56.95 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.263 2.935 . . . . 1.25 109.46 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -81.99 95.65 7.47 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.83 2.729 . . . . 2.8399999999999999 109.818 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 40.3 t -68.1 99.63 0.91 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 126.405 3.002 . . . . 1.1399999999999999 108.746 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 25' ' ' ARG . 16.1 ttt180 -113.37 167.59 10.44 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.292 2.473 . . . . 3.7599999999999998 108.928 -173.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -51.1 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.088 2.851 . . . . 5.0199999999999996 111.134 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 113.1 -40.24 2.59 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 113.225 -1.807 . . . . 0.42999999999999999 112.498 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.851 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.1 pttt -161.21 161.26 30.82 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.585 3.088 . . . . 2.2000000000000002 110.932 -172.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 65.0 m -78.78 139.21 38.44 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 125.693 2.663 . . . . 0.94999999999999996 108.694 170.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.851 HD21 ' HE3' ' A' ' 28' ' ' LYS . 94.8 mt -123.78 114.11 19.46 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 126.145 2.879 . . . . 1.3500000000000001 109.382 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.31 131.55 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 125.626 2.631 . . . . 1.54 108.761 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 12.7 pt20 -74.37 63.47 1.05 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 126.589 3.09 . . . . 2.71 109.954 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.21 59.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 127.012 3.291 . . . . 3.48 109.55 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 125.655 2.645 . . . . 2.1499999999999999 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.77 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 30.7 p -67.43 128.3 35.91 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 125.845 2.736 . . . . 1.05 109.405 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -53.87 143.94 27.93 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 113.017 -1.901 . . . . 0.59999999999999998 113.107 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.62 HG12 ' HB2' ' A' ' 7' ' ' ASP . 40.3 pt -79.32 169.07 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 126.648 3.118 . . . . 0.75 111.169 -176.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.874 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 2.1 pt? -57.44 -6.62 0.47 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 111.796 -2.456 . . . . 1.25 113.54 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 29.5 p80 -154.88 43.36 0.48 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 125.667 2.651 . . . . 1.23 110.722 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.1 t70 -87.56 148.24 24.96 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.79 2.71 . . . . 0.96999999999999997 109.109 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.0 117.74 18.88 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 125.789 2.709 . . . . 2.1899999999999999 109.488 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 6.7 p -156.01 152.21 27.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 126.216 2.912 . . . . 1.1100000000000001 109.864 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 12' ' ' VAL . 14.6 p -81.0 152.53 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-O 125.992 2.806 . . . . 1.7 109.211 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -73.25 66.8 0.92 Allowed 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 126.247 2.927 . . . . 5.54 111.197 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 10' ' ' VAL . 7.2 p -121.24 88.23 45.32 Favored Pre-proline 0 CA--C 1.512 -0.503 0 CA-C-O 126.262 2.934 . . . . 2.4500000000000002 109.064 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 38.6 Cg_endo -67.7 -39.06 12.49 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 CA-C-O 125.682 2.284 . . . . 2.3500000000000001 112.628 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.36 62.28 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 126.013 2.816 . . . . 2.1699999999999999 111.226 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 51.6 tp60 -139.54 47.4 1.87 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 126.326 2.965 . . . . 3.5699999999999998 108.432 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 21.6 p-10 -64.26 116.32 26.93 Favored Pre-proline 0 CA--C 1.512 -0.509 0 CA-C-O 125.986 2.803 . . . . 1.6299999999999999 110.192 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.08 -10.53 17.92 Favored 'Trans proline' 0 CA--C 1.503 -1.049 0 CA-C-O 126.16 2.483 . . . . 0.93999999999999995 111.994 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 7.5 t -79.01 158.85 27.85 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 125.707 2.67 . . . . 1.03 108.6 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.77 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -68.67 148.44 50.42 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 126.308 2.956 . . . . 1.1200000000000001 109.877 -176.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.53 126.41 27.76 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 126.049 2.833 . . . . 4.7199999999999998 109.899 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 33' ' ' VAL . . . 105.22 -10.14 46.84 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 112.934 -1.939 . . . . 0.55000000000000004 110.766 -171.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 5' ' ' LEU . 13.0 mt -119.15 135.95 54.42 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.49 2.566 . . . . 1.25 107.573 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.43 122.83 39.91 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.249 2.928 . . . . 2.8399999999999999 110.429 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.816 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 56.2 m -69.31 111.59 5.32 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 126.072 2.844 . . . . 1.1399999999999999 110.69 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 59.5 ttt180 -92.74 155.3 17.77 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 124.721 2.2 . . . . 3.7599999999999998 106.641 171.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -47.62 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 126.534 3.064 . . . . 5.0199999999999996 111.622 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 119.1 -48.21 0.96 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 112.573 -2.103 . . . . 0.42999999999999999 112.172 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -138.29 141.51 39.83 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 126.201 2.905 . . . . 2.2000000000000002 110.027 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.816 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.7 t -79.02 138.76 38.17 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 125.834 2.731 . . . . 0.94999999999999996 108.449 174.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.12 137.52 51.93 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 126.308 2.956 . . . . 1.3500000000000001 109.971 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.874 ' HB ' ' HB2' ' A' ' 5' ' ' LEU . 6.2 p -73.07 99.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 126.332 2.968 . . . . 1.54 109.223 175.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 5.8 tp60 -73.64 -50.2 22.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 126.384 2.993 . . . . 2.71 109.026 -177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 21' ' ' GLY . 28.1 m -81.9 60.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 126.738 3.161 . . . . 3.48 109.644 176.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HSL . . . . . 0.476 ' HB3' HG13 ' A' ' 31' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 125.744 2.688 . . . . 2.1499999999999999 110.762 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.3 p -89.15 -174.44 4.43 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.364 2.506 . . . . 1.05 107.721 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.693 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -83.34 111.16 3.37 Favored Glycine 0 N--CA 1.444 -0.804 0 O-C-N 120.19 -1.569 . . . . 0.59999999999999998 110.767 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.579 ' HA ' HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -117.87 -179.82 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.939 2.78 . . . . 0.75 110.029 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 5' ' ' LEU . 1.5 pt? -56.42 -4.6 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.168 -2.287 . . . . 1.25 114.238 -166.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.15 37.75 0.63 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 125.861 2.744 . . . . 1.23 110.507 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.99 107.63 19.93 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 125.515 2.579 . . . . 0.96999999999999997 108.877 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -58.46 117.24 4.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 126.441 3.02 . . . . 2.1899999999999999 109.666 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.469 ' H ' ' HA ' ' A' ' 28' ' ' LYS . 40.4 t -161.31 141.43 10.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 125.828 2.728 . . . . 1.1100000000000001 108.815 -166.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.618 HG23 HG13 ' A' ' 12' ' ' VAL . 17.1 m -93.6 -178.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 126.111 2.863 . . . . 1.7 110.274 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 6.9 p90 -68.39 76.68 0.26 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 126.341 2.972 . . . . 5.54 110.837 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 HG23 ' A' ' 10' ' ' VAL . 18.7 m -123.03 74.15 48.06 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-O 125.975 2.798 . . . . 2.4500000000000002 110.374 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 4.1 Cg_exo -74.68 -40.24 1.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 CA-C-O 125.944 2.393 . . . . 2.3500000000000001 111.856 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -16.75 60.17 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 126.033 2.825 . . . . 2.1699999999999999 110.837 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.07 36.18 3.67 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.117 2.389 . . . . 3.5699999999999998 109.449 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -49.95 104.66 0.44 Allowed Pre-proline 0 N--CA 1.473 0.717 0 CA-C-O 125.887 2.756 . . . . 1.6299999999999999 111.078 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -85.35 -4.73 9.39 Favored 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 123.438 2.759 . . . . 0.93999999999999995 111.883 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 79.4 m -78.57 146.58 34.15 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 125.882 2.753 . . . . 1.03 110.418 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m -62.32 134.17 56.12 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 125.922 2.772 . . . . 1.1200000000000001 107.515 172.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -54.69 115.33 2.1 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 126.707 3.146 . . . . 4.7199999999999998 111.901 -163.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.35 -23.53 4.84 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 111.999 -2.364 . . . . 0.55000000000000004 111.267 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.624 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 6.3 mp -102.8 150.35 23.58 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 125.869 2.747 . . . . 1.25 109.523 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -138.29 139.35 39.1 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 126.132 2.873 . . . . 2.8399999999999999 109.682 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.8 m -67.92 112.43 4.94 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 126.055 2.836 . . . . 1.1399999999999999 110.338 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 27' ' ' GLY . 56.7 ttt180 -91.67 159.55 15.81 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 124.58 2.133 . . . . 3.7599999999999998 107.409 170.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -52.03 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 126.254 2.93 . . . . 5.0199999999999996 111.312 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 140.94 -50.24 0.75 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 113.092 -1.867 . . . . 0.42999999999999999 111.494 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -160.34 164.21 32.68 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 126.441 3.02 . . . . 2.2000000000000002 110.105 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 45.5 t -78.89 132.51 36.81 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 125.694 2.664 . . . . 0.94999999999999996 108.878 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.07 155.85 44.78 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 126.051 2.834 . . . . 1.3500000000000001 109.634 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.624 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 38.7 t -73.34 106.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.78 2.705 . . . . 1.54 108.445 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -68.86 124.69 24.38 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 125.708 2.67 . . . . 2.71 109.855 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.5 71.14 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 126.978 3.275 . . . . 3.48 109.13 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 126.399 3.0 . . . . 2.1499999999999999 110.033 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.5 p -85.39 179.06 7.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.996 2.808 . . . . 1.05 109.51 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.57 124.02 26.09 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 113.491 -1.686 . . . . 0.59999999999999998 110.574 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.607 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 24.9 pt -117.6 168.23 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 126.039 2.828 . . . . 0.75 110.128 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.93 2.85 1.78 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 125.453 2.549 . . . . 1.25 112.676 -166.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -150.25 45.57 0.89 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 126.554 3.074 . . . . 1.23 109.858 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.607 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 8.3 t70 -123.05 127.93 49.45 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.356 2.503 . . . . 0.96999999999999997 108.538 174.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.69 135.03 43.66 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 125.532 2.586 . . . . 2.1899999999999999 109.914 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.5 p -165.97 172.27 11.68 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 125.872 2.748 . . . . 1.1100000000000001 109.663 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 12' ' ' VAL . 35.8 m -99.24 153.62 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.434 3.016 . . . . 1.7 110.471 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -75.85 87.44 2.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 126.209 2.909 . . . . 5.54 110.264 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 10' ' ' VAL . 8.6 p -147.17 68.55 11.38 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 126.457 3.027 . . . . 2.4500000000000002 109.777 174.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 19.2 Cg_exo -66.45 -19.83 54.87 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 C-N-CA 122.944 2.429 . . . . 2.3500000000000001 112.781 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.44 -27.92 62.85 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 126.13 2.871 . . . . 2.1699999999999999 110.497 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -130.98 49.35 2.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.492 3.044 . . . . 3.5699999999999998 107.647 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 60.8 t30 -56.68 116.08 12.03 Favored Pre-proline 0 CA--C 1.511 -0.541 0 CA-C-O 126.103 2.859 . . . . 1.6299999999999999 111.249 -173.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.52 -11.05 15.83 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 123.33 2.686 . . . . 0.93999999999999995 112.172 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.569 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 74.1 m -79.13 158.65 27.71 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 125.889 2.757 . . . . 1.03 110.18 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.8 m -66.36 142.8 57.5 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.723 2.677 . . . . 1.1200000000000001 108.761 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -59.01 110.98 1.14 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 126.641 3.115 . . . . 4.7199999999999998 110.39 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.24 -26.27 3.75 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 112.238 -2.255 . . . . 0.55000000000000004 110.739 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 4.6 mp -105.24 152.4 22.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.565 2.603 . . . . 1.25 109.068 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -133.69 129.82 37.32 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.674 2.654 . . . . 2.8399999999999999 110.267 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.7 m -69.64 105.56 2.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.198 2.904 . . . . 1.1399999999999999 110.193 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -101.27 163.56 12.22 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 125.051 2.357 . . . . 3.7599999999999998 107.941 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -50.58 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 126.275 2.94 . . . . 5.0199999999999996 111.221 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.9 -49.39 0.89 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 112.857 -1.974 . . . . 0.42999999999999999 111.899 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.872 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.4 pttt -159.96 162.57 34.42 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 126.808 3.194 . . . . 2.2000000000000002 110.638 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 47.8 t -79.68 124.75 28.85 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 125.894 2.759 . . . . 0.94999999999999996 109.173 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.872 HD21 ' HE3' ' A' ' 28' ' ' LYS . 97.8 mt -122.62 131.53 53.86 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 126.126 2.869 . . . . 1.3500000000000001 109.491 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 33' ' ' VAL . 7.7 p -75.1 145.17 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 125.315 2.483 . . . . 1.54 108.096 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.71 80.82 0.28 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.278 2.942 . . . . 2.71 109.871 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 31' ' ' VAL . 29.8 m -84.0 158.98 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 CA-C-O 126.279 2.942 . . . . 3.48 110.096 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 126.441 3.019 . . . . 2.1499999999999999 110.194 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p -90.33 -172.62 3.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 125.962 2.792 . . . . 1.05 109.554 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.587 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.8 118.24 6.93 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 113.537 -1.665 . . . . 0.59999999999999998 110.224 170.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.516 ' C ' ' H ' ' A' ' 6' ' ' HIS . 8.0 pt -115.02 167.55 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 125.858 2.742 . . . . 0.75 110.119 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.19 12.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 125.42 2.534 . . . . 1.25 112.952 -169.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 4' ' ' ILE . 8.4 p-80 -157.44 41.16 0.31 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 126.068 2.842 . . . . 1.23 110.294 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -115.51 119.23 35.51 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.674 2.654 . . . . 0.96999999999999997 108.816 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.12 123.83 23.7 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.894 2.759 . . . . 2.1899999999999999 109.523 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.2 160.38 43.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 126.034 2.826 . . . . 1.1100000000000001 110.22 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 12' ' ' VAL . 9.3 p -85.87 130.56 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.062 2.839 . . . . 1.7 109.255 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 21.3 p90 -70.14 74.52 0.49 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 126.52 3.057 . . . . 5.54 111.626 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 10' ' ' VAL . 15.7 m -119.12 89.07 38.55 Favored Pre-proline 0 CA--C 1.513 -0.48 0 CA-C-O 126.098 2.856 . . . . 2.4500000000000002 109.664 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.69 -34.07 89.42 Favored 'Trans proline' 0 CA--C 1.507 -0.873 0 C-N-CA 122.995 2.463 . . . . 2.3500000000000001 112.686 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 -25.06 59.31 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 125.784 2.707 . . . . 2.1699999999999999 110.881 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -132.83 39.09 3.35 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 126.021 2.819 . . . . 3.5699999999999998 108.941 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -56.2 111.82 3.66 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 125.884 2.754 . . . . 1.6299999999999999 109.594 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.25 -12.84 19.07 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 CA-C-O 126.267 2.528 . . . . 0.93999999999999995 112.299 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 63.1 m -77.73 150.67 34.4 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 126.054 2.835 . . . . 1.03 110.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.43 145.96 41.82 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 125.75 2.69 . . . . 1.1200000000000001 108.586 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -62.23 102.11 0.28 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 126.399 2.999 . . . . 4.7199999999999998 110.147 -170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.46 -26.04 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 112.483 -2.144 . . . . 0.55000000000000004 110.931 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 6.0 mp -101.2 148.78 24.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 125.821 2.724 . . . . 1.25 109.238 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 32' ' ' GLN . 48.5 tp60 -121.23 129.4 53.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.132 2.872 . . . . 2.8399999999999999 109.543 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 53.5 t -69.58 104.49 2.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.182 2.896 . . . . 1.1399999999999999 108.563 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' GLY . 15.1 mmt180 -86.21 174.6 9.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.562 2.601 . . . . 3.7599999999999998 109.332 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 m-85 -61.25 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.243 2.925 . . . . 5.0199999999999996 110.608 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 116.19 -26.54 8.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.767 -2.015 . . . . 0.42999999999999999 112.636 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 19.1 ptpt -160.17 149.4 17.53 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 126.418 3.009 . . . . 2.2000000000000002 110.626 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.5 t -79.71 129.66 34.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.872 2.749 . . . . 0.94999999999999996 109.817 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 156.77 47.97 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 125.86 2.743 . . . . 1.3500000000000001 109.034 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 61.3 t -69.19 115.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-O 126.068 2.842 . . . . 1.54 109.152 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 58.2 tp60 -90.17 140.12 29.98 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.909 2.766 . . . . 2.71 109.796 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.4 63.52 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 126.883 3.23 . . . . 3.48 108.004 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.983 0 CA-C-O 125.833 2.73 . . . . 2.1499999999999999 110.452 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.0 p -84.5 157.55 21.27 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.766 2.698 . . . . 1.05 108.879 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.591 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -58.75 127.67 45.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 113.627 -1.624 . . . . 0.59999999999999998 111.329 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.559 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 5.9 pt -94.71 -176.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 125.469 2.557 . . . . 0.75 110.912 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 5' ' ' LEU . 2.0 pt? -34.8 -45.43 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 124.841 2.258 . . . . 1.25 114.186 -166.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.649 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 33.4 p80 -142.66 37.75 1.48 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.774 2.702 . . . . 1.23 110.628 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 21.2 t70 -73.97 130.59 40.17 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 125.832 2.729 . . . . 0.96999999999999997 109.253 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.0 m-20 -64.95 134.79 54.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.974 2.797 . . . . 2.1899999999999999 110.39 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.81 161.79 42.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.193 2.901 . . . . 1.1100000000000001 110.209 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 12' ' ' VAL . 23.9 m -89.6 143.54 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 CA-C-O 125.384 2.516 . . . . 1.7 108.362 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -69.11 75.64 0.33 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.449 3.024 . . . . 5.54 110.116 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' VAL . 95.2 t -128.38 98.83 25.1 Favored Pre-proline 0 CA--C 1.506 -0.712 0 CA-C-O 125.572 2.606 . . . . 2.4500000000000002 108.606 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.74 -54.46 0.22 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 122.945 2.43 . . . . 2.3500000000000001 113.201 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.76 75.34 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 125.684 2.659 . . . . 2.1699999999999999 111.612 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.514 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -116.35 35.82 4.37 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 125.952 2.787 . . . . 3.5699999999999998 109.216 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.97 108.86 3.79 Favored Pre-proline 0 CA--C 1.509 -0.623 0 CA-C-O 125.686 2.66 . . . . 1.6299999999999999 110.126 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 83.4 Cg_endo -83.36 48.71 2.75 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 CA-C-O 126.737 2.724 . . . . 0.93999999999999995 110.983 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.591 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 10.6 t -136.86 143.75 43.23 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.105 2.383 . . . . 1.03 107.585 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -59.91 145.87 44.3 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.356 2.979 . . . . 1.1200000000000001 110.67 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.674 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.59 122.1 21.72 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.322 2.963 . . . . 4.7199999999999998 108.899 -174.279 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 117.95 -7.4 15.03 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 112.625 -2.08 . . . . 0.55000000000000004 110.171 -171.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 22' ' ' LEU . 6.3 mp -114.78 139.42 49.74 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.895 2.76 . . . . 1.25 108.708 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.519 ' HB3' HE21 ' A' ' 32' ' ' GLN . 26.3 pt20 -104.47 121.69 43.98 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.624 2.63 . . . . 2.8399999999999999 109.685 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.3 t -80.58 102.05 9.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 126.074 2.845 . . . . 1.1399999999999999 108.632 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.562 ' HG3' HD12 ' A' ' 30' ' ' LEU . 25.4 mmt180 -97.93 163.05 12.94 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 125.197 2.427 . . . . 3.7599999999999998 108.645 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -53.1 93.45 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.018 2.818 . . . . 5.0199999999999996 109.941 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 128.55 -50.82 0.87 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.854 -1.975 . . . . 0.42999999999999999 112.404 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 20.8 pttp -162.47 173.88 13.44 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.395 2.998 . . . . 2.2000000000000002 111.312 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 87.4 m -78.65 143.05 36.71 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 126.043 2.83 . . . . 0.94999999999999996 109.806 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.562 HD12 ' HG3' ' A' ' 25' ' ' ARG . 91.0 mt -126.69 126.82 44.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 125.886 2.755 . . . . 1.3500000000000001 108.469 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 5' ' ' LEU . 2.2 m -66.64 102.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 126.35 2.976 . . . . 1.54 110.741 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.519 HE21 ' HB3' ' A' ' 23' ' ' GLN . 90.2 mt-30 -59.16 -50.98 71.97 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 126.69 3.138 . . . . 2.71 108.795 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.1 m -82.47 62.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-O 126.503 3.049 . . . . 3.48 110.276 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 125.857 2.741 . . . . 2.1499999999999999 110.896 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t -90.5 134.58 34.27 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 125.684 2.659 . . . . 1.05 108.874 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.8 127.66 39.23 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 113.543 -1.662 . . . . 0.59999999999999998 112.532 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.512 ' HB ' HD23 ' A' ' 5' ' ' LEU . 22.9 pt -117.88 178.69 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 126.338 2.97 . . . . 0.75 110.827 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.4 pt? -56.57 -11.71 1.44 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 111.952 -2.386 . . . . 1.25 113.786 -169.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -151.1 47.09 0.84 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.499 3.047 . . . . 1.23 110.067 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.29 119.19 38.41 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 125.434 2.54 . . . . 0.96999999999999997 109.158 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -60.06 112.11 1.76 Allowed 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 126.058 2.837 . . . . 2.1899999999999999 108.802 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.8 t -133.39 149.04 51.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 126.086 2.85 . . . . 1.1100000000000001 110.778 -165.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 12' ' ' VAL . 70.6 t -97.87 133.1 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 125.723 2.678 . . . . 1.7 108.515 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -67.81 86.94 0.23 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 125.981 2.801 . . . . 5.54 110.485 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 10' ' ' VAL . 13.2 m -132.73 90.14 33.37 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-O 125.947 2.784 . . . . 2.4500000000000002 109.488 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.2 -47.98 15.49 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 123.23 2.62 . . . . 2.3500000000000001 113.579 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.67 83.53 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.093 2.854 . . . . 2.1699999999999999 110.598 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -111.41 42.31 1.7 Allowed 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 125.579 2.609 . . . . 3.5699999999999998 109.399 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -54.85 113.43 5.34 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 125.877 2.751 . . . . 1.6299999999999999 110.293 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.75 -13.8 14.34 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.012 2.474 . . . . 0.93999999999999995 112.388 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 98.5 m -78.19 148.21 34.14 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 126.174 2.892 . . . . 1.03 110.568 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' HB2' HD23 ' A' ' 22' ' ' LEU . 54.8 m -66.26 162.11 20.76 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 125.852 2.739 . . . . 1.1200000000000001 109.578 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 20' ' ' ARG . 15.3 ptt180 -61.0 119.76 8.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.302 2.953 . . . . 4.7199999999999998 110.142 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.81 -4.56 56.28 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 113.127 -1.851 . . . . 0.55000000000000004 111.819 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 19' ' ' CYS . 3.7 mm? -101.15 134.97 43.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.008 2.813 . . . . 1.25 109.252 175.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HB2' ' HG3' ' A' ' 32' ' ' GLN . 29.4 tp60 -111.73 110.18 20.43 Favored 'General case' 0 CA--C 1.5 -0.942 0 CA-C-O 125.886 2.755 . . . . 2.8399999999999999 109.325 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.7 t -75.3 129.51 37.53 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.896 2.76 . . . . 1.1399999999999999 109.039 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -117.62 144.57 45.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 124.672 2.177 . . . . 3.7599999999999998 106.875 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -55.79 97.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.569 3.08 . . . . 5.0199999999999996 109.887 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.68 -53.39 0.79 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 112.489 -2.141 . . . . 0.42999999999999999 111.179 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -150.68 153.84 36.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 126.293 2.949 . . . . 2.2000000000000002 109.938 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 35.2 t -95.93 130.78 42.81 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 125.383 2.516 . . . . 0.94999999999999996 108.301 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.18 173.14 8.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.28 2.943 . . . . 1.3500000000000001 110.161 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.39 112.93 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-O 125.735 2.683 . . . . 1.54 108.756 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.709 ' NE2' ' O ' ' A' ' 34' ' ' HSL . 42.7 tt0 -60.67 121.36 12.04 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.189 2.899 . . . . 2.71 109.742 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.62 -34.64 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 126.208 2.908 . . . . 3.48 109.458 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HSL . . . . . 0.709 ' O ' ' NE2' ' A' ' 32' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 125.886 2.755 . . . . 2.1499999999999999 110.355 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.1 p -90.12 157.53 17.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.96 2.791 . . . . 1.05 109.501 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.547 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -63.47 138.54 43.07 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 113.392 -1.731 . . . . 0.59999999999999998 111.097 172.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.518 ' HB ' HD23 ' A' ' 5' ' ' LEU . 19.7 pt -115.51 175.56 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 126.486 3.041 . . . . 0.75 111.047 -174.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.4 pt? -59.07 -6.9 0.94 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 111.922 -2.399 . . . . 1.25 113.223 -171.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -150.1 49.06 0.91 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.253 2.93 . . . . 1.23 109.862 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.506 ' HB2' HG12 ' A' ' 4' ' ' ILE . 39.1 t70 -115.08 133.72 55.8 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.471 2.558 . . . . 0.96999999999999997 109.01 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.6 m-20 -75.88 133.03 40.67 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 125.671 2.653 . . . . 2.1899999999999999 109.831 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.5 p -162.24 162.06 28.04 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 125.905 2.764 . . . . 1.1100000000000001 110.214 -176.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.1 m -92.41 151.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 125.77 2.7 . . . . 1.7 109.389 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.476 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 2.7 p90 -71.43 76.4 0.77 Allowed 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 126.462 3.029 . . . . 5.54 110.521 -172.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.28 70.65 79.26 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-O 125.984 2.802 . . . . 2.4500000000000002 110.247 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 31.7 Cg_exo -60.09 -32.65 95.02 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-O 125.87 2.362 . . . . 2.3500000000000001 111.945 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.16 -40.28 58.24 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 126.22 2.914 . . . . 2.1699999999999999 110.419 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -123.56 46.91 2.11 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.914 2.769 . . . . 3.5699999999999998 108.461 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 46.8 t-20 -49.97 113.12 3.14 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-O 125.876 2.751 . . . . 1.6299999999999999 110.31 -176.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.14 -18.8 14.09 Favored 'Trans proline' 0 CA--C 1.506 -0.895 0 CA-C-O 125.997 2.415 . . . . 0.93999999999999995 112.257 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.6 m -79.7 161.16 25.96 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 125.923 2.773 . . . . 1.03 109.87 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -67.73 142.83 56.17 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.11 2.862 . . . . 1.1200000000000001 109.227 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 32.7 mmt180 -59.94 115.82 3.69 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 126.302 2.954 . . . . 4.7199999999999998 109.929 -175.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.16 -10.0 8.33 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.609 -2.087 . . . . 0.55000000000000004 110.902 -175.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.06 140.87 40.59 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.189 2.899 . . . . 1.25 109.637 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -104.76 101.95 11.54 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.056 2.836 . . . . 2.8399999999999999 109.592 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.8 t -77.33 106.46 9.08 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.184 2.897 . . . . 1.1399999999999999 109.181 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HD3' HD12 ' A' ' 30' ' ' LEU . 79.2 mtp180 -101.67 150.39 23.16 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 125.193 2.425 . . . . 3.7599999999999998 108.077 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -50.25 100.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.313 2.959 . . . . 5.0199999999999996 110.306 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 118.66 -50.9 0.78 Allowed Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 112.555 -2.111 . . . . 0.42999999999999999 111.714 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -143.3 134.3 25.57 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 126.406 3.003 . . . . 2.2000000000000002 110.275 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 34.6 t -87.58 123.26 32.27 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 125.676 2.655 . . . . 0.94999999999999996 108.315 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.406 HD12 ' HD3' ' A' ' 25' ' ' ARG . 82.2 mt -116.65 173.7 6.48 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.993 2.806 . . . . 1.3500000000000001 109.879 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 33' ' ' VAL . 38.9 t -82.04 118.52 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 125.778 2.704 . . . . 1.54 108.724 176.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.83 93.71 0.77 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 125.833 2.73 . . . . 2.71 107.707 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 31' ' ' VAL . 47.6 t -105.39 104.2 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-O 126.097 2.856 . . . . 3.48 109.548 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.931 2.777 . . . . 2.1499999999999999 110.407 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.6 p -83.1 166.8 18.41 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 125.746 2.689 . . . . 1.05 108.706 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -61.4 120.01 20.81 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 113.565 -1.652 . . . . 0.59999999999999998 111.16 173.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 23.6 pt -117.08 178.18 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 125.723 2.678 . . . . 0.75 109.674 -178.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.95 14.38 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 125.256 2.455 . . . . 1.25 113.324 -164.611 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -160.48 31.61 0.16 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 125.914 2.769 . . . . 1.23 110.129 172.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.454 ' HB2' HG12 ' A' ' 4' ' ' ILE . 29.7 t70 -100.93 130.05 46.87 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 125.386 2.517 . . . . 0.96999999999999997 109.36 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -60.9 116.88 4.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.345 2.974 . . . . 2.1899999999999999 109.009 178.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.5 t -139.03 136.37 35.22 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 126.119 2.866 . . . . 1.1100000000000001 109.64 -173.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.546 ' O ' HG22 ' A' ' 12' ' ' VAL . 27.9 m -93.5 145.22 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 125.455 2.55 . . . . 1.7 108.215 175.238 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' H ' ' HD1' ' A' ' 11' ' ' TYR . 8.7 p90 -62.02 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 126.38 2.991 . . . . 5.54 111.579 -174.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 15' ' ' GLN . 12.2 m -127.86 93.18 40.37 Favored Pre-proline 0 CA--C 1.506 -0.718 0 CA-C-O 126.115 2.864 . . . . 2.4500000000000002 109.295 174.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.84 -49.94 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.69 0 CA-C-O 126.145 2.477 . . . . 2.3500000000000001 111.749 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.22 -6.7 25.01 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 125.942 2.782 . . . . 2.1699999999999999 110.91 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 28.9 tt0 -138.56 36.64 2.24 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.038 2.828 . . . . 3.5699999999999998 108.839 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 24.9 t-20 -57.74 113.8 7.12 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 125.799 2.714 . . . . 1.6299999999999999 110.574 -177.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -84.35 -8.31 9.7 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.239 2.626 . . . . 0.93999999999999995 112.139 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.568 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 71.3 m -78.99 159.08 27.81 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 125.742 2.686 . . . . 1.03 110.017 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.36 132.21 44.52 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 125.933 2.778 . . . . 1.1200000000000001 108.139 172.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 20' ' ' ARG . 23.4 mmt180 -56.86 108.61 0.52 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.346 2.974 . . . . 4.7199999999999998 110.327 -172.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.16 -19.49 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 112.68 -2.055 . . . . 0.55000000000000004 110.995 -175.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 22' ' ' LEU . 6.9 mp -105.36 138.38 41.65 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 125.985 2.802 . . . . 1.25 109.562 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 41.1 tt0 -94.04 131.64 39.33 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 125.767 2.699 . . . . 2.8399999999999999 109.351 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 39.0 t -90.91 111.19 22.52 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.04 2.829 . . . . 1.1399999999999999 108.654 174.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -108.31 152.81 24.13 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.324 2.487 . . . . 3.7599999999999998 108.793 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -46.8 96.35 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.082 2.849 . . . . 5.0199999999999996 110.918 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.34 -49.38 0.89 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.045 -1.889 . . . . 0.42999999999999999 112.374 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.96 156.17 42.37 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 126.531 3.062 . . . . 2.2000000000000002 110.42 -174.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 14.6 t -90.87 147.3 23.25 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.29 2.471 . . . . 0.94999999999999996 107.731 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 pp -150.36 161.57 42.22 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 126.03 2.824 . . . . 1.3500000000000001 110.004 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 5' ' ' LEU . 11.7 m -74.39 115.39 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.12 2.867 . . . . 1.54 109.748 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 44.4 tt0 -78.68 54.2 1.46 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 126.486 3.041 . . . . 2.71 109.695 -175.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG13 ' HB ' ' A' ' 31' ' ' VAL . 32.0 m -95.94 151.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 125.87 2.747 . . . . 3.48 109.86 -177.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 125.916 2.769 . . . . 2.1499999999999999 110.443 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t -87.92 125.17 34.35 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 125.92 2.771 . . . . 1.05 108.777 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.73 129.3 33.01 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 113.27 -1.787 . . . . 0.59999999999999998 111.883 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.2 pt -112.72 168.5 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 126.328 2.966 . . . . 0.75 110.35 -176.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -59.54 -4.42 0.62 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 125.255 2.455 . . . . 1.25 113.119 -171.206 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -144.91 50.0 1.27 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 126.358 2.98 . . . . 1.23 109.57 176.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.01 165.68 14.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.191 2.424 . . . . 0.96999999999999997 107.869 172.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 93.6 m-20 -108.42 124.75 50.88 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 125.584 2.611 . . . . 2.1899999999999999 110.08 -172.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 10.4 p -163.12 156.52 19.54 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 125.903 2.763 . . . . 1.1100000000000001 110.102 -173.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.68 152.71 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 126.2 2.905 . . . . 1.7 110.195 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.426 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 64.1 t80 -75.69 77.61 2.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 126.243 2.925 . . . . 5.54 110.455 -176.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 102.54 35.84 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-O 126.006 2.812 . . . . 2.4500000000000002 108.09 173.258 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.1 -52.01 9.76 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.649 2.899 . . . . 2.3500000000000001 113.644 -172.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -19.37 64.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 125.687 2.661 . . . . 2.1699999999999999 111.439 -176.507 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.503 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 52.5 tt0 -126.24 36.01 4.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.961 2.791 . . . . 3.5699999999999998 109.886 -177.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -71.59 106.27 1.85 Allowed Pre-proline 0 CA--C 1.511 -0.529 0 CA-C-O 125.796 2.712 . . . . 1.6299999999999999 108.219 173.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 64.1 Cg_endo -80.95 -8.29 13.2 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 123.242 2.628 . . . . 0.93999999999999995 113.136 -170.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.854 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 71.9 m -78.87 145.13 34.35 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 126.395 2.997 . . . . 1.03 111.074 -171.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -54.78 139.1 40.67 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.294 2.473 . . . . 1.1200000000000001 109.121 177.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -48.13 108.26 0.16 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 126.488 3.042 . . . . 4.7199999999999998 110.979 -175.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.31 -20.41 5.88 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 112.656 -2.065 . . . . 0.55000000000000004 111.318 -176.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.854 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.5 mt -103.19 145.87 29.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 125.667 2.651 . . . . 1.25 109.185 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.27 135.78 37.46 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 125.615 2.626 . . . . 2.8399999999999999 109.285 -177.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 88.6 m -78.95 129.43 34.48 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.447 3.022 . . . . 1.1399999999999999 111.637 -177.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLY . 7.0 tpp180 -84.1 145.92 28.18 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.314 -2.106 . . . . 3.7599999999999998 105.314 159.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -58.44 81.05 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 126.28 2.943 . . . . 5.0199999999999996 110.26 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 145.29 -45.68 0.82 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.135 -1.848 . . . . 0.42999999999999999 111.345 -177.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 20.8 ptmt -149.62 148.35 29.22 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.246 2.927 . . . . 2.2000000000000002 110.758 -176.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 24.0 t -79.83 144.61 33.35 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 125.784 2.707 . . . . 0.94999999999999996 109.682 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -132.28 160.76 35.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.128 2.87 . . . . 1.3500000000000001 110.071 -176.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.85 105.65 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 125.764 2.697 . . . . 1.54 109.189 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -80.66 102.24 9.74 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 126.135 2.874 . . . . 2.71 108.547 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.89 67.22 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 126.866 3.222 . . . . 3.48 109.241 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 125.789 2.709 . . . . 2.1499999999999999 110.565 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 p -68.66 151.45 46.69 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 125.899 2.761 . . . . 1.05 109.583 176.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -57.09 124.68 36.61 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 113.234 -1.803 . . . . 0.59999999999999998 112.302 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' ' 7' ' ' ASP . 33.7 pt -93.13 177.65 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 126.327 2.965 . . . . 0.75 110.778 -176.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.15 -18.58 0.6 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 111.993 -2.367 . . . . 1.25 114.013 -167.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.54 48.66 0.88 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 125.927 2.775 . . . . 1.23 110.11 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 34.9 t70 -91.79 140.92 29.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 125.675 2.655 . . . . 0.96999999999999997 109.253 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.98 125.25 29.0 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.833 2.73 . . . . 2.1899999999999999 109.907 -176.114 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.7 p -175.35 146.1 0.79 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.045 2.831 . . . . 1.1100000000000001 109.871 -177.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 12' ' ' VAL . 30.4 m -79.09 168.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 125.983 2.802 . . . . 1.7 109.749 178.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -77.56 76.52 4.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.452 3.025 . . . . 5.54 109.576 -174.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 HG23 ' A' ' 10' ' ' VAL . 9.6 m -120.78 87.68 42.81 Favored Pre-proline 0 CA--C 1.512 -0.512 0 CA-C-O 126.2 2.905 . . . . 2.4500000000000002 109.622 176.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 74.0 Cg_endo -77.56 -30.89 3.67 Favored 'Trans proline' 0 CA--C 1.509 -0.732 0 C-N-CA 122.595 2.196 . . . . 2.3500000000000001 113.195 -177.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.41 66.4 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.281 2.943 . . . . 2.1699999999999999 110.015 -176.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -124.41 58.58 1.2 Allowed 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.001 2.81 . . . . 3.5699999999999998 108.25 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 11.5 t30 -61.09 109.1 1.82 Allowed Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-O 126.076 2.846 . . . . 1.6299999999999999 109.92 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.38 -7.86 14.99 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.582 2.855 . . . . 0.93999999999999995 113.565 -171.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 90.3 m -78.54 155.09 29.9 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 126.076 2.846 . . . . 1.03 110.319 -175.469 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.3 m -59.65 150.29 27.95 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 125.361 2.505 . . . . 1.1200000000000001 109.067 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -61.21 99.98 0.11 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 126.214 2.911 . . . . 4.7199999999999998 110.254 -173.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 130.1 -2.61 5.9 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 112.958 -1.928 . . . . 0.55000000000000004 111.464 -176.053 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.6 mt -123.76 151.06 43.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 125.274 2.464 . . . . 1.25 108.668 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 65.6 tt0 -140.66 134.2 30.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.847 2.737 . . . . 2.8399999999999999 110.214 -176.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 64.6 m -71.43 118.46 14.27 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.182 2.896 . . . . 1.1399999999999999 110.812 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 27.8 tpt180 -93.89 156.55 16.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.014 2.34 . . . . 3.7599999999999998 107.093 170.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.22 92.92 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 126.187 2.898 . . . . 5.0199999999999996 110.215 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.93 -46.25 1.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 112.952 -1.931 . . . . 0.42999999999999999 111.975 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -159.3 158.04 31.67 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.576 3.084 . . . . 2.2000000000000002 110.393 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 13.4 t -78.89 142.58 36.67 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.79 2.709 . . . . 0.94999999999999996 109.516 -175.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.1 mt -128.44 159.46 35.33 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.26 2.933 . . . . 1.3500000000000001 109.863 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.43 118.43 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 126.294 2.95 . . . . 1.54 110.419 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 80.1 mt-30 -73.4 82.51 1.43 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 125.921 2.772 . . . . 2.71 110.234 177.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.76 61.45 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 126.864 3.221 . . . . 3.48 108.669 172.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 125.641 2.639 . . . . 2.1499999999999999 110.225 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.63 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 17.3 p -81.13 147.96 29.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 125.831 2.729 . . . . 1.05 109.983 -177.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.654 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -73.01 153.56 48.63 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 113.407 -1.724 . . . . 0.59999999999999998 111.351 173.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' HB ' HD23 ' A' ' 5' ' ' LEU . 19.9 pt -101.91 172.21 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 126.877 3.227 . . . . 0.75 111.961 -174.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.1 pt? -58.31 -1.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.093 -2.776 . . . . 1.25 113.961 -169.496 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 27.4 p80 -156.3 50.27 0.51 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.107 2.86 . . . . 1.23 110.335 176.401 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 8' ' ' ASN . 5.7 t70 -99.54 -172.25 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 125.351 2.5 . . . . 0.96999999999999997 109.044 175.009 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 7.8 t30 -113.32 131.61 55.88 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.477 2.56 . . . . 2.1899999999999999 109.502 -175.265 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.783 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 11.5 p -176.77 151.19 0.87 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.299 2.952 . . . . 1.1100000000000001 110.521 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.12 154.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 125.737 2.684 . . . . 1.7 108.749 175.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.9 77.68 0.89 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 126.209 2.909 . . . . 5.54 109.795 -178.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -126.85 99.05 29.78 Favored Pre-proline 0 CA--C 1.513 -0.459 0 CA-C-O 126.1 2.857 . . . . 2.4500000000000002 109.023 173.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.83 -40.86 26.42 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 CA-C-O 125.695 2.29 . . . . 2.3500000000000001 112.371 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.63 -32.31 63.03 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 125.91 2.767 . . . . 2.1699999999999999 111.0 -177.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 13.8 mm100 -127.51 48.19 2.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.708 2.671 . . . . 3.5699999999999998 110.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -67.6 109.58 4.0 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.517 2.579 . . . . 1.6299999999999999 108.574 172.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 96.9 Cg_endo -79.39 -17.16 11.65 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 CA-C-O 125.847 2.353 . . . . 0.93999999999999995 112.775 -175.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.654 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 93.6 m -79.97 161.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 126.179 2.895 . . . . 1.03 110.728 -174.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.63 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 m -61.44 146.8 47.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 126.149 2.881 . . . . 1.1200000000000001 109.432 175.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 20' ' ' ARG . 60.7 mtt180 -67.81 112.67 5.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 126.688 3.137 . . . . 4.7199999999999998 109.777 -174.039 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.57 -7.34 7.91 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 112.14 -2.3 . . . . 0.55000000000000004 110.74 -172.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.8 mt -108.48 144.35 36.22 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.854 2.74 . . . . 1.25 108.947 177.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -112.14 125.7 54.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.045 2.831 . . . . 2.8399999999999999 110.275 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 17' ' ' PRO . 5.2 m -89.29 102.08 14.74 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 125.844 2.735 . . . . 1.1399999999999999 109.623 173.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.957 ' HD3' HD21 ' A' ' 30' ' ' LEU . 52.7 mtp180 -92.22 168.4 11.37 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 125.297 2.475 . . . . 3.7599999999999998 108.494 174.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -55.0 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.238 2.923 . . . . 5.0199999999999996 110.821 -174.376 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.6 -38.69 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 113.131 -1.85 . . . . 0.42999999999999999 112.744 176.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -140.15 147.41 40.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 126.742 3.163 . . . . 2.2000000000000002 111.582 -169.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.783 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 37.0 t -94.81 136.65 34.87 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 125.388 2.518 . . . . 0.94999999999999996 108.036 175.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.957 HD21 ' HD3' ' A' ' 25' ' ' ARG . 2.9 pp -141.64 157.3 45.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.998 2.808 . . . . 1.3500000000000001 110.015 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 7.4 p -71.15 121.4 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 126.203 2.906 . . . . 1.54 109.068 178.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -90.11 129.18 36.43 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.066 2.841 . . . . 2.71 109.033 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.89 134.02 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 125.941 2.782 . . . . 3.48 109.954 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 125.796 2.713 . . . . 2.1499999999999999 110.017 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p -90.44 152.73 20.84 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 126.119 2.866 . . . . 1.05 110.062 -178.169 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.448 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -66.35 147.1 49.66 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 112.985 -1.916 . . . . 0.59999999999999998 112.727 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.57 172.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 126.039 2.828 . . . . 0.75 110.396 -175.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.52 -0.4 0.92 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 125.401 2.524 . . . . 1.25 112.63 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -140.85 46.42 1.77 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 126.597 3.094 . . . . 1.23 109.694 175.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -135.35 129.22 33.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.473 2.559 . . . . 0.96999999999999997 108.109 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 41.7 m-80 -70.26 148.24 48.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 125.346 2.498 . . . . 2.1899999999999999 109.677 -177.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 43.0 t -159.68 160.67 34.42 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.277 2.941 . . . . 1.1100000000000001 110.574 -170.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.83 152.46 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-O 126.226 2.917 . . . . 1.7 109.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -71.76 69.02 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 126.271 2.939 . . . . 5.54 110.932 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.09 82.56 24.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 126.398 2.999 . . . . 2.4500000000000002 109.927 177.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.51 -31.84 32.96 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 122.881 2.388 . . . . 2.3500000000000001 112.317 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.08 -37.1 14.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 126.022 2.82 . . . . 2.1699999999999999 111.167 -176.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.45 59.32 1.51 Allowed 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 126.283 2.944 . . . . 3.5699999999999998 108.564 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.03 123.06 78.76 Favored Pre-proline 0 CA--C 1.508 -0.656 0 CA-C-O 126.1 2.857 . . . . 1.6299999999999999 109.711 175.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 -5.36 16.98 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 123.296 2.664 . . . . 0.93999999999999995 112.549 -176.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 84.5 m -79.09 151.74 31.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 126.353 2.978 . . . . 1.03 110.774 -173.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB2' HD23 ' A' ' 22' ' ' LEU . 8.1 m -61.01 144.24 53.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.392 2.52 . . . . 1.1200000000000001 108.868 177.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -55.49 110.79 0.75 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.194 2.902 . . . . 4.7199999999999998 109.506 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.7 -19.89 5.82 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 112.956 -1.929 . . . . 0.55000000000000004 111.469 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.4 mm? -99.97 166.27 11.13 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 125.751 2.691 . . . . 1.25 109.547 178.003 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.75 138.5 19.83 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 125.847 2.737 . . . . 2.8399999999999999 109.332 177.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 85.0 m -80.12 121.0 25.01 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.23 2.919 . . . . 1.1399999999999999 110.467 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -97.34 158.34 15.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 125.088 2.375 . . . . 3.7599999999999998 107.086 172.117 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -57.24 91.01 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.451 3.024 . . . . 5.0199999999999996 110.069 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 130.5 -46.0 1.1 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 112.389 -2.187 . . . . 0.42999999999999999 111.948 -179.343 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' N ' ' A' ' 9' ' ' CYS . 24.5 pttm -160.57 165.78 30.17 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 126.551 3.072 . . . . 2.2000000000000002 111.182 -174.199 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 17.0 t -86.7 134.28 33.61 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 125.908 2.766 . . . . 0.94999999999999996 109.961 -176.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.78 174.27 10.12 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 125.855 2.74 . . . . 1.3500000000000001 109.299 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 m -85.35 145.32 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-O 126.211 2.91 . . . . 1.54 110.381 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -80.73 94.14 6.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.833 2.73 . . . . 2.71 108.62 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.98 75.33 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 126.416 3.008 . . . . 3.48 109.058 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.4 p . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 125.785 2.707 . . . . 1.05 108.893 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.669 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -52.18 128.32 34.25 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 113.221 -1.808 . . . . 0.6 112.144 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.9 pt -110.21 176.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-O 126.288 2.947 . . . . 0.75 110.66 -175.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.2 pt? -55.26 -11.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 111.821 -2.445 . . . . 1.25 113.731 -169.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -147.86 41.16 1.01 Allowed 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 125.991 2.805 . . . . 1.23 110.314 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.601 ' HB2' HG12 ' A' ' 4' ' ' ILE . 14.3 t70 -107.21 121.49 44.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 125.681 2.658 . . . . 0.97 108.252 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 8.7 p30 -54.02 128.18 29.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 125.99 2.805 . . . . 2.19 110.425 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -160.58 169.5 22.78 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.982 2.801 . . . . 1.11 110.218 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 12' ' ' VAL . 18.6 m -121.24 153.96 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 125.698 2.666 . . . . 1.7 108.863 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 83.5 t80 -73.32 76.91 1.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.303 2.954 . . . . 5.54 110.668 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 10' ' ' VAL . 14.2 m -127.09 79.93 72.3 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-O 126.22 2.914 . . . . 2.45 109.86 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -65.69 -30.97 50.19 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 C-N-CA 122.901 2.4 . . . . 2.35 112.411 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.4 40.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 126.096 2.855 . . . . 2.17 110.984 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -134.96 55.08 1.91 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 126.2 2.905 . . . . 3.57 108.368 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 23.5 t-20 -55.46 115.87 10.39 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-O 125.796 2.712 . . . . 1.63 110.215 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 46.4 Cg_endo -86.77 -4.0 8.17 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 123.25 2.633 . . . . 0.94 112.69 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.669 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 91.5 m -86.62 167.0 14.94 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 126.51 3.052 . . . . 1.03 111.352 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 3.0 m -72.75 131.08 41.88 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.296 2.474 . . . . 1.12 107.822 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -54.04 108.42 0.36 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 126.532 3.063 . . . . 4.72 110.599 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.81 -17.47 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 112.222 -2.263 . . . . 0.55 110.815 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.587 HD22 ' HA ' ' A' ' 31' ' ' VAL . 19.1 mt -110.45 148.35 32.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.49 2.567 . . . . 1.25 108.673 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -135.93 128.35 30.38 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 126.138 2.875 . . . . 2.84 110.313 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 90.7 m -67.49 126.14 28.36 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 126.506 3.05 . . . . 1.14 111.563 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -108.51 149.03 29.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 124.649 2.166 . . . . 3.76 106.952 168.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -55.6 90.24 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.418 3.008 . . . . 5.02 110.465 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 139.1 -50.99 0.77 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 112.486 -2.143 . . . . 0.43 111.141 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HE3' ' CD2' ' A' ' 30' ' ' LEU . 65.0 pttt -155.08 154.08 31.86 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.202 2.906 . . . . 2.2 109.886 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.0 t -79.89 113.95 18.44 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 125.857 2.742 . . . . 0.95 108.923 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD2' ' HE3' ' A' ' 28' ' ' LYS . 81.7 mt -83.81 136.47 34.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 126.286 2.946 . . . . 1.35 110.39 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.587 ' HA ' HD22 ' A' ' 22' ' ' LEU . 7.0 p -75.78 105.15 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 126.21 2.909 . . . . 1.54 108.063 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 CA--C 1.509 -0.624 0 CA-C-O 126.357 2.98 . . . . 2.71 110.313 -173.716 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.473 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p . . . . . 0 CA--C 1.505 -0.765 0 CA-C-O 125.787 2.708 . . . . 1.05 109.638 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.21 152.58 52.56 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 113.709 -1.587 . . . . 0.6 111.724 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 28.2 pt -109.04 168.25 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 126.582 3.087 . . . . 0.75 111.182 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -69.13 14.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 125.214 2.435 . . . . 1.25 113.549 -169.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 4' ' ' ILE . 16.4 p80 -160.37 39.9 0.17 Allowed 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 126.272 2.939 . . . . 1.23 109.872 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 37.8 t70 -121.41 138.44 54.27 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.464 2.554 . . . . 0.97 108.555 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -56.05 136.11 52.41 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 126.148 2.88 . . . . 2.19 110.043 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 17.4 t -159.26 143.86 15.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.015 2.817 . . . . 1.11 109.286 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.24 148.67 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 125.765 2.698 . . . . 1.7 108.872 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 53.9 t80 -73.65 70.62 1.36 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 126.199 2.904 . . . . 5.54 109.369 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -130.38 80.9 69.5 Favored Pre-proline 0 CA--C 1.516 -0.361 0 CA-C-O 126.345 2.974 . . . . 2.45 109.475 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 -31.93 25.89 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 CA-C-O 125.559 2.233 . . . . 2.35 112.627 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.23 68.7 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.121 2.867 . . . . 2.17 110.525 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.33 50.33 1.4 Allowed 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 125.831 2.729 . . . . 3.57 108.805 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 52.4 t-20 -50.88 111.81 2.52 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 125.557 2.598 . . . . 1.63 109.946 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -89.12 4.21 5.35 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.233 2.622 . . . . 0.94 112.786 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 21.3 t -90.82 161.93 15.05 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.517 2.579 . . . . 1.03 108.296 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.473 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 59.4 m -60.66 127.89 33.9 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 126.006 2.813 . . . . 1.12 109.496 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -55.42 116.08 2.66 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.325 2.964 . . . . 4.72 110.072 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.62 7.99 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 112.651 -2.068 . . . . 0.55 110.565 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 40.4 mt -107.87 148.69 29.24 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 125.56 2.6 . . . . 1.25 108.505 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 5.9 tp60 -118.25 123.39 45.31 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 126.071 2.843 . . . . 2.84 109.759 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.7 m -76.3 106.08 7.72 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 126.176 2.893 . . . . 1.14 110.665 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 27' ' ' GLY . 18.7 ttm180 -85.68 149.39 25.34 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.292 2.472 . . . . 3.76 108.107 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 11' ' ' TYR . 53.5 t80 -56.76 89.03 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.234 2.921 . . . . 5.02 109.602 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 141.63 -50.13 0.74 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 112.582 -2.099 . . . . 0.43 111.071 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.717 ' HE2' HD21 ' A' ' 30' ' ' LEU . 23.5 pttm -161.88 161.21 28.79 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.926 2.774 . . . . 2.2 109.538 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.1 t -82.78 139.69 33.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.707 2.67 . . . . 0.95 109.459 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.717 HD21 ' HE2' ' A' ' 28' ' ' LYS . 94.2 mt -128.81 167.11 17.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.039 2.828 . . . . 1.35 109.465 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 5' ' ' LEU . 23.2 m -80.82 134.58 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 125.92 2.771 . . . . 1.54 110.235 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 CA--C 1.499 -1.015 0 CA-C-O 126.025 2.821 . . . . 2.71 108.122 171.5 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.8 t . . . . . 0 CA--C 1.506 -0.742 0 CA-C-O 125.606 2.622 . . . . 1.05 108.837 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -67.31 119.18 11.09 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 113.68 -1.6 . . . . 0.6 112.403 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.25 171.83 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 126.065 2.841 . . . . 0.75 110.278 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.91 -15.9 46.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 125.209 2.433 . . . . 1.25 112.521 -164.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -131.87 52.94 2.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 126.499 3.047 . . . . 1.23 109.84 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -129.31 133.81 47.62 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 125.92 2.771 . . . . 0.97 109.407 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.96 129.97 39.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.904 2.764 . . . . 2.19 109.501 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -148.93 137.94 21.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 126.022 2.82 . . . . 1.11 110.427 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.07 135.64 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 125.741 2.686 . . . . 1.7 108.94 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.21 86.37 0.06 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 126.304 2.954 . . . . 5.54 111.334 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.79 104.11 27.27 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.97 2.795 . . . . 2.45 108.827 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.36 -47.0 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.682 0 CA-C-O 125.666 2.278 . . . . 2.35 113.266 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.21 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.982 2.801 . . . . 2.17 110.425 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 15' ' ' GLN . 53.1 tt0 -108.85 42.24 1.45 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.84 2.734 . . . . 3.57 109.425 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -60.24 111.88 4.65 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 125.949 2.785 . . . . 1.63 110.338 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -92.21 8.58 2.87 Favored 'Trans proline' 0 CA--C 1.506 -0.898 0 C-N-CA 123.466 2.778 . . . . 0.94 111.901 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 4.6 t -93.23 140.39 29.58 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.485 2.564 . . . . 1.03 109.367 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 m -60.86 125.08 22.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 125.507 2.575 . . . . 1.12 109.162 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 3.2 tpm_? -55.41 124.74 18.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 126.287 2.946 . . . . 4.72 110.035 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.57 -34.74 4.64 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 112.775 -2.011 . . . . 0.55 109.69 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.661 ' HG ' HG12 ' A' ' 31' ' ' VAL . 4.5 mp -102.82 130.65 49.89 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 125.623 2.63 . . . . 1.25 107.317 171.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -101.66 130.91 48.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.402 3.001 . . . . 2.84 109.761 -176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 19.2 t -75.38 101.21 4.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 126.064 2.84 . . . . 1.14 109.081 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HD3' HD12 ' A' ' 30' ' ' LEU . 71.9 ttt180 -98.56 155.05 17.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.195 2.426 . . . . 3.76 108.596 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -49.45 92.62 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.002 2.811 . . . . 5.02 111.149 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 120.44 -35.01 3.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 113.483 -1.69 . . . . 0.43 112.344 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HE2' HD11 ' A' ' 30' ' ' LEU . 23.9 pttm -160.27 150.99 18.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.388 2.994 . . . . 2.2 110.973 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 m -80.25 130.01 34.9 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 125.849 2.738 . . . . 0.95 109.439 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.6 HD12 ' HD3' ' A' ' 25' ' ' ARG . 95.4 mt -130.15 138.25 50.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 126.052 2.834 . . . . 1.35 109.713 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.661 HG12 ' HG ' ' A' ' 22' ' ' LEU . 27.5 m -66.9 148.22 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 125.594 2.616 . . . . 1.54 109.18 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 . . . . . 0 CA--C 1.503 -0.847 0 CA-C-O 126.513 3.054 . . . . 2.71 108.616 176.728 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 CA--C 1.505 -0.783 0 CA-C-O 125.909 2.766 . . . . 1.05 109.467 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.67 144.99 46.32 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 113.648 -1.615 . . . . 0.6 111.032 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.463 ' HB ' HD23 ' A' ' 5' ' ' LEU . 32.4 pt -126.94 -178.57 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 126.337 2.97 . . . . 0.75 110.564 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.588 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.3 pt? -55.94 -9.64 0.63 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.215 -2.266 . . . . 1.25 114.368 -166.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.88 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 30.1 p80 -147.16 34.47 0.89 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.943 2.783 . . . . 1.23 110.462 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 16.7 t70 -90.8 114.55 26.96 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 125.493 2.568 . . . . 0.97 108.549 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -61.12 111.39 1.69 Allowed 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 126.109 2.861 . . . . 2.19 108.686 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.485 ' H ' ' HA ' ' A' ' 28' ' ' LYS . 34.7 t -145.12 142.58 29.78 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.012 2.815 . . . . 1.11 109.816 -163.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG13 HG22 ' A' ' 12' ' ' VAL . 7.6 p -81.67 147.21 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 125.955 2.788 . . . . 1.7 109.033 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 67.1 t80 -72.1 79.23 0.94 Allowed 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 126.246 2.926 . . . . 5.54 109.799 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 10' ' ' VAL . 15.3 m -125.46 80.71 65.31 Favored Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 126.11 2.862 . . . . 2.45 109.462 175.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 9.6 Cg_exo -71.13 -37.2 6.29 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 CA-C-O 125.859 2.358 . . . . 2.35 112.656 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.65 68.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 126.151 2.881 . . . . 2.17 110.564 -175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -129.34 42.23 3.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 125.853 2.739 . . . . 3.57 109.058 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 65.0 t30 -63.83 112.05 6.56 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-O 125.624 2.631 . . . . 1.63 110.171 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -90.97 16.32 1.62 Allowed 'Trans proline' 0 CA--C 1.508 -0.793 0 CA-C-O 126.687 2.703 . . . . 0.94 111.837 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -98.43 149.27 22.86 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.584 2.611 . . . . 1.03 108.607 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.31 153.9 25.31 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 126.411 3.005 . . . . 1.12 111.146 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -61.75 119.39 8.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 126.031 2.824 . . . . 4.72 110.057 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 22' ' ' LEU . . . 106.82 2.97 36.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.059 -1.882 . . . . 0.55 111.241 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.585 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 4.9 mp -129.51 139.87 51.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 125.806 2.717 . . . . 1.25 108.866 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 33.7 tt0 -123.22 123.76 41.49 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 125.739 2.685 . . . . 2.84 110.422 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 23.2 m -70.82 97.49 1.4 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.891 2.758 . . . . 1.14 109.863 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 8.0 tmm_? -100.09 157.04 16.85 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.17 2.414 . . . . 3.76 108.32 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -44.97 95.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.139 2.876 . . . . 5.02 111.07 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 129.91 -57.08 0.73 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 112.993 -1.912 . . . . 0.43 111.503 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.88 ' HD2' ' HA ' ' A' ' 6' ' ' HIS . 21.7 pttm -160.49 163.75 32.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 126.247 2.927 . . . . 2.2 109.782 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 28.1 t -81.42 133.66 35.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 125.517 2.58 . . . . 0.95 108.79 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.8 pp -122.85 150.09 43.33 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 125.991 2.805 . . . . 1.35 110.018 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.401 HG12 ' HG ' ' A' ' 22' ' ' LEU . 7.9 m -73.29 92.44 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 126.087 2.851 . . . . 1.54 110.23 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' HB2' ' A' ' 23' ' ' GLN . 20.8 pt20 . . . . . 0 CA--C 1.51 -0.574 0 CA-C-O 126.278 2.942 . . . . 2.71 109.255 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.503 -0.836 0 CA-C-O 125.434 2.54 . . . . 1.05 108.072 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -56.28 123.21 30.61 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 113.674 -1.603 . . . . 0.6 112.057 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.805 HG12 ' HB2' ' A' ' 7' ' ' ASP . 20.1 pt -90.57 173.36 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.257 2.932 . . . . 0.75 110.011 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.86 6.24 0.72 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 125.279 2.466 . . . . 1.25 112.946 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 4' ' ' ILE . 10.0 p80 -161.01 45.86 0.19 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 125.955 2.788 . . . . 1.23 109.619 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 4' ' ' ILE . 31.0 t70 -102.86 131.3 49.85 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.593 2.616 . . . . 0.97 109.184 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.05 133.09 51.66 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 126.104 2.859 . . . . 2.19 110.976 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.7 p -170.58 145.05 2.48 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.944 2.783 . . . . 1.11 109.251 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.574 HG23 HG12 ' A' ' 12' ' ' VAL . 23.3 m -82.19 155.82 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 125.864 2.745 . . . . 1.7 109.396 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.72 76.04 1.55 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 126.03 2.824 . . . . 5.54 109.468 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.574 HG12 HG23 ' A' ' 10' ' ' VAL . 8.1 p -134.98 89.54 24.08 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 126.372 2.987 . . . . 2.45 109.629 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 35.3 Cg_exo -59.69 -39.05 77.29 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 CA-C-O 126.014 2.423 . . . . 2.35 112.038 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -36.57 47.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 125.806 2.717 . . . . 2.17 111.155 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.406 ' H ' HG22 ' A' ' 12' ' ' VAL . 51.0 mt-30 -122.39 39.23 3.96 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 125.745 2.688 . . . . 3.57 109.836 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 25.1 t-20 -72.2 115.41 38.43 Favored Pre-proline 0 CA--C 1.508 -0.658 0 CA-C-O 125.813 2.72 . . . . 1.63 109.76 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 16' ' ' ASN . 87.8 Cg_endo -98.28 11.98 0.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.281 2.654 . . . . 0.94 112.655 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.556 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.6 t -91.92 149.41 21.57 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 125.771 2.701 . . . . 1.03 109.735 -174.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' HB2' HD22 ' A' ' 22' ' ' LEU . 72.5 m -59.51 143.15 50.87 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 125.943 2.782 . . . . 1.12 109.609 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.68 131.61 51.27 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.263 2.935 . . . . 4.72 110.583 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.28 -22.5 36.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 112.94 -1.936 . . . . 0.55 111.243 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.502 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 5.1 mp -97.7 135.2 39.83 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 125.645 2.64 . . . . 1.25 108.404 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -114.91 132.8 56.42 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 125.867 2.746 . . . . 2.84 110.116 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 m -85.04 114.78 22.45 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 126.109 2.861 . . . . 1.14 110.617 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 16.4 mmt180 -87.84 159.21 18.5 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 124.558 2.123 . . . . 3.76 106.192 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.22 78.46 0.24 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 126.218 2.913 . . . . 5.02 109.972 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 146.07 -33.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.974 -1.921 . . . . 0.43 111.754 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.83 143.33 15.73 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 126.012 2.815 . . . . 2.2 110.107 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 29.3 t -87.73 141.69 28.4 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.444 2.545 . . . . 0.95 108.28 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.59 138.73 38.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.583 2.611 . . . . 1.35 108.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.56 113.05 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 126.215 2.912 . . . . 1.54 109.918 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? . . . . . 0 CA--C 1.505 -0.786 0 CA-C-O 126.079 2.847 . . . . 2.71 108.447 178.757 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.52 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 28.3 p . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 125.989 2.804 . . . . 1.05 109.463 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.94 150.93 51.97 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 113.203 -1.817 . . . . 0.6 112.399 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 6' ' ' HIS . 10.1 pt -92.86 167.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 126.137 2.875 . . . . 0.75 110.455 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -68.47 18.92 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 125.45 2.548 . . . . 1.25 112.886 -172.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.535 ' H ' ' C ' ' A' ' 4' ' ' ILE . 14.8 p80 -161.58 41.91 0.15 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.168 2.89 . . . . 1.23 109.714 173.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.2 t0 -116.29 152.96 32.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 125.552 2.596 . . . . 0.97 108.268 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 133.13 37.55 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.089 2.852 . . . . 2.19 111.093 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 12.2 p 177.18 124.62 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 125.888 2.756 . . . . 1.11 108.559 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 12' ' ' VAL . 27.1 m -79.57 -159.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 125.558 2.599 . . . . 1.7 110.695 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.417 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 10.8 p90 -70.27 75.05 0.52 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 126.707 3.146 . . . . 5.54 110.582 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' VAL . 11.8 m -127.97 81.6 70.04 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.991 2.805 . . . . 2.45 109.942 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 3.4 Cg_exo -75.94 -54.86 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.787 0 CA-C-O 125.881 2.367 . . . . 2.35 111.913 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.72 77.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 126.212 2.91 . . . . 2.17 110.077 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -108.68 39.1 2.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 125.65 2.643 . . . . 3.57 109.723 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 54.9 t-20 -64.4 113.03 9.04 Favored Pre-proline 0 CA--C 1.512 -0.502 0 CA-C-O 125.803 2.716 . . . . 1.63 110.156 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 72.3 Cg_endo -91.1 -2.25 4.77 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 123.083 2.522 . . . . 0.94 112.37 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.1 t -87.18 161.37 18.1 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 125.796 2.712 . . . . 1.03 109.214 -175.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.52 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 84.4 m -63.77 135.24 56.5 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 126.181 2.896 . . . . 1.12 110.174 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -58.43 116.3 3.55 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.378 2.99 . . . . 4.72 109.55 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 123.64 -14.9 8.07 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 112.818 -1.992 . . . . 0.55 110.655 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.8 mt -119.16 158.79 25.25 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 125.563 2.602 . . . . 1.25 108.86 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.675 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 28.2 mm-40 -131.89 134.57 45.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.817 2.722 . . . . 2.84 110.051 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 87.3 m -83.03 120.11 25.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 126.147 2.88 . . . . 1.14 110.05 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 19.1 ttt180 -110.79 164.22 12.98 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.087 2.375 . . . . 3.76 108.337 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' N ' ' HG2' ' A' ' 25' ' ' ARG . 70.5 m-85 -45.62 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.319 2.961 . . . . 5.02 110.909 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.58 -54.66 0.73 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.441 -2.163 . . . . 0.43 112.043 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -160.39 166.68 28.89 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 126.554 3.073 . . . . 2.2 110.752 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.725 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 50.9 t -86.84 141.55 28.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 125.804 2.716 . . . . 0.95 109.778 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.67 174.25 10.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.661 2.648 . . . . 1.35 108.792 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.42 136.74 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 125.554 2.597 . . . . 1.54 109.266 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.675 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 6.7 pt20 . . . . . 0 CA--C 1.505 -0.771 0 CA-C-O 126.216 2.912 . . . . 2.71 109.574 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.503 -0.852 0 CA-C-O 126.294 2.949 . . . . 1.05 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.427 ' HA2' ' OD2' ' A' ' 7' ' ' ASP . . . -72.71 123.81 9.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 113.213 -1.812 . . . . 0.6 110.971 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.778 HG12 ' HB2' ' A' ' 7' ' ' ASP . 26.1 pt -90.01 177.23 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 125.848 2.737 . . . . 0.75 110.307 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.8 12.0 0.58 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 125.731 2.682 . . . . 1.25 112.067 -168.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 4' ' ' ILE . 14.1 p80 -160.26 43.32 0.2 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 126.47 3.033 . . . . 1.23 108.59 172.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.778 ' HB2' HG12 ' A' ' 4' ' ' ILE . 47.0 t0 -114.4 138.12 50.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 125.686 2.66 . . . . 0.97 108.721 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.9 m-20 -67.96 130.65 43.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.856 2.741 . . . . 2.19 110.389 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 17' ' ' PRO . 14.2 p -153.1 145.48 24.03 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 126.206 2.907 . . . . 1.11 110.583 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.2 p -88.77 137.88 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 125.09 2.376 . . . . 1.7 107.739 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 26' ' ' TYR . 8.0 p90 -70.45 79.69 0.56 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 126.81 3.195 . . . . 5.54 110.878 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 10' ' ' VAL . 17.6 m -126.84 106.52 22.68 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 125.988 2.804 . . . . 2.45 109.443 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.75 -38.25 4.43 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 CA-C-O 125.692 2.288 . . . . 2.35 112.311 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.99 -52.02 21.48 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 125.88 2.752 . . . . 2.17 110.727 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.17 61.52 0.9 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 126.031 2.824 . . . . 3.57 107.807 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 17.4 t-20 -54.49 117.87 14.78 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 125.736 2.684 . . . . 1.63 110.662 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.413 ' CG ' ' HB2' ' A' ' 9' ' ' CYS . 92.8 Cg_endo -80.68 -14.35 11.43 Favored 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 123.379 2.719 . . . . 0.94 112.777 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 55.7 m -79.42 146.18 32.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 126.013 2.816 . . . . 1.03 109.445 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.59 144.73 56.24 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.754 2.693 . . . . 1.12 108.586 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' C ' ' HD3' ' A' ' 20' ' ' ARG . 2.6 tmt_? -57.16 109.99 0.76 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 126.353 2.978 . . . . 4.72 109.946 -172.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.88 -11.86 7.35 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 112.654 -2.067 . . . . 0.55 111.424 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 31' ' ' VAL . 78.7 mt -112.38 146.44 38.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.994 2.807 . . . . 1.25 109.747 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.646 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 52.3 tt0 -106.19 137.11 44.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.421 2.534 . . . . 2.84 109.173 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 52.2 t -92.47 109.94 21.35 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.448 3.023 . . . . 1.14 109.944 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.575 ' HG3' HD12 ' A' ' 30' ' ' LEU . 35.1 mmt180 -96.83 137.07 36.48 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 124.727 2.204 . . . . 3.76 106.917 170.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.587 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 35.0 p90 -50.32 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 126.659 3.123 . . . . 5.02 110.541 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 134.65 -46.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 112.384 -2.189 . . . . 0.43 111.836 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 22.0 pttm -160.08 154.16 23.24 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 126.539 3.066 . . . . 2.2 111.036 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 84.6 m -79.75 138.87 37.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 125.798 2.713 . . . . 0.95 109.183 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.575 HD12 ' HG3' ' A' ' 25' ' ' ARG . 96.0 mt -130.44 162.33 29.41 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.726 2.679 . . . . 1.35 109.012 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 13.3 m -69.17 112.13 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 126.231 2.919 . . . . 1.54 110.3 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 62.2 tt0 . . . . . 0 CA--C 1.507 -0.695 0 CA-C-O 126.367 2.984 . . . . 2.71 109.374 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p . . . . . 0 CA--C 1.508 -0.636 0 CA-C-O 126.135 2.874 . . . . 1.05 109.655 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.92 126.41 36.76 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 113.116 -1.857 . . . . 0.6 112.666 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.644 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.9 pt -108.29 176.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 126.257 2.932 . . . . 0.75 110.069 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -64.89 3.62 0.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.844 2.259 . . . . 1.25 113.451 -169.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -152.56 36.1 0.51 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 126.16 2.886 . . . . 1.23 109.711 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.603 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.7 t70 -111.31 137.69 48.73 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.657 2.646 . . . . 0.97 109.137 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.79 131.73 50.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.566 2.603 . . . . 2.19 109.561 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -156.35 143.35 18.87 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 126.281 2.943 . . . . 1.11 110.717 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 12' ' ' VAL . 23.7 m -103.82 146.04 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-O 125.494 2.568 . . . . 1.7 108.455 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' HD2' ' H ' ' A' ' 26' ' ' TYR . 3.2 t80 -70.24 86.32 0.58 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 126.176 2.893 . . . . 5.54 110.175 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' VAL . 5.6 p -132.96 84.39 49.29 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-O 126.286 2.946 . . . . 2.45 109.268 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.3 -43.66 17.56 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-O 125.808 2.337 . . . . 2.35 112.833 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.34 -39.15 63.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 126.176 2.893 . . . . 2.17 110.893 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -127.63 48.55 2.23 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.998 2.808 . . . . 3.57 109.146 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -50.69 112.44 2.89 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-O 125.96 2.791 . . . . 1.63 110.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.85 -6.77 17.07 Favored 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 123.239 2.626 . . . . 0.94 112.398 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.9 m -78.75 154.31 30.11 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.292 2.949 . . . . 1.03 110.599 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' HD23 ' A' ' 22' ' ' LEU . 23.5 m -62.86 136.92 58.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 125.306 2.479 . . . . 1.12 107.964 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -55.97 107.7 0.38 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 126.302 2.953 . . . . 4.72 110.426 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.34 -23.3 4.88 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 112.7 -2.046 . . . . 0.55 111.3 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.8 mm? -94.62 134.21 37.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.948 2.785 . . . . 1.25 109.255 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -105.63 118.07 35.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 126.265 2.936 . . . . 2.84 109.203 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 36.6 t -79.59 132.42 36.26 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.963 2.792 . . . . 1.14 110.487 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 15.6 ttm180 -122.95 143.25 50.03 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 125.328 2.489 . . . . 3.76 108.083 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.52 ' H ' ' HD2' ' A' ' 11' ' ' TYR . 9.6 p90 -50.1 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 126.501 3.048 . . . . 5.02 110.726 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.5 -56.84 0.72 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 112.468 -2.151 . . . . 0.43 110.916 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HE3' HD21 ' A' ' 30' ' ' LEU . 64.3 pttt -156.81 161.42 39.74 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 126.619 3.104 . . . . 2.2 109.733 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 11.9 t -88.42 138.02 31.8 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 125.53 2.586 . . . . 0.95 109.352 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.459 HD21 ' HE3' ' A' ' 28' ' ' LYS . 75.4 mt -124.66 167.54 14.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 126.015 2.817 . . . . 1.35 109.633 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.97 136.3 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 CA-C-O 125.382 2.515 . . . . 1.54 108.805 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.701 3.143 . . . . 2.71 109.112 176.258 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.6 p . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 125.991 2.805 . . . . 1.05 109.849 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.499 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.65 136.89 44.39 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 113.302 -1.772 . . . . 0.6 112.077 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.448 ' H ' ' HB2' ' A' ' 7' ' ' ASP . 22.7 pt -100.67 169.03 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 126.684 3.135 . . . . 0.75 111.233 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.653 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.1 pt? -57.09 -6.93 0.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 111.627 -2.533 . . . . 1.25 113.391 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -147.89 51.96 1.04 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.583 3.087 . . . . 1.23 109.31 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 5.6 t0 -112.9 122.6 48.13 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 125.473 2.558 . . . . 0.97 108.559 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.94 123.04 15.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 125.582 2.61 . . . . 2.19 109.661 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 t -161.92 152.79 17.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.068 2.842 . . . . 1.11 110.256 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 24' ' ' CYS . 30.8 m -97.8 171.89 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 125.963 2.792 . . . . 1.7 109.582 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -81.8 73.98 8.81 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 126.178 2.894 . . . . 5.54 110.168 -173.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.9 87.73 50.59 Favored Pre-proline 0 CA--C 1.514 -0.435 0 CA-C-O 126.264 2.935 . . . . 2.45 110.588 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.22 -35.21 5.3 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.981 2.454 . . . . 2.35 112.284 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.05 -28.69 25.95 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.056 2.836 . . . . 2.17 111.152 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 46.8 tp60 -141.73 57.52 1.5 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 125.861 2.744 . . . . 3.57 108.34 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.4 107.67 1.21 Allowed Pre-proline 0 CA--C 1.509 -0.622 0 CA-C-O 125.656 2.646 . . . . 1.63 109.161 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 79.3 Cg_endo -78.92 -8.76 15.62 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 C-N-CA 123.189 2.593 . . . . 0.94 112.469 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 87.0 m -77.49 150.36 34.9 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 126.232 2.92 . . . . 1.03 110.676 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.499 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 4.5 m -58.08 135.48 57.01 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.154 2.407 . . . . 1.12 107.947 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -57.78 113.28 1.78 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 126.509 3.052 . . . . 4.72 110.343 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 126.68 -18.11 6.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 112.123 -2.308 . . . . 0.55 110.331 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 33.9 mt -119.07 148.68 42.77 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 125.428 2.537 . . . . 1.25 108.098 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -139.66 136.13 33.95 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 126.004 2.811 . . . . 2.84 109.914 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 68.0 m -67.19 129.83 41.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.156 2.884 . . . . 1.14 110.492 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.667 ' HD3' HD12 ' A' ' 30' ' ' LEU . 42.9 mtp180 -128.35 133.97 48.77 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 124.993 2.33 . . . . 3.76 107.625 170.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -37.88 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 126.743 3.163 . . . . 5.02 112.302 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 137.66 -58.5 0.63 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 112.226 -2.261 . . . . 0.43 110.759 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 154.9 36.07 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.65 3.119 . . . . 2.2 109.963 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.0 t -79.81 130.13 35.06 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 125.568 2.604 . . . . 0.95 108.545 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.667 HD12 ' HD3' ' A' ' 25' ' ' ARG . 95.9 mt -127.34 160.94 29.86 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 125.912 2.768 . . . . 1.35 109.556 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 t -71.78 109.99 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 125.52 2.581 . . . . 1.54 107.199 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 18.0 pt20 . . . . . 0 CA--C 1.504 -0.795 0 CA-C-O 125.796 2.713 . . . . 2.71 111.566 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 17.7 p . . . . . 0 CA--C 1.503 -0.837 0 CA-C-O 126.065 2.841 . . . . 1.05 109.915 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.577 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.69 128.54 15.17 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 113.271 -1.786 . . . . 0.6 110.931 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.698 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.0 pt -98.34 177.95 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 126.079 2.847 . . . . 0.75 110.183 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.5 pt? -57.12 -7.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.291 -2.231 . . . . 1.25 114.041 -167.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.45 48.5 0.36 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.184 2.897 . . . . 1.23 109.788 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.698 ' HB2' HG12 ' A' ' 4' ' ' ILE . 22.3 t70 -101.41 123.64 45.81 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.745 2.688 . . . . 0.97 109.655 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -64.63 123.17 18.61 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.132 2.872 . . . . 2.19 110.502 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.4 p -157.97 174.25 15.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.73 2.681 . . . . 1.11 109.849 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.24 149.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 126.005 2.812 . . . . 1.7 109.773 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.747 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 40.7 t80 -77.78 76.3 4.31 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 126.276 2.941 . . . . 5.54 110.405 -170.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.49 85.92 48.44 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-O 125.607 2.623 . . . . 2.45 109.271 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.72 -38.04 52.44 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.655 2.236 . . . . 2.35 112.925 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.32 -23.15 63.99 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 126.184 2.897 . . . . 2.17 110.518 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -135.29 47.69 2.3 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 125.917 2.77 . . . . 3.57 109.079 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -58.02 113.58 6.78 Favored Pre-proline 0 CA--C 1.51 -0.595 0 CA-C-O 125.756 2.693 . . . . 1.63 109.406 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 64.2 Cg_endo -79.89 -6.84 14.32 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 123.241 2.627 . . . . 0.94 112.626 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 74.4 m -78.24 155.54 30.22 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 126.174 2.892 . . . . 1.03 110.852 -171.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -62.8 150.32 41.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 125.683 2.659 . . . . 1.12 109.092 174.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -59.87 103.24 0.2 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 126.238 2.923 . . . . 4.72 110.371 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.04 -5.31 8.34 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 112.752 -2.022 . . . . 0.55 111.973 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 75.8 mt -114.36 137.44 51.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 125.879 2.752 . . . . 1.25 109.152 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -116.94 119.4 35.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 126.022 2.82 . . . . 2.84 109.76 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.8 t -73.68 129.59 38.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 126.011 2.815 . . . . 1.14 109.912 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.747 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 36.6 ttm180 -111.97 154.08 25.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 125.154 2.407 . . . . 3.76 108.321 174.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -52.51 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 126.452 3.025 . . . . 5.02 109.697 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.4 -54.4 0.79 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 112.531 -2.122 . . . . 0.43 110.912 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -161.43 159.43 28.14 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.461 3.029 . . . . 2.2 110.344 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 22.8 t -81.47 145.7 30.61 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.4 2.524 . . . . 0.95 109.207 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 168.74 18.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 125.999 2.809 . . . . 1.35 110.076 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.14 155.78 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-O 125.911 2.767 . . . . 1.54 110.053 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 126.144 2.878 . . . . 2.71 110.674 179.511 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.505 -0.762 0 CA-C-O 125.934 2.778 . . . . 1.05 108.395 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.919 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.5 119.81 19.91 Favored Glycine 0 C--O 1.236 0.257 0 CA-C-N 113.333 -1.758 . . . . 0.6 112.333 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 6' ' ' HIS . 13.0 pt -102.16 164.73 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 126.179 2.895 . . . . 0.75 110.236 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -66.77 12.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 125.293 2.473 . . . . 1.25 113.072 -171.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 4' ' ' ILE . 12.4 p80 -154.88 42.16 0.46 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.197 2.903 . . . . 1.23 109.627 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 34.5 t70 -112.69 125.12 53.96 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 125.967 2.794 . . . . 0.97 109.12 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.0 p-10 -76.1 122.48 24.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 126.163 2.887 . . . . 2.19 109.764 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.6 p -149.04 171.61 16.11 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.774 2.702 . . . . 1.11 109.73 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.89 146.9 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 126.218 2.913 . . . . 1.7 109.777 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.572 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.5 p90 -71.63 71.58 0.72 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.503 3.049 . . . . 5.54 110.741 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.31 94.07 31.19 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-O 125.834 2.73 . . . . 2.45 109.261 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.93 -29.88 82.8 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.957 2.438 . . . . 2.35 112.924 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.89 -38.93 17.45 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 125.996 2.807 . . . . 2.17 110.533 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 18.3 tt0 -132.4 65.7 1.57 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.941 2.781 . . . . 3.57 108.498 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -61.47 109.76 2.48 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-O 125.625 2.631 . . . . 1.63 109.377 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 3' ' ' GLY . 70.6 Cg_endo -82.25 -10.04 11.35 Favored 'Trans proline' 0 CA--C 1.498 -1.283 0 CA-C-O 126.241 2.517 . . . . 0.94 112.204 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.919 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 94.4 m -79.69 154.07 28.87 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 126.0 2.809 . . . . 1.03 110.165 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.3 m -65.07 110.01 2.35 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 125.273 2.464 . . . . 1.12 106.308 167.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -51.12 118.6 3.33 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 127.054 3.312 . . . . 4.72 109.935 -173.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -26.37 3.62 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 111.314 -2.676 . . . . 0.55 109.356 -165.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 7.2 mp -105.02 152.53 22.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 125.613 2.625 . . . . 1.25 108.714 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -121.49 135.26 55.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.195 2.902 . . . . 2.84 110.566 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' A' ' 18' ' ' CYS . 3.0 m -77.3 97.44 4.87 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 125.962 2.791 . . . . 1.14 109.696 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.734 ' HD2' HD12 ' A' ' 30' ' ' LEU . 87.8 mtt180 -86.23 157.39 19.96 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 124.922 2.296 . . . . 3.76 107.241 172.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -49.6 94.3 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 126.378 2.99 . . . . 5.02 110.522 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.19 -47.34 1.05 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 112.688 -2.051 . . . . 0.43 112.492 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -130.95 138.68 49.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.582 3.087 . . . . 2.2 111.564 -168.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.8 t -79.67 105.48 10.99 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 125.803 2.716 . . . . 0.95 107.852 170.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 25' ' ' ARG . 94.2 mt -120.6 142.43 49.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 126.016 2.817 . . . . 1.35 109.488 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.701 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 34.5 t -59.15 128.84 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 CA-C-O 125.753 2.692 . . . . 1.54 109.75 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 126.318 2.961 . . . . 2.71 109.205 179.73 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t . . . . . 0 CA--C 1.505 -0.75 0 CA-C-O 125.861 2.743 . . . . 1.05 109.524 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -66.01 109.4 2.87 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 113.391 -1.731 . . . . 0.6 111.666 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.8 pt -91.71 -178.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 125.452 2.549 . . . . 0.75 110.536 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.42 ' N ' HD23 ' A' ' 5' ' ' LEU . 2.5 pt? -37.05 -38.38 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 124.368 2.032 . . . . 1.25 114.617 -166.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -141.94 29.72 1.67 Allowed 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 125.477 2.561 . . . . 1.23 111.284 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.79 132.67 44.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 125.675 2.655 . . . . 0.97 109.049 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 79.7 m-20 -75.31 123.71 25.82 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.022 2.82 . . . . 2.19 110.254 -173.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 p -161.47 178.16 9.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 126.002 2.81 . . . . 1.11 110.44 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.66 143.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 125.954 2.788 . . . . 1.7 109.666 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -69.61 82.46 0.42 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.968 2.794 . . . . 5.54 110.134 -177.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 7.7 p -119.97 91.85 46.05 Favored Pre-proline 0 CA--C 1.513 -0.475 0 CA-C-O 126.133 2.873 . . . . 2.45 108.84 172.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HD3' ' HD1' ' A' ' 11' ' ' TYR . 37.0 Cg_endo -65.98 -47.65 3.45 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 122.791 2.327 . . . . 2.35 113.4 -173.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.17 62.49 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 125.831 2.729 . . . . 2.17 111.241 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -128.65 42.78 3.26 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.008 2.813 . . . . 3.57 109.352 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -59.33 113.34 6.75 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.635 2.636 . . . . 1.63 110.471 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.13 -3.95 11.07 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.047 2.498 . . . . 0.94 112.214 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.549 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 4.8 t -79.63 144.99 33.28 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.531 2.586 . . . . 1.03 108.647 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 22' ' ' LEU . 71.3 m -59.42 143.52 49.53 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.12 2.867 . . . . 1.12 110.177 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -62.73 118.46 7.71 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 126.159 2.885 . . . . 4.72 109.526 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 111.25 -3.23 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.039 -1.891 . . . . 0.55 111.129 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 19' ' ' CYS . 54.9 mt -127.95 133.81 49.26 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.756 2.693 . . . . 1.25 108.328 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.65 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 16.3 mm100 -110.98 120.86 43.79 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 126.148 2.88 . . . . 2.84 109.56 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 38.1 t -79.93 120.46 24.17 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 125.859 2.742 . . . . 1.14 109.65 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.76 HH11 ' HB2' ' A' ' 30' ' ' LEU . 6.1 mpt_? -101.95 164.27 11.8 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 125.176 2.417 . . . . 3.76 108.595 175.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -58.95 85.83 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.428 3.013 . . . . 5.02 110.867 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 144.66 -51.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.731 -2.031 . . . . 0.43 110.894 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 63.5 pttt -163.19 174.24 12.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.351 2.977 . . . . 2.2 110.272 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.5 m -77.98 145.21 36.14 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.117 2.865 . . . . 0.95 110.049 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.76 ' HB2' HH11 ' A' ' 25' ' ' ARG . 87.4 mt -126.45 145.12 50.61 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.917 2.77 . . . . 1.35 108.426 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HA ' HD22 ' A' ' 22' ' ' LEU . 24.3 m -80.38 119.73 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 126.399 2.999 . . . . 1.54 111.195 -172.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HG3' ' HG2' ' A' ' 23' ' ' GLN . 16.2 mm100 . . . . . 0 CA--C 1.497 -1.096 0 CA-C-O 126.461 3.029 . . . . 2.71 109.099 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.3 p . . . . . 0 CA--C 1.504 -0.819 0 CA-C-O 125.768 2.699 . . . . 1.05 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.627 ' H ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.31 139.11 39.38 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 113.564 -1.653 . . . . 0.6 110.697 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.582 ' HB ' HD23 ' A' ' 5' ' ' LEU . 8.5 pt -111.06 -175.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 125.671 2.653 . . . . 0.75 111.357 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.1 pt? -41.58 -35.24 0.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 124.443 2.068 . . . . 1.25 114.375 -165.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -145.07 38.6 1.18 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 125.722 2.677 . . . . 1.23 110.847 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' HB2' HG13 ' A' ' 4' ' ' ILE . 20.0 t70 -88.03 142.16 28.0 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 125.747 2.689 . . . . 0.97 108.697 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 4.6 p-10 -71.33 138.45 49.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 125.718 2.675 . . . . 2.19 110.21 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 p -168.61 175.26 6.25 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 126.211 2.91 . . . . 1.11 109.849 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 12' ' ' VAL . 47.8 t -111.19 144.42 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 125.276 2.465 . . . . 1.7 108.334 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 81.5 t80 -66.34 80.84 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 126.596 3.093 . . . . 5.54 110.189 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 10' ' ' VAL . 18.2 m -128.13 79.58 73.66 Favored Pre-proline 0 CA--C 1.511 -0.552 0 CA-C-O 125.8 2.714 . . . . 2.45 109.266 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 18.8 Cg_endo -58.59 -44.85 33.67 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 CA-C-O 125.996 2.415 . . . . 2.35 112.286 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.61 -24.48 67.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 126.114 2.864 . . . . 2.17 110.495 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 17.3 mm-40 -118.28 31.55 6.62 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 125.652 2.644 . . . . 3.57 109.537 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 46.1 t-20 -52.67 110.14 1.8 Allowed Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-O 125.694 2.664 . . . . 1.63 110.913 -175.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -95.08 7.47 2.07 Favored 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 123.599 2.866 . . . . 0.94 111.575 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 5.1 t -102.8 157.6 16.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 125.269 2.462 . . . . 1.03 108.191 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.2 m -64.71 138.84 58.63 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.557 3.075 . . . . 1.12 109.842 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -65.38 105.81 1.24 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 126.331 2.967 . . . . 4.72 109.837 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 133.85 -9.74 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 112.613 -2.085 . . . . 0.55 110.936 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 22' ' ' LEU . 5.1 mp -115.98 130.75 56.95 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.263 2.935 . . . . 1.25 109.46 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -81.99 95.65 7.47 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.83 2.729 . . . . 2.84 109.818 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 40.3 t -68.1 99.63 0.91 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 126.405 3.002 . . . . 1.14 108.746 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 25' ' ' ARG . 16.1 ttt180 -113.37 167.59 10.44 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.292 2.473 . . . . 3.76 108.928 -173.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -51.1 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.088 2.851 . . . . 5.02 111.134 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 113.1 -40.24 2.59 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 113.225 -1.807 . . . . 0.43 112.498 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.851 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.1 pttt -161.21 161.26 30.82 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.585 3.088 . . . . 2.2 110.932 -172.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 65.0 m -78.78 139.21 38.44 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 125.693 2.663 . . . . 0.95 108.694 170.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.851 HD21 ' HE3' ' A' ' 28' ' ' LYS . 94.8 mt -123.78 114.11 19.46 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 126.145 2.879 . . . . 1.35 109.382 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.31 131.55 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 125.626 2.631 . . . . 1.54 108.761 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 12.7 pt20 . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 126.589 3.09 . . . . 2.71 109.954 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.77 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 30.7 p . . . . . 0 CA--C 1.506 -0.723 0 CA-C-O 125.845 2.736 . . . . 1.05 109.405 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -53.87 143.94 27.93 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 113.017 -1.901 . . . . 0.6 113.107 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.62 HG12 ' HB2' ' A' ' 7' ' ' ASP . 40.3 pt -79.32 169.07 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 126.648 3.118 . . . . 0.75 111.169 -176.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.874 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 2.1 pt? -57.44 -6.62 0.47 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 111.796 -2.456 . . . . 1.25 113.54 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 29.5 p80 -154.88 43.36 0.48 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 125.667 2.651 . . . . 1.23 110.722 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.1 t70 -87.56 148.24 24.96 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.79 2.71 . . . . 0.97 109.109 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.0 117.74 18.88 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 125.789 2.709 . . . . 2.19 109.488 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 6.7 p -156.01 152.21 27.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 126.216 2.912 . . . . 1.11 109.864 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 12' ' ' VAL . 14.6 p -81.0 152.53 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-O 125.992 2.806 . . . . 1.7 109.211 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -73.25 66.8 0.92 Allowed 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 126.247 2.927 . . . . 5.54 111.197 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 10' ' ' VAL . 7.2 p -121.24 88.23 45.32 Favored Pre-proline 0 CA--C 1.512 -0.503 0 CA-C-O 126.262 2.934 . . . . 2.45 109.064 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 38.6 Cg_endo -67.7 -39.06 12.49 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 CA-C-O 125.682 2.284 . . . . 2.35 112.628 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.36 62.28 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 126.013 2.816 . . . . 2.17 111.226 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 51.6 tp60 -139.54 47.4 1.87 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 126.326 2.965 . . . . 3.57 108.432 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 21.6 p-10 -64.26 116.32 26.93 Favored Pre-proline 0 CA--C 1.512 -0.509 0 CA-C-O 125.986 2.803 . . . . 1.63 110.192 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.08 -10.53 17.92 Favored 'Trans proline' 0 CA--C 1.503 -1.049 0 CA-C-O 126.16 2.483 . . . . 0.94 111.994 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 7.5 t -79.01 158.85 27.85 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 125.707 2.67 . . . . 1.03 108.6 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.77 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -68.67 148.44 50.42 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 126.308 2.956 . . . . 1.12 109.877 -176.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.53 126.41 27.76 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 126.049 2.833 . . . . 4.72 109.899 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.22 -10.14 46.84 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 112.934 -1.939 . . . . 0.55 110.766 -171.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 5' ' ' LEU . 13.0 mt -119.15 135.95 54.42 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.49 2.566 . . . . 1.25 107.573 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.43 122.83 39.91 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.249 2.928 . . . . 2.84 110.429 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.816 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 56.2 m -69.31 111.59 5.32 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 126.072 2.844 . . . . 1.14 110.69 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 59.5 ttt180 -92.74 155.3 17.77 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 124.721 2.2 . . . . 3.76 106.641 171.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -47.62 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 126.534 3.064 . . . . 5.02 111.622 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 119.1 -48.21 0.96 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 112.573 -2.103 . . . . 0.43 112.172 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -138.29 141.51 39.83 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 126.201 2.905 . . . . 2.2 110.027 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.816 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.7 t -79.02 138.76 38.17 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 125.834 2.731 . . . . 0.95 108.449 174.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.12 137.52 51.93 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 126.308 2.956 . . . . 1.35 109.971 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.874 ' HB ' ' HB2' ' A' ' 5' ' ' LEU . 6.2 p -73.07 99.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 126.332 2.968 . . . . 1.54 109.223 175.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 5.8 tp60 . . . . . 0 CA--C 1.501 -0.926 0 CA-C-O 126.384 2.993 . . . . 2.71 109.026 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 CA--C 1.503 -0.828 0 CA-C-O 125.364 2.506 . . . . 1.05 107.721 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.693 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -83.34 111.16 3.37 Favored Glycine 0 N--CA 1.444 -0.804 0 O-C-N 120.19 -1.569 . . . . 0.6 110.767 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.579 ' HA ' HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -117.87 -179.82 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.939 2.78 . . . . 0.75 110.029 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.5 pt? -56.42 -4.6 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.168 -2.287 . . . . 1.25 114.238 -166.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.15 37.75 0.63 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 125.861 2.744 . . . . 1.23 110.507 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.99 107.63 19.93 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 125.515 2.579 . . . . 0.97 108.877 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -58.46 117.24 4.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 126.441 3.02 . . . . 2.19 109.666 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.469 ' H ' ' HA ' ' A' ' 28' ' ' LYS . 40.4 t -161.31 141.43 10.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 125.828 2.728 . . . . 1.11 108.815 -166.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.618 HG23 HG13 ' A' ' 12' ' ' VAL . 17.1 m -93.6 -178.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 126.111 2.863 . . . . 1.7 110.274 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.494 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 6.9 p90 -68.39 76.68 0.26 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 126.341 2.972 . . . . 5.54 110.837 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 HG23 ' A' ' 10' ' ' VAL . 18.7 m -123.03 74.15 48.06 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-O 125.975 2.798 . . . . 2.45 110.374 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 4.1 Cg_exo -74.68 -40.24 1.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 CA-C-O 125.944 2.393 . . . . 2.35 111.856 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -16.75 60.17 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 126.033 2.825 . . . . 2.17 110.837 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.07 36.18 3.67 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.117 2.389 . . . . 3.57 109.449 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -49.95 104.66 0.44 Allowed Pre-proline 0 N--CA 1.473 0.717 0 CA-C-O 125.887 2.756 . . . . 1.63 111.078 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -85.35 -4.73 9.39 Favored 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 123.438 2.759 . . . . 0.94 111.883 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 79.4 m -78.57 146.58 34.15 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 125.882 2.753 . . . . 1.03 110.418 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m -62.32 134.17 56.12 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 125.922 2.772 . . . . 1.12 107.515 172.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -54.69 115.33 2.1 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 126.707 3.146 . . . . 4.72 111.901 -163.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.35 -23.53 4.84 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 111.999 -2.364 . . . . 0.55 111.267 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.624 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 6.3 mp -102.8 150.35 23.58 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 125.869 2.747 . . . . 1.25 109.523 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -138.29 139.35 39.1 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 126.132 2.873 . . . . 2.84 109.682 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.8 m -67.92 112.43 4.94 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 126.055 2.836 . . . . 1.14 110.338 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 27' ' ' GLY . 56.7 ttt180 -91.67 159.55 15.81 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 124.58 2.133 . . . . 3.76 107.409 170.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -52.03 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 126.254 2.93 . . . . 5.02 111.312 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 140.94 -50.24 0.75 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 113.092 -1.867 . . . . 0.43 111.494 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -160.34 164.21 32.68 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 126.441 3.02 . . . . 2.2 110.105 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 45.5 t -78.89 132.51 36.81 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 125.694 2.664 . . . . 0.95 108.878 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.07 155.85 44.78 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 126.051 2.834 . . . . 1.35 109.634 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.624 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 38.7 t -73.34 106.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.78 2.705 . . . . 1.54 108.445 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 125.708 2.67 . . . . 2.71 109.855 -176.136 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.503 -0.829 0 CA-C-O 125.996 2.808 . . . . 1.05 109.51 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.57 124.02 26.09 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 113.491 -1.686 . . . . 0.6 110.574 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.607 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 24.9 pt -117.6 168.23 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 126.039 2.828 . . . . 0.75 110.128 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.93 2.85 1.78 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 125.453 2.549 . . . . 1.25 112.676 -166.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -150.25 45.57 0.89 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 126.554 3.074 . . . . 1.23 109.858 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.607 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 8.3 t70 -123.05 127.93 49.45 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.356 2.503 . . . . 0.97 108.538 174.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.69 135.03 43.66 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 125.532 2.586 . . . . 2.19 109.914 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.5 p -165.97 172.27 11.68 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 125.872 2.748 . . . . 1.11 109.663 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 12' ' ' VAL . 35.8 m -99.24 153.62 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.434 3.016 . . . . 1.7 110.471 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -75.85 87.44 2.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 126.209 2.909 . . . . 5.54 110.264 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 10' ' ' VAL . 8.6 p -147.17 68.55 11.38 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 126.457 3.027 . . . . 2.45 109.777 174.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 19.2 Cg_exo -66.45 -19.83 54.87 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 C-N-CA 122.944 2.429 . . . . 2.35 112.781 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.44 -27.92 62.85 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 126.13 2.871 . . . . 2.17 110.497 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -130.98 49.35 2.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.492 3.044 . . . . 3.57 107.647 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 60.8 t30 -56.68 116.08 12.03 Favored Pre-proline 0 CA--C 1.511 -0.541 0 CA-C-O 126.103 2.859 . . . . 1.63 111.249 -173.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.52 -11.05 15.83 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 123.33 2.686 . . . . 0.94 112.172 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.569 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 74.1 m -79.13 158.65 27.71 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 125.889 2.757 . . . . 1.03 110.18 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.8 m -66.36 142.8 57.5 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.723 2.677 . . . . 1.12 108.761 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -59.01 110.98 1.14 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 126.641 3.115 . . . . 4.72 110.39 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.24 -26.27 3.75 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 112.238 -2.255 . . . . 0.55 110.739 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 4.6 mp -105.24 152.4 22.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.565 2.603 . . . . 1.25 109.068 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -133.69 129.82 37.32 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.674 2.654 . . . . 2.84 110.267 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.7 m -69.64 105.56 2.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.198 2.904 . . . . 1.14 110.193 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -101.27 163.56 12.22 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 125.051 2.357 . . . . 3.76 107.941 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -50.58 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 126.275 2.94 . . . . 5.02 111.221 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.9 -49.39 0.89 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 112.857 -1.974 . . . . 0.43 111.899 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.872 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.4 pttt -159.96 162.57 34.42 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 126.808 3.194 . . . . 2.2 110.638 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 47.8 t -79.68 124.75 28.85 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 125.894 2.759 . . . . 0.95 109.173 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.872 HD21 ' HE3' ' A' ' 28' ' ' LYS . 97.8 mt -122.62 131.53 53.86 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 126.126 2.869 . . . . 1.35 109.491 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 22' ' ' LEU . 7.7 p -75.1 145.17 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 125.315 2.483 . . . . 1.54 108.096 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.278 2.942 . . . . 2.71 109.871 -176.826 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p . . . . . 0 CA--C 1.506 -0.722 0 CA-C-O 125.962 2.792 . . . . 1.05 109.554 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.587 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.8 118.24 6.93 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 113.537 -1.665 . . . . 0.6 110.224 170.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.516 ' C ' ' H ' ' A' ' 6' ' ' HIS . 8.0 pt -115.02 167.55 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 125.858 2.742 . . . . 0.75 110.119 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.19 12.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 125.42 2.534 . . . . 1.25 112.952 -169.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 4' ' ' ILE . 18.7 p80 -157.44 41.16 0.31 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 126.068 2.842 . . . . 1.23 110.294 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -115.51 119.23 35.51 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.674 2.654 . . . . 0.97 108.816 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.12 123.83 23.7 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.894 2.759 . . . . 2.19 109.523 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.2 160.38 43.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 126.034 2.826 . . . . 1.11 110.22 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 12' ' ' VAL . 9.3 p -85.87 130.56 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.062 2.839 . . . . 1.7 109.255 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 21.3 p90 -70.14 74.52 0.49 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 126.52 3.057 . . . . 5.54 111.626 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 10' ' ' VAL . 15.7 m -119.12 89.07 38.55 Favored Pre-proline 0 CA--C 1.513 -0.48 0 CA-C-O 126.098 2.856 . . . . 2.45 109.664 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.69 -34.07 89.42 Favored 'Trans proline' 0 CA--C 1.507 -0.873 0 C-N-CA 122.995 2.463 . . . . 2.35 112.686 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 -25.06 59.31 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 125.784 2.707 . . . . 2.17 110.881 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -132.83 39.09 3.35 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 126.021 2.819 . . . . 3.57 108.941 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -56.2 111.82 3.66 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 125.884 2.754 . . . . 1.63 109.594 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.25 -12.84 19.07 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 CA-C-O 126.267 2.528 . . . . 0.94 112.299 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 63.1 m -77.73 150.67 34.4 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 126.054 2.835 . . . . 1.03 110.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.43 145.96 41.82 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 125.75 2.69 . . . . 1.12 108.586 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -62.23 102.11 0.28 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 126.399 2.999 . . . . 4.72 110.147 -170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.46 -26.04 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 112.483 -2.144 . . . . 0.55 110.931 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 6.0 mp -101.2 148.78 24.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 125.821 2.724 . . . . 1.25 109.238 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 32' ' ' GLN . 48.5 tp60 -121.23 129.4 53.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.132 2.872 . . . . 2.84 109.543 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 53.5 t -69.58 104.49 2.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.182 2.896 . . . . 1.14 108.563 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' GLY . 15.1 mmt180 -86.21 174.6 9.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.562 2.601 . . . . 3.76 109.332 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.423 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 m-85 -61.25 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.243 2.925 . . . . 5.02 110.608 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 116.19 -26.54 8.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.767 -2.015 . . . . 0.43 112.636 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 19.1 ptpt -160.17 149.4 17.53 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 126.418 3.009 . . . . 2.2 110.626 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.5 t -79.71 129.66 34.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.872 2.749 . . . . 0.95 109.817 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 156.77 47.97 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 125.86 2.743 . . . . 1.35 109.034 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 61.3 t -69.19 115.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-O 126.068 2.842 . . . . 1.54 109.152 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 58.2 tp60 . . . . . 0 CA--C 1.506 -0.733 0 CA-C-O 125.909 2.766 . . . . 2.71 109.796 -176.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.503 -0.833 0 CA-C-O 125.766 2.698 . . . . 1.05 108.879 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.591 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -58.75 127.67 45.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 113.627 -1.624 . . . . 0.6 111.329 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.559 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 5.9 pt -94.71 -176.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 125.469 2.557 . . . . 0.75 110.912 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 5' ' ' LEU . 2.0 pt? -34.8 -45.43 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 124.841 2.258 . . . . 1.25 114.186 -166.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.649 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 33.4 p80 -142.66 37.75 1.48 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.774 2.702 . . . . 1.23 110.628 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 21.2 t70 -73.97 130.59 40.17 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 125.832 2.729 . . . . 0.97 109.253 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.0 m-20 -64.95 134.79 54.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.974 2.797 . . . . 2.19 110.39 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.81 161.79 42.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.193 2.901 . . . . 1.11 110.209 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 12' ' ' VAL . 23.9 m -89.6 143.54 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 CA-C-O 125.384 2.516 . . . . 1.7 108.362 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -69.11 75.64 0.33 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.449 3.024 . . . . 5.54 110.116 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' VAL . 95.2 t -128.38 98.83 25.1 Favored Pre-proline 0 CA--C 1.506 -0.712 0 CA-C-O 125.572 2.606 . . . . 2.45 108.606 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.74 -54.46 0.22 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 122.945 2.43 . . . . 2.35 113.201 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.76 75.34 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 125.684 2.659 . . . . 2.17 111.612 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.514 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -116.35 35.82 4.37 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 125.952 2.787 . . . . 3.57 109.216 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.97 108.86 3.79 Favored Pre-proline 0 CA--C 1.509 -0.623 0 CA-C-O 125.686 2.66 . . . . 1.63 110.126 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 83.4 Cg_endo -83.36 48.71 2.75 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 CA-C-O 126.737 2.724 . . . . 0.94 110.983 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.591 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 10.6 t -136.86 143.75 43.23 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.105 2.383 . . . . 1.03 107.585 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -59.91 145.87 44.3 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.356 2.979 . . . . 1.12 110.67 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.674 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.59 122.1 21.72 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.322 2.963 . . . . 4.72 108.899 -174.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 117.95 -7.4 15.03 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 112.625 -2.08 . . . . 0.55 110.171 -171.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.3 mp -114.78 139.42 49.74 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.895 2.76 . . . . 1.25 108.708 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.519 ' HB3' HE21 ' A' ' 32' ' ' GLN . 26.3 pt20 -104.47 121.69 43.98 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.624 2.63 . . . . 2.84 109.685 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.3 t -80.58 102.05 9.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 126.074 2.845 . . . . 1.14 108.632 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.562 ' HG3' HD12 ' A' ' 30' ' ' LEU . 25.4 mmt180 -97.93 163.05 12.94 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 125.197 2.427 . . . . 3.76 108.645 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -53.1 93.45 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.018 2.818 . . . . 5.02 109.941 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 128.55 -50.82 0.87 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.854 -1.975 . . . . 0.43 112.404 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 20.8 pttp -162.47 173.88 13.44 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.395 2.998 . . . . 2.2 111.312 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 87.4 m -78.65 143.05 36.71 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 126.043 2.83 . . . . 0.95 109.806 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.562 HD12 ' HG3' ' A' ' 25' ' ' ARG . 91.0 mt -126.69 126.82 44.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 125.886 2.755 . . . . 1.35 108.469 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 5' ' ' LEU . 2.2 m -66.64 102.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 126.35 2.976 . . . . 1.54 110.741 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.519 HE21 ' HB3' ' A' ' 23' ' ' GLN . 90.2 mt-30 . . . . . 0 CA--C 1.499 -1.007 0 CA-C-O 126.69 3.138 . . . . 2.71 108.795 174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 125.684 2.659 . . . . 1.05 108.874 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.8 127.66 39.23 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 113.543 -1.662 . . . . 0.6 112.532 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.512 ' HB ' HD23 ' A' ' 5' ' ' LEU . 22.9 pt -117.88 178.69 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 126.338 2.97 . . . . 0.75 110.827 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.4 pt? -56.57 -11.71 1.44 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 111.952 -2.386 . . . . 1.25 113.786 -169.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -151.1 47.09 0.84 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.499 3.047 . . . . 1.23 110.067 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.29 119.19 38.41 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 125.434 2.54 . . . . 0.97 109.158 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -60.06 112.11 1.76 Allowed 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 126.058 2.837 . . . . 2.19 108.802 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.8 t -133.39 149.04 51.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 126.086 2.85 . . . . 1.11 110.778 -165.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 12' ' ' VAL . 70.6 t -97.87 133.1 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 125.723 2.678 . . . . 1.7 108.515 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -67.81 86.94 0.23 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 125.981 2.801 . . . . 5.54 110.485 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 10' ' ' VAL . 13.2 m -132.73 90.14 33.37 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-O 125.947 2.784 . . . . 2.45 109.488 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.2 -47.98 15.49 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 123.23 2.62 . . . . 2.35 113.579 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.67 83.53 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.093 2.854 . . . . 2.17 110.598 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -111.41 42.31 1.7 Allowed 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 125.579 2.609 . . . . 3.57 109.399 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -54.85 113.43 5.34 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 125.877 2.751 . . . . 1.63 110.293 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.75 -13.8 14.34 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.012 2.474 . . . . 0.94 112.388 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 98.5 m -78.19 148.21 34.14 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 126.174 2.892 . . . . 1.03 110.568 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' HB2' HD23 ' A' ' 22' ' ' LEU . 54.8 m -66.26 162.11 20.76 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 125.852 2.739 . . . . 1.12 109.578 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 20' ' ' ARG . 15.3 ptt180 -61.0 119.76 8.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.302 2.953 . . . . 4.72 110.142 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.81 -4.56 56.28 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 113.127 -1.851 . . . . 0.55 111.819 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 19' ' ' CYS . 3.7 mm? -101.15 134.97 43.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.008 2.813 . . . . 1.25 109.252 175.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HB2' ' HG3' ' A' ' 32' ' ' GLN . 29.4 tp60 -111.73 110.18 20.43 Favored 'General case' 0 CA--C 1.5 -0.942 0 CA-C-O 125.886 2.755 . . . . 2.84 109.325 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.7 t -75.3 129.51 37.53 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.896 2.76 . . . . 1.14 109.039 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -117.62 144.57 45.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 124.672 2.177 . . . . 3.76 106.875 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -55.79 97.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.569 3.08 . . . . 5.02 109.887 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.68 -53.39 0.79 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 112.489 -2.141 . . . . 0.43 111.179 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -150.68 153.84 36.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 126.293 2.949 . . . . 2.2 109.938 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 35.2 t -95.93 130.78 42.81 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 125.383 2.516 . . . . 0.95 108.301 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.18 173.14 8.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.28 2.943 . . . . 1.35 110.161 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.39 112.93 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-O 125.735 2.683 . . . . 1.54 108.756 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 42.7 tt0 . . . . . 0 CA--C 1.507 -0.704 0 CA-C-O 126.189 2.899 . . . . 2.71 109.742 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 CA--C 1.505 -0.763 0 CA-C-O 125.96 2.791 . . . . 1.05 109.501 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.547 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -63.47 138.54 43.07 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 113.392 -1.731 . . . . 0.6 111.097 172.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.518 ' HB ' HD23 ' A' ' 5' ' ' LEU . 19.7 pt -115.51 175.56 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 126.486 3.041 . . . . 0.75 111.047 -174.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.4 pt? -59.07 -6.9 0.94 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 111.922 -2.399 . . . . 1.25 113.223 -171.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -150.1 49.06 0.91 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.253 2.93 . . . . 1.23 109.862 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.506 ' HB2' HG12 ' A' ' 4' ' ' ILE . 39.1 t70 -115.08 133.72 55.8 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.471 2.558 . . . . 0.97 109.01 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.6 m-20 -75.88 133.03 40.67 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 125.671 2.653 . . . . 2.19 109.831 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.5 p -162.24 162.06 28.04 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 125.905 2.764 . . . . 1.11 110.214 -176.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.1 m -92.41 151.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 125.77 2.7 . . . . 1.7 109.389 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.476 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 2.7 p90 -71.43 76.4 0.77 Allowed 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 126.462 3.029 . . . . 5.54 110.521 -172.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.28 70.65 79.26 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-O 125.984 2.802 . . . . 2.45 110.247 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 31.7 Cg_exo -60.09 -32.65 95.02 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-O 125.87 2.362 . . . . 2.35 111.945 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.16 -40.28 58.24 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 126.22 2.914 . . . . 2.17 110.419 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.56 46.91 2.11 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.914 2.769 . . . . 3.57 108.461 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 46.8 t-20 -49.97 113.12 3.14 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-O 125.876 2.751 . . . . 1.63 110.31 -176.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.14 -18.8 14.09 Favored 'Trans proline' 0 CA--C 1.506 -0.895 0 CA-C-O 125.997 2.415 . . . . 0.94 112.257 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.6 m -79.7 161.16 25.96 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 125.923 2.773 . . . . 1.03 109.87 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -67.73 142.83 56.17 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.11 2.862 . . . . 1.12 109.227 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 32.7 mmt180 -59.94 115.82 3.69 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 126.302 2.954 . . . . 4.72 109.929 -175.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.16 -10.0 8.33 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.609 -2.087 . . . . 0.55 110.902 -175.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.06 140.87 40.59 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.189 2.899 . . . . 1.25 109.637 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -104.76 101.95 11.54 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.056 2.836 . . . . 2.84 109.592 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.8 t -77.33 106.46 9.08 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.184 2.897 . . . . 1.14 109.181 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HD3' HD12 ' A' ' 30' ' ' LEU . 79.2 mtp180 -101.67 150.39 23.16 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 125.193 2.425 . . . . 3.76 108.077 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -50.25 100.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.313 2.959 . . . . 5.02 110.306 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 118.66 -50.9 0.78 Allowed Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 112.555 -2.111 . . . . 0.43 111.714 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -143.3 134.3 25.57 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 126.406 3.003 . . . . 2.2 110.275 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 34.6 t -87.58 123.26 32.27 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 125.676 2.655 . . . . 0.95 108.315 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.406 HD12 ' HD3' ' A' ' 25' ' ' ARG . 82.2 mt -116.65 173.7 6.48 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.993 2.806 . . . . 1.35 109.879 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.04 118.52 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 125.778 2.704 . . . . 1.54 108.724 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 125.833 2.73 . . . . 2.71 107.707 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.501 -0.908 0 CA-C-O 125.746 2.689 . . . . 1.05 108.706 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -61.4 120.01 20.81 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 113.565 -1.652 . . . . 0.6 111.16 173.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 23.6 pt -117.08 178.18 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 125.723 2.678 . . . . 0.75 109.674 -178.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.95 14.38 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 125.256 2.455 . . . . 1.25 113.324 -164.611 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -160.48 31.61 0.16 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 125.914 2.769 . . . . 1.23 110.129 172.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.454 ' HB2' HG12 ' A' ' 4' ' ' ILE . 29.7 t70 -100.93 130.05 46.87 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 125.386 2.517 . . . . 0.97 109.36 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -60.9 116.88 4.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.345 2.974 . . . . 2.19 109.009 178.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.5 t -139.03 136.37 35.22 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 126.119 2.866 . . . . 1.11 109.64 -173.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.546 ' O ' HG22 ' A' ' 12' ' ' VAL . 27.9 m -93.5 145.22 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 125.455 2.55 . . . . 1.7 108.215 175.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' H ' ' HD1' ' A' ' 11' ' ' TYR . 8.7 p90 -62.02 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 126.38 2.991 . . . . 5.54 111.579 -174.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 15' ' ' GLN . 12.2 m -127.86 93.18 40.37 Favored Pre-proline 0 CA--C 1.506 -0.718 0 CA-C-O 126.115 2.864 . . . . 2.45 109.295 174.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.84 -49.94 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.69 0 CA-C-O 126.145 2.477 . . . . 2.35 111.749 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.22 -6.7 25.01 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 125.942 2.782 . . . . 2.17 110.91 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 28.9 tt0 -138.56 36.64 2.24 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.038 2.828 . . . . 3.57 108.839 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 24.9 t-20 -57.74 113.8 7.12 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 125.799 2.714 . . . . 1.63 110.574 -177.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -84.35 -8.31 9.7 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.239 2.626 . . . . 0.94 112.139 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.568 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 71.3 m -78.99 159.08 27.81 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 125.742 2.686 . . . . 1.03 110.017 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.36 132.21 44.52 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 125.933 2.778 . . . . 1.12 108.139 172.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 20' ' ' ARG . 23.4 mmt180 -56.86 108.61 0.52 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.346 2.974 . . . . 4.72 110.327 -172.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.16 -19.49 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 112.68 -2.055 . . . . 0.55 110.995 -175.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.9 mp -105.36 138.38 41.65 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 125.985 2.802 . . . . 1.25 109.562 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 41.1 tt0 -94.04 131.64 39.33 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 125.767 2.699 . . . . 2.84 109.351 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 39.0 t -90.91 111.19 22.52 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.04 2.829 . . . . 1.14 108.654 174.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -108.31 152.81 24.13 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.324 2.487 . . . . 3.76 108.793 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -46.8 96.35 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.082 2.849 . . . . 5.02 110.918 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.34 -49.38 0.89 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.045 -1.889 . . . . 0.43 112.374 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.96 156.17 42.37 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 126.531 3.062 . . . . 2.2 110.42 -174.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 14.6 t -90.87 147.3 23.25 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.29 2.471 . . . . 0.95 107.731 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 pp -150.36 161.57 42.22 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 126.03 2.824 . . . . 1.35 110.004 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 5' ' ' LEU . 11.7 m -74.39 115.39 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.12 2.867 . . . . 1.54 109.748 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 44.4 tt0 . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 126.486 3.041 . . . . 2.71 109.695 -175.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t . . . . . 0 CA--C 1.506 -0.734 0 CA-C-O 125.92 2.771 . . . . 1.05 108.777 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.73 129.3 33.01 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 113.27 -1.787 . . . . 0.6 111.883 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.2 pt -112.72 168.5 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 126.328 2.966 . . . . 0.75 110.35 -176.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.614 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -59.54 -4.42 0.62 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 125.255 2.455 . . . . 1.25 113.119 -171.206 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.91 50.0 1.27 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 126.358 2.98 . . . . 1.23 109.57 176.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.01 165.68 14.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.191 2.424 . . . . 0.97 107.869 172.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 93.6 m-20 -108.42 124.75 50.88 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 125.584 2.611 . . . . 2.19 110.08 -172.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 10.4 p -163.12 156.52 19.54 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 125.903 2.763 . . . . 1.11 110.102 -173.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.68 152.71 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 126.2 2.905 . . . . 1.7 110.195 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.426 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 64.1 t80 -75.69 77.61 2.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 126.243 2.925 . . . . 5.54 110.455 -176.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 102.54 35.84 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-O 126.006 2.812 . . . . 2.45 108.09 173.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.1 -52.01 9.76 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.649 2.899 . . . . 2.35 113.644 -172.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -19.37 64.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 125.687 2.661 . . . . 2.17 111.439 -176.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.503 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 52.5 tt0 -126.24 36.01 4.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.961 2.791 . . . . 3.57 109.886 -177.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -71.59 106.27 1.85 Allowed Pre-proline 0 CA--C 1.511 -0.529 0 CA-C-O 125.796 2.712 . . . . 1.63 108.219 173.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 64.1 Cg_endo -80.95 -8.29 13.2 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 123.242 2.628 . . . . 0.94 113.136 -170.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.854 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 71.9 m -78.87 145.13 34.35 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 126.395 2.997 . . . . 1.03 111.074 -171.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -54.78 139.1 40.67 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.294 2.473 . . . . 1.12 109.121 177.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -48.13 108.26 0.16 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 126.488 3.042 . . . . 4.72 110.979 -175.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.31 -20.41 5.88 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 112.656 -2.065 . . . . 0.55 111.318 -176.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.854 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.5 mt -103.19 145.87 29.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 125.667 2.651 . . . . 1.25 109.185 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.27 135.78 37.46 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 125.615 2.626 . . . . 2.84 109.285 -177.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 88.6 m -78.95 129.43 34.48 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.447 3.022 . . . . 1.14 111.637 -177.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLY . 7.0 tpp180 -84.1 145.92 28.18 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.314 -2.106 . . . . 3.76 105.314 159.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -58.44 81.05 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 126.28 2.943 . . . . 5.02 110.26 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 145.29 -45.68 0.82 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.135 -1.848 . . . . 0.43 111.345 -177.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 20.8 ptmt -149.62 148.35 29.22 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.246 2.927 . . . . 2.2 110.758 -176.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 24.0 t -79.83 144.61 33.35 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 125.784 2.707 . . . . 0.95 109.682 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -132.28 160.76 35.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.128 2.87 . . . . 1.35 110.071 -176.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.85 105.65 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 125.764 2.697 . . . . 1.54 109.189 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? . . . . . 0 CA--C 1.504 -0.826 0 CA-C-O 126.135 2.874 . . . . 2.71 108.547 178.777 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.505 -0.78 0 CA-C-O 125.899 2.761 . . . . 1.05 109.583 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -57.09 124.68 36.61 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 113.234 -1.803 . . . . 0.6 112.302 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' ' 7' ' ' ASP . 33.7 pt -93.13 177.65 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 126.327 2.965 . . . . 0.75 110.778 -176.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.15 -18.58 0.6 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 111.993 -2.367 . . . . 1.25 114.013 -167.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.54 48.66 0.88 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 125.927 2.775 . . . . 1.23 110.11 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 34.9 t70 -91.79 140.92 29.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 125.675 2.655 . . . . 0.97 109.253 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.98 125.25 29.0 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.833 2.73 . . . . 2.19 109.907 -176.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.7 p -175.35 146.1 0.79 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.045 2.831 . . . . 1.11 109.871 -177.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 12' ' ' VAL . 30.4 m -79.09 168.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 125.983 2.802 . . . . 1.7 109.749 178.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -77.56 76.52 4.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.452 3.025 . . . . 5.54 109.576 -174.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 HG23 ' A' ' 10' ' ' VAL . 9.6 m -120.78 87.68 42.81 Favored Pre-proline 0 CA--C 1.512 -0.512 0 CA-C-O 126.2 2.905 . . . . 2.45 109.622 176.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 74.0 Cg_endo -77.56 -30.89 3.67 Favored 'Trans proline' 0 CA--C 1.509 -0.732 0 C-N-CA 122.595 2.196 . . . . 2.35 113.195 -177.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.41 66.4 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.281 2.943 . . . . 2.17 110.015 -176.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -124.41 58.58 1.2 Allowed 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.001 2.81 . . . . 3.57 108.25 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 11.5 t30 -61.09 109.1 1.82 Allowed Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-O 126.076 2.846 . . . . 1.63 109.92 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.38 -7.86 14.99 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.582 2.855 . . . . 0.94 113.565 -171.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 90.3 m -78.54 155.09 29.9 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 126.076 2.846 . . . . 1.03 110.319 -175.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.3 m -59.65 150.29 27.95 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 125.361 2.505 . . . . 1.12 109.067 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -61.21 99.98 0.11 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 126.214 2.911 . . . . 4.72 110.254 -173.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 130.1 -2.61 5.9 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 112.958 -1.928 . . . . 0.55 111.464 -176.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.6 mt -123.76 151.06 43.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 125.274 2.464 . . . . 1.25 108.668 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 65.6 tt0 -140.66 134.2 30.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.847 2.737 . . . . 2.84 110.214 -176.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 64.6 m -71.43 118.46 14.27 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.182 2.896 . . . . 1.14 110.812 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 27.8 tpt180 -93.89 156.55 16.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.014 2.34 . . . . 3.76 107.093 170.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.22 92.92 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 126.187 2.898 . . . . 5.02 110.215 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.93 -46.25 1.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 112.952 -1.931 . . . . 0.43 111.975 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -159.3 158.04 31.67 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.576 3.084 . . . . 2.2 110.393 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 13.4 t -78.89 142.58 36.67 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.79 2.709 . . . . 0.95 109.516 -175.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.1 mt -128.44 159.46 35.33 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.26 2.933 . . . . 1.35 109.863 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.43 118.43 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 126.294 2.95 . . . . 1.54 110.419 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 80.1 mt-30 . . . . . 0 CA--C 1.5 -0.954 0 CA-C-O 125.921 2.772 . . . . 2.71 110.234 177.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.63 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 17.3 p . . . . . 0 CA--C 1.508 -0.67 0 CA-C-O 125.831 2.729 . . . . 1.05 109.983 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.654 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -73.01 153.56 48.63 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 113.407 -1.724 . . . . 0.6 111.351 173.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.532 ' HB ' HD23 ' A' ' 5' ' ' LEU . 19.9 pt -101.91 172.21 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 126.877 3.227 . . . . 0.75 111.961 -174.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.1 pt? -58.31 -1.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.093 -2.776 . . . . 1.25 113.961 -169.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 27.4 p80 -156.3 50.27 0.51 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.107 2.86 . . . . 1.23 110.335 176.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 8' ' ' ASN . 5.7 t70 -99.54 -172.25 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 125.351 2.5 . . . . 0.97 109.044 175.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 7.8 t30 -113.32 131.61 55.88 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.477 2.56 . . . . 2.19 109.502 -175.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.783 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 11.5 p -176.77 151.19 0.87 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.299 2.952 . . . . 1.11 110.521 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.12 154.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 125.737 2.684 . . . . 1.7 108.749 175.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.9 77.68 0.89 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 126.209 2.909 . . . . 5.54 109.795 -178.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.4 p -126.85 99.05 29.78 Favored Pre-proline 0 CA--C 1.513 -0.459 0 CA-C-O 126.1 2.857 . . . . 2.45 109.023 173.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.83 -40.86 26.42 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 CA-C-O 125.695 2.29 . . . . 2.35 112.371 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.63 -32.31 63.03 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 125.91 2.767 . . . . 2.17 111.0 -177.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 13.8 mm100 -127.51 48.19 2.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.708 2.671 . . . . 3.57 110.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -67.6 109.58 4.0 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.517 2.579 . . . . 1.63 108.574 172.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 96.9 Cg_endo -79.39 -17.16 11.65 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 CA-C-O 125.847 2.353 . . . . 0.94 112.775 -175.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.654 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 93.6 m -79.97 161.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 126.179 2.895 . . . . 1.03 110.728 -174.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.63 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 m -61.44 146.8 47.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 126.149 2.881 . . . . 1.12 109.432 175.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 20' ' ' ARG . 60.7 mtt180 -67.81 112.67 5.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 126.688 3.137 . . . . 4.72 109.777 -174.039 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.57 -7.34 7.91 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 112.14 -2.3 . . . . 0.55 110.74 -172.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.8 mt -108.48 144.35 36.22 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.854 2.74 . . . . 1.25 108.947 177.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -112.14 125.7 54.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.045 2.831 . . . . 2.84 110.275 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 17' ' ' PRO . 5.2 m -89.29 102.08 14.74 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 125.844 2.735 . . . . 1.14 109.623 173.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.957 ' HD3' HD21 ' A' ' 30' ' ' LEU . 52.7 mtp180 -92.22 168.4 11.37 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 125.297 2.475 . . . . 3.76 108.494 174.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -55.0 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.238 2.923 . . . . 5.02 110.821 -174.376 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.6 -38.69 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 113.131 -1.85 . . . . 0.43 112.744 176.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -140.15 147.41 40.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 126.742 3.163 . . . . 2.2 111.582 -169.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.783 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 37.0 t -94.81 136.65 34.87 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 125.388 2.518 . . . . 0.95 108.036 175.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.957 HD21 ' HD3' ' A' ' 25' ' ' ARG . 2.9 pp -141.64 157.3 45.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.998 2.808 . . . . 1.35 110.015 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 7.4 p -71.15 121.4 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 126.203 2.906 . . . . 1.54 109.068 178.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 CA--C 1.502 -0.89 0 CA-C-O 126.066 2.841 . . . . 2.71 109.033 -179.396 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p . . . . . 0 CA--C 1.508 -0.673 0 CA-C-O 126.119 2.866 . . . . 1.05 110.062 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -66.35 147.1 49.66 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 112.985 -1.916 . . . . 0.6 112.727 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.57 172.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 126.039 2.828 . . . . 0.75 110.396 -175.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.52 -0.4 0.92 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 125.401 2.524 . . . . 1.25 112.63 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -140.85 46.42 1.77 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 126.597 3.094 . . . . 1.23 109.694 175.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -135.35 129.22 33.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.473 2.559 . . . . 0.97 108.109 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 41.7 m-80 -70.26 148.24 48.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 125.346 2.498 . . . . 2.19 109.677 -177.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 43.0 t -159.68 160.67 34.42 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.277 2.941 . . . . 1.11 110.574 -170.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.83 152.46 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-O 126.226 2.917 . . . . 1.7 109.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -71.76 69.02 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 126.271 2.939 . . . . 5.54 110.932 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.09 82.56 24.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 126.398 2.999 . . . . 2.45 109.927 177.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.51 -31.84 32.96 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 122.881 2.388 . . . . 2.35 112.317 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.08 -37.1 14.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 126.022 2.82 . . . . 2.17 111.167 -176.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.45 59.32 1.51 Allowed 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 126.283 2.944 . . . . 3.57 108.564 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.03 123.06 78.76 Favored Pre-proline 0 CA--C 1.508 -0.656 0 CA-C-O 126.1 2.857 . . . . 1.63 109.711 175.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 -5.36 16.98 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 123.296 2.664 . . . . 0.94 112.549 -176.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 84.5 m -79.09 151.74 31.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 126.353 2.978 . . . . 1.03 110.774 -173.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB2' HD23 ' A' ' 22' ' ' LEU . 8.1 m -61.01 144.24 53.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.392 2.52 . . . . 1.12 108.868 177.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -55.49 110.79 0.75 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.194 2.902 . . . . 4.72 109.506 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.7 -19.89 5.82 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 112.956 -1.929 . . . . 0.55 111.469 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.4 mm? -99.97 166.27 11.13 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 125.751 2.691 . . . . 1.25 109.547 178.003 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.75 138.5 19.83 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 125.847 2.737 . . . . 2.84 109.332 177.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 85.0 m -80.12 121.0 25.01 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.23 2.919 . . . . 1.14 110.467 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -97.34 158.34 15.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 125.088 2.375 . . . . 3.76 107.086 172.117 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -57.24 91.01 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.451 3.024 . . . . 5.02 110.069 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 130.5 -46.0 1.1 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 112.389 -2.187 . . . . 0.43 111.948 -179.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' N ' ' A' ' 9' ' ' CYS . 24.5 pttm -160.57 165.78 30.17 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 126.551 3.072 . . . . 2.2 111.182 -174.199 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 17.0 t -86.7 134.28 33.61 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 125.908 2.766 . . . . 0.95 109.961 -176.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.78 174.27 10.12 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 125.855 2.74 . . . . 1.35 109.299 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 m -85.35 145.32 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-O 126.211 2.91 . . . . 1.54 110.381 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 . . . . . 0 CA--C 1.501 -0.905 0 CA-C-O 125.833 2.73 . . . . 2.71 108.62 175.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 126.107 2.86 . . . . 2.15 110.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.4 p -80.11 137.61 36.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 125.785 2.707 . . . . 1.05 108.893 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.669 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -52.18 128.32 34.25 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 113.221 -1.808 . . . . 0.6 112.144 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.9 pt -110.21 176.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-O 126.288 2.947 . . . . 0.75 110.66 -175.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.2 pt? -55.26 -11.85 0.86 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 111.821 -2.445 . . . . 1.25 113.731 -169.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -147.86 41.16 1.01 Allowed 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 125.991 2.805 . . . . 1.23 110.314 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.601 ' HB2' HG12 ' A' ' 4' ' ' ILE . 14.3 t70 -107.21 121.49 44.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 125.681 2.658 . . . . 0.97 108.252 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 8.7 p30 -54.02 128.18 29.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 125.99 2.805 . . . . 2.19 110.425 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 37.8 t -160.58 169.5 22.78 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.982 2.801 . . . . 1.11 110.218 -173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 12' ' ' VAL . 18.6 m -121.24 153.96 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-O 125.698 2.666 . . . . 1.7 108.863 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 83.5 t80 -73.32 76.91 1.35 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.303 2.954 . . . . 5.54 110.668 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 10' ' ' VAL . 14.2 m -127.09 79.93 72.3 Favored Pre-proline 0 CA--C 1.513 -0.452 0 CA-C-O 126.22 2.914 . . . . 2.45 109.86 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -65.69 -30.97 50.19 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 C-N-CA 122.901 2.4 . . . . 2.35 112.411 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.4 40.94 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 126.096 2.855 . . . . 2.17 110.984 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -134.96 55.08 1.91 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 126.2 2.905 . . . . 3.57 108.368 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 23.5 t-20 -55.46 115.87 10.39 Favored Pre-proline 0 CA--C 1.513 -0.471 0 CA-C-O 125.796 2.712 . . . . 1.63 110.215 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 46.4 Cg_endo -86.77 -4.0 8.17 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 123.25 2.633 . . . . 0.94 112.69 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.669 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 91.5 m -86.62 167.0 14.94 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 126.51 3.052 . . . . 1.03 111.352 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 3.0 m -72.75 131.08 41.88 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.296 2.474 . . . . 1.12 107.822 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -54.04 108.42 0.36 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 126.532 3.063 . . . . 4.72 110.599 -175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.81 -17.47 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 112.222 -2.263 . . . . 0.55 110.815 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.587 HD22 ' HA ' ' A' ' 31' ' ' VAL . 19.1 mt -110.45 148.35 32.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 125.49 2.567 . . . . 1.25 108.673 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -135.93 128.35 30.38 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 126.138 2.875 . . . . 2.84 110.313 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 90.7 m -67.49 126.14 28.36 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 126.506 3.05 . . . . 1.14 111.563 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -108.51 149.03 29.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 124.649 2.166 . . . . 3.76 106.952 168.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -55.6 90.24 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.418 3.008 . . . . 5.02 110.465 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 139.1 -50.99 0.77 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 112.486 -2.143 . . . . 0.43 111.141 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HE3' ' CD2' ' A' ' 30' ' ' LEU . 65.0 pttt -155.08 154.08 31.86 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.202 2.906 . . . . 2.2 109.886 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.0 t -79.89 113.95 18.44 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 125.857 2.742 . . . . 0.95 108.923 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD2' ' HE3' ' A' ' 28' ' ' LYS . 81.7 mt -83.81 136.47 34.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 126.286 2.946 . . . . 1.35 110.39 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.587 ' HA ' HD22 ' A' ' 22' ' ' LEU . 7.0 p -75.78 105.15 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 126.21 2.909 . . . . 1.54 108.063 172.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -74.32 66.55 1.32 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.357 2.98 . . . . 2.71 110.313 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 149.86 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 CA-C-O 125.984 2.802 . . . . 3.48 108.753 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 126.151 2.881 . . . . 2.15 110.528 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.473 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p -90.66 156.36 18.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.787 2.708 . . . . 1.05 109.638 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.21 152.58 52.56 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 113.709 -1.587 . . . . 0.6 111.724 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 28.2 pt -109.04 168.25 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-O 126.582 3.087 . . . . 0.75 111.182 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -69.13 14.1 0.09 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 125.214 2.435 . . . . 1.25 113.549 -169.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 4' ' ' ILE . 16.4 p80 -160.37 39.9 0.17 Allowed 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 126.272 2.939 . . . . 1.23 109.872 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 37.8 t70 -121.41 138.44 54.27 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.464 2.554 . . . . 0.97 108.555 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -56.05 136.11 52.41 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 126.148 2.88 . . . . 2.19 110.043 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 17.4 t -159.26 143.86 15.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.015 2.817 . . . . 1.11 109.286 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.24 148.67 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 125.765 2.698 . . . . 1.7 108.872 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 53.9 t80 -73.65 70.62 1.36 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 126.199 2.904 . . . . 5.54 109.369 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -130.38 80.9 69.5 Favored Pre-proline 0 CA--C 1.516 -0.361 0 CA-C-O 126.345 2.974 . . . . 2.45 109.475 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 -31.93 25.89 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 CA-C-O 125.559 2.233 . . . . 2.35 112.627 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.23 68.7 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.121 2.867 . . . . 2.17 110.525 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -121.33 50.33 1.4 Allowed 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 125.831 2.729 . . . . 3.57 108.805 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 52.4 t-20 -50.88 111.81 2.52 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 125.557 2.598 . . . . 1.63 109.946 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -89.12 4.21 5.35 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.233 2.622 . . . . 0.94 112.786 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 21.3 t -90.82 161.93 15.05 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.517 2.579 . . . . 1.03 108.296 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.473 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 59.4 m -60.66 127.89 33.9 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 126.006 2.813 . . . . 1.12 109.496 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -55.42 116.08 2.66 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.325 2.964 . . . . 4.72 110.072 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.62 7.99 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 112.651 -2.068 . . . . 0.55 110.565 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 40.4 mt -107.87 148.69 29.24 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 125.56 2.6 . . . . 1.25 108.505 175.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 5.9 tp60 -118.25 123.39 45.31 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 126.071 2.843 . . . . 2.84 109.759 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.7 m -76.3 106.08 7.72 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 126.176 2.893 . . . . 1.14 110.665 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 27' ' ' GLY . 18.7 ttm180 -85.68 149.39 25.34 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.292 2.472 . . . . 3.76 108.107 172.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 11' ' ' TYR . 53.5 t80 -56.76 89.03 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.234 2.921 . . . . 5.02 109.602 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 141.63 -50.13 0.74 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 112.582 -2.099 . . . . 0.43 111.071 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.717 ' HE2' HD21 ' A' ' 30' ' ' LEU . 23.5 pttm -161.88 161.21 28.79 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.926 2.774 . . . . 2.2 109.538 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.1 t -82.78 139.69 33.42 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.707 2.67 . . . . 0.95 109.459 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.717 HD21 ' HE2' ' A' ' 28' ' ' LYS . 94.2 mt -128.81 167.11 17.8 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.039 2.828 . . . . 1.35 109.465 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' A' ' 5' ' ' LEU . 23.2 m -80.82 134.58 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-O 125.92 2.771 . . . . 1.54 110.235 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -77.29 110.42 12.0 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 126.025 2.821 . . . . 2.71 108.122 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -79.6 80.78 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 126.582 3.087 . . . . 3.48 109.184 -175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 125.987 2.803 . . . . 2.15 110.746 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.8 t -90.7 138.36 31.63 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.606 2.622 . . . . 1.05 108.837 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -67.31 119.18 11.09 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 113.68 -1.6 . . . . 0.6 112.403 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.25 171.83 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 126.065 2.841 . . . . 0.75 110.278 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.91 -15.9 46.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 125.209 2.433 . . . . 1.25 112.521 -164.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -131.87 52.94 2.03 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 126.499 3.047 . . . . 1.23 109.84 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -129.31 133.81 47.62 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 125.92 2.771 . . . . 0.97 109.407 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -72.96 129.97 39.32 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.904 2.764 . . . . 2.19 109.501 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.4 t -148.93 137.94 21.45 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 126.022 2.82 . . . . 1.11 110.427 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 p -92.07 135.64 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 125.741 2.686 . . . . 1.7 108.94 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -65.21 86.37 0.06 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 126.304 2.954 . . . . 5.54 111.334 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.79 104.11 27.27 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.97 2.795 . . . . 2.45 108.827 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.36 -47.0 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.682 0 CA-C-O 125.666 2.278 . . . . 2.35 113.266 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.21 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.982 2.801 . . . . 2.17 110.425 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 15' ' ' GLN . 53.1 tt0 -108.85 42.24 1.45 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.84 2.734 . . . . 3.57 109.425 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -60.24 111.88 4.65 Favored Pre-proline 0 CA--C 1.513 -0.45 0 CA-C-O 125.949 2.785 . . . . 1.63 110.338 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -92.21 8.58 2.87 Favored 'Trans proline' 0 CA--C 1.506 -0.898 0 C-N-CA 123.466 2.778 . . . . 0.94 111.901 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 4.6 t -93.23 140.39 29.58 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.485 2.564 . . . . 1.03 109.367 -175.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.1 m -60.86 125.08 22.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 125.507 2.575 . . . . 1.12 109.162 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 20' ' ' ARG . 3.2 tpm_? -55.41 124.74 18.15 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 126.287 2.946 . . . . 4.72 110.035 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.57 -34.74 4.64 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 112.775 -2.011 . . . . 0.55 109.69 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.661 ' HG ' HG12 ' A' ' 31' ' ' VAL . 4.5 mp -102.82 130.65 49.89 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 125.623 2.63 . . . . 1.25 107.317 171.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -101.66 130.91 48.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.402 3.001 . . . . 2.84 109.761 -176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 19.2 t -75.38 101.21 4.68 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 126.064 2.84 . . . . 1.14 109.081 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HD3' HD12 ' A' ' 30' ' ' LEU . 71.9 ttt180 -98.56 155.05 17.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.195 2.426 . . . . 3.76 108.596 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -49.45 92.62 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 126.002 2.811 . . . . 5.02 111.149 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 120.44 -35.01 3.89 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 113.483 -1.69 . . . . 0.43 112.344 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HE2' HD11 ' A' ' 30' ' ' LEU . 23.9 pttm -160.27 150.99 18.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.388 2.994 . . . . 2.2 110.973 -173.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 m -80.25 130.01 34.9 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 125.849 2.738 . . . . 0.95 109.439 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.6 HD12 ' HD3' ' A' ' 25' ' ' ARG . 95.4 mt -130.15 138.25 50.54 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 126.052 2.834 . . . . 1.35 109.713 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.661 HG12 ' HG ' ' A' ' 22' ' ' LEU . 27.5 m -66.9 148.22 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 125.594 2.616 . . . . 1.54 109.18 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -75.65 94.75 3.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.513 3.054 . . . . 2.71 108.616 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.2 t -80.85 95.06 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 125.992 2.806 . . . . 3.48 109.719 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 126.204 2.906 . . . . 2.15 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p -74.96 163.09 28.0 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 125.909 2.766 . . . . 1.05 109.467 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.67 144.99 46.32 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 113.648 -1.615 . . . . 0.6 111.032 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.463 ' HB ' HD23 ' A' ' 5' ' ' LEU . 32.4 pt -126.94 -178.57 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 126.337 2.97 . . . . 0.75 110.564 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.588 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.3 pt? -55.94 -9.64 0.63 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.215 -2.266 . . . . 1.25 114.368 -166.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.88 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 30.1 p80 -147.16 34.47 0.89 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 125.943 2.783 . . . . 1.23 110.462 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 16.7 t70 -90.8 114.55 26.96 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 125.493 2.568 . . . . 0.97 108.549 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -61.12 111.39 1.69 Allowed 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 126.109 2.861 . . . . 2.19 108.686 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.485 ' H ' ' HA ' ' A' ' 28' ' ' LYS . 34.7 t -145.12 142.58 29.78 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.012 2.815 . . . . 1.11 109.816 -163.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG13 HG22 ' A' ' 12' ' ' VAL . 7.6 p -81.67 147.21 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 125.955 2.788 . . . . 1.7 109.033 177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 67.1 t80 -72.1 79.23 0.94 Allowed 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 126.246 2.926 . . . . 5.54 109.799 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 10' ' ' VAL . 15.3 m -125.46 80.71 65.31 Favored Pre-proline 0 CA--C 1.512 -0.507 0 CA-C-O 126.11 2.862 . . . . 2.45 109.462 175.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 9.6 Cg_exo -71.13 -37.2 6.29 Favored 'Trans proline' 0 CA--C 1.507 -0.831 0 CA-C-O 125.859 2.358 . . . . 2.35 112.656 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.65 68.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 126.151 2.881 . . . . 2.17 110.564 -175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -129.34 42.23 3.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 125.853 2.739 . . . . 3.57 109.058 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 65.0 t30 -63.83 112.05 6.56 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-O 125.624 2.631 . . . . 1.63 110.171 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -90.97 16.32 1.62 Allowed 'Trans proline' 0 CA--C 1.508 -0.793 0 CA-C-O 126.687 2.703 . . . . 0.94 111.837 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -98.43 149.27 22.86 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.584 2.611 . . . . 1.03 108.607 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.31 153.9 25.31 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 126.411 3.005 . . . . 1.12 111.146 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -61.75 119.39 8.65 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 126.031 2.824 . . . . 4.72 110.057 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 22' ' ' LEU . . . 106.82 2.97 36.92 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 113.059 -1.882 . . . . 0.55 111.241 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.585 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 4.9 mp -129.51 139.87 51.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 125.806 2.717 . . . . 1.25 108.866 177.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 33.7 tt0 -123.22 123.76 41.49 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 125.739 2.685 . . . . 2.84 110.422 -176.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 23.2 m -70.82 97.49 1.4 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.891 2.758 . . . . 1.14 109.863 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 8.0 tmm_? -100.09 157.04 16.85 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.17 2.414 . . . . 3.76 108.32 177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -44.97 95.05 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.139 2.876 . . . . 5.02 111.07 -176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 129.91 -57.08 0.73 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 112.993 -1.912 . . . . 0.43 111.503 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.88 ' HD2' ' HA ' ' A' ' 6' ' ' HIS . 21.7 pttm -160.49 163.75 32.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 126.247 2.927 . . . . 2.2 109.782 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 28.1 t -81.42 133.66 35.44 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 125.517 2.58 . . . . 0.95 108.79 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.8 pp -122.85 150.09 43.33 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 125.991 2.805 . . . . 1.35 110.018 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.401 HG12 ' HG ' ' A' ' 22' ' ' LEU . 7.9 m -73.29 92.44 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 CA-C-O 126.087 2.851 . . . . 1.54 110.23 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' HB2' ' A' ' 23' ' ' GLN . 20.8 pt20 -67.8 116.96 9.07 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 126.278 2.942 . . . . 2.71 109.255 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 t -79.78 -7.95 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-O 126.328 2.966 . . . . 3.48 109.902 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 125.884 2.754 . . . . 2.15 110.822 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.1 t -91.5 122.83 34.43 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 125.434 2.54 . . . . 1.05 108.072 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -56.28 123.21 30.61 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 113.674 -1.603 . . . . 0.6 112.057 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.805 HG12 ' HB2' ' A' ' 7' ' ' ASP . 20.1 pt -90.57 173.36 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.257 2.932 . . . . 0.75 110.011 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.86 6.24 0.72 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 125.279 2.466 . . . . 1.25 112.946 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 4' ' ' ILE . 10.0 p80 -161.01 45.86 0.19 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 125.955 2.788 . . . . 1.23 109.619 173.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 4' ' ' ILE . 31.0 t70 -102.86 131.3 49.85 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.593 2.616 . . . . 0.97 109.184 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.05 133.09 51.66 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 126.104 2.859 . . . . 2.19 110.976 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.7 p -170.58 145.05 2.48 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.944 2.783 . . . . 1.11 109.251 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.574 HG23 HG12 ' A' ' 12' ' ' VAL . 23.3 m -82.19 155.82 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 125.864 2.745 . . . . 1.7 109.396 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -73.72 76.04 1.55 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 126.03 2.824 . . . . 5.54 109.468 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.574 HG12 HG23 ' A' ' 10' ' ' VAL . 8.1 p -134.98 89.54 24.08 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 126.372 2.987 . . . . 2.45 109.629 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 35.3 Cg_exo -59.69 -39.05 77.29 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 CA-C-O 126.014 2.423 . . . . 2.35 112.038 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.72 -36.57 47.47 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 125.806 2.717 . . . . 2.17 111.155 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' H ' HG22 ' A' ' 12' ' ' VAL . 51.0 mt-30 -122.39 39.23 3.96 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 125.745 2.688 . . . . 3.57 109.836 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 25.1 t-20 -72.2 115.41 38.43 Favored Pre-proline 0 CA--C 1.508 -0.658 0 CA-C-O 125.813 2.72 . . . . 1.63 109.76 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 16' ' ' ASN . 87.8 Cg_endo -98.28 11.98 0.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.281 2.654 . . . . 0.94 112.655 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.556 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.6 t -91.92 149.41 21.57 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 125.771 2.701 . . . . 1.03 109.735 -174.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' HB2' HD22 ' A' ' 22' ' ' LEU . 72.5 m -59.51 143.15 50.87 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 125.943 2.782 . . . . 1.12 109.609 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.68 131.61 51.27 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.263 2.935 . . . . 4.72 110.583 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.28 -22.5 36.15 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 112.94 -1.936 . . . . 0.55 111.243 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.502 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 5.1 mp -97.7 135.2 39.83 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 125.645 2.64 . . . . 1.25 108.404 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -114.91 132.8 56.42 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 125.867 2.746 . . . . 2.84 110.116 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.7 m -85.04 114.78 22.45 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 126.109 2.861 . . . . 1.14 110.617 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 16.4 mmt180 -87.84 159.21 18.5 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 124.558 2.123 . . . . 3.76 106.192 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -68.22 78.46 0.24 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 126.218 2.913 . . . . 5.02 109.972 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 146.07 -33.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.974 -1.921 . . . . 0.43 111.754 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.83 143.33 15.73 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 126.012 2.815 . . . . 2.2 110.107 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 29.3 t -87.73 141.69 28.4 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.444 2.545 . . . . 0.95 108.28 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.59 138.73 38.19 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 125.583 2.611 . . . . 1.35 108.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.56 113.05 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 126.215 2.912 . . . . 1.54 109.918 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -87.28 103.06 15.09 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 126.079 2.847 . . . . 2.71 108.447 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.77 128.92 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 CA-C-O 125.89 2.757 . . . . 3.48 109.404 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.962 0 CA-C-O 125.573 2.606 . . . . 2.15 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.52 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 28.3 p -90.53 139.01 31.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 125.989 2.804 . . . . 1.05 109.463 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.94 150.93 51.97 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 113.203 -1.817 . . . . 0.6 112.399 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 6' ' ' HIS . 10.1 pt -92.86 167.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 126.137 2.875 . . . . 0.75 110.455 -177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -68.47 18.92 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 125.45 2.548 . . . . 1.25 112.886 -172.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.535 ' H ' ' C ' ' A' ' 4' ' ' ILE . 14.8 p80 -161.58 41.91 0.15 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.168 2.89 . . . . 1.23 109.714 173.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 4' ' ' ILE . 15.2 t0 -116.29 152.96 32.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 125.552 2.596 . . . . 0.97 108.268 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 133.13 37.55 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.089 2.852 . . . . 2.19 111.093 -170.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 12.2 p 177.18 124.62 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 125.888 2.756 . . . . 1.11 108.559 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 12' ' ' VAL . 27.1 m -79.57 -159.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 CA-C-O 125.558 2.599 . . . . 1.7 110.695 -176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 10.8 p90 -70.27 75.05 0.52 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 126.707 3.146 . . . . 5.54 110.582 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' VAL . 11.8 m -127.97 81.6 70.04 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-O 125.991 2.805 . . . . 2.45 109.942 176.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 3.4 Cg_exo -75.94 -54.86 0.07 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.787 0 CA-C-O 125.881 2.367 . . . . 2.35 111.913 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.72 77.76 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 126.212 2.91 . . . . 2.17 110.077 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -108.68 39.1 2.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 125.65 2.643 . . . . 3.57 109.723 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 54.9 t-20 -64.4 113.03 9.04 Favored Pre-proline 0 CA--C 1.512 -0.502 0 CA-C-O 125.803 2.716 . . . . 1.63 110.156 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 72.3 Cg_endo -91.1 -2.25 4.77 Favored 'Trans proline' 0 CA--C 1.507 -0.842 0 C-N-CA 123.083 2.522 . . . . 0.94 112.37 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.1 t -87.18 161.37 18.1 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 125.796 2.712 . . . . 1.03 109.214 -175.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.52 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 84.4 m -63.77 135.24 56.5 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 126.181 2.896 . . . . 1.12 110.174 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -58.43 116.3 3.55 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.378 2.99 . . . . 4.72 109.55 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 123.64 -14.9 8.07 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 112.818 -1.992 . . . . 0.55 110.655 -172.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 32.8 mt -119.16 158.79 25.25 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 125.563 2.602 . . . . 1.25 108.86 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.675 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 28.2 mm-40 -131.89 134.57 45.85 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.817 2.722 . . . . 2.84 110.051 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 87.3 m -83.03 120.11 25.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 126.147 2.88 . . . . 1.14 110.05 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 19.1 ttt180 -110.79 164.22 12.98 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.087 2.375 . . . . 3.76 108.337 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' N ' ' HG2' ' A' ' 25' ' ' ARG . 70.5 m-85 -45.62 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.319 2.961 . . . . 5.02 110.909 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.58 -54.66 0.73 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.441 -2.163 . . . . 0.43 112.043 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -160.39 166.68 28.89 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 126.554 3.073 . . . . 2.2 110.752 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.725 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 50.9 t -86.84 141.55 28.72 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 125.804 2.716 . . . . 0.95 109.778 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.67 174.25 10.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.661 2.648 . . . . 1.35 108.792 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 m -66.42 136.74 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 125.554 2.597 . . . . 1.54 109.266 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.675 ' HB3' ' HG2' ' A' ' 23' ' ' GLN . 6.7 pt20 -88.84 115.25 26.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.216 2.912 . . . . 2.71 109.574 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.93 56.53 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 127.09 3.328 . . . . 3.48 108.419 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 126.067 2.842 . . . . 2.15 110.515 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.47 111.55 22.85 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 126.294 2.949 . . . . 1.05 110.602 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.427 ' HA2' ' OD2' ' A' ' 7' ' ' ASP . . . -72.71 123.81 9.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 113.213 -1.812 . . . . 0.6 110.971 169.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.778 HG12 ' HB2' ' A' ' 7' ' ' ASP . 26.1 pt -90.01 177.23 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 125.848 2.737 . . . . 0.75 110.307 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.8 12.0 0.58 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 125.731 2.682 . . . . 1.25 112.067 -168.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 4' ' ' ILE . 14.1 p80 -160.26 43.32 0.2 Allowed 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 126.47 3.033 . . . . 1.23 108.59 172.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.778 ' HB2' HG12 ' A' ' 4' ' ' ILE . 47.0 t0 -114.4 138.12 50.96 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 125.686 2.66 . . . . 0.97 108.721 178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 91.9 m-20 -67.96 130.65 43.61 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.856 2.741 . . . . 2.19 110.389 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' CG ' ' A' ' 17' ' ' PRO . 14.2 p -153.1 145.48 24.03 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 126.206 2.907 . . . . 1.11 110.583 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' VAL . 7.2 p -88.77 137.88 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 125.09 2.376 . . . . 1.7 107.739 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' ' 26' ' ' TYR . 8.0 p90 -70.45 79.69 0.56 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 126.81 3.195 . . . . 5.54 110.878 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 10' ' ' VAL . 17.6 m -126.84 106.52 22.68 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 125.988 2.804 . . . . 2.45 109.443 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.75 -38.25 4.43 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 CA-C-O 125.692 2.288 . . . . 2.35 112.311 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.99 -52.02 21.48 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 125.88 2.752 . . . . 2.17 110.727 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.17 61.52 0.9 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 126.031 2.824 . . . . 3.57 107.807 173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 17.4 t-20 -54.49 117.87 14.78 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 125.736 2.684 . . . . 1.63 110.662 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.413 ' CG ' ' HB2' ' A' ' 9' ' ' CYS . 92.8 Cg_endo -80.68 -14.35 11.43 Favored 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 123.379 2.719 . . . . 0.94 112.777 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 55.7 m -79.42 146.18 32.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 126.013 2.816 . . . . 1.03 109.445 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.59 144.73 56.24 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.754 2.693 . . . . 1.12 108.586 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' C ' ' HD3' ' A' ' 20' ' ' ARG . 2.6 tmt_? -57.16 109.99 0.76 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-O 126.353 2.978 . . . . 4.72 109.946 -172.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.88 -11.86 7.35 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 112.654 -2.067 . . . . 0.55 111.424 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 31' ' ' VAL . 78.7 mt -112.38 146.44 38.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.994 2.807 . . . . 1.25 109.747 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.646 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 52.3 tt0 -106.19 137.11 44.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.421 2.534 . . . . 2.84 109.173 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 52.2 t -92.47 109.94 21.35 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.448 3.023 . . . . 1.14 109.944 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.575 ' HG3' HD12 ' A' ' 30' ' ' LEU . 35.1 mmt180 -96.83 137.07 36.48 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 124.727 2.204 . . . . 3.76 106.917 170.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.587 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 35.0 p90 -50.32 97.41 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 126.659 3.123 . . . . 5.02 110.541 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 134.65 -46.08 1.07 Allowed Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 112.384 -2.189 . . . . 0.43 111.836 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 22.0 pttm -160.08 154.16 23.24 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 126.539 3.066 . . . . 2.2 111.036 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 84.6 m -79.75 138.87 37.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 125.798 2.713 . . . . 0.95 109.183 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.575 HD12 ' HG3' ' A' ' 25' ' ' ARG . 96.0 mt -130.44 162.33 29.41 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.726 2.679 . . . . 1.35 109.012 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 13.3 m -69.17 112.13 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 126.231 2.919 . . . . 1.54 110.3 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 62.2 tt0 -84.83 64.92 8.88 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 126.367 2.984 . . . . 2.71 109.374 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.08 154.85 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 125.773 2.702 . . . . 3.48 109.044 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 125.837 2.732 . . . . 2.15 110.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -81.09 156.79 25.63 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 126.135 2.874 . . . . 1.05 109.655 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.92 126.41 36.76 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 113.116 -1.857 . . . . 0.6 112.666 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.644 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.9 pt -108.29 176.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-O 126.257 2.932 . . . . 0.75 110.069 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -64.89 3.62 0.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 124.844 2.259 . . . . 1.25 113.451 -169.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -152.56 36.1 0.51 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 126.16 2.886 . . . . 1.23 109.711 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.603 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.7 t70 -111.31 137.69 48.73 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.657 2.646 . . . . 0.97 109.137 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.79 131.73 50.18 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 125.566 2.603 . . . . 2.19 109.561 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.4 t -156.35 143.35 18.87 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 126.281 2.943 . . . . 1.11 110.717 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 12' ' ' VAL . 23.7 m -103.82 146.04 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-O 125.494 2.568 . . . . 1.7 108.455 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' HD2' ' H ' ' A' ' 26' ' ' TYR . 3.2 t80 -70.24 86.32 0.58 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 126.176 2.893 . . . . 5.54 110.175 -171.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 10' ' ' VAL . 5.6 p -132.96 84.39 49.29 Favored Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-O 126.286 2.946 . . . . 2.45 109.268 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.3 -43.66 17.56 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-O 125.808 2.337 . . . . 2.35 112.833 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.34 -39.15 63.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 126.176 2.893 . . . . 2.17 110.893 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -127.63 48.55 2.23 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.998 2.808 . . . . 3.57 109.146 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -50.69 112.44 2.89 Favored Pre-proline 0 CA--C 1.51 -0.578 0 CA-C-O 125.96 2.791 . . . . 1.63 110.319 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.85 -6.77 17.07 Favored 'Trans proline' 0 CA--C 1.505 -0.943 0 C-N-CA 123.239 2.626 . . . . 0.94 112.398 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.9 m -78.75 154.31 30.11 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.292 2.949 . . . . 1.03 110.599 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HB2' HD23 ' A' ' 22' ' ' LEU . 23.5 m -62.86 136.92 58.11 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 125.306 2.479 . . . . 1.12 107.964 175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -55.97 107.7 0.38 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 126.302 2.953 . . . . 4.72 110.426 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.34 -23.3 4.88 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 112.7 -2.046 . . . . 0.55 111.3 -174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 3.8 mm? -94.62 134.21 37.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 125.948 2.785 . . . . 1.25 109.255 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -105.63 118.07 35.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 126.265 2.936 . . . . 2.84 109.203 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 36.6 t -79.59 132.42 36.26 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 125.963 2.792 . . . . 1.14 110.487 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 15.6 ttm180 -122.95 143.25 50.03 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 125.328 2.489 . . . . 3.76 108.083 173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.52 ' H ' ' HD2' ' A' ' 11' ' ' TYR . 9.6 p90 -50.1 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 126.501 3.048 . . . . 5.02 110.726 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.5 -56.84 0.72 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 112.468 -2.151 . . . . 0.43 110.916 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HE3' HD21 ' A' ' 30' ' ' LEU . 64.3 pttt -156.81 161.42 39.74 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 126.619 3.104 . . . . 2.2 109.733 -178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 11.9 t -88.42 138.02 31.8 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 125.53 2.586 . . . . 0.95 109.352 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.459 HD21 ' HE3' ' A' ' 28' ' ' LYS . 75.4 mt -124.66 167.54 14.4 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 126.015 2.817 . . . . 1.35 109.633 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.97 136.3 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 CA-C-O 125.382 2.515 . . . . 1.54 108.805 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -75.13 67.61 1.81 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.701 3.143 . . . . 2.71 109.112 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.35 116.12 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 126.183 2.897 . . . . 3.48 108.779 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 126.124 2.869 . . . . 2.15 110.494 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 25.6 p -90.09 143.24 26.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 125.991 2.805 . . . . 1.05 109.849 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.65 136.89 44.39 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 113.302 -1.772 . . . . 0.6 112.077 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.448 ' H ' ' HB2' ' A' ' 7' ' ' ASP . 22.7 pt -100.67 169.03 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 126.684 3.135 . . . . 0.75 111.233 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.653 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.1 pt? -57.09 -6.93 0.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 111.627 -2.533 . . . . 1.25 113.391 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -147.89 51.96 1.04 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.583 3.087 . . . . 1.23 109.31 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.448 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 5.6 t0 -112.9 122.6 48.13 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 125.473 2.558 . . . . 0.97 108.559 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.94 123.04 15.2 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 125.582 2.61 . . . . 2.19 109.661 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 t -161.92 152.79 17.78 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.068 2.842 . . . . 1.11 110.256 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HB3' ' A' ' 24' ' ' CYS . 30.8 m -97.8 171.89 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-O 125.963 2.792 . . . . 1.7 109.582 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -81.8 73.98 8.81 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 126.178 2.894 . . . . 5.54 110.168 -173.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.9 87.73 50.59 Favored Pre-proline 0 CA--C 1.514 -0.435 0 CA-C-O 126.264 2.935 . . . . 2.45 110.588 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.22 -35.21 5.3 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.981 2.454 . . . . 2.35 112.284 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.05 -28.69 25.95 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.056 2.836 . . . . 2.17 111.152 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.429 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 46.8 tp60 -141.73 57.52 1.5 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 125.861 2.744 . . . . 3.57 108.34 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.4 107.67 1.21 Allowed Pre-proline 0 CA--C 1.509 -0.622 0 CA-C-O 125.656 2.646 . . . . 1.63 109.161 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 79.3 Cg_endo -78.92 -8.76 15.62 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 C-N-CA 123.189 2.593 . . . . 0.94 112.469 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.545 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 87.0 m -77.49 150.36 34.9 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 126.232 2.92 . . . . 1.03 110.676 -172.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.499 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 4.5 m -58.08 135.48 57.01 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.154 2.407 . . . . 1.12 107.947 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -57.78 113.28 1.78 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 126.509 3.052 . . . . 4.72 110.343 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 126.68 -18.11 6.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 112.123 -2.308 . . . . 0.55 110.331 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 33.9 mt -119.07 148.68 42.77 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 125.428 2.537 . . . . 1.25 108.098 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -139.66 136.13 33.95 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 126.004 2.811 . . . . 2.84 109.914 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 68.0 m -67.19 129.83 41.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.156 2.884 . . . . 1.14 110.492 175.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.667 ' HD3' HD12 ' A' ' 30' ' ' LEU . 42.9 mtp180 -128.35 133.97 48.77 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 124.993 2.33 . . . . 3.76 107.625 170.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -37.88 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 126.743 3.163 . . . . 5.02 112.302 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 137.66 -58.5 0.63 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 112.226 -2.261 . . . . 0.43 110.759 -178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.84 154.9 36.07 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.65 3.119 . . . . 2.2 109.963 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.0 t -79.81 130.13 35.06 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 125.568 2.604 . . . . 0.95 108.545 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.667 HD12 ' HD3' ' A' ' 25' ' ' ARG . 95.9 mt -127.34 160.94 29.86 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 125.912 2.768 . . . . 1.35 109.556 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 t -71.78 109.99 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 CA-C-O 125.52 2.581 . . . . 1.54 107.199 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 18.0 pt20 -51.98 -32.06 31.97 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 125.796 2.713 . . . . 2.71 111.566 -171.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.86 140.35 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 125.9 2.762 . . . . 3.48 109.16 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 126.45 3.024 . . . . 2.15 110.065 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 17.7 p -90.62 153.66 20.16 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 126.065 2.841 . . . . 1.05 109.915 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.577 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.69 128.54 15.17 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 113.271 -1.786 . . . . 0.6 110.931 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.698 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.0 pt -98.34 177.95 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 126.079 2.847 . . . . 0.75 110.183 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.5 pt? -57.12 -7.62 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.291 -2.231 . . . . 1.25 114.041 -167.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.45 48.5 0.36 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 126.184 2.897 . . . . 1.23 109.788 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.698 ' HB2' HG12 ' A' ' 4' ' ' ILE . 22.3 t70 -101.41 123.64 45.81 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.745 2.688 . . . . 0.97 109.655 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -64.63 123.17 18.61 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.132 2.872 . . . . 2.19 110.502 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.4 p -157.97 174.25 15.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.73 2.681 . . . . 1.11 109.849 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.24 149.47 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 126.005 2.812 . . . . 1.7 109.773 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.747 ' HD1' ' HA ' ' A' ' 25' ' ' ARG . 40.7 t80 -77.78 76.3 4.31 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 126.276 2.941 . . . . 5.54 110.405 -170.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.49 85.92 48.44 Favored Pre-proline 0 CA--C 1.512 -0.487 0 CA-C-O 125.607 2.623 . . . . 2.45 109.271 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.72 -38.04 52.44 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.655 2.236 . . . . 2.35 112.925 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.32 -23.15 63.99 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 126.184 2.897 . . . . 2.17 110.518 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -135.29 47.69 2.3 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 125.917 2.77 . . . . 3.57 109.079 176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -58.02 113.58 6.78 Favored Pre-proline 0 CA--C 1.51 -0.595 0 CA-C-O 125.756 2.693 . . . . 1.63 109.406 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 64.2 Cg_endo -79.89 -6.84 14.32 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 123.241 2.627 . . . . 0.94 112.626 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 74.4 m -78.24 155.54 30.22 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 126.174 2.892 . . . . 1.03 110.852 -171.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -62.8 150.32 41.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 125.683 2.659 . . . . 1.12 109.092 174.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -59.87 103.24 0.2 Allowed 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 126.238 2.923 . . . . 4.72 110.371 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.04 -5.31 8.34 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 112.752 -2.022 . . . . 0.55 111.973 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 75.8 mt -114.36 137.44 51.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 125.879 2.752 . . . . 1.25 109.152 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -116.94 119.4 35.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 126.022 2.82 . . . . 2.84 109.76 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 42.8 t -73.68 129.59 38.25 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 126.011 2.815 . . . . 1.14 109.912 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.747 ' HA ' ' HD1' ' A' ' 11' ' ' TYR . 36.6 ttm180 -111.97 154.08 25.82 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 125.154 2.407 . . . . 3.76 108.321 174.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -52.51 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 126.452 3.025 . . . . 5.02 109.697 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.4 -54.4 0.79 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 112.531 -2.122 . . . . 0.43 110.912 -177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -161.43 159.43 28.14 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 126.461 3.029 . . . . 2.2 110.344 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 22.8 t -81.47 145.7 30.61 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.4 2.524 . . . . 0.95 109.207 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 168.74 18.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 125.999 2.809 . . . . 1.35 110.076 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -77.14 155.78 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-O 125.911 2.767 . . . . 1.54 110.053 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.38 59.69 0.6 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 126.144 2.878 . . . . 2.71 110.674 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.06 57.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-O 127.077 3.322 . . . . 3.48 109.152 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 126.045 2.831 . . . . 2.15 110.467 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.99 110.54 21.79 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.934 2.778 . . . . 1.05 108.395 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.919 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -61.5 119.81 19.91 Favored Glycine 0 C--O 1.236 0.257 0 CA-C-N 113.333 -1.758 . . . . 0.6 112.333 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 6' ' ' HIS . 13.0 pt -102.16 164.73 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 CA-C-O 126.179 2.895 . . . . 0.75 110.236 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -66.77 12.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 125.293 2.473 . . . . 1.25 113.072 -171.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 4' ' ' ILE . 12.4 p80 -154.88 42.16 0.46 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.197 2.903 . . . . 1.23 109.627 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 34.5 t70 -112.69 125.12 53.96 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 125.967 2.794 . . . . 0.97 109.12 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 5.0 p-10 -76.1 122.48 24.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 126.163 2.887 . . . . 2.19 109.764 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.6 p -149.04 171.61 16.11 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.774 2.702 . . . . 1.11 109.73 -176.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.89 146.9 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 126.218 2.913 . . . . 1.7 109.777 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.572 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.5 p90 -71.63 71.58 0.72 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 126.503 3.049 . . . . 5.54 110.741 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -130.31 94.07 31.19 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-O 125.834 2.73 . . . . 2.45 109.261 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.93 -29.88 82.8 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 C-N-CA 122.957 2.438 . . . . 2.35 112.924 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.89 -38.93 17.45 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 125.996 2.807 . . . . 2.17 110.533 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 18.3 tt0 -132.4 65.7 1.57 Allowed 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 125.941 2.781 . . . . 3.57 108.498 172.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -61.47 109.76 2.48 Favored Pre-proline 0 CA--C 1.508 -0.665 0 CA-C-O 125.625 2.631 . . . . 1.63 109.377 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 3' ' ' GLY . 70.6 Cg_endo -82.25 -10.04 11.35 Favored 'Trans proline' 0 CA--C 1.498 -1.283 0 CA-C-O 126.241 2.517 . . . . 0.94 112.204 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.919 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 94.4 m -79.69 154.07 28.87 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 126.0 2.809 . . . . 1.03 110.165 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.3 m -65.07 110.01 2.35 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 125.273 2.464 . . . . 1.12 106.308 167.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -51.12 118.6 3.33 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 127.054 3.312 . . . . 4.72 109.935 -173.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -26.37 3.62 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 111.314 -2.676 . . . . 0.55 109.356 -165.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 7.2 mp -105.02 152.53 22.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 125.613 2.625 . . . . 1.25 108.714 172.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -121.49 135.26 55.05 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.195 2.902 . . . . 2.84 110.566 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' A' ' 18' ' ' CYS . 3.0 m -77.3 97.44 4.87 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 125.962 2.791 . . . . 1.14 109.696 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.734 ' HD2' HD12 ' A' ' 30' ' ' LEU . 87.8 mtt180 -86.23 157.39 19.96 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 124.922 2.296 . . . . 3.76 107.241 172.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -49.6 94.3 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 126.378 2.99 . . . . 5.02 110.522 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.19 -47.34 1.05 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 112.688 -2.051 . . . . 0.43 112.492 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -130.95 138.68 49.84 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.582 3.087 . . . . 2.2 111.564 -168.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.8 t -79.67 105.48 10.99 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 125.803 2.716 . . . . 0.95 107.852 170.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 25' ' ' ARG . 94.2 mt -120.6 142.43 49.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 126.016 2.817 . . . . 1.35 109.488 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.701 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 34.5 t -59.15 128.84 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 CA-C-O 125.753 2.692 . . . . 1.54 109.75 -178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.2 76.98 2.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.318 2.961 . . . . 2.71 109.205 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.04 139.87 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-O 125.921 2.772 . . . . 3.48 109.247 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.89 0 CA-C-O 126.014 2.816 . . . . 2.15 109.866 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t -80.9 138.29 36.15 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-O 125.861 2.743 . . . . 1.05 109.524 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -66.01 109.4 2.87 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 113.391 -1.731 . . . . 0.6 111.666 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.8 pt -91.71 -178.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 125.452 2.549 . . . . 0.75 110.536 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.42 ' N ' HD23 ' A' ' 5' ' ' LEU . 2.5 pt? -37.05 -38.38 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 124.368 2.032 . . . . 1.25 114.617 -166.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -141.94 29.72 1.67 Allowed 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 125.477 2.561 . . . . 1.23 111.284 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.79 132.67 44.8 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 125.675 2.655 . . . . 0.97 109.049 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 79.7 m-20 -75.31 123.71 25.82 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 126.022 2.82 . . . . 2.19 110.254 -173.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 9.1 p -161.47 178.16 9.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 126.002 2.81 . . . . 1.11 110.44 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.66 143.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 125.954 2.788 . . . . 1.7 109.666 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.636 ' CD2' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -69.61 82.46 0.42 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 125.968 2.794 . . . . 5.54 110.134 -177.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 7.7 p -119.97 91.85 46.05 Favored Pre-proline 0 CA--C 1.513 -0.475 0 CA-C-O 126.133 2.873 . . . . 2.45 108.84 172.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HD3' ' HD1' ' A' ' 11' ' ' TYR . 37.0 Cg_endo -65.98 -47.65 3.45 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 122.791 2.327 . . . . 2.35 113.4 -173.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.17 62.49 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 125.831 2.729 . . . . 2.17 111.241 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -128.65 42.78 3.26 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.008 2.813 . . . . 3.57 109.352 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -59.33 113.34 6.75 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.635 2.636 . . . . 1.63 110.471 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.13 -3.95 11.07 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.047 2.498 . . . . 0.94 112.214 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.549 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 4.8 t -79.63 144.99 33.28 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.531 2.586 . . . . 1.03 108.647 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 22' ' ' LEU . 71.3 m -59.42 143.52 49.53 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.12 2.867 . . . . 1.12 110.177 -177.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -62.73 118.46 7.71 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 126.159 2.885 . . . . 4.72 109.526 -176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 111.25 -3.23 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.039 -1.891 . . . . 0.55 111.129 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 19' ' ' CYS . 54.9 mt -127.95 133.81 49.26 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.756 2.693 . . . . 1.25 108.328 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.65 ' HG2' ' HG3' ' A' ' 32' ' ' GLN . 16.3 mm100 -110.98 120.86 43.79 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 126.148 2.88 . . . . 2.84 109.56 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 38.1 t -79.93 120.46 24.17 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 125.859 2.742 . . . . 1.14 109.65 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.76 HH11 ' HB2' ' A' ' 30' ' ' LEU . 6.1 mpt_? -101.95 164.27 11.8 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 125.176 2.417 . . . . 3.76 108.595 175.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -58.95 85.83 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 126.428 3.013 . . . . 5.02 110.867 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 144.66 -51.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 112.731 -2.031 . . . . 0.43 110.894 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 63.5 pttt -163.19 174.24 12.39 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.351 2.977 . . . . 2.2 110.272 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.5 m -77.98 145.21 36.14 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.117 2.865 . . . . 0.95 110.049 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.76 ' HB2' HH11 ' A' ' 25' ' ' ARG . 87.4 mt -126.45 145.12 50.61 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.917 2.77 . . . . 1.35 108.426 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HA ' HD22 ' A' ' 22' ' ' LEU . 24.3 m -80.38 119.73 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 126.399 2.999 . . . . 1.54 111.195 -172.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HG3' ' HG2' ' A' ' 23' ' ' GLN . 16.2 mm100 -90.93 -55.12 3.67 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 126.461 3.029 . . . . 2.71 109.099 173.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.01 84.51 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-O 126.239 2.924 . . . . 3.48 109.226 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 125.773 2.701 . . . . 2.15 110.385 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.3 p -90.63 158.66 16.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.768 2.699 . . . . 1.05 109.511 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.627 ' H ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.31 139.11 39.38 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 113.564 -1.653 . . . . 0.6 110.697 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.582 ' HB ' HD23 ' A' ' 5' ' ' LEU . 8.5 pt -111.06 -175.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 125.671 2.653 . . . . 0.75 111.357 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.1 pt? -41.58 -35.24 0.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 124.443 2.068 . . . . 1.25 114.375 -165.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -145.07 38.6 1.18 Allowed 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 125.722 2.677 . . . . 1.23 110.847 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' HB2' HG13 ' A' ' 4' ' ' ILE . 20.0 t70 -88.03 142.16 28.0 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 125.747 2.689 . . . . 0.97 108.697 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 4.6 p-10 -71.33 138.45 49.29 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 125.718 2.675 . . . . 2.19 110.21 -173.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.2 p -168.61 175.26 6.25 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 126.211 2.91 . . . . 1.11 109.849 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' O ' HG22 ' A' ' 12' ' ' VAL . 47.8 t -111.19 144.42 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-O 125.276 2.465 . . . . 1.7 108.334 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 81.5 t80 -66.34 80.84 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 126.596 3.093 . . . . 5.54 110.189 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 10' ' ' VAL . 18.2 m -128.13 79.58 73.66 Favored Pre-proline 0 CA--C 1.511 -0.552 0 CA-C-O 125.8 2.714 . . . . 2.45 109.266 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 18.8 Cg_endo -58.59 -44.85 33.67 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 CA-C-O 125.996 2.415 . . . . 2.35 112.286 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.61 -24.48 67.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 126.114 2.864 . . . . 2.17 110.495 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 17.3 mm-40 -118.28 31.55 6.62 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 125.652 2.644 . . . . 3.57 109.537 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 46.1 t-20 -52.67 110.14 1.8 Allowed Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-O 125.694 2.664 . . . . 1.63 110.913 -175.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -95.08 7.47 2.07 Favored 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 123.599 2.866 . . . . 0.94 111.575 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 5.1 t -102.8 157.6 16.84 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 125.269 2.462 . . . . 1.03 108.191 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.2 m -64.71 138.84 58.63 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 126.557 3.075 . . . . 1.12 109.842 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -65.38 105.81 1.24 Allowed 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 126.331 2.967 . . . . 4.72 109.837 -176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . 133.85 -9.74 4.86 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 112.613 -2.085 . . . . 0.55 110.936 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 22' ' ' LEU . 5.1 mp -115.98 130.75 56.95 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 126.263 2.935 . . . . 1.25 109.46 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -81.99 95.65 7.47 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.83 2.729 . . . . 2.84 109.818 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 40.3 t -68.1 99.63 0.91 Allowed 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 126.405 3.002 . . . . 1.14 108.746 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 25' ' ' ARG . 16.1 ttt180 -113.37 167.59 10.44 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 125.292 2.473 . . . . 3.76 108.928 -173.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -51.1 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 126.088 2.851 . . . . 5.02 111.134 -176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 113.1 -40.24 2.59 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 113.225 -1.807 . . . . 0.43 112.498 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.851 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.1 pttt -161.21 161.26 30.82 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.585 3.088 . . . . 2.2 110.932 -172.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 65.0 m -78.78 139.21 38.44 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-O 125.693 2.663 . . . . 0.95 108.694 170.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.851 HD21 ' HE3' ' A' ' 28' ' ' LYS . 94.8 mt -123.78 114.11 19.46 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 126.145 2.879 . . . . 1.35 109.382 175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.31 131.55 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 125.626 2.631 . . . . 1.54 108.761 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 12.7 pt20 -74.37 63.47 1.05 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 126.589 3.09 . . . . 2.71 109.954 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.21 59.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 127.012 3.291 . . . . 3.48 109.55 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 125.655 2.645 . . . . 2.15 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.77 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 30.7 p -67.43 128.3 35.91 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 125.845 2.736 . . . . 1.05 109.405 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 18' ' ' CYS . . . -53.87 143.94 27.93 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 113.017 -1.901 . . . . 0.6 113.107 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.62 HG12 ' HB2' ' A' ' 7' ' ' ASP . 40.3 pt -79.32 169.07 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 CA-C-O 126.648 3.118 . . . . 0.75 111.169 -176.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.874 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 2.1 pt? -57.44 -6.62 0.47 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 111.796 -2.456 . . . . 1.25 113.54 -169.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 29.5 p80 -154.88 43.36 0.48 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 125.667 2.651 . . . . 1.23 110.722 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB2' HG12 ' A' ' 4' ' ' ILE . 38.1 t70 -87.56 148.24 24.96 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 125.79 2.71 . . . . 0.97 109.109 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -77.0 117.74 18.88 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 125.789 2.709 . . . . 2.19 109.488 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 6.7 p -156.01 152.21 27.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 126.216 2.912 . . . . 1.11 109.864 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 12' ' ' VAL . 14.6 p -81.0 152.53 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-O 125.992 2.806 . . . . 1.7 109.211 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -73.25 66.8 0.92 Allowed 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 126.247 2.927 . . . . 5.54 111.197 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 10' ' ' VAL . 7.2 p -121.24 88.23 45.32 Favored Pre-proline 0 CA--C 1.512 -0.503 0 CA-C-O 126.262 2.934 . . . . 2.45 109.064 174.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 38.6 Cg_endo -67.7 -39.06 12.49 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 CA-C-O 125.682 2.284 . . . . 2.35 112.628 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.36 62.28 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 126.013 2.816 . . . . 2.17 111.226 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 51.6 tp60 -139.54 47.4 1.87 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-O 126.326 2.965 . . . . 3.57 108.432 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . 21.6 p-10 -64.26 116.32 26.93 Favored Pre-proline 0 CA--C 1.512 -0.509 0 CA-C-O 125.986 2.803 . . . . 1.63 110.192 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.08 -10.53 17.92 Favored 'Trans proline' 0 CA--C 1.503 -1.049 0 CA-C-O 126.16 2.483 . . . . 0.94 111.994 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 7.5 t -79.01 158.85 27.85 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 125.707 2.67 . . . . 1.03 108.6 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.77 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -68.67 148.44 50.42 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 126.308 2.956 . . . . 1.12 109.877 -176.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.53 126.41 27.76 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 126.049 2.833 . . . . 4.72 109.899 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 33' ' ' VAL . . . 105.22 -10.14 46.84 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 112.934 -1.939 . . . . 0.55 110.766 -171.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 5' ' ' LEU . 13.0 mt -119.15 135.95 54.42 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.49 2.566 . . . . 1.25 107.573 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.43 122.83 39.91 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 126.249 2.928 . . . . 2.84 110.429 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.816 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 56.2 m -69.31 111.59 5.32 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 126.072 2.844 . . . . 1.14 110.69 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 59.5 ttt180 -92.74 155.3 17.77 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 124.721 2.2 . . . . 3.76 106.641 171.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -47.62 91.45 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 126.534 3.064 . . . . 5.02 111.622 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 119.1 -48.21 0.96 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 112.573 -2.103 . . . . 0.43 112.172 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -138.29 141.51 39.83 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 126.201 2.905 . . . . 2.2 110.027 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.816 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 42.7 t -79.02 138.76 38.17 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 125.834 2.731 . . . . 0.95 108.449 174.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.12 137.52 51.93 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 126.308 2.956 . . . . 1.35 109.971 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.874 ' HB ' ' HB2' ' A' ' 5' ' ' LEU . 6.2 p -73.07 99.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 126.332 2.968 . . . . 1.54 109.223 175.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 5.8 tp60 -73.64 -50.2 22.2 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 126.384 2.993 . . . . 2.71 109.026 -177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 21' ' ' GLY . 28.1 m -81.9 60.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 126.738 3.161 . . . . 3.48 109.644 176.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . 0.476 ' HB3' HG13 ' A' ' 31' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 125.744 2.688 . . . . 2.15 110.762 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.3 p -89.15 -174.44 4.43 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.364 2.506 . . . . 1.05 107.721 173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.693 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -83.34 111.16 3.37 Favored Glycine 0 N--CA 1.444 -0.804 0 O-C-N 120.19 -1.569 . . . . 0.6 110.767 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.579 ' HA ' HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -117.87 -179.82 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.939 2.78 . . . . 0.75 110.029 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.5 pt? -56.42 -4.6 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.168 -2.287 . . . . 1.25 114.238 -166.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.15 37.75 0.63 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 125.861 2.744 . . . . 1.23 110.507 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -95.99 107.63 19.93 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 125.515 2.579 . . . . 0.97 108.877 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -58.46 117.24 4.27 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 126.441 3.02 . . . . 2.19 109.666 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.469 ' H ' ' HA ' ' A' ' 28' ' ' LYS . 40.4 t -161.31 141.43 10.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 125.828 2.728 . . . . 1.11 108.815 -166.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.618 HG23 HG13 ' A' ' 12' ' ' VAL . 17.1 m -93.6 -178.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 126.111 2.863 . . . . 1.7 110.274 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 6.9 p90 -68.39 76.68 0.26 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 126.341 2.972 . . . . 5.54 110.837 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.618 HG13 HG23 ' A' ' 10' ' ' VAL . 18.7 m -123.03 74.15 48.06 Favored Pre-proline 0 CA--C 1.518 -0.286 0 CA-C-O 125.975 2.798 . . . . 2.45 110.374 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 4.1 Cg_exo -74.68 -40.24 1.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.868 0 CA-C-O 125.944 2.393 . . . . 2.35 111.856 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -16.75 60.17 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 126.033 2.825 . . . . 2.17 110.837 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.07 36.18 3.67 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.117 2.389 . . . . 3.57 109.449 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -49.95 104.66 0.44 Allowed Pre-proline 0 N--CA 1.473 0.717 0 CA-C-O 125.887 2.756 . . . . 1.63 111.078 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -85.35 -4.73 9.39 Favored 'Trans proline' 0 CA--C 1.5 -1.18 0 C-N-CA 123.438 2.759 . . . . 0.94 111.883 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 79.4 m -78.57 146.58 34.15 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 125.882 2.753 . . . . 1.03 110.418 -172.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 39.1 m -62.32 134.17 56.12 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 125.922 2.772 . . . . 1.12 107.515 172.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -54.69 115.33 2.1 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 126.707 3.146 . . . . 4.72 111.901 -163.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.35 -23.53 4.84 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 111.999 -2.364 . . . . 0.55 111.267 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.624 ' HG ' ' HA ' ' A' ' 31' ' ' VAL . 6.3 mp -102.8 150.35 23.58 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 125.869 2.747 . . . . 1.25 109.523 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -138.29 139.35 39.1 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 126.132 2.873 . . . . 2.84 109.682 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.8 m -67.92 112.43 4.94 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 126.055 2.836 . . . . 1.14 110.338 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 27' ' ' GLY . 56.7 ttt180 -91.67 159.55 15.81 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 124.58 2.133 . . . . 3.76 107.409 170.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -52.03 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 126.254 2.93 . . . . 5.02 111.312 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 140.94 -50.24 0.75 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 113.092 -1.867 . . . . 0.43 111.494 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -160.34 164.21 32.68 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 126.441 3.02 . . . . 2.2 110.105 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.822 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 45.5 t -78.89 132.51 36.81 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 125.694 2.664 . . . . 0.95 108.878 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.07 155.85 44.78 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 126.051 2.834 . . . . 1.35 109.634 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.624 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 38.7 t -73.34 106.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-O 125.78 2.705 . . . . 1.54 108.445 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -68.86 124.69 24.38 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 125.708 2.67 . . . . 2.71 109.855 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.5 71.14 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 126.978 3.275 . . . . 3.48 109.13 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 126.399 3.0 . . . . 2.15 110.033 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.5 p -85.39 179.06 7.24 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 125.996 2.808 . . . . 1.05 109.51 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.569 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.57 124.02 26.09 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 113.491 -1.686 . . . . 0.6 110.574 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.607 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 24.9 pt -117.6 168.23 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 126.039 2.828 . . . . 0.75 110.128 -174.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.93 2.85 1.78 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 125.453 2.549 . . . . 1.25 112.676 -166.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -150.25 45.57 0.89 Allowed 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 126.554 3.074 . . . . 1.23 109.858 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.607 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 8.3 t70 -123.05 127.93 49.45 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.356 2.503 . . . . 0.97 108.538 174.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.69 135.03 43.66 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 125.532 2.586 . . . . 2.19 109.914 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 26.5 p -165.97 172.27 11.68 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 125.872 2.748 . . . . 1.11 109.663 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.453 HG23 HG12 ' A' ' 12' ' ' VAL . 35.8 m -99.24 153.62 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.434 3.016 . . . . 1.7 110.471 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -75.85 87.44 2.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 126.209 2.909 . . . . 5.54 110.264 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 10' ' ' VAL . 8.6 p -147.17 68.55 11.38 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 126.457 3.027 . . . . 2.45 109.777 174.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 19.2 Cg_exo -66.45 -19.83 54.87 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 C-N-CA 122.944 2.429 . . . . 2.35 112.781 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.44 -27.92 62.85 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 126.13 2.871 . . . . 2.17 110.497 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -130.98 49.35 2.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.492 3.044 . . . . 3.57 107.647 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 60.8 t30 -56.68 116.08 12.03 Favored Pre-proline 0 CA--C 1.511 -0.541 0 CA-C-O 126.103 2.859 . . . . 1.63 111.249 -173.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.52 -11.05 15.83 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 123.33 2.686 . . . . 0.94 112.172 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.569 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 74.1 m -79.13 158.65 27.71 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 125.889 2.757 . . . . 1.03 110.18 -177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 28.8 m -66.36 142.8 57.5 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.723 2.677 . . . . 1.12 108.761 173.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -59.01 110.98 1.14 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 126.641 3.115 . . . . 4.72 110.39 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.24 -26.27 3.75 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 112.238 -2.255 . . . . 0.55 110.739 -174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 4.6 mp -105.24 152.4 22.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 125.565 2.603 . . . . 1.25 109.068 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -133.69 129.82 37.32 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.674 2.654 . . . . 2.84 110.267 -176.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 3.7 m -69.64 105.56 2.74 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.198 2.904 . . . . 1.14 110.193 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -101.27 163.56 12.22 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 125.051 2.357 . . . . 3.76 107.941 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -50.58 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 126.275 2.94 . . . . 5.02 111.221 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.9 -49.39 0.89 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 112.857 -1.974 . . . . 0.43 111.899 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.872 ' HE3' HD21 ' A' ' 30' ' ' LEU . 60.4 pttt -159.96 162.57 34.42 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 126.808 3.194 . . . . 2.2 110.638 -173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 47.8 t -79.68 124.75 28.85 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 125.894 2.759 . . . . 0.95 109.173 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.872 HD21 ' HE3' ' A' ' 28' ' ' LYS . 97.8 mt -122.62 131.53 53.86 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 126.126 2.869 . . . . 1.35 109.491 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 33' ' ' VAL . 7.7 p -75.1 145.17 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 125.315 2.483 . . . . 1.54 108.096 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -68.71 80.82 0.28 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.278 2.942 . . . . 2.71 109.871 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 31' ' ' VAL . 29.8 m -84.0 158.98 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 CA-C-O 126.279 2.942 . . . . 3.48 110.096 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 126.441 3.019 . . . . 2.15 110.194 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p -90.33 -172.62 3.51 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 125.962 2.792 . . . . 1.05 109.554 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.587 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.8 118.24 6.93 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 113.537 -1.665 . . . . 0.6 110.224 170.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.516 ' C ' ' H ' ' A' ' 6' ' ' HIS . 8.0 pt -115.02 167.55 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 125.858 2.742 . . . . 0.75 110.119 -174.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.19 12.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 125.42 2.534 . . . . 1.25 112.952 -169.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 4' ' ' ILE . 18.7 p80 -157.44 41.16 0.31 Allowed 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 126.068 2.842 . . . . 1.23 110.294 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -115.51 119.23 35.51 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.674 2.654 . . . . 0.97 108.816 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.12 123.83 23.7 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 125.894 2.759 . . . . 2.19 109.523 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.3 p -152.2 160.38 43.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 126.034 2.826 . . . . 1.11 110.22 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 12' ' ' VAL . 9.3 p -85.87 130.56 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-O 126.062 2.839 . . . . 1.7 109.255 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 26' ' ' TYR . 21.3 p90 -70.14 74.52 0.49 Allowed 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 126.52 3.057 . . . . 5.54 111.626 -174.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 10' ' ' VAL . 15.7 m -119.12 89.07 38.55 Favored Pre-proline 0 CA--C 1.513 -0.48 0 CA-C-O 126.098 2.856 . . . . 2.45 109.664 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.69 -34.07 89.42 Favored 'Trans proline' 0 CA--C 1.507 -0.873 0 C-N-CA 122.995 2.463 . . . . 2.35 112.686 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 -25.06 59.31 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 125.784 2.707 . . . . 2.17 110.881 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -132.83 39.09 3.35 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 126.021 2.819 . . . . 3.57 108.941 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -56.2 111.82 3.66 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 125.884 2.754 . . . . 1.63 109.594 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.25 -12.84 19.07 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 CA-C-O 126.267 2.528 . . . . 0.94 112.299 -176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 63.1 m -77.73 150.67 34.4 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 126.054 2.835 . . . . 1.03 110.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.43 145.96 41.82 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 125.75 2.69 . . . . 1.12 108.586 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -62.23 102.11 0.28 Allowed 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 126.399 2.999 . . . . 4.72 110.147 -170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.46 -26.04 2.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 112.483 -2.144 . . . . 0.55 110.931 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 6.0 mp -101.2 148.78 24.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-O 125.821 2.724 . . . . 1.25 109.238 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 32' ' ' GLN . 48.5 tp60 -121.23 129.4 53.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 126.132 2.872 . . . . 2.84 109.543 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 53.5 t -69.58 104.49 2.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 126.182 2.896 . . . . 1.14 108.563 173.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' GLY . 15.1 mmt180 -86.21 174.6 9.0 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.562 2.601 . . . . 3.76 109.332 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.423 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.3 m-85 -61.25 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 126.243 2.925 . . . . 5.02 110.608 -174.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 116.19 -26.54 8.65 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.767 -2.015 . . . . 0.43 112.636 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 19.1 ptpt -160.17 149.4 17.53 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 126.418 3.009 . . . . 2.2 110.626 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.5 t -79.71 129.66 34.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.872 2.749 . . . . 0.95 109.817 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.1 mt -134.43 156.77 47.97 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 125.86 2.743 . . . . 1.35 109.034 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 61.3 t -69.19 115.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-O 126.068 2.842 . . . . 1.54 109.152 178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 58.2 tp60 -90.17 140.12 29.98 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 125.909 2.766 . . . . 2.71 109.796 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.4 63.52 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 CA-C-O 126.883 3.23 . . . . 3.48 108.004 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.983 0 CA-C-O 125.833 2.73 . . . . 2.15 110.452 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.0 p -84.5 157.55 21.27 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 125.766 2.698 . . . . 1.05 108.879 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.591 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -58.75 127.67 45.81 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 113.627 -1.624 . . . . 0.6 111.329 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.559 ' CG1' ' HB2' ' A' ' 7' ' ' ASP . 5.9 pt -94.71 -176.93 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 125.469 2.557 . . . . 0.75 110.912 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 5' ' ' LEU . 2.0 pt? -34.8 -45.43 0.25 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 124.841 2.258 . . . . 1.25 114.186 -166.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.649 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 33.4 p80 -142.66 37.75 1.48 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 125.774 2.702 . . . . 1.23 110.628 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . 21.2 t70 -73.97 130.59 40.17 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 125.832 2.729 . . . . 0.97 109.253 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.0 m-20 -64.95 134.79 54.7 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 125.974 2.797 . . . . 2.19 110.39 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.81 161.79 42.11 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 126.193 2.901 . . . . 1.11 110.209 -176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 12' ' ' VAL . 23.9 m -89.6 143.54 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 CA-C-O 125.384 2.516 . . . . 1.7 108.362 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -69.11 75.64 0.33 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 126.449 3.024 . . . . 5.54 110.116 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' VAL . 95.2 t -128.38 98.83 25.1 Favored Pre-proline 0 CA--C 1.506 -0.712 0 CA-C-O 125.572 2.606 . . . . 2.45 108.606 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.74 -54.46 0.22 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 122.945 2.43 . . . . 2.35 113.201 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.76 75.34 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 125.684 2.659 . . . . 2.17 111.612 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.514 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 0.9 OUTLIER -116.35 35.82 4.37 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 125.952 2.787 . . . . 3.57 109.216 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -69.97 108.86 3.79 Favored Pre-proline 0 CA--C 1.509 -0.623 0 CA-C-O 125.686 2.66 . . . . 1.63 110.126 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 83.4 Cg_endo -83.36 48.71 2.75 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 CA-C-O 126.737 2.724 . . . . 0.94 110.983 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.591 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 10.6 t -136.86 143.75 43.23 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 125.105 2.383 . . . . 1.03 107.585 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -59.91 145.87 44.3 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 126.356 2.979 . . . . 1.12 110.67 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.674 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -73.59 122.1 21.72 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 126.322 2.963 . . . . 4.72 108.899 -174.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 117.95 -7.4 15.03 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 112.625 -2.08 . . . . 0.55 110.171 -171.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.3 mp -114.78 139.42 49.74 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 125.895 2.76 . . . . 1.25 108.708 174.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.519 ' HB3' HE21 ' A' ' 32' ' ' GLN . 26.3 pt20 -104.47 121.69 43.98 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 125.624 2.63 . . . . 2.84 109.685 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.3 t -80.58 102.05 9.54 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 126.074 2.845 . . . . 1.14 108.632 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.562 ' HG3' HD12 ' A' ' 30' ' ' LEU . 25.4 mmt180 -97.93 163.05 12.94 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 125.197 2.427 . . . . 3.76 108.645 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -53.1 93.45 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.018 2.818 . . . . 5.02 109.941 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 128.55 -50.82 0.87 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.854 -1.975 . . . . 0.43 112.404 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 20.8 pttp -162.47 173.88 13.44 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.395 2.998 . . . . 2.2 111.312 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 87.4 m -78.65 143.05 36.71 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 126.043 2.83 . . . . 0.95 109.806 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.562 HD12 ' HG3' ' A' ' 25' ' ' ARG . 91.0 mt -126.69 126.82 44.15 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 125.886 2.755 . . . . 1.35 108.469 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 5' ' ' LEU . 2.2 m -66.64 102.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 126.35 2.976 . . . . 1.54 110.741 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.519 HE21 ' HB3' ' A' ' 23' ' ' GLN . 90.2 mt-30 -59.16 -50.98 71.97 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 126.69 3.138 . . . . 2.71 108.795 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.1 m -82.47 62.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-O 126.503 3.049 . . . . 3.48 110.276 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 125.857 2.741 . . . . 2.15 110.896 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t -90.5 134.58 34.27 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 125.684 2.659 . . . . 1.05 108.874 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -62.8 127.66 39.23 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 113.543 -1.662 . . . . 0.6 112.532 -178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.512 ' HB ' HD23 ' A' ' 5' ' ' LEU . 22.9 pt -117.88 178.69 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-O 126.338 2.97 . . . . 0.75 110.827 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.4 pt? -56.57 -11.71 1.44 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 111.952 -2.386 . . . . 1.25 113.786 -169.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -151.1 47.09 0.84 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.499 3.047 . . . . 1.23 110.067 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.29 119.19 38.41 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 125.434 2.54 . . . . 0.97 109.158 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -60.06 112.11 1.76 Allowed 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 126.058 2.837 . . . . 2.19 108.802 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 49.8 t -133.39 149.04 51.84 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 126.086 2.85 . . . . 1.11 110.778 -165.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 12' ' ' VAL . 70.6 t -97.87 133.1 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 125.723 2.678 . . . . 1.7 108.515 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -67.81 86.94 0.23 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 125.981 2.801 . . . . 5.54 110.485 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 10' ' ' VAL . 13.2 m -132.73 90.14 33.37 Favored Pre-proline 0 CA--C 1.51 -0.579 0 CA-C-O 125.947 2.784 . . . . 2.45 109.488 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.2 -47.98 15.49 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 123.23 2.62 . . . . 2.35 113.579 -177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.67 83.53 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.093 2.854 . . . . 2.17 110.598 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -111.41 42.31 1.7 Allowed 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 125.579 2.609 . . . . 3.57 109.399 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -54.85 113.43 5.34 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 125.877 2.751 . . . . 1.63 110.293 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.75 -13.8 14.34 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.012 2.474 . . . . 0.94 112.388 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 98.5 m -78.19 148.21 34.14 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 126.174 2.892 . . . . 1.03 110.568 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' HB2' HD23 ' A' ' 22' ' ' LEU . 54.8 m -66.26 162.11 20.76 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 125.852 2.739 . . . . 1.12 109.578 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 20' ' ' ARG . 15.3 ptt180 -61.0 119.76 8.92 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.302 2.953 . . . . 4.72 110.142 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.81 -4.56 56.28 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 113.127 -1.851 . . . . 0.55 111.819 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 19' ' ' CYS . 3.7 mm? -101.15 134.97 43.37 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.008 2.813 . . . . 1.25 109.252 175.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HB2' ' HG3' ' A' ' 32' ' ' GLN . 29.4 tp60 -111.73 110.18 20.43 Favored 'General case' 0 CA--C 1.5 -0.942 0 CA-C-O 125.886 2.755 . . . . 2.84 109.325 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 28.7 t -75.3 129.51 37.53 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 125.896 2.76 . . . . 1.14 109.039 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -117.62 144.57 45.05 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-O 124.672 2.177 . . . . 3.76 106.875 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -55.79 97.11 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 126.569 3.08 . . . . 5.02 109.887 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.68 -53.39 0.79 Allowed Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 112.489 -2.141 . . . . 0.43 111.179 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -150.68 153.84 36.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 126.293 2.949 . . . . 2.2 109.938 -176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 35.2 t -95.93 130.78 42.81 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 125.383 2.516 . . . . 0.95 108.301 176.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.18 173.14 8.96 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 126.28 2.943 . . . . 1.35 110.161 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.39 112.93 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-O 125.735 2.683 . . . . 1.54 108.756 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.709 ' NE2' ' O ' ' A' ' 34' ' ' HSL . 42.7 tt0 -60.67 121.36 12.04 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 126.189 2.899 . . . . 2.71 109.742 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.62 -34.64 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 CA-C-O 126.208 2.908 . . . . 3.48 109.458 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . 0.709 ' O ' ' NE2' ' A' ' 32' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 125.886 2.755 . . . . 2.15 110.355 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.1 p -90.12 157.53 17.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 125.96 2.791 . . . . 1.05 109.501 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.547 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -63.47 138.54 43.07 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 113.392 -1.731 . . . . 0.6 111.097 172.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.518 ' HB ' HD23 ' A' ' 5' ' ' LEU . 19.7 pt -115.51 175.56 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-O 126.486 3.041 . . . . 0.75 111.047 -174.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.4 pt? -59.07 -6.9 0.94 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 111.922 -2.399 . . . . 1.25 113.223 -171.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.6 p80 -150.1 49.06 0.91 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 126.253 2.93 . . . . 1.23 109.862 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.506 ' HB2' HG12 ' A' ' 4' ' ' ILE . 39.1 t70 -115.08 133.72 55.8 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.471 2.558 . . . . 0.97 109.01 176.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 92.6 m-20 -75.88 133.03 40.67 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 125.671 2.653 . . . . 2.19 109.831 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 29.5 p -162.24 162.06 28.04 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 125.905 2.764 . . . . 1.11 110.214 -176.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.1 m -92.41 151.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 125.77 2.7 . . . . 1.7 109.389 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.476 ' C ' ' HD3' ' A' ' 13' ' ' PRO . 2.7 p90 -71.43 76.4 0.77 Allowed 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 126.462 3.029 . . . . 5.54 110.521 -172.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.4 m -128.28 70.65 79.26 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-O 125.984 2.802 . . . . 2.45 110.247 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 11' ' ' TYR . 31.7 Cg_exo -60.09 -32.65 95.02 Favored 'Trans proline' 0 CA--C 1.506 -0.909 0 CA-C-O 125.87 2.362 . . . . 2.35 111.945 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.16 -40.28 58.24 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 126.22 2.914 . . . . 2.17 110.419 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -123.56 46.91 2.11 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 125.914 2.769 . . . . 3.57 108.461 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 46.8 t-20 -49.97 113.12 3.14 Favored Pre-proline 0 CA--C 1.509 -0.617 0 CA-C-O 125.876 2.751 . . . . 1.63 110.31 -176.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.14 -18.8 14.09 Favored 'Trans proline' 0 CA--C 1.506 -0.895 0 CA-C-O 125.997 2.415 . . . . 0.94 112.257 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 85.6 m -79.7 161.16 25.96 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 125.923 2.773 . . . . 1.03 109.87 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 m -67.73 142.83 56.17 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.11 2.862 . . . . 1.12 109.227 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 32.7 mmt180 -59.94 115.82 3.69 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 126.302 2.954 . . . . 4.72 109.929 -175.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.16 -10.0 8.33 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.609 -2.087 . . . . 0.55 110.902 -175.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.06 140.87 40.59 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 126.189 2.899 . . . . 1.25 109.637 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -104.76 101.95 11.54 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 126.056 2.836 . . . . 2.84 109.592 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 18.8 t -77.33 106.46 9.08 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.184 2.897 . . . . 1.14 109.181 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.406 ' HD3' HD12 ' A' ' 30' ' ' LEU . 79.2 mtp180 -101.67 150.39 23.16 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 125.193 2.425 . . . . 3.76 108.077 178.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -50.25 100.85 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.313 2.959 . . . . 5.02 110.306 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 8' ' ' ASN . . . 118.66 -50.9 0.78 Allowed Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 112.555 -2.111 . . . . 0.43 111.714 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -143.3 134.3 25.57 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 126.406 3.003 . . . . 2.2 110.275 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 34.6 t -87.58 123.26 32.27 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 125.676 2.655 . . . . 0.95 108.315 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.406 HD12 ' HD3' ' A' ' 25' ' ' ARG . 82.2 mt -116.65 173.7 6.48 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.993 2.806 . . . . 1.35 109.879 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 33' ' ' VAL . 38.9 t -82.04 118.52 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 125.778 2.704 . . . . 1.54 108.724 176.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.83 93.71 0.77 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 125.833 2.73 . . . . 2.71 107.707 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 31' ' ' VAL . 47.6 t -105.39 104.2 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-O 126.097 2.856 . . . . 3.48 109.548 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.931 2.777 . . . . 2.15 110.407 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.6 p -83.1 166.8 18.41 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 125.746 2.689 . . . . 1.05 108.706 177.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -61.4 120.01 20.81 Favored Glycine 0 C--O 1.243 0.703 0 CA-C-N 113.565 -1.652 . . . . 0.6 111.16 173.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 23.6 pt -117.08 178.18 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 125.723 2.678 . . . . 0.75 109.674 -178.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -72.95 14.38 0.29 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 125.256 2.455 . . . . 1.25 113.324 -164.611 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -160.48 31.61 0.16 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 125.914 2.769 . . . . 1.23 110.129 172.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.454 ' HB2' HG12 ' A' ' 4' ' ' ILE . 29.7 t70 -100.93 130.05 46.87 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 125.386 2.517 . . . . 0.97 109.36 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -60.9 116.88 4.8 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 126.345 2.974 . . . . 2.19 109.009 178.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.5 t -139.03 136.37 35.22 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 126.119 2.866 . . . . 1.11 109.64 -173.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.546 ' O ' HG22 ' A' ' 12' ' ' VAL . 27.9 m -93.5 145.22 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 CA-C-O 125.455 2.55 . . . . 1.7 108.215 175.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' H ' ' HD1' ' A' ' 11' ' ' TYR . 8.7 p90 -62.02 80.54 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 126.38 2.991 . . . . 5.54 111.579 -174.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 15' ' ' GLN . 12.2 m -127.86 93.18 40.37 Favored Pre-proline 0 CA--C 1.506 -0.718 0 CA-C-O 126.115 2.864 . . . . 2.45 109.295 174.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.84 -49.94 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.69 0 CA-C-O 126.145 2.477 . . . . 2.35 111.749 177.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.22 -6.7 25.01 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 125.942 2.782 . . . . 2.17 110.91 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 12' ' ' VAL . 28.9 tt0 -138.56 36.64 2.24 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 126.038 2.828 . . . . 3.57 108.839 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 18' ' ' CYS . 24.9 t-20 -57.74 113.8 7.12 Favored Pre-proline 0 CA--C 1.512 -0.515 0 CA-C-O 125.799 2.714 . . . . 1.63 110.574 -177.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -84.35 -8.31 9.7 Favored 'Trans proline' 0 CA--C 1.506 -0.882 0 C-N-CA 123.239 2.626 . . . . 0.94 112.139 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.568 ' HA ' ' CA ' ' A' ' 3' ' ' GLY . 71.3 m -78.99 159.08 27.81 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 125.742 2.686 . . . . 1.03 110.017 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.0 m -71.36 132.21 44.52 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 125.933 2.778 . . . . 1.12 108.139 172.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 20' ' ' ARG . 23.4 mmt180 -56.86 108.61 0.52 Allowed 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 126.346 2.974 . . . . 4.72 110.327 -172.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.16 -19.49 3.65 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 112.68 -2.055 . . . . 0.55 110.995 -175.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.9 mp -105.36 138.38 41.65 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 125.985 2.802 . . . . 1.25 109.562 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 41.1 tt0 -94.04 131.64 39.33 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 125.767 2.699 . . . . 2.84 109.351 -178.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 39.0 t -90.91 111.19 22.52 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 126.04 2.829 . . . . 1.14 108.654 174.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -108.31 152.81 24.13 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 125.324 2.487 . . . . 3.76 108.793 -178.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -46.8 96.35 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 126.082 2.849 . . . . 5.02 110.918 -178.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.34 -49.38 0.89 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.045 -1.889 . . . . 0.43 112.374 178.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -147.96 156.17 42.37 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 126.531 3.062 . . . . 2.2 110.42 -174.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 14.6 t -90.87 147.3 23.25 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 125.29 2.471 . . . . 0.95 107.731 174.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.706 ' HA ' ' HA ' ' A' ' 5' ' ' LEU . 2.8 pp -150.36 161.57 42.22 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 126.03 2.824 . . . . 1.35 110.004 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 5' ' ' LEU . 11.7 m -74.39 115.39 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 126.12 2.867 . . . . 1.54 109.748 179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 44.4 tt0 -78.68 54.2 1.46 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 126.486 3.041 . . . . 2.71 109.695 -175.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG13 ' HB ' ' A' ' 31' ' ' VAL . 32.0 m -95.94 151.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 CA-C-O 125.87 2.747 . . . . 3.48 109.86 -177.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 125.916 2.769 . . . . 2.15 110.443 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t -87.92 125.17 34.35 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 125.92 2.771 . . . . 1.05 108.777 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 18' ' ' CYS . . . -65.73 129.3 33.01 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 113.27 -1.787 . . . . 0.6 111.883 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 29' ' ' CYS . 18.2 pt -112.72 168.5 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-O 126.328 2.966 . . . . 0.75 110.35 -176.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.614 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -59.54 -4.42 0.62 Allowed 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 125.255 2.455 . . . . 1.25 113.119 -171.206 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.91 50.0 1.27 Allowed 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 126.358 2.98 . . . . 1.23 109.57 176.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.01 165.68 14.37 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 125.191 2.424 . . . . 0.97 107.869 172.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 93.6 m-20 -108.42 124.75 50.88 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 125.584 2.611 . . . . 2.19 110.08 -172.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 10.4 p -163.12 156.52 19.54 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 125.903 2.763 . . . . 1.11 110.102 -173.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.68 152.71 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 126.2 2.905 . . . . 1.7 110.195 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.426 ' HD1' ' O ' ' A' ' 24' ' ' CYS . 64.1 t80 -75.69 77.61 2.66 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 126.243 2.925 . . . . 5.54 110.455 -176.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 102.54 35.84 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-O 126.006 2.812 . . . . 2.45 108.09 173.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.1 -52.01 9.76 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.649 2.899 . . . . 2.35 113.644 -172.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -19.37 64.13 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 125.687 2.661 . . . . 2.17 111.439 -176.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.503 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 52.5 tt0 -126.24 36.01 4.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 125.961 2.791 . . . . 3.57 109.886 -177.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -71.59 106.27 1.85 Allowed Pre-proline 0 CA--C 1.511 -0.529 0 CA-C-O 125.796 2.712 . . . . 1.63 108.219 173.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 15' ' ' GLN . 64.1 Cg_endo -80.95 -8.29 13.2 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 123.242 2.628 . . . . 0.94 113.136 -170.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.854 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 71.9 m -78.87 145.13 34.35 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 126.395 2.997 . . . . 1.03 111.074 -171.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.6 m -54.78 139.1 40.67 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 125.294 2.473 . . . . 1.12 109.121 177.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -48.13 108.26 0.16 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 126.488 3.042 . . . . 4.72 110.979 -175.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.31 -20.41 5.88 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 112.656 -2.065 . . . . 0.55 111.318 -176.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.854 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.5 mt -103.19 145.87 29.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 125.667 2.651 . . . . 1.25 109.185 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.27 135.78 37.46 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 125.615 2.626 . . . . 2.84 109.285 -177.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 88.6 m -78.95 129.43 34.48 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 126.447 3.022 . . . . 1.14 111.637 -177.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLY . 7.0 tpp180 -84.1 145.92 28.18 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 105.314 -2.106 . . . . 3.76 105.314 159.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -58.44 81.05 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 126.28 2.943 . . . . 5.02 110.26 -178.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 145.29 -45.68 0.82 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.135 -1.848 . . . . 0.43 111.345 -177.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 8' ' ' ASN . 20.8 ptmt -149.62 148.35 29.22 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.246 2.927 . . . . 2.2 110.758 -176.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 24.0 t -79.83 144.61 33.35 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 125.784 2.707 . . . . 0.95 109.682 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -132.28 160.76 35.27 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 126.128 2.87 . . . . 1.35 110.071 -176.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.85 105.65 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 125.764 2.697 . . . . 1.54 109.189 177.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -80.66 102.24 9.74 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 126.135 2.874 . . . . 2.71 108.547 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.89 67.22 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 126.866 3.222 . . . . 3.48 109.241 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 125.789 2.709 . . . . 2.15 110.565 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 p -68.66 151.45 46.69 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 125.899 2.761 . . . . 1.05 109.583 176.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 18' ' ' CYS . . . -57.09 124.68 36.61 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 113.234 -1.803 . . . . 0.6 112.302 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' ' 7' ' ' ASP . 33.7 pt -93.13 177.65 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 126.327 2.965 . . . . 0.75 110.778 -176.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.15 -18.58 0.6 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 111.993 -2.367 . . . . 1.25 114.013 -167.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.54 48.66 0.88 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 125.927 2.775 . . . . 1.23 110.11 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 4' ' ' ILE . 34.9 t70 -91.79 140.92 29.22 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 125.675 2.655 . . . . 0.97 109.253 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -76.98 125.25 29.0 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 125.833 2.73 . . . . 2.19 109.907 -176.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 21.7 p -175.35 146.1 0.79 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.045 2.831 . . . . 1.11 109.871 -177.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 12' ' ' VAL . 30.4 m -79.09 168.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-O 125.983 2.802 . . . . 1.7 109.749 178.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -77.56 76.52 4.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 126.452 3.025 . . . . 5.54 109.576 -174.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.478 HG13 HG23 ' A' ' 10' ' ' VAL . 9.6 m -120.78 87.68 42.81 Favored Pre-proline 0 CA--C 1.512 -0.512 0 CA-C-O 126.2 2.905 . . . . 2.45 109.622 176.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 16' ' ' ASN . 74.0 Cg_endo -77.56 -30.89 3.67 Favored 'Trans proline' 0 CA--C 1.509 -0.732 0 C-N-CA 122.595 2.196 . . . . 2.35 113.195 -177.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.98 -43.41 66.4 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 126.281 2.943 . . . . 2.17 110.015 -176.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -124.41 58.58 1.2 Allowed 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 126.001 2.81 . . . . 3.57 108.25 173.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.476 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . 11.5 t30 -61.09 109.1 1.82 Allowed Pre-proline 0 CA--C 1.513 -0.474 0 CA-C-O 126.076 2.846 . . . . 1.63 109.92 179.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.38 -7.86 14.99 Favored 'Trans proline' 0 CA--C 1.505 -0.928 0 C-N-CA 123.582 2.855 . . . . 0.94 113.565 -171.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 90.3 m -78.54 155.09 29.9 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 126.076 2.846 . . . . 1.03 110.319 -175.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.3 m -59.65 150.29 27.95 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 125.361 2.505 . . . . 1.12 109.067 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -61.21 99.98 0.11 Allowed 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 126.214 2.911 . . . . 4.72 110.254 -173.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' GLN . . . 130.1 -2.61 5.9 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 112.958 -1.928 . . . . 0.55 111.464 -176.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.6 mt -123.76 151.06 43.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 125.274 2.464 . . . . 1.25 108.668 178.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' OD1' ' A' ' 16' ' ' ASN . 65.6 tt0 -140.66 134.2 30.06 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 125.847 2.737 . . . . 2.84 110.214 -176.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 64.6 m -71.43 118.46 14.27 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 126.182 2.896 . . . . 1.14 110.812 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' GLY . 27.8 tpt180 -93.89 156.55 16.58 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 125.014 2.34 . . . . 3.76 107.093 170.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -52.22 92.92 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 126.187 2.898 . . . . 5.02 110.215 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 124.93 -46.25 1.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 112.952 -1.931 . . . . 0.43 111.975 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -159.3 158.04 31.67 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 126.576 3.084 . . . . 2.2 110.393 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 13.4 t -78.89 142.58 36.67 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 125.79 2.709 . . . . 0.95 109.516 -175.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.1 mt -128.44 159.46 35.33 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 126.26 2.933 . . . . 1.35 109.863 -179.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.43 118.43 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 126.294 2.95 . . . . 1.54 110.419 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 80.1 mt-30 -73.4 82.51 1.43 Allowed 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 125.921 2.772 . . . . 2.71 110.234 177.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.76 61.45 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 126.864 3.221 . . . . 3.48 108.669 172.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 125.641 2.639 . . . . 2.15 110.225 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.63 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 17.3 p -81.13 147.96 29.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 125.831 2.729 . . . . 1.05 109.983 -177.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.654 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -73.01 153.56 48.63 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 113.407 -1.724 . . . . 0.6 111.351 173.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' HB ' HD23 ' A' ' 5' ' ' LEU . 19.9 pt -101.91 172.21 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 126.877 3.227 . . . . 0.75 111.961 -174.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.1 pt? -58.31 -1.34 0.13 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.093 -2.776 . . . . 1.25 113.961 -169.496 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 27.4 p80 -156.3 50.27 0.51 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 126.107 2.86 . . . . 1.23 110.335 176.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 8' ' ' ASN . 5.7 t70 -99.54 -172.25 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 125.351 2.5 . . . . 0.97 109.044 175.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 7.8 t30 -113.32 131.61 55.88 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.477 2.56 . . . . 2.19 109.502 -175.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.783 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 11.5 p -176.77 151.19 0.87 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 126.299 2.952 . . . . 1.11 110.521 -178.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.12 154.98 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 125.737 2.684 . . . . 1.7 108.749 175.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.9 77.68 0.89 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 126.209 2.909 . . . . 5.54 109.795 -178.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 12' ' ' VAL . 7.4 p -126.85 99.05 29.78 Favored Pre-proline 0 CA--C 1.513 -0.459 0 CA-C-O 126.1 2.857 . . . . 2.45 109.023 173.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.83 -40.86 26.42 Favored 'Trans proline' 0 CA--C 1.507 -0.841 0 CA-C-O 125.695 2.29 . . . . 2.35 112.371 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.63 -32.31 63.03 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 125.91 2.767 . . . . 2.17 111.0 -177.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 13.8 mm100 -127.51 48.19 2.27 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 125.708 2.671 . . . . 3.57 110.089 179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -67.6 109.58 4.0 Favored Pre-proline 0 CA--C 1.51 -0.575 0 CA-C-O 125.517 2.579 . . . . 1.63 108.574 172.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 96.9 Cg_endo -79.39 -17.16 11.65 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 CA-C-O 125.847 2.353 . . . . 0.94 112.775 -175.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.654 ' HA ' ' N ' ' A' ' 3' ' ' GLY . 93.6 m -79.97 161.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 126.179 2.895 . . . . 1.03 110.728 -174.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.63 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 1.1 m -61.44 146.8 47.23 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 126.149 2.881 . . . . 1.12 109.432 175.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 20' ' ' ARG . 60.7 mtt180 -67.81 112.67 5.0 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 126.688 3.137 . . . . 4.72 109.777 -174.039 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.57 -7.34 7.91 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 112.14 -2.3 . . . . 0.55 110.74 -172.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 64.8 mt -108.48 144.35 36.22 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.854 2.74 . . . . 1.25 108.947 177.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -112.14 125.7 54.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 126.045 2.831 . . . . 2.84 110.275 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 17' ' ' PRO . 5.2 m -89.29 102.08 14.74 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 125.844 2.735 . . . . 1.14 109.623 173.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.957 ' HD3' HD21 ' A' ' 30' ' ' LEU . 52.7 mtp180 -92.22 168.4 11.37 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 125.297 2.475 . . . . 3.76 108.494 174.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -55.0 90.64 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.238 2.923 . . . . 5.02 110.821 -174.376 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 115.6 -38.69 3.0 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 113.131 -1.85 . . . . 0.43 112.744 176.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -140.15 147.41 40.14 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 126.742 3.163 . . . . 2.2 111.582 -169.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.783 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 37.0 t -94.81 136.65 34.87 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 125.388 2.518 . . . . 0.95 108.036 175.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.957 HD21 ' HD3' ' A' ' 25' ' ' ARG . 2.9 pp -141.64 157.3 45.26 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 125.998 2.808 . . . . 1.35 110.015 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 7.4 p -71.15 121.4 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 126.203 2.906 . . . . 1.54 109.068 178.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -90.11 129.18 36.43 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 126.066 2.841 . . . . 2.71 109.033 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.89 134.02 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 125.941 2.782 . . . . 3.48 109.954 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 125.796 2.713 . . . . 2.15 110.017 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 6.9 p -90.44 152.73 20.84 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 126.119 2.866 . . . . 1.05 110.062 -178.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.448 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -66.35 147.1 49.66 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 112.985 -1.916 . . . . 0.6 112.727 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 pt -127.57 172.69 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 126.039 2.828 . . . . 0.75 110.396 -175.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.52 -0.4 0.92 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 125.401 2.524 . . . . 1.25 112.63 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -140.85 46.42 1.77 Allowed 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 126.597 3.094 . . . . 1.23 109.694 175.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -135.35 129.22 33.08 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 125.473 2.559 . . . . 0.97 108.109 174.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 41.7 m-80 -70.26 148.24 48.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 125.346 2.498 . . . . 2.19 109.677 -177.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' N ' ' HA ' ' A' ' 28' ' ' LYS . 43.0 t -159.68 160.67 34.42 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 126.277 2.941 . . . . 1.11 110.574 -170.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -96.83 152.46 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 CA-C-O 126.226 2.917 . . . . 1.7 109.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -71.76 69.02 0.65 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 126.271 2.939 . . . . 5.54 110.932 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.09 82.56 24.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 126.398 2.999 . . . . 2.45 109.927 177.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.51 -31.84 32.96 Favored 'Trans proline' 0 CA--C 1.506 -0.908 0 C-N-CA 122.881 2.388 . . . . 2.35 112.317 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.08 -37.1 14.37 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 126.022 2.82 . . . . 2.17 111.167 -176.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -141.45 59.32 1.51 Allowed 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 126.283 2.944 . . . . 3.57 108.564 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.03 123.06 78.76 Favored Pre-proline 0 CA--C 1.508 -0.656 0 CA-C-O 126.1 2.857 . . . . 1.63 109.711 175.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 -5.36 16.98 Favored 'Trans proline' 0 CA--C 1.504 -1.021 0 C-N-CA 123.296 2.664 . . . . 0.94 112.549 -176.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 84.5 m -79.09 151.74 31.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 126.353 2.978 . . . . 1.03 110.774 -173.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' HB2' HD23 ' A' ' 22' ' ' LEU . 8.1 m -61.01 144.24 53.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 125.392 2.52 . . . . 1.12 108.868 177.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -55.49 110.79 0.75 Allowed 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.194 2.902 . . . . 4.72 109.506 -179.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.7 -19.89 5.82 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 112.956 -1.929 . . . . 0.55 111.469 -174.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.4 mm? -99.97 166.27 11.13 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 125.751 2.691 . . . . 1.25 109.547 178.003 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -150.75 138.5 19.83 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 125.847 2.737 . . . . 2.84 109.332 177.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 85.0 m -80.12 121.0 25.01 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 126.23 2.919 . . . . 1.14 110.467 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 27' ' ' GLY . 13.0 tpt180 -97.34 158.34 15.51 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 125.088 2.375 . . . . 3.76 107.086 172.117 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -57.24 91.01 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 126.451 3.024 . . . . 5.02 110.069 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' ARG . . . 130.5 -46.0 1.1 Allowed Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 112.389 -2.187 . . . . 0.43 111.948 -179.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' N ' ' A' ' 9' ' ' CYS . 24.5 pttm -160.57 165.78 30.17 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 126.551 3.072 . . . . 2.2 111.182 -174.199 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 22' ' ' LEU . 17.0 t -86.7 134.28 33.61 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 125.908 2.766 . . . . 0.95 109.961 -176.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.78 174.27 10.12 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 125.855 2.74 . . . . 1.35 109.299 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 m -85.35 145.32 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 CA-C-O 126.211 2.91 . . . . 1.54 110.381 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -80.73 94.14 6.32 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 125.833 2.73 . . . . 2.71 108.62 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 t -78.98 75.33 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 126.416 3.008 . . . . 3.48 109.058 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_